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1  Abbreviations and symbols  
 
Abbreviations  
Ca2+ calcium 
CaM calmodulin 
CFP  cyan fluorescent protein 
CNG cyclic nucleotide-gated channel 
CNGB1 cyclic nucleotide-gated channel subunit B1 
EGF epidermal growth factor 
EGFR epidermal growth factor receptor 
Em emission 
ES endolysosomal system 
Ex excitation 
FRET  Förster resonance energy transfer  
GFP green fluorescent protein 
HEK human embryonic kidney  
Kv7.2 voltage-gated potassium channel 7.2  
L-opsin long wavelength opsin 
LDL low density lipoprotein 
mTOR mechanistic target of rapamycin 
mTORC1 mechanistic target of rapamycin complex 1 
NAADP nicotinic acid adenine dinucleotide phosphate 
NAFLD non alcoholic fatty liver disease 
nm nano meter 
OS outer segment 
PDGFR β platelet-derived growth factor receptor β 
PIP2 phosphatidylinositol 4,5-bisphosphate 
PI(3,5)P2 phosphatidylinositol 3,5-bisphosphate 
rAAV recombinant adeno-associated virus 
SE sensitized emission 
S-opsin short wavelength opsin 
SNARE soluble N-ethylmaleimide-sensitive factor attachment receptor  
Stx syntaxin 
Abbreviations and symbols | II	
TEM transmission electron microscopy 
TM transmembrane domain  
TPC two-pore channel 
TRP transient receptor potential 
TRPML mucolipin family of TRP channels 
YFP yellow fluorescent protein 
 
 
Symbols  
𝜀!"!(436) molar extinction coefficient of CFP at 436 nm 
𝜀!"#(436) molar extinction coefficient of YFP at 436 nm  
Ab fraction of acceptor molecules bound by donor 
Afree fraction of unbound acceptor molecules 
CFPEST estimated number of CFP molecules 
CFPFRET (436, 535, direct) fluorescence signal from a CFP molecule acquired through the 
FRET cube 
Db fraction of donor molecules bound by acceptor 
Dfree fraction of unbound donor molecules 
E true or efficient FRET efficiency 
EA apparent FRET efficiency as determined by SE-FRET 
ED apparent FRET efficiency as determined by E-FRET 
EMAX maximal FRET efficiency 
FC measure of sensitized emission 
G calibration constant; ratio between sensitized emission and 
donor dequenching  
Kd,EFF dissociation constant 
MA proportionality constant relating to the acceptor pathway 
MD proportionality constant relating to the donor pathway 
RA1 constant relating to the spectral properties of YFP 
RD1 constant relating to the spectral properties of CFP 
SCFP (D, 436, 480) fluorescence measurement from a donor-only sample acquired 
through the CFP cube 
SCFP (DA, 436, 480) fluorescence measurement from a sample expressing both 
donor and acceptor acquired through the CFP cube 
Abbreviations and symbols | III	
SFRET (A, 436, 535)  fluorescence measurement from an acceptor-only sample 
acquired through the FRET cube 
SFRET (D, 436, 535) fluorescence measurement from a donor-only sample acquired 
through the FRET cube 
SFRET (DA, 436, 535) fluorescence measurement from a sample expressing both 
donor and acceptor acquired through the FRET cube 
SYFP (A, 500, 535) fluorescence measurement from an acceptor-only sample 
acquired through the YFP cube 
SYFP (DA, 500, 535) fluorescence measurement from a sample expressing both 
donor and acceptor acquired through the YFP cube 
YFPEST estimated number of YFP molecules 
YFPFRET (436, 535, direct) fluorescence signal from a YFP molecule acquired through the 
FRET cube 
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3  Summary  
 
The ability of proteins to specifically interact with each other is a key feature in the 
regulation of biological processes. Knowledge about interaction partners and 
characterization of protein-protein interactions contribute to the understanding of proper 
protein function and cell physiology. In particular, Förster resonance energy transfer 
(FRET) is a suitable method to analyze interactions between proteins in living cells.  
In my PhD thesis, I established a quantitative FRET approach that aims to evaluate binding 
curves for interaction partners. Moreover, I applied the quantitative FRET approach to study 
biological questions, including the investigation of putative interaction partners of the 
endolysosomal ion channel two-pore channel 2 (TPC2), the Kv7.2 potassium channel and 
the photoreceptor-specific transmembrane protein peripherin 2. 
Diverse FRET approaches exist to date. However, while most protocols report the FRET 
efficiency to conclude whether or not two partners may interact with each other, the 
application described in manuscript I computes calibrated FRET efficiencies from 
fluorescent measurements using three-filter cubes and correlates the FRET efficiencies to 
the concentration of donor and acceptor molecules to determine binding curves, which bear 
information about maximal FRET efficiencies and relative binding constants for individual 
FRET pairings. Calibration factors that represent the optical properties of the imaging setup 
and the fluorophores are crucial for quantitative measurements. A detailed description how 
to assess these factors is provided. The quantitative FRET approach is very robust as both 
donor-centric (E-FRET) and acceptor-centric (SE-FRET) efficiencies are obtained 
simultaneously from multiple cells.  
The method was further applied to investigate protein-protein interactions of membrane 
proteins.  
First of all, in manuscript II, an epilepsy-causing mutation in the Kv7.2 potassium channel 
was shown to be implicated in a reduced calmodulin binding affinity to the channel, which 
affects channel regulation.  
A second study identified SNARE proteins, such as syntaxin 7 and syntaxin 6, as novel 
interaction partners of the intracellular ion channel TPC2 (manuscript III), revealing TPC2 
as a putative member of the late endosome-lysosome fusion machinery. In manuscript IV, 
the impact of polymorphic variants of TPC2 on channel dimerization and mTOR binding 
was investigated. 
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Furthermore, in a study covered by manuscripts V and VI, rhodopsin as well as S- and  
M-opsins were identified as novel interaction partners of the retinal protein peripherin 2 in 
rods and cones, respectively. The binding domain underlying the interaction between 
peripherin 2 and rhodopsin, could be assigned to the fourth transmembrane domain of 
peripherin 2. Moreover, it could be demonstrated that disease-associated mutations in 
peripherin 2 attenuated this particular binding, suggesting differential pathophysiological 
consequences of disrupted interactions in rods and cones. In manuscript VIII, peripherin 2 
and its homolog Rom-1 were shown to have opposing effects on rod outer segment targeting 
of disease-linked peripherin 2 mutants by evaluating their binding affinities. Peripherin 2 is 
a scaffold protein exclusively expressed in outer segments of rods and cones. As 
photoreceptors are polarized cells, FRET measurements were not only performed on 
transfected HEK293 cells but also on acutely isolated outer segments of virally transduced 
murine photoreceptors (manuscript VII). 
In summary, this thesis provides a general approach to robustly quantify interactions 
between FRET protein pairings and demonstrates that this quantitative FRET approach 
could successfully be applied to study protein-protein interactions in biological contexts. 
More specifically, novel interaction partners of TPC2 and peripherin 2 were identified. In 
addition, disease-associated mutations in peripherin 2 and Kv7.2 were shown to affect 
protein binding affinities.  
The results gained in this thesis demonstrate that protein interactions play a crucial role in 
the regulation of proper protein function. Loss of binding partners or a reduced binding 
affinity to particular proteins may result in pathophysiological conditions. A deeper 
knowledge about molecular interactions will contribute to the understanding of cellular 
mechanisms, etiology of diseases and may further evaluate putative targets of 
pharmacological interest.  
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Zusammenfassung 
 
Eine fundamentale Eigenschaft von Proteinen in der Regulation biologischer Prozesse ist es, 
spezifisch miteinander wechselzuwirken. Kenntnisse über Interaktionspartner und die 
Charakterisierung von Protein-Protein Wechselwirkungen tragen somit zum Verständnis 
von Proteinfunktion und Zellphysiologie bei. Die Förster Energie Resonanztransfer (FRET, 
Förster Resonance Energy Transfer) stellt eine besonders geeignete Anwendung dar, um 
Proteinwechselwirkungen in lebenden Zellen zu untersuchen.  
In der vorliegenden Dissertation, wurde eine quantitative FRET Methode entwickelt, mit 
dem Ziel, Bindungskurven für Proteininteraktionspartner zu erstellen. Darüber hinaus wurde 
die quantitative FRET Methode angewendet, um biologischen Fragestellungen 
nachzugehen. Im Besonderen wurden mögliche Interaktionspartner des endolysosomalen 
Zwei-Poren-Ionenkanals TPC2 (two-pore channel 2), des spannungsaktivierten 
Kaliumkanals Kv7.2 (voltage-gated potassium channel 7.2) und des Photorezeptor-
spezifischen Transmembranproteins Peripherin 2 untersucht.   
Bislang gibt es verschiedene FRET Anwendungen. Während die meisten Anwendungen die 
bloße FRET Effizienz ausgeben, um zu beurteilen, ob Proteine miteinander wechselwirken 
oder nicht, wird in Manuskript I eine Anwendung beschrieben, bei der kalibrierte FRET 
Effizienzen von 3-Filter Fluoreszenzmessungen berechnet werden. Diese FRET Effizienzen 
können mit den Konzentrationen von Donor und Akzeptor Molekülen korreliert werden, um 
Bindungskurven zu erstellen, die Informationen über maximale FRET Effizienzen und 
relative Bindungsaffinitäten einzelner FRET Interaktionspartner enthalten. 
Kalibrationsfaktoren, die optische Eigenschaften des FRET Gerätes und der 
Fluoreszenzproteine enthalten, sind unerlässlich für quantitative Messungen. Eine 
ausführliche Beschreibung wie diese Faktoren bestimmt werden, wird in dieser Arbeit 
geboten. Die quantitative FRET Methode ist sehr robust, da sowohl Donor-bezogene  
(E-FRET) als auch Akzeptor-bezogene (SE-FRET) Effizienzen simultan von mehreren 
Zellen gemessen werden.    
Die Methode wurde des Weiteren angewendet, um Protein-Protein Interaktionen zwischen 
Membranproteinen zu untersuchen. Zunächst konnte in Manuskript II gezeigt werden, dass 
eine Epilepsie verursachende Mutation im Kaliumkanal Kv7.2 eine verminderte 
Calmodulin-Bindung an diesen zur Folge hat, was die Regulation des Kanals beeinträchtigt. 
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In einer zweiten Studie konnten die SNARE Proteine Syntaxin 6 und Syntaxin 7 als direkte 
Interaktionspartner des intrazellulären Ionenkanals TPC2 identifiziert werden 
(Manuskript III). Diesese Ergebnisse legen nahe, dass TPC2 ein Mitglied der 
endolysosomalen Fusionsmachinerie ist. In Manuskript IV wurden die Auswirkungen 
zweier Polymorphismen im TPC2 Ionenkanal auf die Dimerisierung des Kanals sowie auf 
dessen Bindungsaffinität zu mTOR untersucht.  
In einer weiteren Studie, die die Manuskripte V und VI umfasst, wurden sowohl 
Rhodopsin in Stäbchen als auch S- und M-Opsine in Zapfen als neue Interaktionspartner des 
retinalen Proteins Peripherin 2 identifiziert. Als Bindungsdomäne, die der Interaktion 
zwischen Rhodopsin und Peripherin 2 unterliegt, konnte die vierte Transmembrandomäne 
von Peripherin 2 ermittelt werden. Darüber hinaus konnte gezeigt werden, dass 
krankheitsassoziierte Mutationen in Peripherin 2 Wechselwirkungen abschwächen, was 
möglicherweise pathologische Konsequenzen in Stäbchen bzw. Zapfen zur Folge haben 
kann. In Manuskript VIII konnten Peripherin 2 und dem homologen Protein Rom-1 
gegensätzliche Rollen beim Transport von krankheitsassoziierten Peripherin 2 Mutanten in 
die Außensegmente von Stäbchen-Photorezeptoren zugewiesen werden. Peripherin 2 is ein 
„Gerüstprotein“, das einzig in den Außensegmenten von Photorezeptoren vorkommt. 
Photorezeptoren sind polarisierte Zellen. Daher wurden FRET Messungen nicht nur in 
HEK293 Zellen durchgeführt, sondern auch in akut isolierten Außensegmenten von viral 
transduzierten Mausphotorezeptoren (Manuskript VII).  
Zusammenfassend bietet die vorliegende Arbeit eine allgemeine Anwendung, um robuste 
Wechselwirkungen zwischen FRET Proteinpartnern zu charakterisieren. Es konnte 
außerdem gezeigt werden, dass die quantitative FRET Methode erfolgreich angewendet 
werden kann, um Proteinwechselwirkungen im biologischen Kontext zu untersuchen. Neue 
Interaktionspartner von TPC2 und Peripherin 2 konnten identifiziert werden. Des Weiteren, 
konnte gezeigt werden, dass krankheitsassoziierte Mutationen in Peripherin 2 und dem 
Kv7.2 Kanal Proteinbindungen abschwächen.  
Die Ergebnisse dieser Arbeit zeigen, dass Proteininteraktionen eine entscheidende Rolle in 
der Regulation von spezifischen Proteinfunktionen haben. Ein Verlust von 
Bindungspartnern oder eine Reduktion der Bindungsaffinität zu bestimmten Proteinen kann 
möglicherweise pathophysiologische Konsequenzen haben. Ein tieferes Verständnis von 
Interaktionen auf molekularer Ebene wird zur Aufklärung zellulärer Mechanismen und 
Krankheitsursachen führen und wird weiterhin mögliche Ziele von pharmakologischem 
Interesse hervorbringen.  
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4  Introduction 
 
Since its initial description by Theodor Förster in 1948 (Förster, 1948), Förster resonance 
energy transfer (FRET) has become an invaluable tool for the evaluation of molecular 
distance between specific pairs of cellular proteins. Förster proposed that the rate of 
resonance energy transfer depends on the sixth power of the donor-to-acceptor separation 
distance. It is this strong dependence on separation distance that makes FRET imaging 
suitable to detect molecular interactions on a 1 nm – 10 nm scale (Förster, 1948; Stryer and 
Haugland, 1967; Vogel et al., 2006). This resolution is substantially higher than that of 
conventional fluorescence microscopy (Hell, 2006; Lakowicz, 2006).  
Accompanied by the advent of suitable genetically encoded green fluorescent protein (GFP) 
color mutants (Miyawaki et al., 1997; Patterson et al., 2001; Shaner et al., 2005) that can be 
fused to the protein of interest, the FRET methodology has become a widely used tool to 
study protein-protein interactions.  
In the following, I will introduce a novel approach to characterize FRET interactions 
quantitatively. It measures the apparent FRET efficiency and correlates it to the fraction of 
donor and acceptor molecules in a cell. Considering a large cohort of cells with excess 
donor and excess acceptor molecules, respectively, the approach allows to decipher binding 
curves and to robustly quantify the maximal FRET efficiency for a given interaction pair. In 
the end, three projects will be introduced, in which the FRET approach was applied. 
	
4. 1  Principles of SE-FRET and E-FRET  
 
FRET occurs when a donor fluorophore is excited and nonradiatively transfers energy to a 
nearby acceptor molecule (physical principles are nicely summarized in(Clegg, 1992; Jares-
Erijman and Jovin, 2003; Kenworthy, 2001). Three prerequisites concerning fluorescent 
proteins must be fulfilled in order for FRET to occur (Vogel et al., 2006): First, the emission 
spectrum of the donor must overlap the excitation spectrum of the acceptor. A typical pair 
of fluorescent proteins is CFP and YFP or optimized color mutants of those, respectively. 
(Patterson et al., 2001; Patterson et al., 2000). Fluorescence spectra of CFP and YFP are 
illustrated in figure 1. Secondly, the fluorophores need to be located within a distance of 
less than 2 times the Förster distance, typically less than 10 nm. Finally, the emission dipole 
moment of the donor and the excitation dipole moment of the acceptor must be 
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appropriately oriented to each other: FRET declines when the dipole moments are not 
oriented in parallel and eventually becomes zero when the dipole moments are 
perpendicular to each other.  
 
 
 
 
Figure 1 | Excitation (dashed lines) and emission (solid lines) spectra of CFP (cyan) and YFP (green). The 
emission spectrum of CFP overlaps the excitation as well as the emission spectrum of YFP.  
 
 
In the presence of FRET, a characteristic double-peaked spectrum arises from a sample 
expressing both binding partners at the same time (Figure 2A). The energy transfer from 
donor to acceptor is reflected in the decrease of donor emission (‚donor quenching’) as well 
as in an increase of acceptor emission (‚sensitized emission’).  
 
Hence, there are two ways to quantify FRET: For SE-FRET measurements, the increase in 
acceptor emission, e.g. YFP, is quantified. As this approach focusses on changes in acceptor 
emission, it is an acceptor-centric approach. Accordingly, the efficiency of FRET transfer 
can be expressed related to SE. In that case, the apparent FRET efficiency (EA) is given by 
the amount of measured SE in relation to maximal SE that occurs for a FRET efficiency of 
1. Alternatively, the FRET efficiency can be quantified from donor quenching. The apparent 
FRET efficiency (ED) is then given by the ratio of the amount of measured donor quenching 
in relation to the total CFP fluorescence after photobleaching. This approach is termed  
E-FRET, and represents a donor centric approach focusing on the decrease in donor 
emission. 
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Figure 2 | Spectral properties of FRET (A) Shown is the emission spectrum that arises from a specimen, in 
which CFP and YFP are coexpressed, in the presence (black line) and absence (gray line) of FRET. FRET 
results in a decreased donor fluorescence (donor quenching) as well as in an increased acceptor fluorescence 
(sensitized emission). (B) Illustration of components that contribute to the fluorescence signal at 535 nm 
emission. Total emission at 535 nm is composed of direct CFP emission (point 3), direct YFP emission (point 
5) and YFP emission due to FRET (points 4 -5). CFP emission is maximal at 440 nm (point 2). (C) Excitation 
(dashed line) and emission (solid line) spectra of CFP. SCFP and SFRET indicate CFP emission in response to 
excitation at 436 nm when measured through the CFP or FRET cube, resp. (D) Excitation (dashed line) and 
emission (solid line) spectra of YFP. SYFP and SFRET indicate YFP emission measured though the YFP cube 
(excitation at 500 nm) or FRET cube (excitation at 436 nm), resp.. 
 
 
Determination of FRET as „real“ net increase in acceptor fluorescence is considerably 
complicated, as several components contribute to the detectable acceptor emission (Figure 
2B). The emission at 535 nm, the peak of YFP emission (Point 1), is the sum of direct CFP 
emission (donor bleed-through, Point 3) and YFP emission (Point 4), which in turn 
comprises YFP emission due to direct excitation (acceptor cross-excitation, Point 5) and 
YFP emission due to FRET (sensitized emission, Point 4 – 5).  
The fluorescence measurements required for the computation of SE-FRET and E-FRET are 
obtained using three fluorescent filter cubes. Two of the filter sets are optimized to acquire 
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specific donor (CFP cube) or acceptor (YFP cube) emission when illuminated at the peak of 
the respective excitation spectrum. A third cube allows the detection of acceptor’s emission 
following excitation of the donor (FRET cube).  
For the derivations, I will use the following definitions of fluorescence signals: a 
fluorescence signal measured through a particular cube is defined as SCUBE(DA, Ex, Em) 
where „cube“ denotes CFP, YFP or FRET cube; „D“ indicates donor, „A“ acceptor and 
„AD“ denotes both; „Ex“ indicates excitation wavelength, „Em“ denotes emission 
wavelength. A fluorescence signal from a particular CFP or YFP molecule is denoted as 
XFPCUBE(Ex, Em, Direct/ FRET) where „Ex“ indicates excitation wavelength and „Em“ 
represents emission wavelength. „Direct/FRET“ corresponds to the mode of excitation of 
the given molecule.  
The expected donor bleed-through (Figure 2B; Point 3), i.e. the CFP fluorescence in the 
emission channel of the acceptor (535 nm) due to the overlap in the emission spectra of CFP 
and YFP, can be quantified using a predetermined spectral constant RD1 (Figure 2C). This 
constant is derived from cells expressing donor molecules only. 
 
𝑅!! =  
𝐶𝐹𝑃!"#$$#%& !" !"!
𝐶𝐹𝑃!"#$$#%& !" !"# 
 =  
𝑆!"#$  (𝐷, 436, 535)
𝑆!"# (𝐷, 436, 480)
   
 
The ratio of CFP emission at 535 nm and CFP emission at 480 nm is the same in every 
sample that expresses CFP. Hence, the ratio RD1 can be used to optically isolate the pure 
CFP signal at 535 nm in a sample expressing both donor and acceptor when knowing the 
CFP emission at 480 nm.  
Accordingly, donor bleed-through can be quantified by the equation:  
 
𝐶𝐹𝑃!"#! 436, 535,𝑑𝑖𝑟𝑒𝑐𝑡 =  𝑅!!  ∙  𝑆!"#(𝐷𝐴, 436, 480) 
 
Furthermore, excitation at 436 nm light through the FRET cube induces a small fraction of 
YFP emission at 535 nm. Since excitation at 500 nm only excites YFP but not CFP, direct 
YFP excitation can be determined using the YFP cube and a predetermined spectral ratio 
RA1 (Figure 2D), which is measured from cells expressing acceptor molecules only. The 
shape of the emission spectrum is independent of excitation wavelength and intensity: only 
the amplitude of the emission spectrum changes over excitation wavelength (shape 
invariance of emission spectrum) (Lakowicz, 2006). Accordingly, the ratio RA1 is defined as 
the fractional excitation of YFP through the FRET cube relative to the YFP cube:  
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𝑅!! =  
𝑌𝐹𝑃!"#$$#%& !" !"! !"#! !"# !"#$%&%$'( 
𝑌𝐹𝑃!"#$$#%& !" !"! !"#! !"" !"#$%&%$'( 
 =  
𝑆!"#$  (𝐴, 436, 535)
𝑆!"# (𝐴, 500, 535)
   
 
Consequently, the cross-excitation of YFP through the FRET cube in cells expressing both 
YFP and CFP may be revealed by the equation:  
 
𝑌𝐹𝑃!"#$ 436, 535,𝑑𝑖𝑟𝑒𝑐𝑡 =  𝑅!!  ∙  𝑆!"#(𝐷𝐴, 500, 535) 
 
In summary, RD1 and RA1 are determined in cells in which acceptor or donor alone are 
expressed and then applied to transform signals obtained from cells in which a mixture of 
acceptor and donor are expressed. The ratios depend only on the spectral properties of donor 
and acceptor molecules, and are independent of the excitation power, the concentrations of 
donor or acceptor in the field of view and the possibility of binding and FRET between 
donor and acceptor molecules.  
 
Finally, the contribution of sensitized emission of YFP through the FRET cube can be 
calculated as  
 
C FRET D1 CFP A1 YFP(DA,436,535) (DA,436,480) (DA,500,535)F S R S R S= − ⋅ − ⋅  
 
The fluorescence intensities measured with the three cubes contain not only information 
about the amount of FRET in the sample but are also dependent on the instrumentation used 
(filters, objectives, detectors etc.). Thus, the FC signal obtained is not necessarily 
comparable to that gained in experiments performed using other equipment (Vogel et al., 
2006). Hence, the measurement of FC needs to be converted into an universal FRET 
efficiency, which should be the same for a particular sample regardless of the 
instrumentation used. 
To this end, two more instrument-specific calibration constants, i.e. G and 
𝜀!"# (436)/ 𝜀!"# (436), need to be determined from FRET experiments using a set of CFP-
YFP dimers (see below, Figure 4). 𝜀!"# (436)/ 𝜀!"# (436) represents the ratio of acceptor to 
donor fluorescence intensity for equimolar concentrations in the absence of FRET. G is 
defined as the ratio of sensitized acceptor emission to the amount of donor dequenching and 
depends on the spectral properties of the fluorophores as well as the optical components 
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installed in the FRET imaging setup, including excitation light source, filter cubes and 
objective (Figure 3). However, G is constant for a particular fluorophore pair and imaging 
setup (Chen et al., 2006). 
 
The FRET efficiency EA is linearly related to FC and is computed as the ratio of sensitized 
emission (Figure 2B; Point 4) to the emission of YFP due to direct excitation (Figure 2B; 
Point 5), corrected by the calibration constant 𝜀!"# (436)/ 𝜀!"# (436):  
 
C YFP
A b
A1 YFP CFP
(436)
(DA,500,535) (436)
FE E A
R S
ε
ε
= ⋅ =
⋅
 
 
The very same fluorescence intensity measurements can be used to nondestructively 
calculate the net decrease in donor fluorescence due to FRET. As mentioned above, the 
quenching of CFP is expressed as the FRET efficiency ED. ED can be computed from FC and 
the calibration constant G: 
 
C
D b
C D1 CFP (DA,436,480)
FE E D
F G R S
= ⋅ =
+ ⋅ ⋅
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Figure 3 | Schematic illustration of optical components of a typical FRET imaging setup. All essential optical 
components within the excitation pathway (1 – 6a) as well as the emission pathway (6b – 10) are shown. 
Excitation light from a light source (1) passes excitation filters (2 and 3), a dichroic mirror (4) and an objective 
(5) before it excites a fluorescent specimen (6) with a particular excitation spectrum (6a). The emission 
pathway comprises the emission spectrum of the fluorophore (6b), an objective (7), a dichroic mirror (8), an 
emission filter (9) and the detector (10). 
 
 
As mentioned above, G and 𝜀!"# (436)/ 𝜀!"# (436) are determined in experiments using a 
set of dimer constructs, in which CFP and YFP molecules are connected by a linker with 
variable size (Figure 4A). For each dimer construct, CFP and YFP molecules become 
expressed in a strict 1:1 ratio and interact with defined efficiency. Accordingly, sensitized 
emission equals the amount of donor dequenching, i.e. EA equals ED. Equations for EA and 
ED (see previous page) can be combined and a rearrangement yields the following equation: 
 
FC
RA1 ⋅ SYFP(DA,500,535)
= −G
RD1 ⋅ SCFP(DA,436,480)
RA1 ⋅ SYFP(DA,500,535)
+
εCFP(436)
εYFP(436)
 
 
The equation has the form of a straight line, y = mx + b, where x and y can be 
experimentally determined from direct fluorescent measurements (Figure 4B). The y-
intercept of this relation corresponds to the three cube FRET calibration constant 
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𝜀!"# (436)/ 𝜀!"# (436), whereas the slope determines the E-FRET calibration constant G. 
By using a set of dimers with different efficiencies, both calibration constants can be 
reliably calculated.  
Alternatively, both constants can be computed based on the known optical properties of the 
imaging setup, including transmission rates of filter cubes and spectral properties of the 
fluorophores. Both approaches are specified in detail in manuscript I.  
 
 
 
 
Figure 4 | Experimental determination of calibration constants G and 𝜀!"# (436)/ 𝜀!"# (436). (A) Schematic 
illustration of CFP-YFP dimer constructs harboring a defined number of glycines (G) as a linker. The 
individual distance between both fluorophores results in different FRET efficiencies. (B) Each dimer gives rise 
to FC/(RA1 ∙ SYFP) and (RD1 ∙ SCFP) /(RA1 ∙ SYFP) coordinates that can be plotted onto the y-axis and x-axis of the 
graph, resp.. The graph is fitted by a straight line. G can be calculated from the slope of the line, whereas the  
y-intercept yields information about the calibration constant 𝜀!"# (436)/ 𝜀!"# (436). 
 
 
It is important to emphasize that EA and ED depend on the fraction of acceptor molecules 
that are bound to donor molecules (Ab) and the fraction of donor molecules with an 
associated acceptor (Db), respectively. In other words, EA and ED would change with 
different Ab and Db, respectively. The true or genuine FRET efficiency (E) is obtained if Ab 
or Db equals 1 (as it is true for dimers), as given by the following equations: 
 
 
 
This relation can be utilized to calculate binding curves for FRET pairings as outlined in the 
next paragraph.  
 
A b b DE E A E E D E= ⋅ = = ⋅ =
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4. 2  Calculation of binding curves 
 
A very powerful application of quantitative FRET measurements arises from the possibility 
to determine the fraction of bound donor and acceptor molecules within a single cell. The 
measured FRET efficiencies (both EA and ED) obtained from multiple cells can then be 
displayed as a function of the concentration of CFP-tagged or YFP-tagged molecules 
allowing to calculate individual binding curves for putative interaction partners (Ben Johny 
et al., 2013; Erickson et al., 2001; Erickson et al., 2003). 
In order to determine the concentration of donor and acceptor, it is essential to estimate the 
total number of donor (CFPEST) and acceptor (YFPEST) molecules for a given cell from three 
cube FRET measurements. In principle, the concentration is proportional to the total YFP 
and CFP fluorescence corrected for FRET.  
These calculations require two more constants, G and 𝜀!"# (436)/ 𝜀!"# (436) (see paragraph 
4.1). G incorporates information about light attenuation within the acceptor pathway (MA 
constant) as well as within the donor pathway (MD constant) by the equation:  
 
𝐺 =  
𝑀!
𝑀!
 ∙  
𝜀!"# (436)
𝜀!"# (436)
  
 
The ratio MA/MD can be experimentally determined using a set of CFP-YFP dimers as 
shown in figure 4. Alternatively, individual values for both MA and MD can be theoretically 
calculated based on the optical properties of an imaging setup, i.e. transmission rates of 
excitation and emission filter, intensity profile of the lamp, quantum yields and fluorescent 
spectra of the fluorophores.  
Although the ratio MA/ MD, instead of their precise absolute values, is relevant for the 
purpose of obtaining relative binding affinities, it is necessary to look at them individually 
when converting fluorescence measurements into total number of YFP (YFPEST) and CFP 
molecules (CFPEST). The fluorescence signal measured using the YFP cube is free of any 
contribution from CFP. As MA is a measure of the attenuation of brightness of YFP (when 
viewed through the FRET cube), the total number of YFP molecules can be estimated by:  
 
FRET A1 YFP
EST
A A
(436,535,direct) (DA,500,535)YFP R SYFP
M M
⋅
= =  
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It is more complex to estimate the total number of CFP molecules from CFP intensity, as a 
considerable portion of CFP fluorescence is quenched during the FRET measurement. The 
expected CFP intensity after photobleaching can be estimated by dividing the CFP intensity 
measured through the CFP cube before photobleaching by the apparent E-FRET efficiency:  
 
prebleach D1 CFP
postbleach
D D
(436,535,direct) (DA,436,480)(436,535,direct)
1 1
CFP R SCFP
E E
⋅
= =
− −
 
 
In analogy to YFPEST calculation, the total number of CFP molecules in a given cell is 
related to the corrected total CFP intensity in the absence of FRET by the proportionality 
constant MD, thus:  
 
D1 CFP A A1 YFP
EST
D
(DA,436,480) (DA,500,535)R S E R SCFP
M
⋅ + ⋅ ⋅
=  
 
For the evaluation of a binding curve, it is necessary to obtain FRET efficiencies from a 
large cohort of cells expressing the fluorophore-tagged interaction partners with different 
levels of protein expression. The FRET efficiencies EA and ED depend on the fractional 
binding of acceptor and donor, respectively, which differ among individual cells with 
concentrations of the molecules. Thus, each cell gives rise to a single apparent EA and ED 
value (along with individual concentrations of donor and acceptor) and measurements from 
many cells are required to collect data points that populate each segment of a binding curve 
(Figure 5). Although a broad range of donor and acceptor concentrations may result already 
from stochastic expression in a cell population, one can evoke various ratios in CFP to YFP 
expression by adjusting the transfection ratios or by the choice of different promoters 
(Erickson et al., 2003). For binding curves, EA is plotted as a function of free donor 
concentration (Dfree) or ED is plotted as a function of free acceptor concentration (Afree). 
Both Dfree and Afree are computed based on estimates of CFPEST and YFPEST. The binding 
curve is then calculated by imposing a simple binding model and by performing a data 
fitting including all acquired measurements.  
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Figure 5 | Schematic representation of binding curves (A) Putative interaction partners tagged to CFP and 
YFP fluorophores, resp.. (B, C) Binding curves obtained by SE-FRET (B) and E-FRET (C) measurements. 
FRET efficiencies EA and ED are plotted against the fraction of free donor (Dfree) and free acceptor (Afree), 
resp.. One dot represents data obtained from an individual cell. The black line results from curve fitting. 
Binding isotherms reach a saturating plateau with increasing free donor and acceptor concentration that bears 
information about maximal FRET efficiency EMAX. Note that points at low Dfree in panel B correspond to 
points at high Afree in panel C (red circles). Likewise, blue circles in panel B and C correspond to each other.  
 
 
Based on a bimolecular binding reaction where a 1:1 complex is formed,  
 
  
 
the experimentally determined apparent SE-FRET (EA) and E-FRET (ED) efficiencies are 
linked to the free concentrations of donor (Dfree) and acceptors (Afree) by the following 
relations: 
 
	
 
	
 
The maximal efficiency (EMAX) equals the true efficiency (E) and should be, as it is true for 
Kd,EFF, the same for a 1:1 binding interaction, regardless whether resulting from SE-FRET 
or E-FRET calculations (Ben Johny et al., 2016). Accordingly, with CFPEST and YFPEST, 
Afree and Dfree can be computed as follows: 
 
	
free
max max
free d,EFF
A b
DE E A E
D K
= ⋅ = ⋅
+
free
max max
free d,EFF
D b
AE E D E
A K
= ⋅ = ⋅
+
2
EST d,EFF EST EST d,EFF EST d,EFF EST
free
( ) 4
2
YFP K CFP YFP K CFP K CFP
A
− − + − − + ⋅ ⋅
=
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Initially, guessed values for EMAX and Kd,EFF are required to solve this expressions. 
Subsequently, data from various cells are fitted iteratively using a nonlinear least-squares 
regression analysis to estimate Dfree and Afree in individual cells. The parameters EMAX and 
Kd,EFF are then adjusted until the squared errors ((EA, predicted – EA)2 and (ED, predicted – ED)2 ) 
are minimized. 
Figure 5 illustrates typical binding curves resulting from SE-FRET and E-FRET 
measurements. The slope, in particular Kd,EFF, bears information about the relative binding 
affinity between two binding partners, whereas the saturating portion of the curve represents 
EMAX, the true efficiency, which is required to calculate the molecular distance between two 
FRET partners.  
 
 
  
2
EST d,EFF EST EST d,EFF EST d,EFF EST
free
( ) 4
2
CFP K YFP CFP K YFP K YFP
D
− − + − − + ⋅ ⋅
=
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4. 3  Application of FRET to identify intermolecular interaction partners   
 
The method was implemented using Calmodulin (CaM) and two of its known interaction 
partners as model (Figure 6).    
CaM is a small protein that regulates numerous calcium-mediated processes. It has two 
lobes (C- and N-domain), each containing two high affinity calcium-binding sites. Upon 
calcium binding, CaM undergoes a conformational change, which regulates subsequent 
CaM-binding to different target proteins (Chin and Means, 2000). 
 
Initially, the interaction between CaM and Myosin V was investigated (Figure 6A). Myosin 
V is a motor protein that transports cargo in non-muscle cells, such as melanocytes, 
epithelial cells and neurons (Trybus, 2008). As characteristic for myosins, it possesses four 
structural domains, a motor domain containing the actin and ATP-binding site, a lever arm 
that is composed of six CaM-binding motifs (IQ domains), and an alpha-helical rod region 
followed by a globular tail, which is important for cargo binding (Houdusse et al., 2006; 
Trybus, 2008). In the absence of calcium, each IQ motif is bound to an apo-CaM (calcium-
free) molecule (Houdusse et al., 1996), thus stabilizing the motor protein. From structural 
studies it is well known that a single CaM molecule binds to an IQ motif (Houdusse et al., 
2006) resulting in a strict 1:1 binding stoichiometry. Low calcium levels lead to a 
conformational change in CaM accompanied by an activation of myosin, whereas high 
calcium levels inhibit motility and processive movements by dissociating CaM from one or 
more of the IQ domains (Houdusse et al., 2006). 
For FRET measurements, only a fragment of myosin V, a single IQ domain, was used as 
FRET partner (Figure 6A) and measurements were performed under low calcium levels. 
The IQ domain was fused to YFP and coexpressed with CFP tagged CaM in HEK293 cells. 
Figure 6A shows SE-FRET as well as E-FRET binding curves arising from the interaction 
between CaM and IQMYOSINV. Apparent FRET efficiencies EA and ED were plotted as a 
function of the corresponding fraction of free donor and acceptor, respectively. Each gray 
dot represents a single cell. It is important to emphasize that three cube measurements from 
an individual cell were used to calculate both the apparent FRET efficiencies EA (for  
SE-FRET) and ED (for E-FRET). The whole data set was subsequently used to determine a 
binding relation for the FRET partners. 
For a 1:1 binding interaction, the binding relation obtained by SE-FRET equals the one 
obtained by E-FRET (Ben-Johny et al., 2016). Accordingly, the maximal or true FRET 
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efficiency for CaM-CFP and IQMYOSINV-YFP could robustly be quantified from the 
saturating portion of the binding curve and was calculated to be EMAX = 0.21. 
 
 
 
 
Figure 6 | Binding curves arising from CFP-tagged calmodulin (CaM) and YFP-tagged isolated IQ-domain of 
the myosin V neck domain (A) and the voltage-gated Cav1.2 channel (B). In both panels, interaction partners 
are schematically shown on the left, appendant SE-FRET and E-FRET measurements are shown in the middle 
and on the right, resp.. Gray dots represent measurements from individual cells and the black curve indicates 
the binding relation between the interaction partners, as calculated based on the Langmuir relation. Note that 
the same raw data, i.e. fluorescence intensity measurements, were used to calculate SE-FRET (EA) and E-
FRET (ED) efficiencies. Further note, that the fitted binding curve (black curve) obtained by SE-FRET equals 
the one obtained by E-FRET (see manuscript I). 
 
 
Next, the binding between CaM and the IQ domain of the voltage-gated calcium channel 
Cav1.2 was studied (Figure 6B). Cav1.2 is a L-type calcium channel, most important in 
cardiac myocytes and various neuronal cells (Ben-Johny and Yue, 2014; Minor and 
Findeisen, 2010). It possesses an intracellular C-terminal domain consisting of an EF hand 
and an IQ domain. Under calcium free conditions, apo-CaM is associated with the IQ 
domain. Upon calcium binding to CaM, its interaction with the IQ domain gets stronger. 
Elevated intracellular calcium concentrations lead to a conformational change in CaM 
rendering the Cav1.2 channel inactive. This feedback regulation mechanism, called CDI – 
calcium dependent inactivation, is common for various voltage-gated calcium channels 
(reviewed in(Ben-Johny and Yue, 2014). 
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Binding curves resulting from interaction between CaM and IQCAv1.2 are shown in figure 
6B. FRET measurements were done under high intracellular calcium-conditions upon 
application of ionomycin. CaM was tagged to CFP, whereas IQCAv1.2 was fused to YFP. As 
the IQCAv1.2 domain is only a C-terminal fragment of the channel, its expression resulted in a 
cytosolic distribution. CaM and the IQCAv1.2 domain interact in a 1:1 binding stoichiometry 
(Ben Johny et al., 2012). Indeed, the binding relation obtained by SE-FRET equals the one 
obtained by E-FRET and EMAX = 0.35 could be calculated for CaM-CFP and IQCAv1.2-YFP 
(Figure 6B). 
  
In conclusion, the novel FRET approach presented in this thesis can readily be used to 
quantitatively characterize protein interactions. It was consequently applied – with project-
related modifications – in several individual projects, which will be introduced in the 
following sections.  
 
4. 3. 1 An epilepsy-causing mutation in Kv7.2 affects calmodulin binding  
 
Encouraged by the achievements in quantitatively detecting FRET interactions, CaM 
regulation of Kv7.2 potassium channel was further investigated.  
The Kv7.2 channel belongs to the family of Kv voltage-gated potassium channels that 
comprises five members (Kv7.1 – Kv7.5), encoded by the mammalian KCNQ1-5 genes. 
Kv7.1 and Kv7.4 subunits are mainly expressed in the heart and inner ear, respectively, 
whereas Kv7.2, Kv7.3 and Kv7.5 subunits are highly expressed in the brain and peripheral 
nervous system (reviewed in(Brown and Passmore, 2009; Jentsch, 2000). In neurons, Kv7.2 
subunits can homotetramerize or form heterotetramers with Kv7.3 and Kv7.5 subunits 
(Brown and Passmore, 2009). Neuronal Kv channels are especially important in regulating 
the excitability of neurons since they potently suppress repetitive firing of action potentials 
(Brown and Passmore, 2009; Robbins, 2001). Consistent with this, they suppress seizures, 
and dysfunctions of neuronal Kv channels are implicated in various neurological diseases 
such as epilepsy, autism and schizophrenia (Jentsch, 2000) 
The common core structure of Kv channels is composed of six transmembrane segments 
with a voltage-sensing domain (S1-S4), a pore domain (S5-S6) and intracellular N- and C-
terminal regions (Figures 7A, B). The large intracellular C-terminus harbors four helical 
regions (denoted as A-D domains) and is critical for assembly, trafficking and interaction 
with various signaling proteins (Chung, 2014;(Haitin and Attali, 2008). The AB domain is 
  Introduction | 16	
important for channel gating. It binds some lipids and several proteins, including CaM. 
Helix D is suggested to be crucial for oligomerization of the channel subunits, whereas helix 
C is supposed to be a structural linker.  
 
 
 
 
Figure 7 | Identification of an epileptogenic mutation as destabilizer for the calmodulin assembly to the 
voltage-gated potassium channel Kv7.2 (A) Graphical illustration of Kv7.2. The large intracellular C-terminus 
harbors 4 helical regions (denoted as A-D) with distinct functions. (B) Graphical illustration of a calmodulin 
(CaM) bound channel assembly. Note that only two subunits are represented. (C) Three cube FRET 
measurements evaluating the binding between CFP-tagged CaM and schematically indicated YFP-tagged 
truncated proteins. The reported binding between AB and CaM could be confirmed (left, positive control), 
while CD and CaM showed no specific binding (middle left, negative control). The high FRET efficiency 
between ABCD and CaM (middle right) was attenuated upon insertion of an epilepsy-causing mutation 
(L609R) in helix D (right), suggesting a destabilizing effect of L609R on channel oligomerization with 
functional consequences (see manuscript II). 
    
 
In this study, the role of an epileptogenic mutation in the Kv7.2 C-terminal D domain in 
CaM binding was investigated using FRET.  
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To this end, C-terminal fragments containing either the AB domain, CD domain, wildtype 
full length C-terminus or the full length C-terminus bearing an epilepsy-causing L609R 
mutation (Richards et al, 2004) were fused to YFP and the binding to CaM, tagged to CFP, 
for each fragment was investigated in HEK293 cells (Figure 7B). 
CaM binding to the AB domain could be confirmed (Sachyani et al., 2014; Villarroel et al., 
2014), whereas no FRET between CaM and the CD domain occurred. This is in line with 
previous studies that rule out a role for CD helices in CaM binding (Sachyani et al., 2014; 
Yus-Najera et al., 2002). The binding relation obtained for the full length C-terminal 
fragment and its interaction partner CaM was very strong, even stronger than that between 
the single AB domain and CaM. This suggests an enhanced binding affinity mediated by the 
presence of the CD domains and concomitant tetramerization of the channel subunits, 
causing a subsequent clustering of donor and acceptor molecules. The mutation within the D 
domain of the channel destabilized the tetramerization of the channel and resulted in a 
substantial loss of CaM binding affinity.  
These results strongly support the hypothesis that impaired CaM-binding to the channel 
contributes to the pathophysiology in epilepsy. Beside its physiological impact, the study 
validated the application of the FRET approach in a novel study.     
 
4. 3. 2 Two-pore channel 2 and its role in the endolysosomal system  
 
The FRET approach was moreover applied to study putative binding partners of the ion 
channel TPC2. FRET measurements were thereby challenged as the channel is 
intracellularly located within the endolysosomal system (ES). 
 
The ES is specialized for the breakdown of proteins, lipids and other molecules and present 
in all mammalian cells (Figure 8A). The ES comprises intracellular membrane-enclosed 
compartments such as early and late endosomes, recycling endosomes, lysosomes and 
lysosome-related organelles (Grant and Donaldson, 2009; Luzio et al., 2007b; Repnik et al., 
2013). Each organelle is suggested to be a transient, but distinct, compartment that 
elaborates into the next stage by maturation (e.g. early to late endosome) or fusion (e.g. late 
endosome to lysosome). Each stage is thereby characterized by a unique set of biomolecules 
resulting particularly in different pH environments and protein-activity states and, 
accordingly, in diverse organelle-associated functions (Bonifacino and Glick, 2004; Huotari 
and Helenius, 2011; Luzio et al., 2007a; Luzio et al., 2000). The lysosome is the terminal 
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degradation organelle (Xu and Ren, 2015). Moreover, it plays a role in sensing nutrient 
availability and autophagy (Cang et al., 2013; Medina et al., 2015).  
 
 
 
 
Figure 8 | TPC2 and the endolysosomal system (A) The endolysosomal system comprises vesicles such as 
early and late endosomes (EE and LE), recycling endosomes (RE), lysosomes (LY) and lysosome-related 
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(Figure 8 continued) organelles (e.g. autophagosomes (AP)). NU: Nucleus (B) Two-pore channel 2 (TPC2) 
has 12 transmembrane domains and two pore domains on each subunit. Two subunits assemble to build a 
functional channel. (C) Graphical illustration of a fusion event between endolysosomal vesicles. SNARE 
proteins from different membranes assemble upon a local increase in cytosolic calcium concentration. The 
calcium channel which provides calcium has not been identified so far. (D) Under nutrient-rich conditions, 
mTORC1 blocks TPC2 activity by direct interaction. Upon starvation, mTORC1 translocates from the 
lysosome resulting in increased TPC2 activity. (E) FRET measurements evaluating the interaction between 
TPC2 and Stx6 and Stx7, resp. Shown are average Fc values obtained from HEK293 cells overexpressing the 
indicated FRET pairs. (F) Representative binding curve arising from quantitative FRET measurements on 
cerulean-tagged TPC2 and citrine-tagged mTOR. FRET efficiencies (EA) were plotted as a function of the 
corresponding free donor fraction. Clustered values from 3-6 individual cells were binned, gray dots represent 
the average values (± S.E.M.). (Manuscripts III and IV). 
 
 
Two-pore channels (TPCs) have recently emerged as a group of endolysosomal cation 
channels (Grimm et al., 2017; Patel, 2015). Their name refers to two pore domains that are 
found on each subunit (Figure 8B). TPCs belong to the family of transient receptor potential 
(TRP) channels and are distantly related in particular to the mucolipin family of TRP 
channels (TRPML channels). Two TPC members, TPC1 and TPC2, are encoded by the 
human and murine genome. 
Different findings hint at a role for TPC2 in endolysosomal trafficking, in particular 
lysosomal fusion (Grimm et al., 2014; Hockey et al., 2015; Lin-Moshier et al., 2014; Ruas 
et al., 2014). TPC2 is implicated in trafficking defects of the bacterial cholera toxin B (Ruas 
et al., 2010), EGF/EGFR and LDL-cholesterol trafficking (Grimm et al., 2014) as well as 
delayed degradation of platelet-derived growth factor receptor β (PDGFR β) (Ruas et al., 
2014). Similarly, mice lacking both TPCs are resistant to Ebola virus infection, most 
probably due to defective fusion between endosomal membrane and viral membrane 
(Sakurai et al., 2015). Moreover, two independent interactome screens revealed putative 
interaction partners for TPC2 that are involved in intracellular vesicle trafficking and fusion 
processes, such as Rab- and soluble N-ethylmaleimide-sensitive factor attachment receptor 
(SNARE-) proteins (Grimm et al., 2014; Lin-Moshier et al., 2014).  
Rab proteins are important for the initiation of a fusion event. They function as markers for 
membrane identity and recruit SNARE proteins (Jahn et al., 2003). SNARE proteins are the 
engines that drive membrane fusion. Each organelle is outfitted with a unique set of vesicle 
(v-)-SNARES and target (t-)-SNARES. Recruited by Rab proteins, a distinct v-SNARE 
assembles with a unique cognate t-SNARE at the appropriate target membrane (Chen and 
Scheller, 2001; Kummel and Ungermann, 2014). Once the SNARE complex is assembled, it 
generates the energy to overcome the energy barrier of lipid bilayer merging. Both 
homotypic and heterotypic fusion events in the ES require a local increase in cytosolic 
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calcium in order to occur (Luzio et al., 2007a; Pryor et al., 2000). The molecular identity of 
the calcium source remains to be identified (Figure 8C).  
 
As it is true for TPC1, no disease has been associated with a mutation in the TPCN2 gene so 
far. In humans, two TPC2 polymorphisms, namely M484L and G734E, are linked to 
pigmentation variants in hair color (Figure 8B) (Sulem et al., 2008). Recently, a direct role 
for TPC2 in pigmentation has been postulated (Ambrosio et al., 2016; Bellono et al., 2016). 
According to these studies, it is most likely that pH regulation and melanin production in 
melanocytes depend on the activation state of TPC2. TPC2-deficient melanosomes, the 
melanin producing organelles in melanocytes, showed an increase in pH and size, resulting 
most likely in an enhanced tyrosinase activity and increased melanin production. In contrast, 
TPC2 activation or overexpression had the opposite effect. 
The activation mechanism of TPCs remains to be fully elucidated but has been reported to 
involve the second messenger nicotinic acid adenine dinucleotide phosphate (NAADP) and 
the endosomal membrane lipid phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) (Brailoiu 
et al., 2009; Calcraft et al., 2009; Zong et al., 2009). The mechanism underlying NAADP 
activation is currently a matter of debate as NAADP-induced TPC calcium currents are not 
seen consistently (Ruas et al., 2015; Ruas et al., 2010; Wang et al., 2012). NAADP 
activation may be mediated by a yet unknown protein that binds to TPCs in order to open 
the channel (Grimm et al., 2017; Marchant et al., 2012). 
Moreover, mechanistic target of rapamycin (mTOR) (Perl, 2015), part of the mTOR 
complex 1 (mTORC1), has been identified as a mediator that blocks TPC activation after 
ATP stimulation by direct protein-protein interaction (Cang et al., 2013). mTOR is a 
nutrient sensing kinase. Under nutrient-rich conditions, it is recruited to the lysosomal 
membrane, from where it is liberated upon starvation (Figure 8D) (Perl, 2016).     
Polymorphic TPC2 variants in the context of channel gating and pigmentation have not yet 
been characterized.   
 
FRET experiments accompanied two studies dealing with TPC2. First, it was investigated, 
whether TPC2 directly interacts with lysosome-associated SNARE proteins, such as 
syntaxin 6 (Stx6) or Stx7 (Figure 8C, E). Second, dimerization between wildtype TPC2 and 
its polymorphic variants as well as the binding to mTOR was assessed (Figure 8D, F).  
 
  Introduction | 21	
FRET measurements on intracellular organelles are highly complex. The system is three-
dimensional; endolysosomal vesicles are very motile and dynamic and undergo steadily 
homo- and heterotypic fusion events. Since TPC2 resides in diverse endolysosomal 
organelles, its interaction partner can be located on the same membrane structure or on 
different vesicles.  
It is therefore of great importance to choose biological controls considering proteins with a 
similar physiological function and distribution. In case of the first study dealing with TPC2 
and SNARE proteins (Figure 8E) the positive control was Stx7 and Vamp7, two SNARE 
proteins known to reside on the same vesicles and interact with each other (Bogdanovic et 
al., 2002; Pryor et al., 2004), while in the TPC2 polymorphism study, another lysosomal 
transmembrane protein (TMEM192) was used as negative control.  
For the experiment shown in figure 8E, FC values rather than universal FRET efficiency 
(EA) values were calculated, as the set-up specific calibration constants G and 
𝜀!"#(436)/ 𝜀!"#(436) were not yet implemented at that time point. The FC values shown 
represent the average of FC values obtained from multiple cells within a sample. FC values 
(see page 5) are set-up specific. They contain information derived solely from intensity 
measurements without calibration, i.e. consideration of spectral properties of the 
fluorophore and light attenuation. Only when knowing the calibration constants, it is 
possible to determine the fraction of bound donor and bound acceptor molecules, 
respectively, and, accordingly, to determine robust binding curves. It is not ensured that FC 
values represent the maximal FRET efficiency of a binding pair. Or simply said, it is not 
known which point of the binding curve is represented by the FC value. However, it is valid 
to compare   values between samples, provided that the cells were treated in the same way 
and that the expression ratio – ensured by the amount of cDNA transfection – of interaction 
partners (donor and acceptor) is the same in every condition.    
Once the calibration constants G and 𝜀!"# (436)/ 𝜀!"# (436) were determined and the novel 
FRET approach was implemented on the imaging setup, it was possible to calculate binding 
curves from endolysosomal channel proteins as well. Figure 8E shows a representative 
binding curve for wildtype TPC2 and mTOR, where EA is plotted as a function of Dfree. 
Values populate each portion of the binding isotherm. For clarity, values for individual cells 
were binned and only the averaged values for the binned groups of cells are shown. 
However, the binding isotherm was calculated from raw data.     
Data was measured under nutrient-rich conditions, when mTOR is supposed to be 
associated with the lysosomal membrane (Figure 8D).  
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4. 3. 3 Peripherin 2 and its role in photoreceptor outer segments 
 
Furthermore, FRET was used to examine the role of peripherin 2 in photoreceptor outer 
segments (OS) (Figure 9). Peripherin 2 is a photoreceptor-specific scaffold protein located 
in the OS of both rods and cones (Figure 9A-D) (Stuck et al., 2016). The OS of 
photoreceptors are built up as a stack of membrane discs (Figure 9B). In rods, the discs are 
intracellular and thus physically separated from the plasma membrane. In cones, the discs 
are invaginations of the plasma membrane (Mustafi et al., 2009; Sung and Chuang, 2010). 
The region, where the lateral membrane segments of the disc membrane faces the plasma 
membrane is called rim region (Figure 9B, C). Here, the phototransduction cascade is 
anchored. There is evidence that peripherin 2 resides primarily in the rim region and 
structurally stabilizes the phototransduction cascade (Ding et al., 2015). Peripherin 2 plays a 
crucial role in the biogenesis of photoreceptors and is assigned to be important for 
membrane curvature (Arikawa et al., 1992; Ding et al., 2015) and membrane fusion 
(Boesze-Battaglia et al., 1997; Boesze-Battaglia et al., 1998) in photoreceptor disc 
formation. It has been shown that peripherin 2 binds to the beta-subunit of the rod cyclic 
nucleotide gated channel 1 (CNGB1) as well as to both isoforms of the glutamin acid-rich 
protein (GARP) (Poetsch et al., 2001; Ritter et al., 2011) suggesting a stabilizing role in 
connecting the plasma membrane to neighboring rim regions (Stuck et al., 2016). 
Furthermore, its homologue Rom-1 has been identified as an interaction partner (Bascom et 
al., 1992). In cones, however, peripherin 2 does not interact with the CNG channel (Conley 
et al., 2010) pointing to a differential role of peripherin 2 in rods and cones.  
More than 100 disease-causing mutations in the human peripherin 2 gene (PRPH2/RDS) are 
known to date (Boon et al., 2008). The majority of the mutations are point mutations located 
in exon 2, which encodes for a part of a large extracellular/intradiscal loop as well as for a 
part of transmembrane domain 4 (TM4) (Figure 9D). Remarkably, some of the mutations 
lead to defects of rod photoreceptors in the affected individuals whereas others affect cones 
only (Boon et al., 2008; Wells et al., 1993). The molecular mechanisms underlying these 
distinct mutations have not been elucidated so far. 
 
During the progress of this thesis, protein interactions between peripherin 2 and putative 
binding partners, with an emphasis on rhodopsin and cone opsins, were assessed. More 
specifically, the binding affinities of mutant peripherin 2 and the newly identified 
interaction partners were analyzed. In particular, the G266D, P210L and C214S mutations, 
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which are linked to retinitis pigmentosa (Sohocki et al., 2001) and the V268I mutation, 
associated with adult vitelliform macular dystrophy (Felbor et al., 1997) were investigated. 
 
 
 
  
Figure 9 | Peripherin 2 is a scaffold protein in the outer segments (OS) of photoreceptors (A) The retina has a 
laminated structure and contains a variety of cell types. The outermost layer consists of photoreceptors,  
where the phototransduction takes place (Purves, 2001). (B) Rods and cones are highly polarized cells.  
The OS of photoreceptors are built up with a stack of membrane discs. The red boxes indicate the rim region. 
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(Figure 9 continued) (C) Illustration of proteins of the rod phototransduction cascade, including the 
photopigments or opsins (in rods: rhodopsin, in cones: M-opsin and S-opsin). Proteins are located in a disc 
membrane region facing to the plasma membrane, so called rim regions, or in the adjacent plasma membrane. 
(D) Peripherin 2 has four transmembrane domains. Most of disease-causing mutations are located in exon 2, 
which encodes a part of transmembrane 4 and part of the extracellular loop. Known amino acids that are linked 
to disease causing mutations are shown in red. (E, F) Representative binding curves obtained from FRET 
measurements in acutely isolated rod outer segments of retinas co-injected with (E) cerulean (cer)-tagged 
wildtype peripherin 2 (cer-perWT) and citrine (cit)-tagged wildtype peripherin 2 (cit-perWT) or (F) cer-
perWT and cit-tagged mutant peripherin 2 (cit-perC214S). FRET efficiency EA was plotted against the cer/cit 
molar ratio (MR) and a binding isotherme (black line) was iteratively fitted from single data points. Gray dots 
represent mean values of 1-7 single cells (+- S.E.M.).The two displayed binding curves reveal differential 
binding characteristics of corresponding FRET pairs. (Manuscripts V – VIII). 
 
 
Given the postulated highly specialized scaffolding function of peripherin 2 in outer 
segments, it was necessary to perform FRET experiments not only in HEK293 cells but also 
in native outer segments of photoreceptors.  
To this end, an approach was developed, where fluorophore-tagged binding partners were 
virally transduced into the retina of wildtype mice by subretinal injections. The outer 
segments were subsequently purified and FRET was measured ex vivo on either isolated 
cones or rods. This approach preserves not only the native environment of peripherin 2 but 
takes also the distinct protein composition of rods and cones into account.   
For ex vivo experiments, the mouse retina was cotransduced with donor- and acceptor-
tagged interaction partners. Additionally, mice with donor-tagged and acceptor-tagged only 
samples were examined to determine the amount of bleed through of the fluorophores. 
Figure 9 shows representative binding curves obtained on acutely isolated photoreceptors 
for dimerization of wildtype peripherin 2 (Figure 9E) and peripherin 2 and its mutant variant 
C214S (Figure 9F). The FRET efficiency EA is plotted as a function of the molar ratio of the 
fluorescent proteins cerulean/citrine rather than the fraction of free donor molecules. This 
modification was necessary as many endogenously expressed proteins, i.e. unlabeled 
proteins, are present in outer segments. Hence, one can expect a high number of binding 
events between endogenously expressed unlabeled and transduced fluorophore tagged 
molecules. A calculation of the fraction of bound donor and/ or acceptor molecules based on 
fluorescence intensity measurements as outlined in section 4.1 can therefore yield to 
inaccurate values. In vivo transduction efficiencies are usually not as high as transfection 
efficiencies in cultured cells, where the amount of transiently expressed, i.e. fluorophore 
tagged, proteins far exceeds the number of endogenously expressed proteins. The impact of 
binding events between fluorescence-tagged and unlabeled endogenous proteins can be 
neglected in case of transfected cultured cells.   
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Although information about donor and/ or acceptor concentrations is lacking, plotting EA as 
a function of the molar ratio of cerulean/ citrine, i.e. the ratio of cerulean/ CFP and 
citrine/ YFP fluorescence, yields a saturating binding relation, which reveals information 
about relative binding affinities.  
Altogether, protein-protein interactions could robustly be quantified, even in highly 
specialized cell types, such as photoreceptors. 
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5  Aims of the thesis 
 
The objective of the present thesis was to learn more about protein-protein interactions 
using FRET. The focus was thereby on a quantitative FRET method originally developed by 
Erickson et al.. In 2010, the group of David T. Yue provided a nondestructive acceptor-
centric method for detecting the strength of FRET interactions, termed FRET ratio, from 
fluorescent measurements obtained with three filter cubes. They furthermore provided a 
way to calculate the fraction of acceptor molecules bound to donor molecules in a cell.   
However, a methodological approach how to convert FRET ratios into universal FRET 
efficiencies was lacking. Moreover, it was not clarified how to determine the fraction of 
bound acceptor without knowing detailed spectral properties of the particular imaging setup.  
 
Aim 1 can consequently be specified as follows:  
To establish a quantitative FRET approach that allows to determine both acceptor-
centric and donor-centric FRET efficiencies and binding isotherms while including 
control of setup calibration and collisional FRET corrections.  
 
The thesis further aims (Aim 2)  
to uncover molecular interactions in a biological context by applying quantitative 
FRET measurements.  
 
Specifically, the following questions were addressed:  
       
(1) Can the FRET approach established in Aim 1 be validated in a biological context?  
(2) Does an epileptogenic mutation affect the binding of calmodulin to Kv7.2 potassium 
channel? 
(3) Does TPC2 interact with members of the endolysosomal fusion machinery?  
Do polymorphic variants of TPC2 affect binding characteristics as compared to 
wildtype TPC2?  
(4) Does peripherin 2 in rod photoreceptors interact with other proteins of the 
phototransduction cascade except the rod CNGB1 channel subunit? Does peripherin 2 
interact with proteins of the phototransduction cascade in cone photoreceptors?  
Do some disease-associated mutations affect peripherin 2 interactions? 
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6  Short summary of manuscripts  
 
6. 1  Quantifying macromolecular interactions in living cells using 
FRET two-hybrid assays 
 
Elisabeth S. Butz*, Manu Ben-Johny*, Michael Shen, Philemon S. Yang, Lingjie 
Sang, Martin Biel, David T. Yue, Christian Wahl-Schott 
2016, Nature Protocols, 11(12): 2470-2498 
*equal contribution  
 
This manuscript demonstrates a FRET approach to quantitatively assess binding affinities in 
living cells.  
FRET-based assays have been employed to study molecular interactions of a broad range of 
biological molecules including ion channels, G-protein coupled receptors, immunoglobulins 
and cytosolic enzymes. Commonly, it is desired to quantify molecular interactions by 
determining binding constants and true FRET efficiencies for these interactions. However, 
such experiments require quantification of relative concentrations of interacting proteins and 
thus quantitative FRET microscopic approaches.  
In this study, we describe an approach for robust quantification of relative binding affinities 
of protein-protein interactions by measuring FRET efficiency nondestructively. SE-FRET as 
well as E-FRET analysis can be performed on the same set of data, while control 
measurements allow to correct for collisional FRET.     
The protocol includes a detailed step-by-step protocol comprising sample preparation, data 
aquisition and analysis. Furthermore, we outline in-depth how to calibrate the imaging setup 
and control for idiosyncrasies of the optical elements. 
This manuscript is part of a collaboration with the group of Prof. David Yue (Johns Hopkins 
University, Baltimore, United States).  
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6. 2 Uncoupling PIP2-calmodulin regulation of Kv7.2 channels by an 
assembly destabilizing epileptogenic mutation 
 
Araitz Alberdi*, Carolina Gomis-Perez*, Ganeko Bernardo-Seisdedos, Alessandro 
Alaimo, Covadonga Malo, Juncal Aldaregia, Carlos Lopez-Robles, Pilar Areso, 
Elisabeth S. Butz, Christian Wahl-Schott, Alvaro Villarroel 
2015, Journal of Cell Science, 128(21), 4014-4023 
*equal contribution  
 
The publication deals with the calmodulin (CaM) regulation of the Kv7.2 potassium channel 
and shows that the phosphatidylinositol 4,5-bisphosphate (PIP2) dependency of the channel 
is affected by the assembly of distant intracellular channel domains involving different 
CaM-binding modes.  
With quantitative FRET measurements, in particular, we investigated the structural 
assembly of Kv7.2 and its influence on CaM binding. The channel has a large intracellular 
domain, containing four helical regions (A-D) and assembles as a tetramer with a coiled-coil 
formation between the distal D helices. It could be demonstrated that the CaM binding site 
is located within the AB helical regions, as the FRET efficiency between CaM and soluble 
CD fragments was completely lost. However, a disruption of the coiled-coil structure by an 
epilepsy-causing mutation within the D helix (L609R) abolished CaM interaction indicating 
that a coiled-coil formation is essential for CaM regulation of Kv7.2. 
This study is part of a collaboration with Prof. Alvaro Villarroel and his group from 
University of Bilbao, Spain.  
 
 
Declaration of Contribution: All quantitative FRET measurements shown in this paper, 
were conducted on our FRET imaging setup. I supervised Araitz Alberdi during a short term 
stay in our lab and conducted FRET measurements during the revision process of the 
publication. Additionally, I analyzed all FRET experiments.  
Quantitative FRET experiments account for the substantial key statements of this 
publication.  
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6. 3 High susceptibility to fatty liver disease in two-pore channel 2-
deficient mice 
 
Christian Grimm, Lesca M. Holdt*, Cheng-Chang Chen*, Sami Hassan*, Christoph 
Müller, Simone Jörs, Hartmut Cuny, Sandra Kissing, Bernd Schröder, Elisabeth S. 
Butz, Bernd Northoff, Jan Castonguay, Christian A. Luber, Markus Moser, Saskia 
Spahn, Renate Lüllmann-Rauch, Christina Fendel, Norbert Klugbauer, Oliver 
Griesbeck, Albert Haas, Matthias Mann, Franz Bracher, Daniel Teupser, Paul Saftig, 
Martin Biel, Christian Wahl-Schott  
2014, Nature Communications, 5:4699 
*equal contribution  
 
TPC2 is a non-selective cation channel localized to vesicles along the endolysosomal 
pathway, which plays a crucial role in trafficking, breakdown and receptor-mediated 
recycling of macromolecules. In the liver, receptor-mediated uptake of low-density 
lipoproteins (LDLs) and subsequent endolysosomal transport is essential for hepatic 
cholesterol homeostasis and plasma lipoprotein metabolism and dysfunction within this 
pathway results in liver disease such as non-alcoholic fatty liver disease (NAFLD). 
In this publication, we showed that a lack of TPC2 leads to an accumulation of LDL-
cholesterol and EGF/EGF-receptor by conducting trafficking assays in mouse embryonic 
fibroblasts and hepatocytes derived from TPC2-deficient mice. The defects are most likely 
due to a failure in late endosome to lysosome fusion. On systemic level, TPC2-deficient 
mice are more susceptible to hepatic cholesterol overload and liver damage than wildtype 
mice as seen after a Western-type diet rich in cholesterol, which is consistent with NAFLD. 
Our results render TPC2 as a key player for trafficking within the endolysosomal pathway 
that might be involved in the homeostatic control of macromolecules and cell metabolites.  
 
 
Declaration of Contribution: I conducted all FRET measurements and concomitant analysis. 
I designed and engineered cDNA plasmids used in the study.  
Quantitative FRET experiments revealed a direct interaction between TPC2 and Stx7, a 
SNARE protein crucial for homo- & heterotypic lysosomal fusion, indicating TPC2 as the 
putative Ca2+-permeable channel that may provide local calcium for fusion.  	 	
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6. 4 TPC2 polymorphisms associated with a hair pigmentation 
phenotype in humans result in gain of channel function by 
independent mechanisms 
 
Yu-Kai Chao*, Verena Schludi*, Cheng-Chang Chen, Elisabeth S. Butz, O.N. 
Phuong Nguyen, Martin Müller, Jens Krüger, Claudia Kammerbauer, Manu Ben-
Johny, Angelika Vollmar, Carola Berking, Martin Biel, Christian Wahl-Schott, 
Christian Grimm 
2017, accepted in Proceedings of the National Academy of Sciences  
*equal contribution  
 
Two human polymorphisms in the endolysosomal cation channel TPC2 (M484L and 
G734E) are associated with a shift from brown to blond hair color. On cellular level, this is 
most probably due to a regulatory role of TPC2 in pH and size of melanosomes, which 
controls the amount of melanin produced. However, a functional characterization of the 
polymorphic TPC2 variants was lacking.  
In this study, we investigated the polymorphic channel characteristics. Both polymorphisms 
were found to lead to a gain of function by independent mechanisms. Whereas the M484L 
variant leads to an increased basal channel activity, the G734E variant is less prone to ATP 
inhibition.  
Genotyping of more than 100 blond hair and brown/ black haired individuals confirmed that 
wildtype individuals are more brown haired, whereas polymorphic variants were 
predominantly found in blond haired individuals. Finally, in fibroblasts isolated from 
selected donors, the key electrophysiological in vitro findings were successfully validated.  
 
 
Declaration of Contribution: I supervised Verena Schludi in FRET experiments and 
analyzed FRET data.  
FRET experiments were conducted to assess the TPC2 wildtype and polymorphic variant 
dimerization and their binding to mTOR. 
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6. 5 Peripherin-2 couples rhodopsin to the CNG channel in outer 
segments of rod photoreceptors  
 
Elvir Becirovic*, O.N. Phuong Nguyen*, Christos Paparizos, Elisabeth S. Butz, 
Gabi Stern-Schneider, Uwe Wolfrum, Stefanie M. Hauck, Marius Ueffing, Christian 
Wahl-Schott, Stylianos Michalakis, Martin Biel 
2014, Human Molecular Genetics, 23(22), 5989-5997 
*equal contribution  
 
Peripherin 2 is a tetraspanin transmembrane protein localized in the outer segments of 
photoreceptors. Mutations in peripherin 2 in rod photoreceptors are associated with retinitis 
pigmentosa in humans, a degenerative retinal disease eventually leading to blindness.  
In this publication, we unraveled a direct interaction of peripherin 2 with two essential 
proteins of the rod phototransduction cascade, namely CNGB1a, a core subunit of the rod 
cyclic nucleotide-gated (CNG) channel, and rhodopsin, a light-sensitive protein, by 
employing in vivo and in vitro imaging, biochemical and immunoaffinity methods.  
In order to identify components of the CNG channel complex, a preliminary affinity 
purification of mouse retinal proteins was followed by mass spectrometry. In combination 
with FRET measurements and co-immunoprecipitations, we consequently found that 
peripherin 2 links CNGB1a to rhodpsin. Moreover, FRET measurements utilizing C-
terminally truncated peripherin 2 showed that transmembrane domain 4 (TM4) is central to 
the binding of the tetraspanin protein to rhodopsin. Interestingly, a retinitis pigmentosa 
associated mutation (G226D) found within TM4 selectively abolished the binding of 
peripherin 2 to rhodopsin. 
In summary, the study sheds light on the role of peripherin 2 in the phototransduction 
complex and suggests a direct contribution of the protein to the pathophysiology of retinitis 
pigmentosa.  
 
 
Declaration of Contribution: I performed and analyzed all in vitro in in vivo FRET 
measurements in HEK293 cells and in outer segments of native photoreceptors.  
The results gained in the FRET experiments, highlight the physiological role of peripherin 2 
and are central to the study. 	 	
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6. 6  Peripherin-2 differentially interacts with cone opsins in outer 
segments of cone photoreceptors  
 
O.N. Phuong Nguyen, Sybille Böhm, Andreas Gießl, Elisabeth S. Butz, Uwe 
Wolfrum, Johann H. Brandstätter, Christian Wahl-Schott, Martin Biel, Elvir 
Becirovic 
2016, Human Molecular Genetics, 25(12), 2367-2377 
 
 
In Becirovic et al., 2014 (Manuscript V, section. 6.5), we demonstrated a direct interaction 
between peripherin 2 and the rod opsin. However, the role of peripherin 2 in cone outer 
segments remained elusive. 
In this study, we show that peripherin 2 localized in cone outer segments binds to both  
S-opsin and M-opsin with different affinities by using a combination of  
co-immunoprecipitation, quantitative FRET measurements and transmission electron 
microscopy (TEM) based immunolabeling experiments.  
FRET measurements of the respective interactions revealed a reduced binding affinity of 
peripherin 2 to S-opsin compared to its interaction with M-opsin, which could be confirmed 
by subsequent TEM studies. Furthermore, quantitative FRET measurements in acutely 
isolated cone outer segments showed that the cone-degeneration causing V268I mutation in 
peripherin 2 selectively reduced binding to M-opsin without affecting the peripherin 2 
interaction to S-opsin or rhodopsin.  
These results point to a so far unknown role of peripherin 2 in cones and further underline 
the importance of direct interaction between the scaffold protein peripherin 2 and opsins.  
 
 
Declaration of Contribution: I performed all in vitro in in vivo FRET measurements in 
HEK293 cells and in outer segments of native photoreceptors. I supervised Sybille Böhm in 
FRET experiments.   
This publication represents a FRET-based study that reveals novel interaction partners of 
peripherin 2 in cone photoreceptors and examines the effect of peripherin 2 mutations on 
binding affinities.  
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6. 7 AAV Vectors for FRET-based analysis of protein-protein 
interactions in photoreceptor outer segments  
 
Elvir Becirovic, Sybille Böhm, Ong N. P. Nguyen, Lisa M. Riedmayr, Verena 
Hammelmann, Christian Schön, Elisabeth S. Butz, Christian Wahl-Schott, Martin 
Biel, Stylianos Michalakis 
2016, Frontiers in Neuroscience, 10:356 
 
 
The successfully performed ex vivo FRET measurements on acutely isolated OS of 
photoreceptors in manuscripts V (Section 6.5) and VI (Section 6.6) resulted in the 
publication of a methodological paper, which describes for the first time how to combine 
AAV-vector mediated co-delivery of genetically encoded FRET partners in mouse models 
with subsequent quantitative FRET measurements. In this paper, a rapid and robust protocol 
for monitoring protein-protein interactions in acutely isolated photoreceptor OS of both rods 
and cones was established. Using recombinant adeno-associated virus (rAAV)-mediated 
gene transfer, fluorescently labeled FRET partners were delivered to their genuine 
expression locus. Critically, a high co-transduction efficiency is central for the success of 
the experiment. The procedure can be used to analyze protein-protein interactions of wild 
type or mutant OS proteins in their native environment. Moreover, the principal approach  
should be readily be transferable to other cell types.   
 
 
Declaration of Contribution: I performed and analyzed the FRET experiments. In addition, I 
optimized sample preparation for FRET measurements and contributed to writing of the 
manuscript.  
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6. 8 Peripherin-2 and Rom-1 have opposing effects on rod outer segment 
targeting of retinitis pigmentosa-linked peripherin-2 mutants 
 
Sybille Böhm*, Lisa M. Riedmayr*, O.N. Phuong Nguyen, Andreas Gießl, Toni 
Liebscher, Elisabeth S. Butz, Christian Schön, Stylianos Michalakis, Christian 
Wahl-Schott, Martin Biel, Elvir Becirovic 
2017, Scientific Reports, 7(1):2321  
*equal contribution  
 
Peripherin 2 forms homomeric protein complexes as well as heteromeric complexes with its 
homolog Rom-1 in photoreceptor OS. Mutations in the peripherin 2 gene are associated 
with autosomal dominant retinitis pigmentosa (adRP), whereas mutations in  
Rom-1 cause digenic RP only in combination with a heterozygous mutation in peripherin 2. 
Rom-1 is thus suggested to function as genetic modifier that influences disease progression.  
Until now it is not known how the different complexes assembled by various combinations 
of wildtype and mutant peripherin 2 or Rom-1, which can be formed in heterozygous 
patients, result in adRP.  
In this study, two adRP-linked peripherin 2 mutants, namely P210L and C214S, were 
analyzed with regard to binding characteristics, subunit assembly, and rod OS targeting in 
heteromeric complexes containing wildtype, mutant peripherin 2 and/or Rom-1. These 
complexes can be formed in patients heterozygous for peripherin 2 mutations. 
The results show that both mutants are misfolded and mislocalized. Moreover, their binding 
to wildtype peripherin 2 and Rom-1 was strongly decreased. Finaly, both mutants are 
preferentially forming non-covalent dimers with wildtype peripherin 2 and Rom-1. 
However, only complexes containing a wildtype peripherin 2 could be transported to the rod 
OS. Other complexes were retained in the inner segments.   
In conclusion, the study reveals opposing roles of wildtype peripherin 2 and Rom-1 in rod 
OS targeting of adRP-linked peripherin 2 mutants.  
 
 
Declaration of Contribution: I supervised Sybille Böhm in FRET experiments and analyzed 
part of the FRET data.
References | 35	
7  References 
 
	
Ambrosio, A.L., Boyle, J.A., Aradi, A.E., Christian, K.A., and Di Pietro, S.M. (2016). 
TPC2 controls pigmentation by regulating melanosome pH and size. Proc Natl Acad Sci U 
S A 113, 5622-5627. 
Arikawa, K., Molday, L.L., Molday, R.S., and Williams, D.S. (1992). Localization of 
peripherin/rds in the disk membranes of cone and rod photoreceptors: relationship to disk 
membrane morphogenesis and retinal degeneration. J Cell Biol 116, 659-667. 
Bascom, R.A., Manara, S., Collins, L., Molday, R.S., Kalnins, V.I., and McInnes, R.R. 
(1992). Cloning of the cDNA for a novel photoreceptor membrane protein (rom-1) 
identifies a disk rim protein family implicated in human retinopathies. Neuron 8, 1171-
1184. 
Bellono, N.W., Escobar, I.E., and Oancea, E. (2016). A melanosomal two-pore sodium 
channel regulates pigmentation. Sci Rep 6, 26570. 
Ben Johny, M., Yang, P.S., Bazzazi, H., and Yue, D.T. (2013). Dynamic switching of 
calmodulin interactions underlies Ca2+ regulation of CaV1.3 channels. Nat Commun 4, 
1717. 
Ben-Johny, M., Yue, D.N., and Yue, D.T. (2016). Detecting stoichiometry of 
macromolecular complexes in live cells using FRET. Nat Commun 7, 13709. 
Ben-Johny, M., and Yue, D.T. (2014). Calmodulin regulation (calmodulation) of voltage-
gated calcium channels. J Gen Physiol 143, 679-692. 
Boesze-Battaglia, K., Kong, F., Lamba, O.P., Stefano, F.P., and Williams, D.S. (1997). 
Purification and light-dependent phosphorylation of a candidate fusion protein, the 
photoreceptor cell peripherin/rds. Biochemistry 36, 6835-6846. 
Boesze-Battaglia, K., Lamba, O.P., Napoli, A.A., Jr., Sinha, S., and Guo, Y. (1998). Fusion 
between retinal rod outer segment membranes and model membranes: a role for 
photoreceptor peripherin/rds. Biochemistry 37, 9477-9487. 
Bogdanovic, A., Bennett, N., Kieffer, S., Louwagie, M., Morio, T., Garin, J., Satre, M., and 
Bruckert, F. (2002). Syntaxin 7, syntaxin 8, Vti1 and VAMP7 (vesicle-associated membrane 
protein 7) form an active SNARE complex for early macropinocytic compartment fusion in 
Dictyostelium discoideum. Biochem J 368, 29-39. 
Bonifacino, J.S., and Glick, B.S. (2004). The mechanisms of vesicle budding and fusion. 
Cell 116, 153-166. 
References | 36	
Boon, C.J., den Hollander, A.I., Hoyng, C.B., Cremers, F.P., Klevering, B.J., and Keunen, 
J.E. (2008). The spectrum of retinal dystrophies caused by mutations in the peripherin/RDS 
gene. Prog Retin Eye Res 27, 213-235. 
Brailoiu, G.C., Brailoiu, E., Parkesh, R., Galione, A., Churchill, G.C., Patel, S., and Dun, 
N.J. (2009). NAADP-mediated channel 'chatter' in neurons of the rat medulla oblongata. 
Biochem J 419, 91-97, 92 p following 97. 
Brown, D.A., and Passmore, G.M. (2009). Neural KCNQ (Kv7) channels. Br J Pharmacol 
156, 1185-1195. 
Calcraft, P.J., Ruas, M., Pan, Z., Cheng, X., Arredouani, A., Hao, X., Tang, J., Rietdorf, K., 
Teboul, L., Chuang, K.T., et al. (2009). NAADP mobilizes calcium from acidic organelles 
through two-pore channels. Nature 459, 596-600. 
Cang, C., Zhou, Y., Navarro, B., Seo, Y.J., Aranda, K., Shi, L., Battaglia-Hsu, S., Nissim, I., 
Clapham, D.E., and Ren, D. (2013). mTOR regulates lysosomal ATP-sensitive two-pore 
Na(+) channels to adapt to metabolic state. Cell 152, 778-790. 
Chen, H., Puhl, H.L., 3rd, Koushik, S.V., Vogel, S.S., and Ikeda, S.R. (2006). Measurement 
of FRET efficiency and ratio of donor to acceptor concentration in living cells. Biophys J 
91, L39-41. 
Chen, Y.A., and Scheller, R.H. (2001). SNARE-mediated membrane fusion. Nat Rev Mol 
Cell Biol 2, 98-106. 
Chin, D., and Means, A.R. (2000). Calmodulin: a prototypical calcium sensor. Trends Cell 
Biol 10, 322-328. 
Clegg, R.M. (1992). Fluorescence resonance energy transfer and nucleic acids. Methods 
Enzymol 211, 353-388. 
Conley, S.M., Ding, X.Q., and Naash, M.I. (2010). RDS in cones does not interact with the 
beta subunit of the cyclic nucleotide gated channel. Adv Exp Med Biol 664, 63-70. 
Ding, J.D., Salinas, R.Y., and Arshavsky, V.Y. (2015). Discs of mammalian rod 
photoreceptors form through the membrane evagination mechanism. J Cell Biol 211, 495-
502. 
Erickson, M.G., Alseikhan, B.A., Peterson, B.Z., and Yue, D.T. (2001). Preassociation of 
calmodulin with voltage-gated Ca(2+) channels revealed by FRET in single living cells. 
Neuron 31, 973-985. 
Erickson, M.G., Liang, H., Mori, M.X., and Yue, D.T. (2003). FRET two-hybrid mapping 
reveals function and location of L-type Ca2+ channel CaM preassociation. Neuron 39, 97-
107. 
References | 37	
Felbor, U., Schilling, H., and Weber, B.H. (1997). Adult vitelliform macular dystrophy is 
frequently associated with mutations in the peripherin/RDS gene. Hum Mutat 10, 301-309. 
Förster, T. (1948). Intermolecular energy migration and fluorescence. Annalen der Physik 2, 
55-75. 
Grant, B.D., and Donaldson, J.G. (2009). Pathways and mechanisms of endocytic recycling. 
Nat Rev Mol Cell Biol 10, 597-608. 
Grimm, C., Chen, C.C., Wahl-Schott, C., and Biel, M. (2017). Two-Pore Channels: 
Catalyzers of Endolysosomal Transport and Function. Front Pharmacol 8, 45. 
Grimm, C., Holdt, L.M., Chen, C.C., Hassan, S., Muller, C., Jors, S., Cuny, H., Kissing, S., 
Schroder, B., Butz, E., et al. (2014). High susceptibility to fatty liver disease in two-pore 
channel 2-deficient mice. Nat Commun 5, 4699. 
Haitin, Y., and Attali, B. (2008). The C-terminus of Kv7 channels: a multifunctional 
module. J Physiol 586, 1803-1810. 
Hell, S. (2006). Handbook of biological confocal microscopy 3rd edn (New York: Springer 
Science + Buisness). 
Hockey, L.N., Kilpatrick, B.S., Eden, E.R., Lin-Moshier, Y., Brailoiu, G.C., Brailoiu, E., 
Futter, C.E., Schapira, A.H., Marchant, J.S., and Patel, S. (2015). Dysregulation of 
lysosomal morphology by pathogenic LRRK2 is corrected by TPC2 inhibition. J Cell Sci 
128, 232-238. 
Houdusse, A., Gaucher, J.F., Krementsova, E., Mui, S., Trybus, K.M., and Cohen, C. 
(2006). Crystal structure of apo-calmodulin bound to the first two IQ motifs of myosin V 
reveals essential recognition features. Proc Natl Acad Sci U S A 103, 19326-19331. 
Houdusse, A., Silver, M., and Cohen, C. (1996). A model of Ca(2+)-free calmodulin 
binding to unconventional myosins reveals how calmodulin acts as a regulatory switch. 
Structure 4, 1475-1490. 
Huotari, J., and Helenius, A. (2011). Endosome maturation. EMBO J 30, 3481-3500. 
Jahn, R., Lang, T., and Sudhof, T.C. (2003). Membrane fusion. Cell 112, 519-533. 
Jares-Erijman, E.A., and Jovin, T.M. (2003). FRET imaging. Nat Biotechnol 21, 1387-1395. 
Jentsch, T.J. (2000). Neuronal KCNQ potassium channels: physiology and role in disease. 
Nat Rev Neurosci 1, 21-30. 
Kenworthy, A.K. (2001). Imaging protein-protein interactions using fluorescence resonance 
energy transfer microscopy. Methods 24, 289-296. 
References | 38	
Kummel, D., and Ungermann, C. (2014). Principles of membrane tethering and fusion in 
endosome and lysosome biogenesis. Curr Opin Cell Biol 29, 61-66. 
Lakowicz, J.R. (2006). Principles of Fluorescence Spectroscopy (New York: Springer). 
Lin-Moshier, Y., Keebler, M.V., Hooper, R., Boulware, M.J., Liu, X., Churamani, D., 
Abood, M.E., Walseth, T.F., Brailoiu, E., Patel, S., et al. (2014). The Two-pore channel 
(TPC) interactome unmasks isoform-specific roles for TPCs in endolysosomal morphology 
and cell pigmentation. Proc Natl Acad Sci U S A 111, 13087-13092. 
Luzio, J.P., Bright, N.A., and Pryor, P.R. (2007a). The role of calcium and other ions in 
sorting and delivery in the late endocytic pathway. Biochem Soc Trans 35, 1088-1091. 
Luzio, J.P., Pryor, P.R., and Bright, N.A. (2007b). Lysosomes: fusion and function. Nat Rev 
Mol Cell Biol 8, 622-632. 
Luzio, J.P., Rous, B.A., Bright, N.A., Pryor, P.R., Mullock, B.M., and Piper, R.C. (2000). 
Lysosome-endosome fusion and lysosome biogenesis. J Cell Sci 113 ( Pt 9), 1515-1524. 
Marchant, J.S., Lin-Moshier, Y., Walseth, T.F., and Patel, S. (2012). The Molecular Basis 
for Ca2+ Signalling by NAADP: Two-Pore Channels in a Complex? Messenger (Los 
Angel) 1, 63-76. 
Medina, D.L., Di Paola, S., Peluso, I., Armani, A., De Stefani, D., Venditti, R., Montefusco, 
S., Scotto-Rosato, A., Prezioso, C., Forrester, A., et al. (2015). Lysosomal calcium 
signalling regulates autophagy through calcineurin and TFEB. Nat Cell Biol 17, 288-299. 
Minor, D.L., Jr., and Findeisen, F. (2010). Progress in the structural understanding of 
voltage-gated calcium channel (CaV) function and modulation. Channels (Austin) 4, 459-
474. 
Miyawaki, A., Llopis, J., Heim, R., McCaffery, J.M., Adams, J.A., Ikura, M., and Tsien, 
R.Y. (1997). Fluorescent indicators for Ca2+ based on green fluorescent proteins and 
calmodulin. Nature 388, 882-887. 
Mustafi, D., Engel, A.H., and Palczewski, K. (2009). Structure of cone photoreceptors. Prog 
Retin Eye Res 28, 289-302. 
Patel, S. (2015). Function and dysfunction of two-pore channels. Sci Signal 8, re7. 
Patterson, G., Day, R.N., and Piston, D. (2001). Fluorescent protein spectra. J Cell Sci 114, 
837-838. 
Patterson, G.H., Piston, D.W., and Barisas, B.G. (2000). Forster distances between green 
fluorescent protein pairs. Anal Biochem 284, 438-440. 
References | 39	
Perl, A. (2015). mTOR activation is a biomarker and a central pathway to autoimmune 
disorders, cancer, obesity, and aging. Ann N Y Acad Sci 1346, 33-44. 
Perl, A. (2016). Activation of mTOR (mechanistic target of rapamycin) in rheumatic 
diseases. Nat Rev Rheumatol 12, 169-182. 
Poetsch, A., Molday, L.L., and Molday, R.S. (2001). The cGMP-gated channel and related 
glutamic acid-rich proteins interact with peripherin-2 at the rim region of rod photoreceptor 
disc membranes. J Biol Chem 276, 48009-48016. 
Pryor, P.R., Mullock, B.M., Bright, N.A., Gray, S.R., and Luzio, J.P. (2000). The role of 
intraorganellar Ca(2+) in late endosome-lysosome heterotypic fusion and in the reformation 
of lysosomes from hybrid organelles. J Cell Biol 149, 1053-1062. 
Pryor, P.R., Mullock, B.M., Bright, N.A., Lindsay, M.R., Gray, S.R., Richardson, S.C., 
Stewart, A., James, D.E., Piper, R.C., and Luzio, J.P. (2004). Combinatorial SNARE 
complexes with VAMP7 or VAMP8 define different late endocytic fusion events. EMBO 
Rep 5, 590-595. 
Purves (2001). Neuroscience. In Neuroscience, A.G. Purves D, Fitzpatrick D., ed. 
(Sunderland (MA): Sinauer Associates). 
Repnik, U., Cesen, M.H., and Turk, B. (2013). The endolysosomal system in cell death and 
survival. Cold Spring Harb Perspect Biol 5, a008755. 
Ritter, L.M., Khattree, N., Tam, B., Moritz, O.L., Schmitz, F., and Goldberg, A.F. (2011). 
In situ visualization of protein interactions in sensory neurons: glutamic acid-rich proteins 
(GARPs) play differential roles for photoreceptor outer segment scaffolding. J Neurosci 31, 
11231-11243. 
Robbins, J. (2001). KCNQ potassium channels: physiology, pathophysiology, and 
pharmacology. Pharmacol Ther 90, 1-19. 
Ruas, M., Chuang, K.T., Davis, L.C., Al-Douri, A., Tynan, P.W., Tunn, R., Teboul, L., 
Galione, A., and Parrington, J. (2014). TPC1 has two variant isoforms, and their removal 
has different effects on endo-lysosomal functions compared to loss of TPC2. Mol Cell Biol 
34, 3981-3992. 
Ruas, M., Galione, A., and Parrington, J. (2015). Two-Pore Channels: Lessons from Mutant 
Mouse Models. Messenger (Los Angel) 4, 4-22. 
Ruas, M., Rietdorf, K., Arredouani, A., Davis, L.C., Lloyd-Evans, E., Koegel, H., Funnell, 
T.M., Morgan, A.J., Ward, J.A., Watanabe, K., et al. (2010). Purified TPC isoforms form 
NAADP receptors with distinct roles for Ca(2+) signaling and endolysosomal trafficking. 
Curr Biol 20, 703-709. 
Sachyani, D., Dvir, M., Strulovich, R., Tria, G., Tobelaim, W., Peretz, A., Pongs, O., 
Svergun, D., Attali, B., and Hirsch, J.A. (2014). Structural basis of a Kv7.1 potassium 
References | 40	
channel gating module: studies of the intracellular c-terminal domain in complex with 
calmodulin. Structure 22, 1582-1594. 
Sakurai, Y., Kolokoltsov, A.A., Chen, C.C., Tidwell, M.W., Bauta, W.E., Klugbauer, N., 
Grimm, C., Wahl-Schott, C., Biel, M., and Davey, R.A. (2015). Ebola virus. Two-pore 
channels control Ebola virus host cell entry and are drug targets for disease treatment. 
Science 347, 995-998. 
Shaner, N.C., Steinbach, P.A., and Tsien, R.Y. (2005). A guide to choosing fluorescent 
proteins. Nat Methods 2, 905-909. 
Sohocki, M.M., Daiger, S.P., Bowne, S.J., Rodriquez, J.A., Northrup, H., Heckenlively, 
J.R., Birch, D.G., Mintz-Hittner, H., Ruiz, R.S., Lewis, R.A., et al. (2001). Prevalence of 
mutations causing retinitis pigmentosa and other inherited retinopathies. Hum Mutat 17, 42-
51. 
Stryer, L., and Haugland, R.P. (1967). Energy transfer: a spectroscopic ruler. Proc Natl 
Acad Sci U S A 58, 719-726. 
Stuck, M.W., Conley, S.M., and Naash, M.I. (2016). PRPH2/RDS and ROM-1: Historical 
context, current views and future considerations. Prog Retin Eye Res 52, 47-63. 
Sulem, P., Gudbjartsson, D.F., Stacey, S.N., Helgason, A., Rafnar, T., Jakobsdottir, M., 
Steinberg, S., Gudjonsson, S.A., Palsson, A., Thorleifsson, G., et al. (2008). Two newly 
identified genetic determinants of pigmentation in Europeans. Nat Genet 40, 835-837. 
Sung, C.H., and Chuang, J.Z. (2010). The cell biology of vision. J Cell Biol 190, 953-963. 
Trybus, K.M. (2008). Myosin V from head to tail. Cell Mol Life Sci 65, 1378-1389. 
Villarroel, A., Taglialatela, M., Bernardo-Seisdedos, G., Alaimo, A., Agirre, J., Alberdi, A., 
Gomis-Perez, C., Soldovieri, M.V., Ambrosino, P., Malo, C., et al. (2014). The ever 
changing moods of calmodulin: how structural plasticity entails transductional adaptability. 
J Mol Biol 426, 2717-2735. 
Vogel, S.S., Thaler, C., and Koushik, S.V. (2006). Fanciful FRET. Sci STKE 2006, re2. 
Wang, X., Zhang, X., Dong, X.P., Samie, M., Li, X., Cheng, X., Goschka, A., Shen, D., 
Zhou, Y., Harlow, J., et al. (2012). TPC proteins are phosphoinositide- activated sodium-
selective ion channels in endosomes and lysosomes. Cell 151, 372-383. 
Wells, J., Wroblewski, J., Keen, J., Inglehearn, C., Jubb, C., Eckstein, A., Jay, M., Arden, 
G., Bhattacharya, S., Fitzke, F., et al. (1993). Mutations in the human retinal degeneration 
slow (RDS) gene can cause either retinitis pigmentosa or macular dystrophy. Nat Genet 3, 
213-218. 
Xu, H., and Ren, D. (2015). Lysosomal physiology. Annu Rev Physiol 77, 57-80. 
References | 41	
Yus-Najera, E., Santana-Castro, I., and Villarroel, A. (2002). The identification and 
characterization of a noncontinuous calmodulin-binding site in noninactivating voltage-
dependent KCNQ potassium channels. J Biol Chem 277, 28545-28553. 
Zong, X., Schieder, M., Cuny, H., Fenske, S., Gruner, C., Rotzer, K., Griesbeck, O., Harz, 
H., Biel, M., and Wahl-Schott, C. (2009). The two-pore channel TPCN2 mediates NAADP-
dependent Ca(2+)-release from lysosomal stores. Pflugers Arch 458, 891-899. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Publications | 42	
8  Publications 
 
Original Publications  
 
Chen C-C*, Butz ES*, Chao Y-K, Grishchuk Y, Becker L, Heller S, Slaugenhaupt SA, Biel 
M, Wahl-Schott C, Grimm C (2017) Small molecules for early endosome specific patch-
clamping Cell Chem Biol 24(7):907-916.e4 
* Authors contributed equally 
 
Böhm S, Riedmayr LM, Nguyen O.N., Gießl A, Liebscher T, Butz ES, Schön C, 
Michalakis S, Wahl-Schott C, Biel M and Becirovic E (2017) Rom-1 prevents rod outer 
segment targeting of retinitis pigmentosa-linked peripherin-2 mutants. Sci Rep May 
24:7(1):2321. doi: 10.1038/s41598-017-02514-5 
 
Chen C-C*, Cang C*, Fenske S, Butz E, Chao Y-K, Biel M, Ren D, Wahl-Schott C, Grimm 
C (2017) Patch clamp technique to characterize ion channels in enlarged individual 
endolysosomes Nat Protoc 12(8):1639-1658 
 
Butz ES*, Ben-Johny M*, Shen M, Yang PS, Sang L, Biel M, Yue DT, Wahl-Schott C 
(2016) Quantifying macromolecular interactions in living cells using FRET two-hybrid 
assays. Nat Protoc 11(12): 2470-2498 
* Authors contributed equally 
 
Becirovic E., Böhm S., Nguyen O.N., Riedmayr L.M., Hammelmann V., Schön C., 
Butz E.S., Wahl-Schott C., Biel M., Michalakis S. (2016) AAV Vectors for FRET-Based 
analysis of protein-protein interactions in photoreceptor outer segments., Front Neurosci. 
28;10:356. doi: 10.3389/fnins.2016.00356.  
 
Nguyen O.N., Böhm S., Gießl A., Butz E.S., Wolfrum U., Brandstätter J.H., Wahl-Schott 
C., Biel M., Becirovic E. (2016) Peripherin-2 differentially interacts with cone opsins in 
outer segments of cone photoreceptors. Hum Mol Genet. 15;25(12):2367-2377 
 
Alberdi A, Gomis-Perez C, Bernardo-Seisdedos G, Alaimo A, Malo C, Aldaregia J, Lopez-
Robles C, Areso P, Butz E, Wahl-Schott C, Villarroel A. (2015) Uncoupling PIP2-
calmodulin regulation of Kv7.2 channels by an assembly destabilizing epileptogenic 
mutation. J Cell Sci. 2015 Nov 1;128(21):4014-23. doi: 10.1242/jcs.176420.  
 
Butz E., Peichl L., Müller B. (2014) Cone bipolar cells in the retina of the microbat 
Carollia Perspicillata. J Comp Neurol doi: 10.1002/cne.23726  
 
Grimm C., Holdt L.M., Chen C.-C., Hassan S., Müller C., Jörs S., Cuny H., Kissing S., 
Schröder B., Butz E., Northoff B., Castonguay J., Luber C.A., Moser M., Spahn S., 
Publications | 43	
Lüllmann-Rauch R., Fendel C., Klugbauer N., Griesbeck O., Haas A., Mann M., Bracher F., 
Teupser, D., Saftig P., Biel M., Wahl-Schott C. (2014) High susceptibility to fatty liver 
disease in two-pore channel 2-deficient mice, Nature Commun., 5:4699. doi: 
10.1038/ncomms5699  
 
Becirovic E.*, Nguyen ON.*, Paparizos C., Butz E., Stern-Schneider G., Wolfrum U., 
Hauck SM., Ueffing M., Wahl.Schott C., Michalakis S., Biel M. (2014) Peripherin-2 
couples rhodopsin to the CNG channel in outer segments of rod photoreceptors Hum Mol 
Genet 23(22):5989-97. doi: 10.1093/hmg/ddu323  
 
Müller B., Butz E., Peichl L., Haverkamp S. (2013) The rod pathway of the microbat 
retina has bistratified rod bipolar cells and tristratified AII amacrine cells, J Neurosci, 
33(3): 1014-1023; doi: 10.1523/JNEUROSCI.2072-12.2013  
 
Weissbach A., Djarmati A., Klein C., Dragasević N., Zühlke C., Raković A:, Guzvić M., 
Butz E., Tönnies H., Siebert R., Petrović I., Svetel M., Kostić V.S., Lohmann K. (2010) 
Possible genetic heterogeneity of spinocerebellar ataxia linked to chromosome 15 
Movement Disorders 25(11):1577-82 doi: 10.1002/mds.22857  
 
 
Review  
 
Grimm C., Butz E., Chen C.C., Wahl-Schott C., Biel M. (2017) From mucolipidosis type 
IV to Ebola: TRPML and two-pore channels at the crossroads of endo-lysosomal 
trafficking and disease., Cell Calcium Apr 23. pii: S0143-4160(17)30046-5.  
doi: 10.1016/j.ceca.2017.04.003.  
 
 
Submitted manuscripts 
 
Chao Y.K.*, Schludi V.*, Chen C.C., Butz E.S., NguyenO.N.P., Müller M., Krüger J., 
Kammerbauer C., Ben-Johny M., Vollmar A., Berking C., Biel M., Wahl-Schott C., Grimm 
C. (2017) TPC2 polymorphisms associated with a hair pigmentation phenotype in humans 
result in gain of channel function by independent mechanisms., submitted to Proceedings 
to the National Academy of Science (PNAS) 
 
 
Conference participations and Poster  
 
C.C. Chen, E. Butz, E. Plesch, Y.K. Chao, F. Bracher, C. Wahl-Schott, M. Biel, C. Grimm 
Characterization of TRPML3 currents in endolysosomal system CRC/TRR152 
Symposium, 28. Sep. – 1. Oct. 2016,  Herrsching  
 
Publications | 44	
Butz E., Chen C.C., Hassan S., Armandi G., Griesbeck O., Wahl-Schott C., Biel M. 
Neuronal phenotype of TPC2-deficient mice CRC/TRR152 Symposium, 28. – 31. Oct. 
2015,  Herrsching  
 
C. Grimm, E. Butz, C.C. Chen, M. Biel, C. Wahl-Schott High susceptibility to non-
alcoholic fatty liver disease in two-pore channel 2-deficient mice (2940-POS) 
Biophysical Society 59th Annual Meeting, 7. – 11. Feb. 2015, Baltimore 
 
E. Butz, M. Biel, C. Wahl-Schott Quantitative FRET approach to monitor binding 
affinities between ion channesl and its putative interaction partners, Sommer School  
18. – 20. Jul. 2014, Frauenchiemsee 
 
 
 
 
 
Acknowledgement | 45	
9  Acknowledgement 
 
Hiermit möchte ich mich bei allen bedanken, die das Entstehen dieser Doktorarbeit möglich 
gemacht haben. Es war eine sehr prägende und lehrreiche Zeit für mich.  
 
Mein aufrichtigster Dank gilt im Besonderen... 
  
... Prof. Dr. Martin Biel für die Aufnahme in den Arbeitskreis, die andauernde 
Förderung und die finanzielle Unterstützung, die die Verwirklichung vieler Projekte 
erst möglich gemacht hat.  
... Prof. Dr. Christian Wahl für die gute Betreuung, die stete Ermutigung und 
Förderung. Lieber Christian, vielen Dank für das Vertrauen, das Du in mich gesetzt 
hast! 
... Dr. Dr. Christian Grimm für die kontinuierliche wissenschaftliche und 
moralische Unterstützung, die Geduld und gute Zusammenarbeit über das 
Dissertationsthema hinaus. Lieber Christian, es war immer sehr motivierend, mit Dir 
zu arbeiten! 
... Dr. Elvir Becirovic für das Angebot, mich in seine Projekte einzubringen und das 
freundliche Überlassen einzelner Abbildungen. Danke, dass Du mich immer in die 
thematischen Hintergründe einbezogen hast!  
... Dr. Manu Ben Johny für die interessante Zeit an der Johns Hopkins in Baltimore 
und den intensiven wissenschaftlichen Austausch.  
... Dr. Verena Hammelmann für die vielen geduldigen und aufrichtigen Antworten 
auf all meine Fragen.  
... Dr. Cheng-Chang Chen und Yu-Kai Chao für die gute Zusammenarbeit. It was 
a pleasure working with you!   
... Verena Schludi für viele Jahre kollegiale Sitznachbarschaft, unermüdlichen 
Optimismus und gute Laune.  
... meinen treuen Studenten Renè Rötzer, Anna Rößing und Tamara Kiwitt für 
ihre Hilfe, Unterstützung und Motivation in einer für mich sehr stressigen Zeit.  
... den aktuellen wie auch ehemaligen Kollegen des gesamten Arbeitskreises für 
die angenehme Arbeitsatmosphäre, anregende Diskussionen und die 
Hilfsbereitschaft; viele lustige gemeinsame Abende und auch für das ein oder andere 
Gläschen Wein zur richtigen Zeit.   
 
Von ganzem Herzen möchte ich meiner Familie, insbesondere meinen Eltern und 
Geschwistern, für ihre konstante Unterstützung und das große Vertrauen danken, das sie in 
mich setzen. Ohne euren Rückhalt hätte ich so einiges nicht geschafft! 
 
 
 
Appendix | 46	
10  Appendix 
 
In the following, manuscripts I to VIII are reprinted: 
 
 
I. Butz et al., (2016) Quantifying macromolecular interactions in living cells using 
FRET two-hybrid assays, Nature Protocols, 11(12): 2470-2498 
 
II. Alberdi et al., (2015) Uncoupling PIP2-calmodulin regulation of Kv7.2 channels by 
an assembly destabilizing epileptogenic mutation, Journal of Cell Science, 128(21), 
4014-4023 
 
III. Grimm et al., (2014) High susceptibility to fatty liver disease in two-pore channel 2-
deficient mice, Nature Communications, 5:4699 
 
IV. Chao et al., (2017) TPC2 polymorphisms associated with a hair pigmentation 
phenotype in humans result in gain of channel function by independent mechanisms 
2017, accepted in Proceedings of the National Academy of Sciences  
 
V. Becirovic et al., (2014) Peripherin-2 couples rhodopsin to the CNG channel in outer 
segments of rod photoreceptors Human Molecular Genetics, 23(22), 5989-5997 
 
VI. Nguyen et al., (2016) Peripherin-2 differentially interacts with cone opsins in outer 
segments of cone photoreceptors Human Molecular Genetics, 25(12), 2367-2377 
 
VII. Becirovic et al., (2016) AAV vectors for FRET-based analysis of protein-protein 
interactions in photoreceptor outer segments Frontiers in Neuroscience, 10:356 
 
VIII. Böhm et al., (2017) Peripherin-2 and Rom-1 have opposing effects on rod outer 
segment targeting of retinitis pigmentosa-linked peripherin-2 mutants Scientific 
Reports, 7(1):2321  
	
©
20
16
 M
ac
m
ill
an
 P
u
b
lis
h
er
s 
L
im
it
ed
, p
ar
t 
o
f 
S
p
ri
n
g
er
 N
at
u
re
. A
ll 
ri
g
h
ts
 r
es
er
ve
d
.
protocol
2470 | VOL.11 NO.12 | 2016 | nature protocols
IntroDuctIon
FRET is a powerful technique used to probe close-range molecu-
lar interactions and to estimate atomic-scale distances. Physically, 
the FRET phenomenon manifests as a dipole–dipole interaction 
between closely juxtaposed fluorescent molecules. For instance, 
after photoexcitation, a fluorophore may de-excite through direct 
emission of a photon of appropriate wavelength. However, in the 
presence of a nearby acceptor, the donor nonradiatively transfers 
energy to the acceptor molecule, resulting in quenched donor 
fluorescence—a phenomenon termed FRET. The excited acceptor 
molecule may subsequently emit a photon with a shifted spec-
trum. In principle, by monitoring the hue of the emitted photon, 
one can detect a molecular interaction and infer the approximate 
spatial arrangement of the two molecules. The physical principles 
underlying FRET and its application as a spectroscopic ruler have 
been reviewed at length in the past1,2.
With the advent of an expanded color palette of genetically 
encoded fluorophores, the FRET methodology has garnered 
much interest in regard to studying biological systems3. To date, 
several strategies have been used to determine FRET efficiencies 
nondestructively4–10. Traditional approaches such as acceptor 
photobleaching quantify the donor fluorescence before and 
after photodestruction of the acceptor. This approach requires 
the sample to be exposed to high-intensity light, often resulting 
in cellular phototoxicity. The destructive nature of this popular 
approach means that only a single FRET measurement can be 
attained. Nondestructive assays assess FRET efficiency from brief 
low-intensity light pulses, enabling rapid and dynamic measure-
ments with relatively minimal photodamage.
Development of the protocol
The FRET two-hybrid assay is a valuable method for detecting 
and quantifying binding interactions between biological mac-
romolecules in living cells. A single cell is considered to be a 
‘biological cuvette’, and FRET efficiency is systematically meas-
ured between pairs of fluorophore-tagged molecules from many 
single cells for quantitative determination of bimolecular interac-
tions. The protocol presented here provides the theoretical and 
experimental framework to integrate two existing FRET two-
hybrid approaches: 33-FRET and E-FRET. This analysis enables 
microscope-dependent calibration constants to be experimentally 
determined, apparent donor- and acceptor-centric FRET efficien-
cies to be computed, and robust, reproducible binding curves of 
high quality to be obtained—permitting rigorous biochemical 
analysis in living cells.
The methodology and formalism elaborated here is built upon 
work by Erickson et al. that was first applied to characterize the 
interaction of the Ca2+-binding protein calmodulin with the 
L-type Ca2+ channel complex9,10. In this experimental paradigm, 
fluorescence measurements are obtained from three distinct 
filter cubes. The filters are chosen to specifically detect donor, 
acceptor and FRET signals. The use of three filter cubes allows 
for accurate dissection of the FRET signal from pure donor and 
acceptor signals, leading to its name 33-FRET. The ‘sensitized 
emission’ or the net increase in acceptor fluorescence due to FRET 
is computed from these measurements. Importantly, this metric 
corresponds to an acceptor-centric measurement of FRET, and 
the efficiencies computed are reported as ‘EA’. The very same 
measurements can be used to nondestructively calculate the net 
decrease in donor fluorescence due to FRET. This metric corre-
sponds to FRET efficiencies obtained using donor dequenching 
or acceptor photobleaching methods. This methodology is termed 
‘E-FRET’ and corresponds to a donor-centric FRET measurement 
denoted here as ‘ED’. Experimental determination of both 33-FRET 
and E-FRET efficiency measurements rely on two instrument- 
specific constants that need to be either computed based on 
the optical properties of the imaging system (Supplementary 
Note 1, Supplementary Data 1) or experimentally determined 
using a series of cyan fluorescent protein–yellow fluorescent pro-
tein (CFP–YFP) dimers (‘Determination of calibration constants 
using dimers’ section).
Quantifying macromolecular interactions in living 
cells using FRET two-hybrid assays
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Förster resonance energy transfer (Fret) is a versatile method for analyzing protein–protein interactions within living cells. this 
protocol describes a nondestructive live-cell Fret assay for robust quantification of relative binding affinities for protein–protein 
interactions. unlike other approaches, our method correlates the measured Fret efficiencies to relative concentration of interacting 
proteins to determine binding isotherms while including collisional Fret corrections. We detail how to assemble and calibrate the 
equipment using experimental and theoretical procedures. a step-by-step protocol is given for sample preparation, data acquisition 
and analysis. the method uses relatively inexpensive and widely available equipment and can be performed with minimal training. 
Implementation of the imaging setup requires up to 1 week, and sample preparation takes ~1–3 d. an individual Fret experiment, 
including control measurements, can be completed within 4–6 h, with data analysis requiring an additional 1–3 h. 
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Once 33-FRET or E-FRET efficiencies are determined, the FRET 
two-hybrid assay correlates these efficiencies with the free con-
centrations of donor or acceptor molecules, respectively. The first 
important step in the workflow is the experimental determination 
of the total number of donor and acceptor proteins present in 
any given cell based on the total YFP and CFP fluorescence cor-
rected for quenching due to FRET. Data from many single cells 
are then compiled to construct a single binding curve. In practice, 
the stochastic expression of CFP and YFP molecules in cells yields 
a broad range of free donor or acceptor concentrations, and each 
cell populates various segments of a binding curve.
Theoretical underpinnings of the FRET two-hybrid assay
For the illustrative experiments described in this protocol, the 
FRET measurement setup (Fig. 1) is composed of a wide-field 
fluorescence microscope, a xenon-lamp-based excitation system, 
a motorized turret containing three filter cubes and a photomulti-
plier-based detection system (Figs. 1 and 2). Any donor–acceptor 
fluorescent protein pairs that are suitable for FRET measure-
ments, together with matched filter cubes, can be used for these 
experiments11. We will describe the method for the enhanced 
CFP–enhanced YFP (CFP–YFP) donor–acceptor pair, which is a 
popular choice for FRET. Three filter cubes are required: a CFP 
cube, a FRET cube and a YFP cube (Table 1). As the venus–cerulean 
FRET pairs are highly similar to CFP–YFP pairs, the same filter 
cubes can be used, although the instrument-specific calibration 
constants should be explicitly measured for these pairs, given their 
distinct quantum yields.
For typical FRET experiments, proteins of interest are fused to 
either CFP or YFP, and expressed pairwise in mammalian HEK293 
cells. Fluorescence signal from each cell is analyzed using three 
filter cubes (Table 1) to compute apparent FRET efficiencies. 
Illumination of the sample at the peak of the donor excitation 
spectrum (λ ~ 436 nm) results in a double-peaked spectrum com-
posed of CFP emission superimposed on YFP emission. In part, 
the net YFP fluorescence is the result of weak direct excitation 
by the 436-nm light (~1–3%). In addition, with FRET, CFP 
transfers energy to YFP, resulting in quenching of the CFP fluo-
rescence (observed at ~480 nm) and an enhancement in the 
YFP fluorescence detected at ~535 nm (ref. 12). FRET can be 
measured either as the fractional increase in the acceptor inten-
sity (‘sensitized emission’) or as the fractional decrease in the 
donor intensity (‘donor quenching’) (Fig. 3a). In the first case, 
the apparent FRET efficiency (EA), is given by the amount of 
measured sensitized emission in relation to maximal sensi-
tized emission that would be present for a FRET efficiency of 1. 
Alternatively, FRET can be measured using donor dequenching, 
in which case the apparent FRET efficiency (ED), will be the ratio 
of the enhancement in CFP fluorescence acceptor photobleach-
ing to the total CFP fluorescence after photobleaching (Fig. 3b). 
In this protocol, we use a nondestructive approach to determine 
ED that uses an experimentally determined calibration constant 
(G factor) that relates the enhancement in YFP fluorescence to 
the decrease in CFP fluorescence (Fig. 3). In this protocol, we 
follow the mathematical conventions defined in Erickson et al.9, 
and the fluorescence signal measured through a particular cube is 
defined as Scube(DA, λex, λem), where cube denotes a CFP, YFP or 
FRET cube; D denotes donor, A denotes acceptor and DA denotes 
both; λex denotes excitation wavelength; and λem denotes emis-
sion wavelength. In addition, fluorescence signal from a particular 
CFP or YFP molecule may be represented as XFPcube(λex, λem, 
direct/FRET) when measured with excitation light of wavelength 
λex, emission of wavelength λem. direct/FRET corresponds to the 
mode of excitation of the given molecule9,10.
Determination of spectral factors RD1, RD2 and RA1. Calculation 
of EA and ED requires robust dissection of sensitized emission 
(Fig. 4). This determination is complicated by spectral overlap 
between donors (CFP) and acceptors (YFP) resulting from their 
broad excitation and emission spectra. Three confounding factors 
may obfuscate computation of FRET efficiencies (Fig. 2). First, 
the overlap in the emission spectra of CFP and YFP could lead 
Filter cube turret
Viewing eyepiece
PMT detector
PMT housing
Oculars
Arc lamp
DeltaRam
4 Knobs to control aperture size
Measure/view knob
Electronic box
Arc lamp
a
DeltaRam
b
Figure 1 | Equipment setup for FRET imaging. (a) Photograph of the FRET setup comprising an inverted microscope and a photomultiplier detection system 
(PMT detector and PMT housing). The PMT housing contains an eyepiece and four knobs to control the aperture size. The measure/view knob is set to direct 
the light to either the eyepiece for visualization or the PMT for data acquisition. All major components are indicated. Note that the CCD camera connected to 
our microscope is not necessary to perform the FRET two-hybrid assays described here. (b) For excitation, a DeltaRam monochromator containing a xenon arc 
lamp is used; the one shown has knobs to adjust the slit width for excitation light. 
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to a small bleed-through of CFP fluorescence in the FRET cube 
(emission~535 nm). The expected bleed-through can be quanti-
fied from cells expressing CFP alone at the peak of their absorp-
tion spectrum (~436 nm) and computing the fractional emission 
through the FRET cube—RD1 = SFRET(D, 436, 535)/SCFP(D, 
436, 480). This strategy is effective, as CFP fluorescence can 
be isolated from cells expressing both CFP and YFP, using the 
CFP cube. The effective CFP fluorescence bleed-through in 
the FRET cube is then 
CFP R S DADFRET direct  ( , , ) ( , , ) ( )436 535 436 480 11= ⋅ CFP
RD1 ~ 0.25 for our experimental setup. RD1 values are typically 
stable, as they probe the emission properties of CFP, and dras-
tic changes in these values may signify changes in the detection 
subsystem such as diminished detector sensitivity or aging of 
emission filters.
Second, a small fraction of YFP is cross-excited by the 436-
nm light through the FRET cube. The direct YFP signal can 
be optically isolated using the YFP cube with negligible CFP 
excitation (Fig. 4). The ratio RA1 is defined as the fractional 
excitation of YFP through the FRET cube relative to the YFP 
cube—RA1 = SFRET(A, 436, 535)/SYFP(A, 500, 535). The cross-
excitation of YFP through the FRET cube in cells expressing both 
YFP and CFP can be unmixed by computing: 
YFP R S DAFRET A1 YFPdirect( , , ) ( , , ) ( )436 535 500 535 2= ⋅
RA1 ~ 0.03 for our experimental setup. Experimentally, some day-
to-day variability in RA1 values is observed due to changes in 
xenon arc lamp spectra or the excitation subsystem.
(1)
(2)
Third, a small fraction of CFP molecules may be directly excited 
through the YFP cube, leading to overestimation of the total YFP 
signal, YFPYFP(500, 535, direct). RD2 is the ratio of CFP fluores-
cence output through the YFP cube relative to the CFP cube: 
R S D S DD2 YFP = ( , , )/ ( , , ) ( )500 535 436 480 3CFP
The corrupting CFP signal through the YFP cube is then: 
CFP direct S DAYFP D2 CFP( , , ) ( , , ) ( )500 535 436 480 4= ⋅R
In practice, the ratio RD2 is negligibly small (~0.009 for our exper-
imental setup). This factor can be a concern in cells in which CFP 
values far exceed YFP values. FRET efficiency estimation is prone 
to substantial errors in this case.
In summary, RD1 and RA1 are determined in cells in which 
acceptor or donor alone are individually expressed and then 
applied to transform signals from different cells containing both 
acceptors and donors. Critically, these ratios are independent of 
the excitation intensity (I0) and the number of donors (ND) or 
acceptors (NA) in the field of view; instead, they depend only 
on the spectral properties of the donor or acceptor, respectively 
(Fig. 4). These ratios can be used to optimize or troubleshoot 
the FRET experimental setup while establishing the method and 
testing associated hardware components.
Determination of FRET efficiencies. Once spectral ratios are 
determined, EA and ED can be calculated based on the fluo-
rescence measurements from the CFP, YFP and FRET cubes 
according to equations (5–7) in Box 1 (Supplementary Note 2). 
(3)
(4)
A
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ra
350 500 650
Wavelength (nm)
(6a) Fluorophore excitation 
(6b) Fluorophore emission 
(6) Cell
(10) Detector
(3) Excitation filter
(1) Light source
(1) (6a) (2–5) (6a) (7–10)
N • I0  (�) • [ �XFP(�) ] �min  ≤ �  ≤ �max • QYXFP  • [ ƒXFP(�)] �min  ≤ � ≤ �max
• QY
CFP • [ ƒCFP(�)]520 nm < � < 550 nm
• QY
YFP 
• [ ƒYFP(�)]520 nm < � < 550 nm
F(480)ˆG(436)
MD = [�CFP(�) ]426 nm < � < 446 nm
MA = [�YFP(�) ]426 nm < � < 446 nm
ba
(5) Objective
(4) Dichroic
mirror
(7) Objective
(8) Dichroic
     mirror
(9) Emission
      filter
(2) Additional
     excitation filter
           
Figure 2 | Schematic of optical components of the FRET setup for a given filter cube and fluorophore. (a) The excitation pathway (1–6a) consists of the light 
source (1), excitation filters (2 and 3), a dichroic mirror that reflects the excitation light (4), a 40× objective (5) and the excitation spectrum of the fluorophore 
contained in a cell (6, 6a). The emission pathway (6b–9) consists of the emission spectrum and the quantum yield (QY) of the fluorophore expressed in the 
cell (6b), the objective (7), the dichroic that transmits the emission light (8), the emission filter (9) and the detector (10). (b) Top: Fluorescence intensity 
output can be calculated from setup-specific optical components in the excitation (1–6a) and emission pathways (6b–9) by multiplying together all relevant 
parameters: XFP is the fluorophore in question. N is the number of fluorophores excited, I0 represents the overall intensity of the excitation lamp (over all 
wavelengths) and εXFP(λ) represents the wavelength-dependent absorption properties of the fluorophore as given by the excitation spectrum of the fluorophore. 
The optical properties of the excitation pathway, such as the spectral properties of the excitation light source and the spectral properties of the excitation  
filter and dichroic mirror of the cube, are incorporated into the wavelength range depicted. fXFP(λ) and QYXFP correspond to the emission spectrum and QY of the 
fluorophore. The spectral properties of the dichroic mirror and the emission filter of the FRET filter cube, as well as frequency-dependent sensitivity of the PMT 
detector, are incorporated into the wavelength range shown. MD and MA correspond to the brightness of a single donor and acceptor fluorophore.
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The graphical interpretation of this computation is shown in 
Figure 4a. Sensitized emission of YFP is calculated by realizing 
that emission at 535 nm (Fig. 4a, point 1) is the sum of direct 
CFP emission (donor bleed-through; Fig. 4a, point 3), YFP emis-
sion due to direct excitation (acceptor cross-excitation; Fig. 4a, 
point 5) and YFP emission due to FRET excitation (FC; Fig. 4a, 
points 4 and 5). The contribution of direct CFP emission at 535 
nm (Fig. 4a, point 3) is computed based on CFP measurement 
using the CFP cube (Fig. 4a, point 2) and the spectral ratio RD1. 
The contribution of YFP emission due to direct excitation (Fig. 4a, 
point 5) is determined based on YFP cube measurement (Fig. 4d) 
and the spectral ratio RA1. The 33-FRET efficiency EA is computed 
as the ratio of sensitized emission (Fig. 4a, points 4 and 5) to the 
emission of YFP due to direct excitation (Fig. 4a, point 5), cor-
rected by a calibration constant that represents the ratio of extinc-
tion coefficients (Box 1). This latter factor (RA1 · SYFP(DA, 500, 
535) · εCFP(436)/εYFP(436)) is the maximal sensitized emission of 
YFP observable if EA = 1. By contrast, the E-FRET computation 
converts the sensitized emission of YFP (FC; Fig. 4a, points 4 and 
5) to an equivalent quenching of CFP fluorescence due to FRET 
by the calibration constant G. E-FRET reports the ratio of the CFP 
quenching to total CFP output in the absence of FRET.
An important distinction is that EA and ED depend on the 
bound fraction of the donor (Ab) and acceptor (Db), respectively. 
As Ab or Db approaches 1, the apparent efficiency equals true 
efficiency (E). We will use a quantitative description of the total 
number of CFP and YFP molecules in a cell along with a 1:1 bind-
ing model to calculate Db or Ab and to resolve a binding relation. 
The following section will define and outline the experimental 
strategy for determination of the instrument-specific calibration 
constants εYFP(436)/εCFP(436) and G.
Determination of calibration constants for 33-FRET and E-
FRET. The instrument-specific calibration constants (εYFP(436)/
εCFP(436) and G) can either be computed by analysis of the optical 
properties of the FRET experimental setup or be experimentally 
determined using CFP–YFP dimers tethered with variable size 
linkers (Fig. 5a). Here, we adopt the second approach, using four 
distinct CFP–YFP dimers to deduce these coefficients. The plas-
mids encoding various dimers have been deposited to Addgene13. 
The genetic fusion of CFP and YFP ensures that the stoichiometry 
is 1:1 and Ab=Db=1. The apparent FRET efficiencies for these 
constructs, measured using 33-FRET and E-FRET, must equate: 
E E A E E D EA b b D= ⋅ = = ⋅ = ( )8
Thus, rearranging equations (6 and 7) in Box 1 yields equation 
(9), a convenient expression to experimentally determine the 
calibration constants. 
(8)
F
R S
G
R S
R S
C
A1
CFP
YFPDA
DA, 436, 480)
DA, 5⋅
= − ⋅
⋅YFP
D
A( , , )
(
(500 535
1
1 00, 535
CFP
YFP)
( )
( )
( )+ e
e
436
436
9
Here, SYFP(DA, 500, 535) and SCFP(DA, 436, 480) are direct 
measurements of the CFP–YFP dimer using the YFP and CFP 
cubes. FC corresponds to sensitized emission of YFP, deter-
mined as described by equation (5) (Box 1), and RA1 and RD1 are 
spectral factors. Equation (9) in fact describes a straight line, 
y = m ⋅ x + b where 
x
R S
R S
y
F
R S
= ⋅
⋅
=
⋅
D1 CFP
A1 YFP
C
A1
DA, 436, 480)
DA, 500, 535)
and
(
( (YFP DA, , )500 535
both experimentally determined. The intercept of this relation cor-
responds to the 33-FRET calibration constant εCFP(436)/εYFP(436), 
whereas the slope determines the E-FRET calibration constant G 
(Fig. 5b). The x and y pair of values are computed individually for 
each cell for a given dimer, and the complete data set is plotted to 
obtain the calibration constants.
Calculation of the total number of CFP and YFP molecules. The 
apparent 33-FRET and E-FRET efficiencies depend on the bound 
fraction of acceptors (Ab) and donors (Db) in a cell, respectively 
(Box 2, equations (10,12,15–23); Supplementary Note 3). To calcu-
late the bound fractions, the total concentrations of CFP (CFPEST) 
and YFP (YFPEST) are estimated from single cells expressing an 
(9)
table 1 | Properties of the filter cubes present in the FRET rig.
cube excitation Dichroic emission
CFP 426–446 nm T455lp 460–500 nm
YFP 490–510 nm T515lp 520–550 nm
FRET 426–446 nm T455lp 520–550 nm
Amount of donor
quenching
SCFP|after– SCFP|before
No FRET
FRET
Sensitized
emission
FC
450 500 550 600
Emission wavelength (nm)
a
EA =
ED =
Measured sensitized emission
Measured amount of donor quenching 
Maximal sensitized emission if E = 1
Total donor fluorescence in the absence of FRET 
Sensitized emission 
Amount of donor quenching
G =
b
CF
P YFP
Figure 3 | Spectral properties of FRET. (a) Double-peaked spectrum arising 
from CFP and YFP coexpressing cells in the presence (black line) and absence 
of FRET (gray line). FRET reduces donor fluorescence (donor quenching)  
and increases acceptor fluorescence (sensitized emission). (b) Sensitized 
emission can be measured and converted into FRET efficiency using the 
general formula for EA presented in box 1. Sensitized emission can also  
be used for the determination of ED by using a nondestructive FRET  
approach instead of acceptor photobleaching. This method requires the 
determination of the G factor, a factor that converts the amount of  
sensitized emission into donor dequenching (box 1).
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interacting pair of donor and acceptor proteins. For noninteracting 
fluorophores, the fluorescence intensity is proportional to the total 
number of fluorophores in the given cell. As previously described 
by Erickson et al.9, we use proportionality constants MA and MD 
for YFP and CFP molecules, respectively, to convert fluorescence 
intensities into the effective number of molecules9,10. These pro-
portionality coefficients encode the brightness of the two fluoro-
phores viewed using the FRET cube (λex ~ 436 and λem ~ 535).
The fluorescence signal measured using the YFP cube 
(SYFP(DA, 500, 535)) is devoid of any contribution from CFP. 
Thus, the total number of YFP molecules can be estimated 
as follows: 
YFP
YFP
M
R S
MEST
FRET
A
A1 YFP
A
436, 535, direct) DA, 500, 535)= = ⋅( ( (10)
(10)
CFP(direct) + YFP(direct)
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400300
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N • I0 • C1 • [�CFP (�)]� = 426–446 nm• QYCFP • C2 • [ ƒCFP(�)]� = 520–550 nm N • I0 • C1 • [�YFP (�)]� = 426–446 nm• QYYFP • C2 • [ ƒYFP(�)]� = 520–550 nm
N • I0 • C1 • [�YFP (�)]� = 490–510 nm• QYYFP • C2 • [ ƒYFP(�)]� = 520–550 nm
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[�YFP (�)]� = 426–446 nm
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=
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›
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Figure 4 | Components of the fluorescence signal at 535-nm emission. (a) Combined emission spectrum of donor and acceptor. Maximal emission of CFP at 
480 nm (point 2). The total fluorescence signal at 535 nm (point 1) is composed of donor bleed-through (point 3), fluorescence emission due to acceptor 
cross-excitation (point 5) and sensitized emission due to FRET (points 4 and 5). (b) Specifications of CFP, FRET and YFP filter cubes. Excitation: excitation 
wavelength, emission: emission wavelength. SCFP, SFRET and SYFP are the output signals measured using the CFP, the FRET and the YFP filters, respectively.  
The detailed filter parameters are elaborated in table 1. (c) Excitation (Ex) and emission (Em) spectra of CFP. SFRET(D, 436, 535) and SCFP(D, 436, 480) are the 
fluorescence signals measured at emission wavelengths of 535 nm and 480 nm, respectively, after excitation at 436 nm. From these signals, RD1 is calculated as 
indicated. (d) Excitation and emission spectra of YFP. SFRET(A, 436, 535) and SYFP(A, 500, 535) are the fluorescence signals measured at an emission wavelength 
of 535 nm after excitation at 436 nm or 500 nm, respectively. From these signals, RA1 is calculated as indicated. (e) RA1 and RD1 values mainly depend on the 
excitation lamp and detector response. Excitation subsystem: all parameters related to the excitation pathway. Emission subsystem: all parameters related to 
the emission pathway. Fluorescence intensity output is calculated according to the expression in Figure 2b (top). The ratio RD1 depends only on factors derived 
from the emission pathway; all factors from the excitation pathway cancel out. Therefore, RD1 reflects maturation of fluorescent proteins, which influences 
fCFP(535) and fCFP(480), as well as detector functions such as quantum efficiency, high voltage gain and stability of the detection. The ratio RA1 depends only  
on factors derived from the excitation pathway; all factors from the emission pathway cancel out. RA1 therefore reflects the number of fluorophores that may  
be affected by bleaching between the recordings of the two cubes, and fluctuations of the excitation lamp between the two recordings. Tabulation of RD1 and 
RA1 over a period of days and weeks (Fig. 9a,b) is very useful when establishing the method, as they serve to evaluate the stability of the light source (RA1) and 
the detector (RD1). FRET cannot be reliably measured until both values are stable. Differences between corresponding filters—e.g., the excitation filter  
of the CFP and the FRET cube or the excitation filter of the YFP and the FRET cube—are negligible. All variables are as defined in Figure 2.
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MA = εYFP(436) · fYFP(535) · QYYFP , where εYFP(436) is the aver-
age molar extinction coefficient of YFP over the bandwidth of the 
FRET cube excitation filter (Table 1); fYFP(535) is the average YFP 
emission spectrum over the bandwidth of the FRET cube emission 
filter (Table 1); and QYYFP is the quantum yield of YFP (0.61). The 
emission spectrum fYFP(λ) is normalized to have unitary area. The 
proportionality constant is related to the brightness of a single 
YFP molecule probed using the FRET cube. This approximation 
relies on the fact that optical transfer functions for the excitation 
and emission paths of the microscope are nearly constant over the 
respective bandwidths. Although the MA value can be computed 
for any microscope system, the precise value is not essential.
By contrast, the estimation of the total number of CFP mol-
ecules from CFP intensity is more complex, as FRET results in 
quenching of the donor signal. There are two methods of com-
pensating for this loss. First, FRET efficiency determined by the 
E-FRET method is equivalent to that determined by the donor 
dequenching method. Thus, the expected CFP intensity after 
acceptor photobleaching can be estimated by dividing the CFP 
intensity measured through the CFP cube before photobleaching 
by the apparent E-FRET efficiency, as shown in equation (11). 
CFP
CFP
postbleach
prebleach
(436, 535, direct) 
436, 535, direct
=
( )
1
DA, 436, 480)
1
D1 CFP
−
= ⋅
−
E
R S
E
D
D
( ( )11
The total number of CFP molecules in a given cell is related 
to the corrected total CFP intensity in the absence of 
FRET (CFPpostbleach(436, 535, direct)) by proportionality 
constant MD. Thus, 
CFP
R S
E MD
EST
D CFP
D
DA, 436, 480)
(1
= ⋅
− ⋅
1 12
(
)
( )
(11)
(12)
Here, MD = εCFP(436) · fCFP (535) QYCFP, and εCFP(436) is the 
average molar extinction coefficient of CFP over the excitation 
bandwidth of the FRET cube (Table 1); fCFP(535) is the average 
CFP emission over the emission bandwidth of the FRET cube 
(Table 1); and QYCFP is the quantum yield of CFP (0.4).
A second strategy is to add the amount of fluorescence signal 
lost via FRET to the quenched CFP intensity by adding the term 
EA · YFPFRET(436, 535, direct) · MD/MA. This correction factor 
assumes a 1:1 donor–acceptor stoichiometry. The total number 
of CFP molecules is given by 
CFP
R S E R S
MEST
D CFP A A YFP
D
DA, 436, 480) DA, 500, 535= ⋅ + ⋅ ⋅1 1 13( ( ) ( )
The two strategies will yield similar estimates for CFPEST, but equa-
tion (13) is valid only for a 1:1 interaction. For the purposes of 
obtaining relative binding affinities, calculating the precise value 
of MA or MD individually is not critical; however, the ratio of MA 
to MD is crucial. The parameter MA/MD can be obtained experi-
mentally from the calibration constants for 33-FRET and E-FRET 
efficiency, as the ratio of slope to intercept from equation (9). 
M
M
GA
D
CFP
YFP
= e
e
( )
( )
( )
436
436
14
This relation depends upon the fact that G = (fYFP(535) · QYYFP)/
( fCFP(535) · QYCFP), which is the ratio of the quantum yields of 
the two fluorophores and the probability of emitting a photon of 
the given wavelength. Once MA/MD is determined, one possibility 
is to set MD = 1. This maneuver would scale the relative binding 
affinities by an arbitrary scale factor. For our FRET setup, the MA/
MD value was found to be 0.440. MA and MD can also be calculated 
based on the optical properties of the imaging system (Fig. 2). 
(13)
(14)
Box 1 | Experimental computation of 33-FRET and E-FRET 
The measurement of FRET efficiencies using 33-FRET and E-FRET for CFP–YFP FRET pairs relies on fluorescence measurements from three 
cubes: (1) SCFP(DA, 436, 535) or the CFP cube; (2) SYFP(DA, 436, 480) or the YFP cube; and (3) SFRET(DA, 436, 535) or the FRET cube. 
These fluorescence measurements are then used to spectrally unmix the contribution of sensitized emission of YFP through the FRET 
cube using the spectral ratios RD1 and RA1 as follows: 
F S R S R SC FRET D1 CFP A1 YFPDA, 436, 535) DA, 436, 480) DA, 500,= − ⋅ − ⋅( ( ( 535) ( )5
The FRET efficiency as ascertained by the 33-FRET method is proportional to the ratio of sensitized emission to the direct excitation  
of YFP. Thus, 
E E A
F
R SA b
C
A1 YFP
YFP
CFPDA, 500, 535
= ⋅ =
⋅ ( )
( )
( )
( )
e
e
436
436
6
Similarly, the FRET efficiency as ascertained by the E-FRET method is given by the equation: 
E E D
F
F G R SD b
C
C D1 CFP DA, 436, 480
= ⋅ =
+ ⋅ ⋅ ( )
( )7
Computation of FRET efficiencies by both methods require the instrument-specific calibration constants εYFP(436)/εCFP(436) and G.  
The procedure to experimentally determine these coefficients is outlined in Procedure Steps 78–99. These equations importantly  
assume a low-excitation limit at which the excitation power is low enough that there is no substantial ground-state depletion.  
Derivations for all equations are given in supplementary note 2.
(5)
(6)
(7)
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The strategy for theoretical computation of MA and MD is out-
lined in Supplementary Note 1 and Supplementary Data 1.
Calculation of binding curves. FRET efficiency measurements 
from many individual cells are collectively analyzed to deduce 
binding curves. The stochasticity in the expression of CFP- and 
YFP-tagged proteins among different cells allows for high vari-
ability in free donor and acceptor concentrations, yielding a 
saturating relationship for the apparent 33-FRET and E-FRET 
efficiencies. Accordingly, either EA is plotted as a function of 
free donor concentration (Dfree) or ED is plotted as a function 
of free acceptor concentration (Afree). Both Dfree and Afree are 
computed based on estimates of CFP and YFP concentrations 
(CFPEST and YFPEST, respectively) and by imposing a simple 
binding model on the entire data set. For a 1:1 binding interac-
tion, the two curves should yield identical maximal efficiencies 
(Emax values) and relative binding affinities (Kd,EFF values). The 
maximal FRET efficiency (obtained with either Db = 1 or Ab = 1) 
reflects the overall spatial arrangement of the CFP and YFP 
molecules in the complex.
Procedurally for each individual cell, 33-FRET (EA) and E-FRET 
(ED) efficiencies are computed based on equations (6 and 7), 
respectively. YFPEST and CFPEST are determined using equations 
(10 and 12), respectively. The data from many cells are then fit 
iteratively using a nonlinear least-squares procedure that com-
putes Dfree and Afree values for each individual cell based on a 
simple Langmuir binding isotherm with the dissociation constant 
Kd,EFF. The equations used in this fitting procedure are provided in 
Box 2. Both Dfree and Afree, the independent variables of the FRET 
two-hybrid binding curves, are computed based on the relative 
dissociation constant Kd,EFF, CFPEST and YFPEST, and requires an 
iterative nonlinear least-squares fitting procedure, as described in 
Box 2 (equations (10,12,15–23)). Typically, fluorescence measure-
ments from 20 to 30 cells are used to obtain an evenly sampled 
‘complete’ binding relation. Once a fit is obtained, EA and ED are 
plotted against Dfree and Afree, respectively. The maximal FRET 
efficiencies (Emax values), the saturating portion of the Langmuir 
relation, can often be estimated independently of the iterative 
fitting procedure. In general, EA,max (the maximal EA value) and 
ED,max (the maximal ED value) can be constrained to be between 
0 and 1. Similarly, Kd,EFF cannot be negative, and the practical 
upper limit is influenced by other factors (e.g., collisional FRET). 
These considerations provide constraints to obtain robust fits 
for both 33-FRET and E-FRET. Figure 6 shows an example FRET 
two-hybrid binding curve.
Determination of spurious FRET. One additional confounding 
factor to consider when evaluating binding interactions using the 
FRET two-hybrid assay is the possibility of spurious FRET. When 
fluorophores are present at high bulk concentrations, a donor and 
an acceptor may be within the Förster distance by random chance 
and would undergo FRET even in the absence of a genuine under-
lying binding interaction. Accordingly, to obtain reliable 33-FRET 
or E-FRET binding curves, the contribution of spurious FRET 
must be subtracted. Unlike with binding interactions, spurious 
33-FRET and E-FRET efficiencies are linearly proportional to the 
concentration of donors and acceptors, respectively. As the total 
fluorescence intensity from a single cell is proportional to the 
total number of CFP or YFP molecules in the cell, the magnitude 
of spurious FRET by the 33-FRET and E-FRET methods can be 
related to the measured CFP and YFP fluorescence intensity by 
the following equations11: 
E R D
R
V
R S
MA,spurious cell
D1 CFP
D
= ⋅ ⋅ ⋅ = ⋅ ⋅ ⋅−
−2
3
10
2
3
102
0
3 27
2
0
3 27
p p ( )24
33
= ⋅
−
m S
FRET CFP
E R A
R
V
R S
MD,spurious cell
A1 YFP
A
= ⋅ ⋅ ⋅ = ⋅ ⋅ ⋅−
−2
3
10
2
3
102
0
3 27
2
0
3 27
p p ( )25
= ⋅m SE-FRET CFP
Here, R0 corresponds to the Förster distance, Vcell is the volume 
of the cell, RD1 and RA1 are spectral factors and MD and MA  
are the calibration constants defined earlier. As CFP and YFP 
share a similar structure, the slopes of the two spurious FRET 
relations are related, 
m
R
R
M
M
mE-FRET
A1
D1
D
A FRET
=
−33
26( )
Empirically, spurious FRET can be obtained through fluorescence 
measurements from roughly 10–15 cells coexpressing untagged 
CFP and YFP molecules. As monomeric fluorescent proteins 
are typically used, the FRET efficiencies obtained correspond to 
spurious FRET and not to an underlying binding reaction. The 
33-FRET efficiencies obtained are subsequently plotted against 
the CFP intensity, whereas the corresponding E-FRET efficien-
cies are plotted against the YFP intensities, and the respective 
slopes are estimated. Once the two relations are obtained, the 
FRET efficiencies obtained from each cell with the interacting 
(24)
(25)
(26)
1
4 G
YEP GFP
GFP
GFP
GFP
YEP
YEP
YEP
10 G
40 G
80 G
10a b100 Practical range
High-efficiency
dimers
G
(RD1 • SCFP)/(RA1 • SYFP)
�C/�Y
Low-efficiency
dimers
1 10
No. of glycines
100
0
0
= –G
FC
RA1 • SYFP
�C(440)
�Y(440)
+
RD1 • SCFP
RA1 • SYFP
FC
RA1 • SYFP
Figure 5 | Calibration experiments using cells expressing CFP–YFP dimers of 
high, intermediate and low FRET efficiency. (a) Schematic representation of  
individual dimers in which CFP and YFP are linked by a defined number 
of glycines (G), resulting in different FRET efficiencies. (b) For each 
dimer, FC/(RA1·SYFP) coordinates and (RD1·SCFP)/(RA1·SYFP) coordinates 
are calculated and then plotted onto the graph. A higher FRET efficiency 
corresponds to higher donor quenching and a lower SCFP values. Therefore, 
high-FRET-efficiency dimers are localized more to the left on the x axis with 
respect to lower-FRET-efficiency dimers. Similarly, a higher FRET efficiency 
implies higher sensitized emission. Therefore, high-FRET-efficiency dimers 
are localized more to higher values of the y axis with respect to lower-
FRET-efficiency dimers. The gray area on the graph indicates the predicted 
range of possible FRET efficiencies, which is usually <40%. The graph is fit 
by a straight line. The slope of the line is –G and the y intercept yields the 
excitation ratio of CFP and YFP: εCFP(436)/εYFP(436).
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Box 2 | Determination of FRET binding curves 
For a simple one-step bimolecular binding interaction with 1:1 stoichiometry, 
D A DA
d EFF
+
,
 
the experimentally measured apparent 33-FRET (EA) and E-FRET (ED) efficiencies must relate to the free concentrations of donors (Dfree) 
and acceptors (Afree) by Langmuir isotherms: 
E E A E
D
D KA
= ⋅ = ⋅
+max maxb
free
free d,EFF
E E D E
A
A KD
= ⋅ = ⋅
+max maxb
free
free d,EFF
For any given cell, the total number of YFP molecules is related to the YFP intensity through the YFP cube and is given by 
YFP
R S
MEST
A1 YFP
A
DA
=
⋅ ( , , )500 535
Note that MA is a microscope-specific calibration constant. Similarly, the total number of CFP molecules in a given cell is related to the 
CFP intensity measured through the CFP cube and is given by 
CFP
R S
E MEST
D1 CFP
D D
DA
=
⋅
− ⋅
( , , )
( )
436 480
1
To construct FRET two-hybrid binding curves, guessed Emax and Kd,EFF values are initially used to estimate Dfree and Afree concentrations 
for each individual cell, given the total YFPEST and CFPEST concentrations determined by the following equations: 
D
CFP K YFP CFP K YFP K
free
EST d,EFF EST EST d,EFF EST d,EF=
− − + − − + ⋅( )2 4 F EST⋅ YFP
2
Once Dfree is estimated, Afree can be computed as 
A YFP CFP Dfree EST EST free= − −( )
Alternatively, a symmetric formula for Afree based on equation (16) can be derived as follows: 
A
YFP K CFP YFP K CFP K
free
EST d,EFF EST EST d,EFF EST d,EF=
− − + − − + ⋅( )2 4 F EST⋅ CFP
2
The bound fraction of donor and acceptor molecules can be computed as follows: 
D D CFPb free EST = −1 /
A A YFPb free EST = −1 /
Subsequently, predicted EA,pred and ED,pred values are determined for each cell by substituting computed Dfree and Afree estimates with 
the guessed Kd,EFF and Emax values into equations (14 and 15). Both Emax and Kd,EFF are then iteratively optimized to simultaneously 
minimize the error in predicted EA or ED versus experimentally determined EA or ED for each cell i by a least-squares criteria: 
K E
i i
i
E E
d,EFF max
A,pred A
,
min ( )−∑ 2
K E
i i
i
E E
d,EFF max
D,pred D
,
min ( )−∑ 2
Notice that the Dfree and Afree values for each cell are recomputed after each iteration. Derivations for all equations are given in  
supplementary text 2 and 3.
(15)
(16)
(10)
(12)
(17)
(18)
(19)
(20)
(21)
(22)
(23)
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pair of CFP- and YFP-tagged molecules is corrected for spurious 
FRET by the following equations: 
E E m Si iA,corrected A FRET CFP
= − ⋅
−33
E E m Si iD,corrected D E FRET YFP= − ⋅−
One important consideration pertains to studying FRET between 
molecules residing in a restricted volume in certain subcellular 
localizations such as the plasma membrane. For such proteins, 
the slope of the spurious FRET relation can be unusually high, 
as the effective volume in the given compartment is smaller. 
One strategy for quantifying the magnitude of spurious FRET 
between proteins in such subcellular compartments is to localize 
CFP and YFP to these environments through appropriate target-
ing sequences. Importantly, FRET binding assays are suitable for 
studying the interaction of cytosolic binding partners with plasma 
membrane proteins such as voltage-gated Ca2+ channels9,14. For 
such experiments, a transmembrane binding partner such as the 
CaV1.3 pore-forming α-subunit is fused to YFP, and a cytosolic 
partner such as CaM is fused to CFP (ref. 14). Experimentally, the 
slope of the spurious FRET curve can be estimated by coexpress-
ing CFP- or YFP-tagged membrane proteins with freely diffusing 
YFP or CFP. Practically, given this arrangement, the slope of the 
spurious FRET curve is quite similar to that obtained when CFP 
and YFP are freely diffusing entities14 (Supplementary Note 4). 
Finally, for the interaction of two membrane-localized proteins, 
an important consideration is the relative size of the binding part-
ners. As many transmembrane proteins, such as ion channels, are 
large in size, the tagged fluorophores tend to be further apart and 
less likely to interact by chance, resulting in low spurious FRET.
Estimation of FRET distance. The maximum FRET efficiencies 
for a given CFP–YFP dimer pair depend on a variety of factors, 
including the distance between the CFP and YFP molecules, an 
orientational factor (κ2) and spectral overlap between the donor 
(27)
(28)
emission and acceptor excitation. FRET efficiency between a 
donor and an acceptor molecule is given by 
E
R
R
=
+




1
1
0
6
where R is the distance of separation between the CFP and YFP 
molecules, and R0 is the Förster distance where E = 0.5. Often, 
the two fluorophores are assumed to be randomly oriented with 
respect to each other, allowing for theoretical estimation of R0 
= 4.9 nm for a CFP–YFP pair. Thus, the approximate molecular 
distance between the donor and acceptor is 
⇒ = −



R R
E
E0
6
1
For example, a FRET efficiency of 0.15 corresponds to a molec-
ular distance of 6.5 nm between CFP and YFP. Maximal FRET 
efficiencies range between 0.10 and 0.40 for fluorescent proteins 
as the b-barrel structure impedes close apposition of the two 
fluorophores15,16.
Overview of the procedure
An overview of the experimental design of the FRET assay is out-
lined in Figures 7 and 8. The first section of the protocol outlines 
the setup and calibration of the FRET microscope, including soft-
ware customization for data acquisition (Steps 1–21), construc-
tion of a high-voltage-gain lookup table (HV-LUT; Steps 22–41) 
and other cell-based calibration measurements to ensure stable 
and reliable acquisition of FRET data (Steps 42–48). In the sec-
ond section, we describe the steps for conducting routine FRET 
two-hybrid assays, including all control measurements (Fig. 8, 
Steps 100–128). A custom analysis sheet is provided, along with 
a detailed workflow for data analysis.
(29)
(30)
Partner A
Partner B
YFP
E-FRET
CFP
FRET
pair
0 0
EA ED
0 Dfree 0 Afree
Adjust CFP/YFP expression
Low donor,
excess acceptor
Excess donor,
low acceptor
Excess donor,
low acceptor
Low donor,
excess acceptor
33-FRET
a b c
Figure 6 | Conceptual graph of FRET binding curves. (a) Diagram depicts hypothetical FRET binding partners A and B, tagged with YFP and CFP, respectively. 
Both molecules are coexpressed in single cells. (b) 33-FRET efficiency (EA) values measured from single cells were plotted versus Dfree, the concentration of free 
donor molecules (CFP—B molecules), to form a binding isotherm. The relative expression of CFP and YFP molecules in a cell is adjusted to attain a  
broad range of free donor concentrations. Cells with excess donor molecules will fall on the plateau of the isotherm. (c) E-FRET efficiency values (ED) for single 
cells plotted versus Afree, the free concentration of acceptor molecules (YFP—A), also form a binding isotherm. Note that the point located at low Dfree in 
panel b (red circle) corresponds to the point located at high Afree in panel c. Likewise, the point located at high Dfree in panel b (blue circle) corresponds to 
the point located at low Afree in panel c.
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Software implementation. During the setup phase of the FRET 
rig, acquisition programs for obtaining fluorescence measure-
ments are first configured. A typical experiment initiates with 
a visual screen for cells that are suitable for measurement. To 
select cells, two programs are required—(i) continuous excitation 
of CFP and (ii) continuous excitation of YFP. The actual FRET 
measurements are then performed using the CFP, FRET and YFP 
cubes with a brief excitation pulse. Two distinct excitation pro-
grams are required—(i) excitation using 436-nm-wavelength light 
for the CFP and FRET cubes and (ii) excitation using 500-nm- 
wavelength light for the YFP cube. Macros are defined that 
sequentially call the programs for the CFP, FRET and YFP cubes 
and store the acquired signals in a data file. All acquisition 
programs require subtraction of dark current.
Construction of an HV-LUT. One advantage of a photomulti-
plier tube (PMT) in fluorescence measurements is its ability to 
quantify intensities with high sensitivity and low noise over a 
broad range by controlling the high voltage set on the dynode. 
For FRET experiments, the donor and acceptor molecules are 
expressed at varying levels and require the use of multiple HV 
gains to detect fluorescence over a wide range. The light inten-
sity reported by the photomultiplier detection system (PMT) 
follows a power-law relation with the HV gain. A lookup table 
is determined for a given microscope setup over limited HV 
gains used in FRET experiments. To construct an HV-LUT, we 
measure the fluorescence intensity of synthetic dyes mimick-
ing spectral properties of CFP and YFP at different dilutions at 
predetermined HV gains. A standard HV gain is then chosen 
and the fluorescence intensities are normalized to the intensity 
at the standard HV gain. This procedure is performed during 
the setup phase of the FRET rig.
Cell-dependent calibration measurements. Both calibration 
constants (the G factor and the ratio of extinction coefficients) 
and spectral factors (RA1 and RD1) differ for a given imaging setup 
by choice of fluorophores. These values have to be determined 
during the calibration phase of the setup from cells expressing 
CFP–YFP dimers, and donors or acceptors individually. Stability 
of all constants must be ascertained.
FRET two-hybrid binding experiments. Once the setup has been 
calibrated, robust FRET data can be obtained. For actual FRET 
experiments, six different cell samples are prepared that need to 
be measured on the day of the experiment: (i) nontransfected 
cells, for the determination of the background autofluorescence; 
(ii) cells expressing CFP alone, for the determination of the spec-
tral factors RD1 and RD2; (iii) cells expressing YFP alone, for the 
determination of the spectral factor RA1; (iv) the CFP–YFP dimer, 
as a positive control; (v) cells expressing untagged CFP along 
with YFP, to determine spurious FRET; and (vi) cells expressing 
donor-tagged and acceptor-tagged binding pairs, for the actual 
FRET measurement. Background autofluorescence results from 
cell metabolites and weakly fluorescent amino acids. This value 
must to be subtracted for each of the three cubes (CFP, YFP and 
FRET cubes). Typically, the autofluorescence is <5% of the total 
signal through the cubes. The spectral ratios RA1, RD1 and RD2 are 
determined before each FRET experiment from cells expressing 
YFP or CFP only. As a positive control, FRET efficiency is evalu-
ated for a CFP–YFP dimer pair to evaluate daily performance of 
the microscope. Finally, spurious FRET and FRET efficiencies for 
the desired CFP- and YFP-tagged binding pairs are measured.
Workflow of data analysis. For data analysis, we provide a 
MATLAB script, which converts FelixGX data output to an input 
format suitable for Excel spreadsheets (Supplementary Data 2). 
In addition, a template Excel sheet is available (Supplementary 
Data 3). Alternatively, the analysis can be performed using soft-
ware packages such as Origin or MATLAB. Once the raw data 
are acquired and filled in on the template Excel sheet, most of 
Steps
1–6
7–9
10–15
16–21
22–41
42–48
49–52
53–62
63–77
78–99
Objective
Generation of acquisition programs
Cell-independent calibration measurements
Cell-dependent calibration measurements
Cell preparation and transfection
General steps
Determination of background autofluorescence
Determination of spectral factors RD1, RD2 and RA1
Determination of calibration constants using dimers
Establishing an HV lookup table (HV-LUT)
Implementation of acquisition programs
for screening and selecting cells 
Implementation of acquisition programs
for FRET two-hybrid binding experiments
Implementation of macros
Determination of dark current of the PMT
No. of iterationsDuration
Once
Once
Once
Daily over 1 week
Daily over 1 week
Daily over 1 week,
10–15 cells
Daily over 1 week,
10–15 cells
Daily over 1 week,
15–20 cells
15 min
15 min
45 min
45 min
3 h
2–3 d
30 min
90 min
90 min
Figure 7 | Overview of the calibration phase of the FRET rig. Outline of 
the workflow for reliable calibration of the FRET rig. There are three major 
phases—generation of acquisition programs, cell-independent calibration 
measurements and cell-dependent calibration measurements.
TimingObjectiveSteps
100
101
102–109
110–111
115–128 Construction of a binding curve
Determination of FRET efficiencies from
CFP- and YFP-tagged FRET pairs
Determination of background
autofluorescence, RD1, RD2 and RA1
Determination of spurious FRET
Cell preparation and transfection 2–3 d
90 min
30 min
1–3 h
30 min–2 h
Figure 8 | Overview of a FRET two-hybrid binding experiment. Summary of 
steps required for conducting a single FRET two-hybrid experiment, along 
with the approximate timing for each step. 
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the analysis is performed automatically, as the worksheets and 
relevant cells are linked with each other. The dimer analysis sheet 
calculates the G factor, the MA/MD ratio and the ratio of extinction 
coefficients. For the actual fitting procedure, points are calculated 
for each dimer, averaged across cells for each dimer and plotted on 
the graph. A least-squares linear fit is obtained by adjusting slope 
and y intercept. The sheet for the FRET two-hybrid binding data 
subtracts background signals and deposits the corrected signals in 
the binding curve sheet. This sheet calculates all FRET parameters 
with and without correction for spurious FRET, and it graphically 
displays binding curves for EA versus Dfree and ED versus Afree. 
Finally, nonlinear curve fitting is performed in order to obtain the 
binding curves defined by the Emax and Kd,EFF values.
Applications of the assay and target audience
The method is of interest to researchers characterizing protein–
protein interactions within living cells, wherein such interactions 
correspond to cellular signaling events. As FRET efficiencies are 
obtained nondestructively, this methodology can be applied to 
quantitatively monitor both dynamic and steady-state aspects of 
binding interactions. FRET-based assays have been used to study 
a wide range of biological molecules, including ion channels, 
G-protein-coupled receptors, immunoglobulins and cytosolic 
enzymes such as protein kinase A and Ca2+/calmodulin-depend-
ent kinase II, as well as numerous other enzymes and recep-
tors9,17–19. This methodology has been applied extensively to 
study the binding of voltage-gated Ca2+ channel holomolecules 
or subsegments with various channel-interacting proteins such as 
calmodulin9,10,20,21, the auxiliary CaVb subunit22, G proteins23,24 
and members of the small GTPase family25,26. In addition, the 
comparative ease of obtaining relative binding affinities using the 
FRET two-hybrid assay has enabled systematic characterization of 
mutational effects on a binding interface such as the CaM-binding 
segment of the CaV1.3 channel20,21. FRET binding assays are also 
well suited for studying binding of molecules in distinct subcel-
lular localizations such as the interaction between STIM1 in the 
ER membrane and Orai1 channel in the plasma membrane27,28.
Advantages of the assay
This method has several advantages as compared with alternative 
FRET approaches. It is possible to quantitatively describe protein–
protein interactions in living cells with binding curves from which 
relative affinities can be derived. Furthermore, the assay is robust 
because two independent metrics for FRET efficiencies (donor-
centric and acceptor-centric) are determined and correlated. 
Molecular FRET distances can be calculated based on maximal 
FRET. Unlike acceptor photobleaching, the assay is completely 
nondestructive9,13. The specificity of the calculated FRET efficien-
cies is high, as spurious FRET is measured and subtracted from 
total binding curves11,21. Any cell type, such as cultured cells or 
primary cells, can be used25,29–32. These cells can be transfected by 
standard transfection or viral gene transfer25. Finally, this method 
can be readily translated to a dynamic FRET assay28,33.
Technologically, one important advantage is that the approach 
can be highly automated and data acquisition and analysis is 
fast34. In principle, a single binding curve can be obtained within 
an hour, excluding time required for cell culture. Furthermore, 
the method exploits relatively inexpensive and widely accessible 
equipment, and therefore can be easily implemented. Minimally, a 
simple wide-field epifluorescence microscope including a motor-
ized filter wheel, an excitation system composed of an optically 
stabilized xenon arc lamp, and a detection system consisting of a 
PMT and housing is sufficient.
Limitations of the assay
One disadvantage of the PMT-based system for determining 
FRET efficiencies is the lack of subcellular spatial resolution. For 
certain applications, determining spatial variation in FRET may 
lend important insights into biological function. This limitation 
can be overcome by using either a camera-based or a confocal 
imaging system. Such applications may require further cali-
bration measurements to account for chromatic and spherical 
aberration of the objective and may require additional lookup 
tables to account for detector gains (e.g., for charge-coupled 
device (CCD) cameras). For confocal imaging, stability of opti-
cal parts and fluctuations of laser power may pose substantial 
challenges35. Confocal imaging setups may also be expensive. 
This approach is also less suited to high-throughput experi-
ments. However, the method could potentially be implemented 
using a flow-cytometry-based system34,36. In addition, the cur-
rent approach is not well suited to extremely fast and highly 
dynamic processes, as the time required to switch filter cubes can 
be hundreds of milliseconds. Faster imaging could be attained 
using multiple PMT detectors and filter wheels. Moreover, as 
changes in binding would alter only fluorescence measurements 
from the CFP and FRET cubes, only these measurements need 
to be obtained simultaneously and rapidly. Over a very short 
period of time, the changes in direct YFP fluorescence would 
be negligible. Thus, the protocol described here can be adapted 
to study fast time-scale events. Finally, the protocol assumes 
a single-step binding interaction with a 1:1 stoichiometry for 
determining relative dissociation constants. These constants 
could be experimentally ascertained if the maximal 33-FRET 
and E-FRET efficiencies are identical37.
table 2 | Plasmids for FRET analysis.
name Description catalog number
ECFP Untagged donor for 
spectral factors
84951
EYFP Untagged acceptor  
for spectral factors
84952
YFP–G4–CFP Dimer for calibration 84953
YFP–G10–CFP Dimer for calibration 84954
YFP–G40–CFP Dimer for calibration 84955
YFP–G80–CFP Dimer for calibration 84956
ECFP–CaMWT Donor-tagged binding  
partner
84957
EYFP–Myosin Va IQ Acceptor-tagged  
binding partner
84959
EYFP–CaV1.2 IQ Acceptor-tagged  
binding partner
84958
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Comparison with alternative approaches
There are numerous methods available for detecting FRET efficien-
cies from biological systems that are suitable to a variety of applica-
tions2. Acceptor photobleaching or donor dequenching is a classic 
and widely used technique that measures the fractional enhance-
ment in donor fluorescence upon photodestruction of the asso-
ciated acceptor molecule. As such, this intensity-based technique 
does not require any instrument-specific calibration constants. 
Although simple to perform, this technique is destructive and is 
substantially more time-consuming. A second method of obtain-
ing FRET efficiencies quantitatively is fluorescence lifetime imaging 
microscopy38. This technique measures changes in the fluorescence 
lifetime of donor molecules to infer FRET in a spatially resolved 
manner. Lifetime measurements can be attained using either a time-
resolved fluorescence response to a brief pulse of light or through 
frequency domain measurements39. Moreover, it can be used in 
conjunction with multiphoton excitation to further enhance spa-
tial resolution and sensitivity39,40. The use of multiphoton excita-
tion could make this technique suitable to in vivo applications40. 
Although powerful for studying biological systems, one disadvan-
tage is that this method requires expensive equipment that may 
preclude its widespread application39. In addition, many fluores-
cent proteins exhibit multiexponential fluorescence decays and may 
therefore confound accurate detection of fluorescence lifetimes39. 
Moreover, the concentration of acceptor molecules is generally 
not considered, and therefore this method is not typically used to 
quantitatively characterize the strength of binding interactions.
A key confounding factor in intensity-based measurements of 
FRET is the possibility of spectral cross talk as a consequence 
of the broad excitation and emission spectrum observed for 
typical fluorescent proteins. Spectral FRET measures the known 
spectrum of donor and acceptor molecules to unmix these con-
founding factors and estimate FRET efficiency by determining 
the full spectrum of the donor41–44. However, such measurements 
will also require expensive equipment to characterize fluorescence 
signals across a large spectrum.
Binding curves have been measured using approaches similar to 
the 33-FRET method described here45–48. First, plotting apparent 
acceptor-centric FRET efficiencies as a function of the ratio of 
CFP and YFP fluorescence intensity yields a saturating relation-
ship that can be analyzed to determine changes in conformation 
or relative affinity45,46. A similar approach can be used to relate 
donor-centric FRET efficiencies as a function of the ratio of the 
number of YFP molecules to the number of CFP molecules in 
a cell by a saturating Langmuir relation47. However, the fitting 
constant in this method does not correspond to dissociation con-
stants47. Moreover, this method also requires fluorescence lifetime 
imaging microscopy measurements for calibration47,49. Finally, 
the E-FRET (donor-centric) efficiencies can be correlated with the 
free concentration of acceptors to obtain a relative dissociation 
constant48. In all cases, a 1:1 binding stoichiometry is assumed.
Experimental design
Robust quantitative determination of FRET requires a well- 
calibrated microscope setup, a stable excitation source and a linear 
detection system, as described in the following section.
Setting up and calibrating the FRET rig. During the initial setup 
of the FRET rig, identical measurements required for routine 
FRET experiments (Figs. 7 and 8) are performed, generating 
large data sets from which the HV-LUT, the spectral factors 
and the FRET efficiency calibration constants are determined. 
The stability of these constants is confirmed over a period of a 
week. Large fluctuations in these constants will result in mis-
estimation of FRET efficiency, adding to noise in FRET binding 
assays and often leading to irreproducible results.
Stability of the excitation light source. As FRET two-hybrid assay 
uses corrected total fluorescence output to estimate the concen-
trations of donors and acceptors, instability in the excitation 
source may lead to variable reporting of relative binding affinities. 
Commonly, xenon arc lamps are used for exciting fluorophores. 
An intrinsic problem of arc-lamp-based excitation systems is the 
short-term fluctuations of fluorescence output. Therefore, it is 
helpful to use xenon lamps equipped with a computer-controlled 
optical feedback system. Ideally, the feedback system measures 
lamp intensity output and adjusts any short-term fluctuations 
via a servo-controlled feedback system by regulating the power 
supply. Such systems are available from Newport (Oriel Research 
Xenon arc lamp (cat. no. 66477-150XF-R1) plus Light Intensity 
Controller LIK-LMP). Alternatively, a monochromator system 
that is driven by a stabilized power supply can be used in order to 
minimize intensity fluctuations. Furthermore, LED-based systems 
with or without optical feedback stabilization or temperature 
control are also available. Irrespective of the system used, excita-
tion intensity output should be set to the low or middle dynamic 
range to minimize photobleaching. If necessary, neutral-density 
filters or optical grids (fluorescence intensity manager for Leica 
microscopes) can be used to reduce excitation intensity. We use 
a 150 W xenon arc lamp with slit widths of the monochromator 
output adjusted to 5 nm.
Stability of the emission light detector. Instability in the emission 
detector may also contribute to mis-estimation of total donors 
and acceptors, resulting in unreliable reporting of relative binding 
affinity. We use a PMT-based detection system. The advantage 
of the PMT is that the detection gain can be controlled over a 
wide range by changing the high voltage. Certain photodiode-
based systems have a limited detection range and may necessitate 
further optimization. Another advantage of the photomultiplier 
system is that HV gain can be controlled by the software, which 
allows for very fast and automated data acquisition. CCD camera 
systems, which are also equipped with a gain control, are suit-
able for quantitative FRET experiments and require calibrations 
similar to those of PMT-based systems. However, FRET experi-
ments using camera-based setups are more complex, as chromatic 
aberration may result in spatially varying spectral ratios35.
Linear response of the emission light detector. Our FRET-based 
binding assay relies on robust determination of the number of 
donor and acceptor fluorophores in a given cell. It is therefore 
critical that fluorescence intensity measured using the PMT be 
linearly dependent on the concentration of fluorophores. In some 
cases, PMT detectors have been shown to respond nonlinearly 
to the intensity of the incident light44,50,51, although some non-
linearities could be corrected50. Therefore, we confirmed a lin-
ear relation between the fluorescence intensity measured using 
the PMT and the concentration of fluorophores determined 
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by characterizing the fluorescence output of droplets of the 
synthetic dyes Alexa Fluor 514 and Proflavin, which mimic 
the spectral properties of YFP and CFP, respectively35. Indeed, 
the net fluorescence intensity was linearly dependent on the 
concentrations of Alexa Fluor 514 (Supplementary Fig. 1a) and 
Proflavin (Supplementary Fig. 1b). These results suggest that 
fluorescence intensity measured using our PMT setup is linearly 
proportional to the number of fluorophores in a cell.
MaterIals
REAGENTS
Sodium chloride (NaCl; VWR, cat. no. 27810)
Potassium chloride (KCl; Carl Roth, cat. no. 6781)
Magnesium chloride hexahydrate (MgCl2·6H2O; Carl Roth,  
cat. no. 2189)
Calcium chloride dihydrate (CaCl2·2H2O; VWR, cat. no. 22317)
Glucose monohydrate (Carl Roth, cat. no. 6887)
HEPES (Sigma-Aldrich, cat. no. H3375)
Sodium hydroxide (NaOH; VWR, 28244) ! cautIon Sodium hydroxide is 
a corrosive alkali. Wear protective gear while handling to avoid contact with 
skin and eyes.
Poly-l-lysine hydrobromide (Sigma-Aldrich, cat. no. P2636)
Polyethylenimine (PEI; Polysciences, cat. no. 23966-2)
Cell sample of choice; here, we use the example of HEK293 cells (DSMZ, 
cat. no. ACC 305) ! cautIon For cell lines used in your research, it is  
essential to ensure that the cells are authentic and free from contamination 
such as mycoplasma.
DMEM (low glucose) (Gibco, cat. no. 21885)
FBS (Biochrom, cat. no. S 0615)
Penicillin/streptomycin (P/S; Biochrom, cat. no. A2212)
Alexa Fluor 514 succinimidyl ester (Molecular Probes, cat. no. A3-0002)
Proflavin hemisulfate salt hydrate (Sigma-Aldrich, cat. no. P2508)  
! cautIon Proflavin is toxic and an irritant. Wear appropriate eye shields 
and gloves when handling this compound.
Plasmid constructs (see Table 2); all plasmids used in the PROCEDURE are 
available from Addgene (http://www.addgene.org)
EQUIPMENT
Microtubes, 1.5 ml (e.g., Sarstedt, cat. no. 72.690.001)
Glass-bottom dishes, 35 mm (In Vitro Scientific, cat. no. D35-20-1.5-N). 
 crItIcal Cell culture dishes with glass bottoms are recommended for 
imaging. The glass bottom is optimized for minimal autofluorescence.  
For complete adherence of cells, it is recommended to coat dishes with 
poly-l-lysine (PLL; see Equipment Setup).
Inverted fluorescence microscope (Leica, cat. no. DMI6000B)
HC PL APO 40×/1.3 oil-immersion objective (Leica, cat. no. 11506329)
CFP-filter cube, excitation: ET436/20×, dichroic: T455lp, emission: 
ET480/40 m, transmission rate 93–97% (Chroma Technology,  
cat. no. 49001)
YFP-filter cube, excitation: ET500/20×, dichroic: T515lp, emission: 
ET535/30 m, transmission rate 93–97% (Chroma Technology,  
cat. no. 49003)
FRET-filter-cube, excitation: ET436/20×, dichroic: T455lp, emission: 
ET535/30 m, transmission rate 93–97% (Chroma Technology,  
cat. no. 49052)
DeltaRamX (Horiba)
Xenon short arc lamp type (Ushio, model no. UXL-75XE)
C-mount adaptor (specific for Leica microscope type)
Microscope photometer (Horiba, model no. D-104 B)
PMT housing (Horiba, model no. 914)
PMT (Horiba, model no. R1527)
FelixGX v4.3.6904 (Horiba)
Excel 2013 (Microsoft Corporation)
MATLAB vR2014b (MathWorks)
REAGENT SETUP
FRET imaging buffer For typical FRET two-hybrid assays, a bath (Tyrode’s 
solution, containing 140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2,  
10 mM glucose and 10 mM HEPES in ddH2O) is used. Adjust the pH to 7.4 
with 5 M NaOH. Prepare aliquots and store them at −20 °C for up to 1 year. 
Thawed aliquots can be stored at 4 °C for up to 1 week.
HEPES buffer Dissolve 2.38 g of HEPES in 1 liter of ddH2O to attain a final 
concentration of 10 mM, and adjust the pH to 7.0 with 5 M NaOH. The 
buffer can be stored at 4 °C for up to 1 year.
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
Alexa Fluor 514 dye (1 mg/ml) Dissolve 1 mg in 1 ml of HEPES buffer and 
incubate the mixture overnight at room temperature (22 °C). The stock  
solution may be stored at 4 °C and is stable for several months. Prepare  
dilutions on the day of use with HEPES buffer.  crItIcal It is important  
to protect this solution from light to prevent photobleaching.
Proflavin dye (100 mg/ml) Mix a total of 100 mg with 1 ml of HEPES  
buffer, and vortex and centrifuge the mixture for 1 min at 10,000g at room 
temperature to remove undissolved particles. This stock solution can be 
stored at 4 °C and is stable for several months. Prepare all dilutions freshly 
with HEPES buffer on the day of use.  crItIcal It is important to protect 
this solution from light to prevent photobleaching.
Growth medium Supplement 450 ml of DMEM low-glucose medium with 
50 ml of heat-inactivated FCS (10% (vol/vol) final) and 5 ml of P/S (1% 
(vol/vol) final). Store the medium at 4 °C for up to 4 weeks.
Transfection medium To 50 ml of unsupplemented DMEM low-glucose 
medium, add 250 µl of P/S (1% (vol/vol) final). Store the medium at 4 °C for 
up to 4 weeks.
Polyethylenimine transfection reagent Prepare 25 ml of a 1 mg/ml polyeth-
ylenimine (PEI) stock solution in endotoxin-free ddH2O with pH adjusted  
to 7.0. Sterilize the solution using a 0.22-µm syringe filter, prepare aliquots and 
store them at −20 °C. A working stock can be stored at 4 °C for up to 4 weeks.
Poly-l-lysine stock (50 mg/ml) Dissolve 100 mg of PLL in 2 ml of ddH2O 
for a poly-l-lysine (PLL) stock solution. The stock solution can be stored  
at 4 °C for up to 6 months.
EQUIPMENT SETUP
Preparation of imaging dishes Wash glass-bottom cell culture dishes with 
80% (vol/vol) ethanol and let them dry completely. Coat each dish with 
600 µl of 1:50,000 PLL dilution for 30 min at room temperature. Aspirate the 
PLL solution, wash twice with ddH2O and allow the dishes to dry. Once dried, 
the dishes may be stored at room temperature for a few days.
Microscope Our measurements were obtained using a Leica DMI6000B 
inverted fluorescent microscope equipped with a motorized turret and a  
40× objective (Fig. 1). The microscope is furnished with a motorized  
filter-wheel that enables rapid switching of filter cubes within 300 ms.  
If you are using filter cubes other than those listed in EQUIPMENT section, 
it is critical to ensure that the filter designs permit optimal transmission of 
desired optical signals.
Fluorescence excitation system We use a DeltaRamX monochromator  
containing a xenon short arc lamp (Fig. 1) for excitation. The excitation 
intensity of this light source can be adjusted by manually setting the slit  
control, which we typically set to 5 nm. For quantitative FRET microscopy,  
a stable excitation light source is essential. Arc-lamp-based excitation systems 
have the disadvantage of long-term decay in fluorescence output due to aging 
of the excitation lamp. To ensure long-term stability, the intensity of the lamp 
should be adjusted often to yield a target amount of YFP bleaching in a fixed 
time interval. For example, when the monochromator slits are opened to ~5 
nm, the YFP bleaches to ~60% of initial intensity within 440 s. Repeat this 
measurement monthly and adjust the output of the xenon lamp, so that the 
reference value is reached. In practice, this adjustment can be attained by 
simply adjusting the slit width of the monochromator or by adjusting the 
power supply. Alternatively, excitation light intensity in the objective plane 
can be measured using a power intensity meter. The excitation light bulb 
needs to be replaced based on the lifetime of the light bulb used.
Fluorescence detection system The fluorescence intensity is detected by a 
PMT (Horiba) consisting of photometer housing and a PMT. In the analog 
mode, the PMT can operate at different HV gains, allowing for fluorescence 
measurement over a broad intensity range. The aperture can be adjusted by 
four aperture control knobs and, for the example used in PROCEDURE, is 
set to the size of a single HEK293 cell. A viewing scope enables control of 
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the aperture size and positioning of the relevant cell within the viewing area. 
Light beams arising from the sample can be directed to either the PMT  
or the eyepieces by toggling to the ‘Measure’ or ‘View’ position. To protect 
the PMT, the toggle is set to the ‘Measure’ position only when fluorescence 
signals are acquired.
Data acquisition and analysis We use FelixGX for signal acquisition and 
control of the monochromator and individual detector gains. Offline data 
analysis is performed with a custom-written MATLAB script and a  
customized Excel spreadsheet, which are provided as Supplementary Data 2 
and 3, respectively. In principle, any commercially available image  
acquisition and data analysis software can be used. For automatization of 
the workflow, custom-written programs (e.g., with MATLAB) can be used to 
control all critical components of the system (e.g., light source, microscope, 
and filter cube turret).
proceDure
Generation of acquisition programs for screening and selecting cells ● tIMInG 15 min
 crItIcal Steps 1–21 describe how to generate appropriate acquisition programs for FRET two-hybrid-binding assays 
using the FelixGX software. Alternatively, customized software (e.g., MATLAB) can be used to operate the monochromator. 
Independent of the data acquisition software used, key parameters such as the wavelength for excitation and emission, the 
duration of fluorescence recording and the sampling rate of data digitalization can be set as outlined here. Other parameters 
that are unique to the detection system or the excitation system may differ and will need to be specified according to the 
hardware used.
1| If you are using FelixGX for data acquisition, confirm that ‘914 default gain’ is set to 950. This value is set  
incorrectly by the supplier and impedes the correct performance of the PMT. To set this value, start FelixGX and click the 
‘DeltaRamAnalog’ tab (supplementary Fig. 2) to open the hardware configuration window (supplementary Fig. 3a).  
Set the parameter to 950. Then validate and close the window.
2| Create an acquisition program for continuous illumination of donor fluorescence (Steps 2–5). This program is suitable 
for screening and selecting fluorescent cells. In FelixGX, select the ‘Setup’ tab in the left lower corner of the main graphical 
user interface (supplementary Fig. 2); this opens the ‘Setup’ window. The window has 10 tabs; choose the ‘Acquisition Type’ 
tab and select ‘Timebased’ (supplementary Fig. 3b).
3| Select ‘Acquisition Settings’ from the ‘Setup’ window (supplementary Fig. 4a) and specify the excitation wavelength for 
the CFP cube. The excitation wavelength needs to match the center wavelength of the individual excitation filter (e.g., 436 
nm for CFP excitation). In the panel on the right side, set duration of the data acquisition to 600 s. The continuous illumina-
tion mode usually has an acquisition duration of 5–10 min. Set the sampling rate to 100 points per s and accept. All other 
settings can be left as default.
 crItIcal step Users are encouraged to implement acquisition programs that match the properties of their given imaging 
setup. The sampling rate, acquisition duration and excitation wavelength may therefore be adjusted to yield good signals 
without inducing photobleaching.
4| Select ‘PMTs’ from the ‘Setup’ window (supplementary Fig. 4b). Specify the gain voltage (e.g., 850 V) and accept.  
For screening of cells, it is convenient to use a standard HV gain of 850 V.
5| Save the program, e.g., as ‘continuous CFP excitation’. This program will be invoked to screen for appropriate cells to 
collect FRET data and terminated after an appropriate cell is chosen. Note that the cells will never be exposed for the full 
acquisition duration, in order to avoid photobleaching effects.
6| Create an acquisition program for continuous illumination of acceptor fluorescence. Repeat Steps 2–5 and create a  
similar acquisition program for YFP illumination. Use the same settings, except for excitation wavelength, which should be 
set to match YFP excitation wavelength (e.g., 500 nm).
Determination of the dark current of the pMt ● tIMInG 15 min
7| All specific programs require the dark current of the detector to be subtracted. To quantify the dark current, completely 
isolate the detector from incoming light by setting the photometer knob to ‘View’ (Fig. 1) and direct the light beam toward 
the oculars of the microscope. This blocks the light beam to the photometer and protects the PMT from saturation.
 crItIcal step Daily measurements of dark current evaluate the stability of the detection pathway and are important  
during the setup phase of the FRET rig.
8| Place the CFP filter cube in the light beam. Start continuous CFP illumination (e.g., using the program set up in  
Steps 2–5) and record the signal for ~10 s.
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9| Calculate the average signal of the trace acquired in Step 8. Using FelixGX, go to ‘Math’ → ‘Trace Math’ → ‘Average’  
(supplementary Fig. 2) and read out the value in the pop-up window. This value is the dark current of the PMT, which  
needs to be subtracted in all acquisition programs (Steps 12 and 13).
Generation of acquisition programs for Fret two-hybrid binding experiments ● tIMInG 45 min
10| To conduct actual FRET measurements, create acquisition programs for the donor and acceptor using shorter acquisition 
durations (in the range of milliseconds to seconds). The pulse length needs to be adjusted so that it is long enough to have 
an optimal fluorescence signal without inducing photobleaching. To do this, repeat Steps 2 and 3 for excitation of CFP using 
the same settings, except for duration of acquisition, which should be set to 1 s (supplementary Fig. 4a).
11| Set the gain voltage to ‘600’, as described in Step 4.
12| Implement subtraction of dark current from the acquired signal, using the specific dark current value determined  
in Steps 7–9. In FelixGX, select ‘Backgrounds’ from the ‘Setup’ window (supplementary Fig. 4c). Note that the term  
‘Background’ used in this window refers to the dark current caused by spontaneous discharge of electrons by the PMT, where-
as the term ‘autofluorescence background’ refers to fluorescence intensity of cells lacking fluorophores typically generated 
by cellular metabolites. The dark current signal defines the lower limit of the resolution of the detection system. To activate 
dark current subtraction, select ‘Manual Input’ and activate the option ‘Use Background’ by clicking the box and ‘Accept’.
13| Select ‘Traces’ from the ‘Setup’ window (supplementary Fig. 4d) and specify the dark current value obtained in  
Step 9 (–0.2957 mV, for our system). Specify a name for the acquisition program (e.g., ‘CFP 600’), activate ‘Visible Graph’  
by clicking the box and ‘Accept’.
14| For the purpose of signal acquisition for binding curves, it is necessary to implement acquisition programs designated  
to detect signals with different detector gains. Usually, gains from 600 V to 1,150 V are in the operational range of the  
detector. Repeat Steps 10–13, but in Step 11 set the gain voltage to the desired value (e.g., ‘650’). Save the program  
with an appropriate name (e.g., ‘CFP 650’) and repeat this step for further HV gains. We recommend implementation of  
acquisition programs with intervals of 50 V. When this step has been successfully completed, 12 programs for specific HV 
gain will have been created.
15| Create analogous acquisition programs for YFP excitation by repeating Steps 10–14, but instead specify the excitation 
wavelength to be 500 nm for the YFP cube.
Generation of macros for Fret two-hybrid binding experiments ● tIMInG 45 min
 crItIcal Steps 16–21 describe how to use the FelixGX software to create separate macros for each HV gain (corresponding 
to 600–1150 V, in intervals of 50 V) using the acquisition programs created in Steps 10–15. Note that the acquisition  
protocol for donor excitation is suitable for fluorescence intensity readings using the CFP and FRET filter cubes, whereas  
the acquisition protocol for acceptor excitation is used to read signals using the YFP filter cube. An example macro sequence 
might be: donor excitation (CFP cube) → donor excitation (FRET cube) → acceptor excitation (YFP cube). Note that the HV 
gains used for donor excitation must be the same as those used for acceptor excitation.
16| On the main graphical user interface (supplementary Fig. 2), select the ‘Action’ tab to open the ‘Macro’ window  
(supplementary Fig. 5). Click the green ‘+’ button in the upper left corner of the window to open the ‘Macro Editor’ window 
(supplementary Fig. 5a).
17| To add a pause step to the macro, highlight ‘Pause’ from the list on the left side and click the ‘Add’ button  
(supplementary Fig. 5b). This adds ‘Pause [indefinite]’ to the macro window (black panel) on the left side of the list.  
During an experiment, the pause point allows the appropriate filter cube to be brought into position.
18| Next, add the acquisition protocol for donor excitation at the first HV gain (e.g., ‘CFP 600’) to the macro by selecting 
‘Run Acquisition (existing)’ from the list, and choosing the ‘CFP 600’ protocol from the pop-up list (supplementary Fig. 5c).
19| Repeat Steps 17 and 18 to add pause steps and acquisition protocols for the FRET cube and the YFP cubes at HV gain  
of 600 V. Pause steps need to be added between each of the protocols for the three individual cubes and after the final  
acquisition protocol, as shown in supplementary Figure 5, to allow switching of filter cubes when conducting a macro.
20| Save the macro with a name that specifies the HV gain—e.g., ‘FRET 600’.
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21| Repeat Steps 16–20 for all remaining gains. Once successfully completed, a total of 12 macros corresponding to each of 
the specific HV gains will have been created.
establishment of an HV-lut to normalize pMt gains ● tIMInG 3 h daily over 1 week
22| Place an empty imaging dish on the microscope stage.
23| For background measurements, pipette 80 µl of HEPES buffer onto one edge of the empty dish.
24| Cover the dish with a lid in order to prevent rapid evaporation of the buffer.
25| Using bright-field illumination, navigate the objective to the border of the solution and focus. Subsequently, navigate 
toward the center of the solution and turn off bright-field illumination.
26| Direct the light beam to the PMT and obtain measurements using the ‘FRET 600’ macro. Repeat for all predetermined PMT 
HV gains. These measurements will give you 12 data points for each filter cube.
27| Rename the data set with a descriptive name and export as ‘Export Group’. This creates a .txt file that can be read and 
converted to Excel-compatible data using the provided MATLB script (supplementary Data 2).
28| Navigate to another region of the solution and repeat Steps 25–27 for at least 6–8 more spots of solution. Make sure to 
record several different positions in each dish.
29| Pipette 80 µl of a 1:10,000 dilution of Alexa Fluor 514 dye onto another edge of the imaging dish and ensure that the 
solutions remain well separated. Alternatively, a new imaging dish can be used.
 crItIcal step Make sure that the dye solution is homogeneous and that no undissolved or contaminating particles reside 
in the light beam.
30| Collect fluorescence signals with all available gains, as described in Steps 25–27. Reject data if the fluorescence signal 
collected is beyond saturation of the PMT detector or if the signal-to-noise ratio is low.
31| Navigate carefully to another region of the dye solution, and repeat the measurement (as described in Step 30) for at 
least eight more regions.
32| Repeat Steps 29–31 using two more dilutions of the Alexa Fluor 514 dye—e.g. 1:2,000 and 1:50,000 dilutions. Using the 
three different dilutions, fluorescence signals will be obtained that cover a broad range of the PMT gains.
? troublesHootInG
33| Use a new imaging dish and repeat Steps 29–31 with 80 µl of Proflavin at a 1:10,000 dilution.
34| Collect data for 1:2,000 and 1:100,000 dilutions of Proflavin dye, as described in Steps 29–31. Again reject data by 
criteria set in Step 30.
? troublesHootInG
35| Export the data as ‘Export Group’. For computation of the HV-LUT, read the exported data files derived from measure-
ments of different dilutions of Proflavin and Alexa Fluor 514 dye and background measurements (Steps 27 and 35) using the 
provided MATLAB script (supplementary Data 2), as described in Steps 36–41.
36| Subtract the background fluorescence from the dye measurements and use background-subtracted values for further 
calculations. The resulting table provides signal amplifications for each gain.
37| For Alexa Fluor 514 dye, use only signals that are measured using the FRET and YFP cubes. Similarly, for Proflavin dye, 
analyze only signals that are measured using the FRET and CFP cubes. Remove all other signals.
38| Normalize all signals to gain HV800 by dividing by the appropriate LUT factor. This yields the normalized amplification 
factor for each gain. The normalized amplification factor for gain HV800 will be 1.
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39| For each dye dilution, average the normalized fluorescence signals from all three filter cubes. This gives signals for 
HV600–HV1150 for the CFP cube, the YFP cube and twice for the FRET cube.
40| Visualize the data for the CFP cube, the YFP cube and the FRET cube by plotting HV gains (x axis) against the  
normalized amplification factors. The power-law relation can be visualized on a logarithmic plot. In this case, the relation 
forms a straight line. Exclude outliers at the extreme gains for each dye concentration.
41| Average normalized signals from different dilutions for the CFP and YFP cubes. Pool FRET cube signals measured by  
either of the dyes and average. The outcome is the final HV-LUT.
cell preparation and transfection for calibration of the setup ● tIMInG 2–3 d
42| Seed HEK293 cells at a density of 1 × 105 to 5 × 105 cells in 2 ml of growth medium on a 35-mm glass-bottom dish at 
least 2 d before the experiment. Prepare at least one imaging dish per sample. Refer to the table below to assess the total 
number of cell dishes needed for setup calibration.
sample purpose plasmid number of dishes to prepare
Background Determining background fluorescence according to Steps 53–62 No transfection 1
Donor only Determining RD1 and RD2 values according to Steps 63–73 Untagged CFP 1
Acceptor only Determining RA1 value according to Steps 74–77 Untagged YFP 1
Dimer Determining G-factor and MA/MD value according to Steps 78–99 YFP–G4–CFP 
YFP–G40–CFP 
YFP–G80–CFP
3 (1 dish per dimer plasmid)
 crItIcal step It is important that cells be well separated after seeding and after transfection. For FRET experiments, only 
single fluorescent cells are used, in order to avoid collection of light from adjacent cells.
43| Transfer cells to an incubator (37 °C and 10% CO2 atmosphere) and allow them to grow overnight to a density of  
60% confluence.
44| For transfection of cDNA plasmids, we use 25-kDa linear polymer PEI. Bring the transfection medium (serum free),  
transfection reagent PEI and relevant plasmids to room temperature and place them in a laminar flow work bench.
45| In a sterile 1.5-ml microtube, dilute 400–1,200 ng of appropriate cDNA plasmids in 200 µl of transfection medium.
46| Add PEI (1 mg/ml) to the diluted DNA mixture at a 3:1 ratio of total PEI (µg):total DNA (µg) to prepare DNA-containing 
liposomes. For example, for 1 µg of CFP plasmid, 3 µg of PEI would be added. The optimal PEI:cDNA ratio can vary between 
1:1 and 3:1 and may need to be adjusted to obtain optimal protein expression.
47| Incubate the cDNA/PEI mixture for 5–15 min at room temperature, and subsequently add this mixture to the cells.
48| Incubate the cells for 24–72 h at 37 °C and 10% CO2 atmosphere to allow for expression of the protein of interest.  
This time window needs to be individually adjusted to account for variability in rates of expression for proteins of interest.
preparation for Fret two-hybrid binding experiments ● tIMInG 20 min
49| Set the aperture of the adjustable pinhole or iris of the photometer (Fig. 1) to an appropriate size so as to acquire the 
fluorescence signal from an individual cell. In general, keep the size of the pinhole to a minimum; it should be just larger 
than a typical cell in order to reduce background fluorescence and enhance signal-to-noise ratio. This aperture is set before 
experimentation and maintained throughout the duration of each experiment. The pinhole is placed at the center of the field 
of view, as chromatic and spherical aberrations of the objective are least near the center of the optical axis. As a rule  
of thumb, only cells with a fluorescence signal at least seven times higher than background autofluorescence should be  
considered. This rule applies to the CFP and YFP cubes only, not to the FRET cube.
50| Turn on the fluorescence arc lamp at least 20 min before the experiment to ensure stable light output.
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51| Open the FelixGX software or equivalent software to control the monochromator and to acquire fluorescence measurements.
52| Ensure that the ‘Measure/View’ knob of the photometer is set to ‘View’ mode at all times other than during data  
acquisition, in order to protect the PMT from saturation.
Determination of background autofluorescence ● tIMInG 30 min daily over 1 week
53| Place a dish containing untransfected cells (background sample from Step 43) on the microscope stage.
54| Use bright-field illumination to bring a cell into focus (choose a cell with representative morphology).
55| Center the cell to the field of view of the pinhole by moving the microscope stage.
56| Toggle the photomultiplier to the ‘Measure’ position to enable fluorescence measurement.
57| Acquire fluorescence signals with all three filter cubes (CFP, FRET and YFP cubes) for all predetermined HV gains  
(i.e., ‘FRET 600’ macro to ‘FRET 1150’ macro). Start with the ‘FRET 600’ macro. Switch the filter cubes when prompted.  
For each cell, there will be 12 signals per filter cube.
58| Rename the data set with a unique descriptive notation (e.g., ‘Cell 1’) and export as ‘Export Group’.
59| Repeat Steps 54–58 for 10–15 more cells and export the data.
60| For calculation of background autofluorescence, open MATLAB and execute the ‘ReadFRETdata’ script (supplementary 
Data 2) for the data containing background measurements from Step 58. The MATLAB script converts the FelixGX data output 
to an input format suitable for Excel spreadsheets. The file exported in Step 58 contains data acquired from a single cell for 
the complete set of gains. The MATLAB script returns the average value of each trace for the fluorescence signals obtained 
with the CFP, FRET and YFP filter cubes. Alternatively, mean data can be computed with FelixGX or other software.
61| Open the Template Excel sheet provided as supplementary Data 3. Start with ‘Cell 1’ and paste data from Step 60  
into the ‘Background’ worksheet (supplementary Fig. 6). In column D the HV gain is specified, and in columns E–G the 
fluorescence signals specified in the header are deposited.
62| Repeat Steps 60 and 61 for the remaining files containing background data (from Step 59) and paste them into the provided 
space for ‘Cell 2’, ‘Cell 3’ and so on. in the Excel sheet. In the ‘Background’ worksheet, the average value of all cells for each gain 
and filter cube is automatically calculated (column: K8–M19) and transferred to all other sheets except the ‘HV lookup’ worksheet.
? troublesHootInG
Determination of the spectral factors RD1 and RD2 ● tIMInG 45 min daily over 1 week 
63| Place a dish containing cells expressing untagged CFP (donor sample, from Step 48) on the microscope stage. Move the 
CFP filter cube to within the light beam and start the ‘Continuous CFP excitation’ protocol.
64| Select an isolated fluorescent cell and place it into the field of view of the pinhole. Once a suitable cell is chosen, 
terminate the fluorescence illumination until you are ready to perform data measurement, in order to diminish  
photobleaching. If necessary, the bright-field light source can be used to position the cell.
65| Choose an appropriate HV gain for fluorescence measurement. The optimal HV gain depends on the expression level of 
the transfected plasmid and should match the brightness of the cell. Start with the ‘FRET 800’ macro when initially screening 
a sample. This standard gain is appropriate for intermediate-expressing cells. Switch to a higher or lower HV gain if necessary. 
For a sufficiently high signal-to-noise ratio, output signals between 100 mV and 4 V are required.
66| Load the appropriate macro, toggle the photomultiplier to the ‘Measure’ position and record data by starting the  
macro. Switch the filter cubes when prompted. You will obtain three fluorescence intensity signals from this measurement. 
The signal through the FRET cube yields SFRET(D, 436, 535), the signal through the CFP cube yields SCFP(D, 436, 480),  
and the signal through the YFP cube yields SYFP(D, 500, 535).
67| Rename the recording with an informative title and export as ‘Export Group’.
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68| Follow Steps 64–67 for an additional 10–15 individual cells. Select cells that express CFP at variable levels in order to 
collect data at different HV gains.
69| Calculate the spectral factors RD1 and RD2 from the data acquired in Steps 67 and 68 using the Template Excel sheet pro-
vided as supplementary Data 3, or create your own analysis template. If you are using the Template Excel file, convert the 
data obtained in Step 67 using MATLAB as described in Step 60 and paste them into columns E–G (raw data) of the ‘RD value’ 
worksheet (supplementary Fig. 7). Continue for all cells acquired in Step 68.
 crItIcal step The spectral ratios RD1 and RD2 are specific for a given FRET setup and need to be determined for each  
individual FRET setup. It is necessary to verify these values before daily experiments.
? troublesHootInG
70| For each cell, specify the HV gain at which the signal was recorded in column D.
71| Subtract background signals for the corresponding HV gain from each trace. In the ‘RD value’ worksheet of the Excel 
spreadsheet, background subtraction is automatically performed (columns: I–K).
72| Calculate the RD1 value by dividing the background-subtracted FRET signal by the background-subtracted CFP signal (RD1 = 
SFRET(D, 436, 535)/SCFP(D, 436, 480)). This step is automatically performed in the Excel worksheet. The RD2 value is also calculated  
at this point (RD2 = SYFP(D, 500, 535)/SCFP(D, 436, 480)). For our setup, RD2 is so small that it will not be further considered.
73| Average the RD1 and RD2 values from single cells (data in column M) to obtain the overall RD1 and RD2 values (cells P9  
and Q9). The calculated RD1 value is automatically transferred to the dimer sheet and the binding curve analysis (‘BC analysis’) 
sheet for further analysis.
Determination of the spectral factor Ra1 ● tIMInG 45 min daily over 1 week
74| For determination of spectral factor RA1, use YFP-only-expressing cells (from Step 48) and follow Steps 63–68 using  
500-nm excitation and ‘Continuous YFP excitation’ for selection of cells. Again, measure 10–15 individual cells.
75| Read out the data using MATLAB (Step 60), paste these values into columns E–G (raw data) of the ‘RA value’ worksheet 
(supplementary Data 3, supplementary Fig. 7) and specify the HV gain in column D. The background is automatically 
subtracted (columns I–K).
 crItIcal step The spectral ratio RA1 is specific to an individual FRET setup and needs to be determined for each individual 
FRET setup. It is necessary to verify the value before daily experiments.
? troublesHootInG
76| Calculate the RA1 ratio by dividing the background-subtracted FRET signal by the background-subtracted YFP signal  
(RA1 = SFRET(A, 436, 535)/SYFP(A, 500, 535)). The value is automatically computed in the Excel sheet, column M.
77| Average the RA1 values from single cells to obtain the mean RA1 value (cell P9). The calculated RA1 value is automatically 
transferred to the ‘Dimer’ sheet and the ‘BC Analysis’ sheet for further analysis.
Determination of calibration constants using dimers ● tIMInG 90 min daily over 1 week
78| For determination of FRET efficiencies from dimers, place cells expressing a dimer plasmid (e.g., YFP–G4–CFP, from Step 
48) under the microscope.
79| Under continuous CFP illumination, select an isolated cell expressing the dimer at an intermediate level.
80| Switch to continuous YFP illumination and inspect the YFP expression of the cell.
81| Switch to bright-field illumination and center the cell in the visual field.
82| Direct the light beam to the photomultiplier and center the cell in the pinhole aperture of the photometer.
83| Record fluorescence intensities with an appropriate gain as described in Step 65. Choose a gain so that the signal falls 
into a range between 100 mV and 4 V.
? troublesHootInG
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84| Export the data and repeat Steps 78–83 for at least 15 cells. Choose cells with different expression levels.
85| Collect data for multiple dimers (each dimer separately, for example Y–G40–C, Y–G80–C) by following Steps 78–84.
 crItIcal step We recommend measuring three cube fluorescence measurements from all dimers across several days.  
Once a stable calibration curve is calculated, it is sufficient to determine FRET efficiencies for one dimer daily.
? troublesHootInG
86| For calculation of FRET efficiencies from dimers, read data files acquired in Step 84 using MATLAB and paste them into 
columns E–G of the ‘Dimer’ worksheet (supplementary Fig. 8).
87| Specify the gain used for each cell in column D.
88| Subtract the corresponding background value from each measurement (columns J–L).
89| Calculate the Fc/(RA1 · SYFP) value according to equation (5) (box 1) using the computed RD1 and RA1 values  
(Steps 73 and 77; Excel spreadsheet cell F2 and cell F3), respectively.
90| Continue with data from cells expressing each of the distinct dimers (Step 85) and repeat Steps 86–88 for analysis and 
calculate the Fc/(RA1 · SYFP) values of these dimers. The sheet calculates the average Fc/(RA1 · SYFP) value for each dimer  
and deposits it in column O in the cell indicated.
91| To analyze the dimer series experiment, open the ‘Dimer Analysis’ worksheet provided in the Excel spreadsheet  
(supplementary Fig. 9).
92| Transfer the background-subtracted raw data (SCFPFRET, SFRETFRET, SYFPFRET) from Steps 89 and 90 to the ‘Dimer Analysis’ 
worksheet, columns D–G.
93| For each cell from Step 92, compute FC according to equation (5) and subsequently compute the Fc/SYFP and SCFP/SYFP 
values using the background-subtracted raw data. This step is automated in the worksheet (columns H–J, subheader  
‘Calibration by Dimer Series’).
94| Substitute actual RA1 and RD1 values measured daily (in contrast to dimers) in the equations RD1/RA1 · SCFP/SYFP and 
1/RA1 · Fc/SYFP. These values represent the x and y coordinates for individual points (columns K,L) in the graph (top right).
 crItIcal step For a FRET two-hybrid binding experiment, the RA1 and RD1 values should be updated each day, to  
account for daily fluctuations. By contrast, it is sufficient to use measurements from dimers acquired during the calibration 
phase of the rig.
95| Plot the data from Step 94 in a linear diagram. In the Excel sheet, data are automatically plotted in the top graph  
on the right-hand side. Data points for each dimer cluster together.
96| Calculate the mean SCFP/SYFP · RD1/RA1 and FC/(RA1 · SYFP) values for each dimer construct (columns M and N) and plot 
them into a graph, as shown in the lower graph on the right-hand side in the worksheet.
97| Compute a linear regression line for the data obtained in Step 96 and calculate both the y intercept and the slope of the 
regression. The values are used to determine the G factor and MA/MD value. Copy the y intercept and slope and paste them 
into cells T56 and T57, respectively, of the ‘Dimer Analysis’ worksheet. Please note that this step needs to be performed 
manually.
98| From the data obtained in Step 97, calculate the εYFP(436)/εCFP(436) value by dividing 1 by the y intercept, and  
calculate the MA/MD value by dividing the negative slope (G factor) by the y intercept. These values should be pasted  
into cells W56 and W57. Please note that this step needs to be performed manually.
99| Set MD to 1 in order to obtain MA (MA then equals the MA/MD ratio). Alternatively, the computed MD value could be set 
here. In the latter case, the MA value is then set such that MA/MD is as experimentally determined. Transfer the MA/MD ratio 
and the εYFP(436)/εCFP(436) value to cells F7 and F10 of the ‘BC Analysis’ sheet. Please note that this step needs to be  
performed manually (supplementary Data 3).
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cell preparation and transfection to perform a Fret two-hybrid experiment ● tIMInG 2–3 d
100| For a FRET two-hybrid experiment, seed and transfect cells as described in Steps 42–48. The table below lists the 
samples required for an experiment. Prepare experimental cells as required according to the experimental design. Depending 
on the expression efficiency of the cDNA plasmids, it may be necessary to prepare more than one imaging dish for coexpres-
sion of interacting partners (biological samples), in order to achieve variable expression levels, which is fundamental to the 
outcome of the binding assay. We recommend starting with a 1:1 transfection (CFP-tagged protein:YFP-tagged protein) and 
to subsequently adjust the ratio to obtain varying ratios of donor and acceptor expression.
 crItIcal step To obtain a completely populated binding curve, it is important to achieve variability in expression levels 
of interaction partners. In our experience, a PEI transfection reagent is best suited to obtaining heterogeneous expression 
levels. However, we encourage researchers to test other transfection reagents for their particular cDNA plasmid.
sample purpose plasmid number of dishes to prepare
control cells
Background Determining background fluorescence (Step 101) No transfection 1
Donor only Determining RD1 and RD2 values (Step 101) Untagged CFP 1
Acceptor only Determining RA1 value (Step 101) Untagged YFP 1
Dimer (optional) Positive control (Step 101) e.g., YFP–G4–CFP 1
Spurious FRET Determining collisional FRET (Steps 102–109) Cotransfect untagged  
CFP and untagged YFP
1
experimental cells
Biological samples Determining the interaction of proteins Cotransfect protein- 
tagged CFP and YFP
1 or morea
Control biological samples Positive control 1 or morea
aDepending on experimental design.
Measurement of background, spectral factors Ra1 and RD1, and dimer control ● tIMInG 90 min
101| Measure and analyze the control samples from Step 100 as described in Steps 53–84 in order to determine the  
following: background autofluorescence (background sample, Steps 53–62), RD1 and RD2 values (donor-only sample, Steps 
63–73), RA1 value (acceptor-only sample, Steps 74–77) and the efficiency of one dimer to ensure stability of measurements 
between experimental days (dimer sample, Steps 78–84, for one dimer). It is recommended to include one dimer per  
experimental day in routine FRET experiments.
 crItIcal step The background autofluoresence results from cellular metabolites and weakly fluorescent amino acids in 
proteins. These contaminating factors may vary daily depending on the cell conditions. It is therefore critical to measure 
autofluorescence background before each FRET experiment and use these values for analysis.
 crItIcal step On a calibrated setup, it is sufficient to measure 5–8 cells, as the values are expected to be reasonably  
stable within a cell preparation. If the RA1 and RD1 values are not stable, FRET cannot be measured reliably.
Determination of spurious Fret ● tIMInG 30 min 
102| For the determination of spurious FRET, acquire fluorescence signals from cells expressing untagged CFP and YFP  
molecules (from Step 100) according to Steps 79–83.
103| Repeat signal acquisition for 10–15 cells and export data.
104| Use the MATLAB script to import the raw data obtained in Step 103 into columns D–F of the ‘Spurious FRET’ worksheet 
(supplementary Fig. 10). In column C, specify the HV gain.
105| For each measurement, subtract the corresponding appropriate background value (columns H–J).
106| Calculate Fc/(RA1 · SYFP) (column K) and EA (column M) according to equations (5 and 6), respectively. The values for 
RA1 and RD1 are picked from cells F3 and F4.
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107| Determine CFPEST, taking the HV-LUT (Sheet 9) into consideration to normalize for different HV gains. Calculate CFPEST 
according to equation (12) (automatically performed in the Excel worksheet, column L). The RD1 and MD values required for 
this calculation are chosen from cells F4 and F5.
108| Plot EA as a function of CFPEST and perform a linear regression on the data points (graph on the right-hand side  
in the worksheet).
109| Transfer the slope of the regression line to cell P7.
Determination of Fret efficiencies from cFp- and YFp-tagged Fret pairs ● tIMInG 1–3 h
110| For the determination of FRET efficiencies from CFP- and YFP-tagged biomolecular interaction partners, record signals 
from at least 25 cells according to Steps 79–83. Perform measurements on imaging dishes transfected with different ratios  
of CFP- and YFP-tagged proteins, if necessary.
 crItIcal step For binding analysis, it is necessary to choose cells with varying expression of CFP- and YFP-labeled  
proteins. Inspect the sample carefully under both CFP and YFP excitation, and preferentially include cells displaying varying 
ratios of CFP and YFP expression. This variability in cellular expression is critical to populating both the rising and saturating 
portions of the FRET two-hybrid binding curve (Fig. 6).
? troublesHootInG
111| To calculate the FRET efficiencies of CFP- and YFP-tagged interaction proteins, read fluorescence intensities obtained in 
Step 110 using MATLAB and paste the data into columns E–G of the ‘Samples’ worksheet.
112| Specify the gain used for each cell in column D.
113| From each measurement, subtract the corresponding appropriate background value (columns J–L).
114| Calculate FC/(RA1 · SYFP) using the RA1 and RD1 values from cells G2 and G3, respectively. This is automated in  
the Excel template. These values are further used for construction of a binding curve and automatically linked to the  
‘BC Analysis’ worksheet.
construction of a binding curve ● tIMInG 30 min–2 h
115| The table on the top left of the ‘BC Analysis’ worksheet is subdivided into three sections (supplementary Fig. 11). 
The left part contains the FRET parameters. Here, RA1 (cell F4), RD1 (cell F5), MA (F8) and the MA/MD ratio (F10) are collected 
from the linked worksheets. Calculate MD (cell F9) according to supplementary note 1 and supplementary Data 1 and 
transfer the εYFP(436)/εCFP(436) value (cell F7) manually from the ‘Dimer Analysis’ worksheet. The middle part of the table 
contains parameters required for spurious FRET correction. Here, the slopes of the spurious FRET relations for 33-FRET  
(cell I5; SpFRET_E_3Cube) and EFRET (cell I6; SpFRET_E_EFRET) are tabulated. Confirm that the values in the left and the 
middle part of the table have been correctly transferred from the individual sheets linked to this table. The right part of  
the table contains parameters relevant for the fitting procedure (Steps 121–128).
116| Make sure that background-subtracted values, including the respective gains and the FC/(RA1 · SYFP) values from Steps 
113 and 114 are transferred from the ‘Samples’ worksheet into columns D–H of the ‘BC Analysis’ worksheet.
117| Calculate the EA and ED efficiencies according to equations (6 and 7) presented in box 1 and deposit the values in 
columns I and K, respectively. This step is automatically performed in the Excel sheet.
118| Correct the EA and ED efficiencies for spurious FRET (automated in columns J and L of the Excel sheet) according to 
equations (27 and 28), respectively, and the parameters presented in the top table in the ‘BC Analysis’ worksheet.
119| Total CFPEST (column M) and YFPEST (column N) are calculated according to equations (10 and 12), respectively, using 
parameters specified in the top table (‘BC Analysis’ worksheet). Ensure that both formulas are corrected for HV gain, that  
the background is subtracted from the raw signals and that efficiencies are corrected for spurious FRET.
120| Divide CFPEST by YFPEST. For dimers, this value is expected to be ~1 (column O).
 crItIcal step For FRET-binding curves, only cells with a CFP/YFP ratio <20 are probed. Importantly, a CFP fluorescence 
value that is too large, in comparison with the YFP fluorescence value, could corrupt the measurement of sensitized emission 
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and lead to large errors in measured FRET efficiencies. These general criteria must be adjusted to account for the quantum 
yields of the fluorescent pairs and the microscopy setup.
? troublesHootInG
121| To fit a binding curve to FRET data, FRET efficiencies (EA and ED), as well as CFPEST and YFPEST values, have to be 
calculated for each individual cell as specified in Steps 115–120. For the fitting procedure, the right-hand side of the table 
(‘BC Analysis’ worksheet), the graphs titled ‘three cube FRET’ and ‘E-FRET’ (‘BC Analysis’ worksheet), and columns P–AA are 
relevant (supplementary Data 3). Placeholders for Kd,EFF, EA,max and ED,max have been prepared in the right-hand side of 
the table. These parameters are called Kd,EFF, EA,max and ED,max and have been deposited in cells K4, K6 and K7, respectively. 
SUM_Err_3Cube (cell K8) and SUM_Err_EFRET (K9) represent the sum of squared error between predicted and experimentally 
observed EA and ED values. Total Error (K10) is the sum of both types of error (SUM_Err_3Cube + SUM_Err_EFRET).  
The parameters ND/NA (K5) and ND/NA exp (K11) are the theoretical and the experimentally observed stoichiometries of the 
binding reaction and are assumed to be 1 in a 1:1 binding reaction, as presented in the example data set. The idea of the 
fitting procedure is as follows: By analyzing the entire data set, a nonlinear least-square fitting procedure is performed to 
obtain an estimate of the Dfree and Afree values (columns P and Q), the maximal efficiencies EA,max and ED,max (K6 and K7), 
and the relative binding affinity Kd,EFF of the binding reaction (K4). To obtain approximations of the parameters EA,max or 
ED,max and Kd,EFF for the single-site binding model, a visual fit is performed first. Start with initial guesses for Kd,EFF (cell K4), 
EA,max (K6) and ED,max (K7). The final fit for the binding curve is obtained following an iterative fitting procedure.
122| According to equations (17 and 19) in box 2, estimate Dfree and Afree and deposit the values in columns P and Q of  
the sheet. Both Dfree and Afree change as Kd,EFF changes. Thus, it is helpful to visualize the data points on the corresponding 
test binding curve during the fitting procedure. Accordingly, both 33-FRET (EA) and E-FRET (ED) are plotted against Dfree and 
Afree, respectively (top graphs, middle and right). To build an intuition for the procedure, manually change the Kd,EFF value 
and observe how the Dfree and Afree values change. In addition to Dfree and Afree, Ab and Db are calculated according to  
equations (20 and 21) (box 2) and deposited into columns R and S, respectively.
123| In parallel, predicted EA and ED values are calculated according to equations (6 and 7) (box 1) and deposited into 
columns T and V. From predicted EA and ED values and experimentally determined EA and ED values, the errors ‘EA pred  
Error’ (column U) and ‘ED pred Error’ (column W) are calculated. The sums of ‘ED pred Error’, ‘EA pred Error’, and ‘total error’ 
are deposited in cells K8, K9 and K10, respectively.
124| Iteratively adjust the fitting parameters to obtain a best fit (lowest errors). Maximal FRET efficiencies and Kd,EFF values 
should be identical for 33-FRET (EA,max) and E-FRET (ED,max) for a 1:1 binding stoichiometry.
125| Subsequently, use the Excel solver to optimize these parameters using the visual fit parameters from Steps  
125–128 as initial guesses. Open the Excel solver by clicking ‘Data’ → ‘Solver’ (supplementary Fig. 12)52. In case the  
Excel solver is not activated, activate it by clicking ‘Folders’ → ‘Options’ → ‘Add-Ins’. Choose ‘Excel-Add-Ins’ in the ‘Manage’ 
drop-down menu, and hit the ‘OK’ button. In the ‘Add-Ins’ window, check the ‘Solver’ checkbox and click ‘OK’. When asked  
to confirm, choose ‘Yes’.
126| In the ‘Solver Parameters’ window, specify entries for ‘Set Target Cell’, ‘Equal To’, ‘By Changing Variable Cells’ and ‘Subject  
to the Constraints’. supplementary Figure 12 shows how the parameters are set. ‘Set Target Cell’ determines which value  
is to be optimized. In the sample spreadsheet, this is set to cell K10 (supplementary Fig. 12a), which is the total error 
(e.g., SumErr_3Cube plus SumErr_3Cube). In this case, 33-FRET and E-FRET curves are fitted simultaneously. If you would  
like to fit the 33-FRET graph alone, the target cell to be optimized needs to be set to cell K8 (SumErr_3Cube; supplementary 
Fig. 12b); if you would like to fit the E-FRET curve alone, then set target cell to K9 (SumErr_ECube).
127| Set ‘Min’ in the ‘Equal To’ selection. ‘By Changing Variable Cells’ defines the adjustable parameters, which in our case 
are Kd,EFF, EA,max and ED,max, contained in cells K4, K6 and K7, respectively. In ‘Subject to the Constraints’ impose constraints 
on the adjustable parameters. Here, it is useful to constrain Kd,EFF, EA,max and ED,max to ≥0.
128| In the ‘Solver Parameters’ window (supplementary Fig. 12), click the ‘Solve’ button to initialize Solver.  
Now, a prediction is calculated and the difference is calculated according to equations (22 and 23) (box 2).  
The solver now minimizes the sum-of-square errors between predicted and observed values. The results are deposited  
in cells K4, K6 and K7.
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? troublesHootInG
Troubleshooting advice can be found in table 3.
● tIMInG
Implementation and calibration of the FRET imaging setup: 1-week period
Steps 1–6, generation of acquisition programs for screening and selecting cells: 15 min
Steps 7–9, determination of the dark current of the PMT: 15 min
Steps 10–15, generation of acquisition programs for FRET two-hybrid binding experiments: 45 min
Steps 16–21, generation of macros for FRET two-hybrid binding experiments: 45 min
Steps 22–41, establishment of an HV-LUT: 3 h daily over 1 week
Steps 42–48, cell preparation and transfection for calibration of the setup: 2–3 d
Steps 49–52, preparation for FRET two-hybrid binding experiments: 20 min
Steps 53–62, determination of background autofluorescence: 30 min daily over 1 week
Steps 63–77, determination of spectral factors RD1 and RD2: 45 min daily over 1 week
Steps 74–77, determination of the spectral factor RA1: 45 min daily over 1 week
Steps 78–99, determination of calibration constants using dimers: 90 min daily over 1 week
Step 100, cell preparation and transfection to perform a FRET two-hybrid experiment: 2–3 d
Step 101, measurement of background, spectral factors RA1 and RD1, and dimer control: 90 min
Steps 102–109, determination of spurious FRET: 30 min
table 3 | Troubleshooting table.
step problem possible reason solution
32, 34 Not all HV gains are covered Fluorescence intensity of the dyes 
does not match the detection range
Prepare new dilutions
62 Automated background subtraction  
is not correct
The link within the Excel sheet is  
not correctly defined
Check and redefine the lookup function in the 
Excel spreadsheet
69 Large intra-experimental fluctuations 
in RD1 values
Problem with detector Check hardware settings; stabilize the detector
Large interexperimental fluctuations 
in RD1 values
Problem with detector Check hardware settings; stabilize the detector
Filters are aging Exchange filter sets
75 Large intra-experimental fluctuations 
in RA1 values
Unstable excitation lamp Prewarm the excitation lamp; stabilize power 
supply; exchange lamp bulb
Large interexperimental fluctuations 
in RA1 values
Unstable excitation lamp Stabilize power supply; exchange lamp bulb
Systematic shift and drift of RA1 value, 
which is not improved by changing 
the light bulb
Filters are aging Exchange filter sets
83 PMT saturation Fluorescence intensity is too high Use a lower HV gain; retransfect cells
85 RA1 and RD1 values are stable but 
FC/RA1*SYFP and FRET efficiencies  
vary considerably for one dimer
Related to fluorophore maturation Use cerulean and venus fluorescent  
proteins instead of CFP and YFP
110 Less variation in expression levels Suboptimal transfection of cells Transfect a smaller amount of cDNA; wait 
longer for expression
Data points do not populate all 
phases of a binding curve
No variability in expression levels of 
interacting partners
Transfect different ratios of CFP- and  
YFP-tagged proteins
120 CFPEST/YFPEST ratio is much larger  
than 1 for dimers
Degradation of cDNA Use another batch of plasmids
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Steps 110–114, determination of FRET efficiencies from CFP- and YFP-tagged FRET pairs: 1–3 h
Steps 115–128, construction of a binding curve: 30 min–2 h.
antIcIpateD results
Indicators of a successful microscope setup
A stable FRET microscopy setup is critical for high-quality quantitative FRET experiments. The three key indicators of a  
successful setup are as follows:
 Stability of the excitation light source indicated by stable RA1values. The RA1 value is mainly determined by the excitation  
system (Fig. 4) and is measured daily while establishing the FRET setup and during the course of FRET –two-hybrid experiments. 
Short-term (i.e., day-to-day and over the course of a single experiment) fluctuations in fluorescence output and/or intensity of 
the arc lamp are indicated by variability of RA1 values (Fig. 9; table 4). For our setup, the range of RA1 values is 0.025–0.045 
for YFP and should be stable in cells (Fig. 9a). RA1 measurements using dyes should also be very stable (for our setup, the 
range of RA1 values for Alexa514 dye was 0.049–0.058). An important cause of highly variable RA1 values is fluctuations of the 
excitation lamp caused by an unstable power supply or intensity fluctuations of the light bulb. When RA1 values are stable when 
measured using the Alexa Fluor 514 dye but unstable in cells, the problem may pertain to cell transfection and fluorophore 
maturation. Standardization of cell transfection and culture conditions will alleviate this potential problem. Long-term decay 
(i.e., over the course of several months) in fluorescence output due to aging of the excitation lamp is indicated by variation  
in RA1 values over the course of several months and needs to be compensated for, as outlined in Equipment Setup.
 Stability of the detection system, indicated by RD1values. RD1 mainly depends on the emission pathway, in particular, on the 
detector (Fig. 4). Thus, stability of the emission light detector is indicated by low variability of RD1 values. However, for RD1 
values to faithfully represent stability of the detection system, the following system parameters must be low: the dark  
current of the PMT; the noise level associated with empty glass imaging dishes; and background fluorescence in nontrans-
fected cells. Representative and acceptable values for these parameters are given in table 4. For our setup, the range of RD1  
values obtained for Proflavin dye was 1.025–1.049, and the observed range of RD1 values for CFP was 0.24–0.27 (Fig. 9b).  
RD1 can be roughly calculated for the filter cubes used from the emission spectrum of CFP and also from the quantum  
•
•
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Figure 9 | Stability of spectral correction factors and amplification factors. (a) Typical daily variation in RA1 values observed over 20 experimental days. 
(b) Daily variation in RD1 values, observed over the same time period. (c) Plot of the normalized amplification factor (Step 41) obtained based on intensity 
measurements of fluorescent dyes versus high voltage shows a power-law relation. Amplification factors are normalized to a standard PMT HV gain of 800 V. 
PMT HV, photomultiplier tube high voltage. 
table 4 | Background and RA1, RD1 and RD2 values (at HV gain 800).
entity cFp cube Fret cube YFp cube
Blank cells (autofluorescence) 0.0129 mV (±0.0001) 0.0132 mV (±0.0001) 0.0097 mV (±0.0001)
Noise from empty imaging dish 0.0923 mV (±0.0001) 0.0729 mV (±0.0001) 0.0443 mV (±0.0001)
Noise from imaging buffer 0.0109 mV (±0.0001) 0.0093 mV (±0.0001) 0.0082 mV (±0.0001)
Dark current range 0.2957 mV (±0.005) 0.2957 mV (±0.005) 0.2957 mV (±0.005)
Ra, RD values
RD1 value 0.2651 (±0.0001)
RD2 value 0.0008 (±3.8E-05)
RA1 value 0.03394 (±5.079E-05)
Values are means (n = 15) ± s.e.m.
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efficiency of the detector used. Deviation of the  
experimentally determined RD1 value from the theoretical 
value suggests a likely malfunction of the detection system 
or the PMT. Possible causes of deviations include incorrect 
mode of operation for the PMT (photon counting instead of 
analog) or specific hardware settings in the configuration  
panel of the software. Importantly, the detector is nonlinear 
below a HV gain of 600 V and may contribute to unreliable 
measurements. We recommend recording of data from dim 
cells at a high HV gain. The optimal HV range is 600–1, 
150 V. For very dim cells that may require an HV gain of 
1,150 V or above, the signal-to-noise ratio decreases,  
which makes them are prone to measurement errors.
 Stability of the HV-LUT for the PMT. Stability of the HV-LUT is 
indicated by low fluctuations of individual values for a given 
gain, as presented in Figure 9c and table 5. Before  
determination of the HV-LUT, it is absolutely required that RD1 
and RA1 recordings be stable in cells throughout all HV gains. 
The lookup table is typically determined using fluorescence 
dyes and can be verified by measuring intensity signals from 
fluorescent cells using a range of HV gain settings during 
the calibration phase of the FRET rig (table 5). In addition, 
intensity recordings from nontransfected cells should be used 
for validation of the table. Once the lookup table has been 
generated, it can be repeated yearly to confirm reproducibility of the system.
assessing the outcome of Fret –two-hybrid analysis
Once the RD1 and RA1 values are stable and an HV-LUT is obtained, actual FRET measurements can be performed. For FRET 
experiments, five controls are required in addition to the FRET measurements from CFP- and YFP-tagged binding pairs;  
these help gauge the validity of the FRET experiment:
 Background autofluorescence in untransfected cells
 RA1 values from YFP-only-expressing cells
 RD1 values from CFP-only-expressing cells
 Measurements from cells expressing CFP–YFP dimers to generate a calibration curve
 Measurement of spurious FRET from cells expressing CFP and YFP monomers
Background autofluorescence values in untransfected cells, RA1 values from YFP-only-expressing cells and RD1 values from 
CFP-only-expressing cells need to be stable, and there are four quality checks to ensure the validity of these measurements:
•
•
•
•
•
•
table 5 | Lookup table for PMT HV gain factor.
pMt high-voltage HV (V)
amplification factor SX(HV)/
SX(800 V) (mean ± s.e.m.)
600 0.118 ± 0.001
650 0.214 ± 0.002
700 0.371 ± 0.002
750 0.617 ± 0.002
800 1
850 1.579 ± 0.003
900 2.420 ± 0.008
950 3.647 ± 0.013
1,000 5.427 ± 0.025
1,050 7.961 ± 0.050
1,100 11.306 ± 0.059
1,150 16.231 ± 0.140
20
10
0
0 1 2
Fc
RA1 • SYFP
(RD1 • SCFP)/(RA1 • SYFP)
C/   Y = 18.6
G = 8.3
ε ε
YFP–G4–CFP
YFP–G10–CFP
YFP–G40–CFP
YFP–G80–CFP
Y–G4–C Y–G40–C
Y–G10–C Y–G80–C
EA
(mean ± s.e.m.)
0.296 ± 0.001 0.299 ± 0.004
0.223 ± 0.003
0.158 ± 0.002
0.116 ± 0.002
0.228 ± 0.002
0.156 ± 0.002
0.116 ± 0.001
ED
(mean ± s.e.m.)
a b
Figure 10 | Determination of the G factor and the excitation ratio using dimers. (a) Calibration line obtained from CFP and YFP dimers connected by linkers 
of either 4, 10, 40 or 80 glycine (G) residues. Mean values are given by the larger colored circles. Individual data points are the smaller open colored points. 
From the linear regression line (black line), the G factor (slope) and the ratio of excitation coefficients (y intercept) are determined. (b) Table shows mean 
33-FRET and E-FRET values experimentally determined for the various CFP–YFP dimers transfected into HEK293 cells, computed using equations for 33-FRET 
(EA, equation 6) and E-FRET (ED, equation 7) with experimentally determined calibration factors (n = 12–15).
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(1) Inspect RA1 values: if negative RA1 values are obtained (RA1 < 0), autofluorescence intensity recordings are not stable and 
are possibly overestimated.
(2) Inspect FRET efficiencies: efficiencies <0 suggest that RD1 values are not stable and may be overestimated.
(3) For YFP-only-expressing cells, FRET efficiency should equal 0. If not, RA1 has not been determined correctly.
(4) For CFP-only-expressing cells, SFRET(DA, 436, 453) – RD1·SCFP(DA, 436, 480) should be zero. If not, RD1 has not been 
determined correctly.
The measurements of several CFP–YFP dimers are used to calculate a calibration curve from which the G factor and the  
excitation ratio are determined (Fig. 10). Depending on the donor and acceptor fluorophores used, the variation of individual  
data points of this curve is more or less pronounced. Given that RD1 and RA1 values are stable, variations in FRET efficiencies 
are larger for CFP and YFP dimers compared with cerulean and venus pairs. The cerulean and venus pairs may mature faster 
and more completely (~100%), resulting in more robust FRET measurements. For CFP–YFP dimers, EA and ED should be the 
same, and plotting ED versus EA should result in the line of unity. Furthermore, the experimentally determined CFPEST (ND) 
and YFPEST (NA) values should be equal, as the two fluorophores are tethered. Deviation from equality would suggest  
proteolysis or immature proteins. The range of FRET efficiencies for the set of dimers used is between 10 and 40%.
Spurious FRET is determined by using cells expressing CFP and YFP monomers (Fig. 11a) and plotting EA and ED versus 
CFPEST and YFPEST, respectively. The relationship should be linear. This value is subtracted from binding curves in order to 
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Figure 11 | Examples of spurious FRET and FRET two-hybrid binding curves. (a) Left, diagram illustrates untagged CFP and YFP FRET pair used to determine 
spurious FRET by 33-FRET (middle) and E-FRET (right). (b) Left, schematic of a FRET two-hybrid assay evaluating the binding of CFP-tagged calmodulin 
(CFP–CaMWT) to the sixth YFP-tagged myosin Va IQ domain (YFP-IQ) at resting Ca2+ concentrations. Middle, 33-FRET computed from three cube fluorescence 
measurements from single cells expressing both YFP-IQ and CFP–CaMWT, plotted against the free concentration of donor molecules (CFP–CaMWT), reveal a  
robust binding curve. Right, E-FRET efficiency computed from the same fluorescence measurements is plotted against the free acceptor concentration  
(YFP-IQ). Note that estimates for the maximum or saturating FRET efficiency (Emax) and the relative binding affinity (Kd,EFF) are identical using the 33-FRET 
and E-FRET methods (Dfree or Afree at half-saturation, respectively). (c) Robust binding of YFP-tagged IQ domain from the voltage-gated Ca2+ channel CaV1.2 
to CFP–CaMWT at elevated cellular Ca2+ conditions. Format as in panel b. Note again that the binding isotherms estimated are identical using the 33-FRET and 
E-FRET methods (black fit).
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quantify FRET as a result of binding. Spurious FRET can also occur between two dimers. The amount of spurious FRET depends 
on the cell volume. As splitting of the cells during cell culture can change cell volume on a day-to-day basis, spurious FRET 
control experiments need to be performed daily.
Example results from two FRET two-hybrid binding assays are shown in Figure 11b,c. Figure 11b presents representative  
graphs for 33-FRET and E-FRET binding curves between myosin Va IQ peptide and calmodulin under low Ca2+ conditions. 
Figure 11c presents representative graphs for 33-FRET and E-FRET binding curves for interaction of CaV1.2 IQ peptide with 
calmodulin under elevated Ca2+ conditions. From the graph it is evident that all points are localized very closely to the fitted 
line, indicating low noise in FRET measurement. The results illustrate the high-affinity binding of calmodulin to the distal  
IQ segment of myosin Va (Fig. 11b) and the IQ domain of CaV1.2 (Fig. 11c) at basal cytosolic Ca2+ levels. The differences  
in maximal apparent FRET efficiencies for CaM binding to the two IQ domain peptides indicate that their binding conforma-
tions may be distinct. The high affinity binding for both IQ domain peptides fit with in vitro binding assays53,54. Together, 
these results demonstrate that FRET two-hybrid assays are well suited for in-depth quantification of macromolecular  
interactions in living cells.
Note: Any Supplementary Information and Source Data files are available in the 
online version of the paper.
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Supplementary Figure 1 
Linearity of fluorescence detection subsystem 
(a) Fluorescence intensity measured through the YFP cube is linearly proportional to the concentration of Alexa Fluor 514 
dye. This result illustrates the linearity of the PMT detector enabling robust estimation of number of acceptor molecules. 
(b) Fluorescence intensity measured through the CFP cube is also linearly proportional to the concentration of Proflavin 
dye. 
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Supplementary Figure 2 
Main graphical user interface of Felix GX 
(a) The tab “Delta Ram Analog” (right upper corner) is clicked to open the “Hardware Configuration” window 
(Supplementary Fig. 2a). (b) The setup tab is selected (left lower corner) to open the “Setup” window (Supplementary 
Fig. 2b). (c) The “Action” tab opens the “Macro” window from which the “Macro Editor” window is opened 
(Supplementary Fig. 4). 
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Supplementary Figure 3 
The “Hardware Configuration” window and the “Setup” window. 
(a) Settings for the “Hardware Configuration” window. (b) Settings for the “Setup” window. From the 10 tabs in the 
“Setup” window select “Acquisition Type” and click the option “Timebased”. 
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Supplementary Figure 4 
Parameter settings specific for Timebased acquisition in the “Setup window”. 
(a) Acquisition settings; (b) PMTs; (c) Backgrounds; (d) Traces tab. 
Nature Protocols: doi:10.1038/nprot.2016.128
 
 
 
 
Supplementary Figure 5 
Setup of Macros using the “Macro” and the “Macro Editor” window. 
(a) Open the “Macro” window by clicking the “Action“ tab in the main graphical user interface (Supplemental Fig. 1). 
Click the green “+” button to open the “Macro Editor” window (b and c). In this window, different actions (listed on the 
left hand side) can be added to the macro (list on the black panel on the right hand side). In this example, a pause step (b) 
and a protocol (Run Acquisition; c) is added to the macro by clicking the Add tab. 
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Supplementary Figure 6 
Data input field of the Background sheet. 
(a) Raw data pasted into the respective columns from measurements using CFP- FRET- and YFP-cubes at a distinct HV 
gain. (b) The excel sheet contains 9 individual sub sheets (labeled from left to right: Background, RD-value (CFP), RA-
value (YFP), Dimer sheet, Dimer Analysis, Spurious FRET, Samples (FRET sample data), BC Analysis and HV lookup. 
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Supplementary Figure 7 
Data input field of the RD-value (CFP) and the RA-value (YFP) sheets. 
Raw data are pasted into the respective columns on the left hand side from measurements in (a) CFP-only or (b) YFP-
only expressing cells using CFP- FRET- and YFP-cubes at a distinct HV gain. Background subtraction and RA value 
calculation is performed automatically.  (c) The mean RD and RA value, resp., is calculated on the right hand side (gray 
panel). Statistical values (Standard deviation of the mean (SEM), Minimum (Min) and Maximum (Max)) provide a useful 
tool to assess the variability of the values. Note that only the mean RD1 and RA1 values are used for subsequent analysis. 
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Supplementary Figure 8 
Data input field of the Dimer sheet. 
(a) Raw data are pasted into the respective columns on the left hand side from measurements in CFP-YFP dimer 
expressing cells using CFP- FRET- and YFP-cubes at a distinct HV gain. Raw data for individual cells are collected 
separately for a given dimer as indicated. (b) Background subtracted values are shown on the right. RA1 and RD1 values are 
automatically picked from RD-value (CFP) and the RA-value (YFP) sheets. Statistics are shown on the right hand side 
(Mean, SEM). 
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Supplementary Figure 9 
Dimer analysis sheet. 
(a) Columns D-G list background subtracted raw data from the “Dimer” sheet. Data for individual cells are collected 
separately for a given dimer as indicated in Column B. RA1 and RD1 values are automatically transferred from “RD-value 
(CFP)” and the “RA-value (YFP)” sheets (grey panel on the top, left). Columns H-P comprise calculations as outlined in 
Procedure Step 97. (b) The graph (column K plotted against column L) depicts data points for individual cells. For each 
dimer, cells cluster together. In the table below, the mean values of EA and ED for each dimer as well as mean values of 
the x- and y- coordinates (from columns M and N) are indicated. (c) The latter can be plotted in a new graph and analyzed 
by a linear regression line. In this template, the regression line is automatically computed and the resulting equation 
displayed in the graph. Note, that the y-intercept and the slope of this line is copied to cell T56 and T57 respectively for 
further analysis.  
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Supplementary Figure 10 
Data input field of the “Spurious FRET” sheet. 
(a) Raw data from cells expressing untagged eCFP and eYFP are transferred to respective cells in Columns C-G. (b) 
Background-subtraction as well as subsequent calculation of Fc/(RA1*SYFP), CFPEST and EA (columns K-M) is 
automatically performed referring to the constants in the gray panel at the upper left. (c) The graph at the right hand side, 
illustrates CFPEST as a function of EA. The slope of the regression line is used for spurious FRET correction in the “BC 
analysis sheet”. The equation of the regression line is automatically displayed in the graph. The slope is subsequently 
entered into cell “P7” linked to the “BC analysis” sheet. 
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Supplementary Figure 11 
Data input field of the binding curve analysis (“BC analysis”) sheet. 
(a) Background subtracted raw data (columns D-H) are automatically adopted from the “Samples” sheet. The principal 
calculation steps required in order to solve binding curves are automatically performed in columns I-W for each 
(biological) cell according Steps 117-130 outlined in the Procedure section. (b) The table in the upper left of the 
worksheet contains all parameters (columns F and I) necessary to correct for spectral properties and spurious FRET. 
Thereby, all values except the excitation ratio ((Ɛ YFP(440)/Ɛ CFP(440)) are automatically transferred from previously 
analyzed sheets. Values for KdEff, EAmax and EDmax (Column K) are place holders that are adjusted during the fitting 
procedure. (c) Graphs shown displays data points for individual biological cells (blue dots) and the fitted binding 
isotherme (black lines). The graphs represent data for 33-FRET (Dfree plotted against EA) and E-FRET (Afree plotted against 
ED) and allow a control of the fitting procedure. 
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Supplementary Figure 12 
Setting up Excel Solver for optimizing 33-FRET and E-FRET binding parameters. 
(a) Least squares optimization of Cell K8 (Sum_Err_3Cube) by changing both KD_eff (KD,EFF, relative affinity) and 
EAmax (EA,max, maximum 3
3-FRET efficiency). In this scenario, two constraints are EAmax>0, and Kd_eff>0 in 
accordance with physical principles. (b) Least squares optimization of Cell K10 (Total Error) by changing both KD_eff 
(KD,EFF, relative affinity), EAmax (EA,max, maximum 3
3-FRET efficiency), and EDmax (ED,max, maximum E-FRET 
efficiency). Three constraints are imposed: EDmax>0, EAmax>0, and Kd_eff>0. 
 
 
Nature Protocols: doi:10.1038/nprot.2016.128
	
1	
	
Supplementary	Note	1	|	Theoretical	calculation	of	MD	and	MA	
The microscope specific calibration coefficients MD and MA correspond to the effective 
brightness of a single donor or acceptor molecule when observed through the FRET cube. 
Accordingly,  
 
 
For the computation of these constants, spectra of CFP and YFP, the intensity profile of the 
xenon lamp as well as the transmission rates of the FRET filter cube provided in sheets 1-6 
(Supplementary Data 1) are used. In this section, it is described how to use the FRET Excel 
spreadsheet to calculate MD and MA. 
The Excel spreadsheet for theoretical calculation of MD and MA is composed of eight 
different worksheets (Supplementary Data 1). To activate these worksheets eight different tabs 
are present on the bottom of the excel sheet. In the input worksheets raw data are collected for 
the excitation and emission spectra of CFP and YFP (Sheet 1; labeled “1 ECFP Excitation 
Spectrum”; Sheet 2, labeled “2 ECFP Emission Spectrum”; Sheet 3 “3 EYFP Excitation 
Spectrum” and Sheet 4, labeled “4 EYFP Emission Spectrum”). The spectra of the fluorophores 
are experimentally determined from suspended HEK293 cells expressing ECFP and EYFP. The 
spectrum of the xenon arc lamp is deposited in Sheet 5 (labeled “5 Lamp profile”). The 
transmission spectrum of the emission filter and the excitation filter as well as the transmission 
and reflection spectrum of the dichroic mirror (all for the FRET filter cube) are collected in Sheet 
6 (labeled “6 FRET Filter Cube”). Based on the data deposited in sheets 1-6, MD and MA are 
theoretically calculated in Sheet 7 (labeled “7 Calculation MD (CFP)”) and Sheet 8 (labeled “8 
Calculation MA (YFP)”), respectively  
1 | In the Worksheet “1 ECFP Excitation Spectrum”, the wavelength and intensity raw data of 
the CFP excitation spectrum are given in column A and B respectively. Table 1 is present in 
sheet 1-4 and is taken from (Patterson et al., 2001). In column C, the maximum peak (at 437 nm) 
of the excitation spectrum of CFP is scaled to the maximal molecular extinction coefficient for 
CFP ( ; red box in Table 1). In addition, the maximal peak of the CFP 
excitation spectrum is normalized to 1 (Column D). Values in Column D are transferred to sheet 
7 (labeled “7 Calculation MD (CFP)”), column E. 
2 | Worksheet “2 ECFP Emission Spectrum” contains raw fluorescence intensity data for CFP 
emission (Column B) for wavelengths ranging from 420nm – 600nm (Column A). Col D 
contains the CFP emission spectrum from column B and scaled to a maximum value of 1 at 
wavelength 475nm. The normalized spectrum is copied to column O of sheet 7. Col C contains 
the emission spectrum of CFP taken from column D and scaled in such a way that the integral 
equals the quantum yield of CFP (QYCFP = 0.4; (Patterson et al., 2001)). This is done by 
integrating the normalized spectrum from Column D over the entire range of wave lengths 
yielding the value of 65.11. The value of the integral is deposited in the table of sheet 7 (Cell 
CFP 430 450 CFP 505 575 CFP[ ] [ ]DM f QY       
YFP 430 450 YFP 505 575 YFP[ ] [ ]AM f QY       
1 1
max 26000M cm
 
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D4). The integral is then used to normalize the emission spectrum by dividing the entire 
spectrum by 65.11 and multiplying by the quantum yield of CFP (0.4; Column C).  
3 | In the Worksheet “3 EYFP Excitation Spectrum”, the wavelength and intensity raw data of 
the YFP excitation spectrum are given in column A and B respectively. In column C, the 
maximum peak of the excitation spectrum of YFP is scaled to the maximal molecular extinction 
coefficient for YFP ( ; red box in Table 1). In addition, the maximal peak of 
the YFP excitation spectrum is normalize to 1 (Column D). Column D is transferred to sheet 8 
(labeled “8 Calculation MA”, column E). 
4 | Worksheet “4 EYFP Emission Spectrum” contains raw fluorescence intensity data for YFP 
emission (Column B) for wavelengths ranging from 400nm – 700nm (Column A). Column D 
contains the YFP emission spectrum from column B and scaled to a maximum value of 1 at a 
wavelength of 527nm. The normalized spectrum is copied to column O of Sheet 8 (“8 
Calculation MA”). Column C contains the emission spectrum of YFP taken from column D and 
scaled in such a way that the integral equals the quantum yield of YFP (QYCFP = 0.61). This is 
done by integrating the normalized spectrum from Column D over the entire range of wave 
lengths yielding the value of 39.53. The value of the integral is deposited the table of sheet 8 
(Cell D4). The integral is then used to normalize the emission spectrum by dividing the entire 
spectrum by 39.53 and multiplying by the quantum yield of YFP (0.61; Column C). 
5 | In the worksheet “5 lamp profile” the wavelength and intensity raw data of the intensity 
spectrum of the excitation arc lamp are given in column A and B respectively. Column C 
contains the spectrum from column B normalized to a peak value of 1. Column C is transferred 
to column B in sheets 7 and 8. 
6 | In worksheet “6 FRET filter cube” the wavelength (Column A) and intensity raw data of the 
transmission spectrum of the excitation filter (Column B), the emission filter (Column C) and the 
dichroic mirror (Column D) for the FRET cube are given. The reflection spectrum of the dichroic 
mirror is presented in column E. The spectra are all transferred to column C (excitation filter), 
column D (reflection of dichroic), column P (transmission of the dichroic) and column Q 
(emission filter) in sheets 7 and 8, resp..  
7 | The top of sheet 7 contains the extinction coefficient for CFP (Cell D2) which is here 
0.26	μ  (please note that units are different from (Patterson et al., 2001)) and 
the quantum yield of CFP (Cell D3). The value for the integral of the entire CFP emission 
spectrum normalized to maximum emission of 1 (Cell D4) is picked from Sheet 2 (“2 ECFP 
Emission Spectrum”, cell D183). In addition, there are 5 place holders (D5-D9) for the excitation 
integral (D5; Ex integral), the emission integral (D6, Em integral), The MD (D7) and the MA 
value (D8), and the MA/MD ratio (D9). The calculation of these five parameters are given below. 
8 | The lower part of sheet 7 contains spectral data for the excitation pathway (Column A-F) and 
the emission pathway (Column N-R). For the excitation pathway the data are the wavelengths 
(Column A), the intensity spectrum of the xenon arc lamp (Column B), the transmission 
spectrum of the excitation filter (Column C), the reflection spectrum of the dichroic (Column D) 
1 1
max 84000M cm
 
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and the excitation spectrum for CFP (Column E). The spectra are all taken from sheets 1, 5 and 6 
and represent the versions normalized to a maximum of one at the specified wavelength. They 
are plotted in graph A. Column F is calculated by multiplying together the values contained in 
column B-E. The result is plotted in graph B. For the emission pathway the data are the 
wavelengths (Column N), the emission spectrum for CFP (Column O), the transmission 
spectrum of the dichroic (Column P) and the emission filter (Column Q). The spectra are all 
taken from sheets 2 and 6 and represent the versions normalized to a maximum of one at the 
specified wavelength. They are plotted in graph C. Column R is calculated by multiplying 
together the values contained in columns O-Q. The result is plotted in Graph D.  
9 | The excitation integral is calculated by integrating the data contained in Column F (Graph B) 
and deposited in Cell L7 and D5. 
10 | The emission integral is calculated by integrating the data contained in Column R (Graph D) 
and deposited in Cell W7 and D6. 
11 | MD is calculated by scaling the excitation and emission integral (D5 and D6) by multiplying 
it by the maximal extinction coefficient (Cell D2) and by dividing it by the integral of the entire 
emission spectrum (Cell D4) times the quantum yield (Cell D3). The result is deposited in Cell 
D7. 
12 | MA is picked from cell D7 in sheet 8. 
13 | MA/MD is calculated by dividing Cell D8 by Cell D7 and deposited in Cell D9. 
14 | Sheet 8 (“8 Calculation MA”) has an analogous design as Sheet 7. However, it contains 
spectral properties that are specific for YFP. The top of Sheet 8 contains the extinction 
coefficient for YFP (Cell D2) which is 0.84	μ  (please note that units are 
different from (Patterson et al., 2001)) and the quantum yield of YFP (Cell D3) picked from 
Table 1. The value for the integral of the entire YFP emission spectrum normalized to maximum 
emission of 1 (Cell D4) is picked from Sheet 4 (“4 EYFP Emission Spectrum”, cell D134). In 
addition, there are 3 place holders (D5-D7) for the excitation integral (Cell D5; Ex integral), the 
emission integral (D6, Em integral) and the MA value (D7). Excitation and emission spectra for 
YFP are deposited in columns E and O, respectively. The calculation of the values for the 
excitation integral and emission integral and the graphs are analogous as described for CFP.  
Note that both MA and MD are independent of Io, the overall intensity of the arc lamp, and 
the constant C that accounts for optical transmission properties of the microscope other than the 
filter cubes. For our setup, the calculated values are MA = 0.6320 and MD = 0.14149. 
 
References 
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Supplementary Note 2 | Determination of 33-FRET and E-FRET efficiencies  
The experimental determination of 33-FRET and E-FRET efficiencies depend on the 
robust measurement of fluorescence intensities using three filter cubes as summarized in Box 1. 
Here, we present a formalism to model the fluorescence output from a single cell expressing two 
types of fluorophores, a donor assumed to be the cyan fluorescent protein (CFP) and an acceptor 
assumed to be the yellow fluorescent protein (YFP). In the dark, all fluorophores are assumed to 
be in their ground state (D, donor and A, acceptor) and upon photoexcitation convert to an 
excited state (D* and A*). Relaxation from the excited state results in the release of a photon. 
Each cell is assumed to contain ND total donor molecules and NA total acceptor molecules 
(Supplementary Note 2 Fig. 1a). Moreover, the fraction of donor molecules bound to an 
acceptor in each cell is given by Db, and the fraction of acceptor molecules bound to a donor is 
given by Ab. Only the bound fraction of fluorophores is able to undergo FRET. The 
epifluorescence microscope setup measures the total fluorescence intensity from single cells 
using three filter cubes: the CFP cube (Supplementary Note 2 Fig. 1b), the YFP cube 
(Supplementary Note 2 Fig. 1c), and the FRET cube (Supplementary Note 2 Fig. 1d). There 
are two key sets of microscope specific parameters to define: (1) the wavelength-specific 
propensity of the excitation subsystem to excite a given fluorophore and (2) the wavelength-
specific efficacy of the detection subsystem to detect the emitted photons.  
First, we consider the propensity of a given fluorophore to be excited using the given 
microscope setup. For any filter cube x, the excitation rate (in units of transitions per second) of 
a single ground-state fluorophore is given by I0·Gx(y, ex,x). The variable I0 denotes the intensity 
of the light emitted by the arclamp, y specifies the type fluorophore we are concerned with 
(either D or A), and ex,x denotes the particular wavelength of the excitation light used to excite 
the fluorophore. Notice that Gx(D, ex,x) is a constant that incorporates the spectral properties of 
the lamp, optical properties of the excitation filter and dichroic mirror of the cube x, and the 
wavelength-dependent absorption properties of the fluorophore given by its molar extinction 
coefficient x(). For example, for the CFP cube I0·GCFP(D, ex,CFP) signifies the rate of 
excitation for a single CFP fluorophore given the properties of the CFP filter cube.  
Second, we introduce the term Fx(y, em,x) to denote the fluorescence output of the 
photomultiplier tube (PMT) in response to photons emitted by the fluorophore y when measured 
using the filter cube x. Here, Fx(y, em,x) is a constant that incorporates the emission spectrum of 
fluorophore within the wavelength limits specified by em,x, the optical properties of the dichroic 
mirror and the emission filter of cube x, and the spectral response properties of the PMT 
detector. For example, FCFP(D, em,CFP) corresponds to the output transfer function for photons 
emitted from a single donor molecule (D) measured using the CFP cube. Figure Sxb-d provides a 
visual representation of these instrument specific constants. We now develop an explicit model 
for the donor and acceptor fluorescence output as a result of direct excitation or through FRET.  
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Direct excitation of acceptor molecules 
To deduce the fluorescence output of acceptor molecules when evaluated through the YFP 
cube, we consider the YFPX(ex,x, em,x, direct) branch (pathway 3) of the state transition diagram 
shown in Fig. Sxe. The probability that an acceptor molecule is in the excited state is given by,  
  (S1.1) 
In general, for the purposes of fluorescence measurements, the typical data acquisition 
times (several milliseconds) are substantially longer than the characteristic fluorescence 
relaxation time (several nanoseconds) such that the system could be assumed to have reached 
steady state. Moreover, in typical FRET experiments, the excitation power used is sufficiently 
low that there is minimal ground state depletion for either A fluorophores (PA ~ 1). This 
assumption could be experimentally verified by testing for linearity of fluorescence output with 
respect to the excitation light intensity. Thus, the steady-state probability of an acceptor molecule 
occupying the excited state follows the relation,  
  (S1.2) 
Next, we consider the emission-detection subsystem to estimate the rate of emission of photons 
from an excited acceptor and the efficacy by which such photons are detected. The rate of 
excited acceptor relaxations that result in the emission of a photon is given by         . Thus, the 
total fluorescence output by all acceptor molecules in a cell is given by,  
  (S1.3) 
Substituting S1.2 into S1.3 and exploting the fact the quantum yield of the acceptor is given by,  
 
yields the relation,  
  (S1.4) 
Note that the emission transfer function X em,x( , )F A  now incorporates the QYA of the acceptor,
X em,x A X em,x
ˆ( , ) ( , )F A QY F A   . Note that this equation specifies the YFP intensity due to direct 
excitation through any filter cube. For example, the YFP intensity due to direct excitation 
through YFP cube would be given by,  
Similarly, the YFP intensity due to direct excitation through the FRET cube is given by,  
  
*
*
0 x ex,x A A,nr( , ) ( )
A
A A
dP
I G A P k k P
dt
  
*
AAk P
*
X em,x
ˆ ( , )A A AN k P F A   
A
A
A A,nr
k
QY
k k


*
0 x ex,x*
A,nr
( , )
0
( )
A
A
A
I G AdP
P
dt k k

  

x ex,x em,x 0 x ex,x X em,x( , ,direct) ( , ) ( , )AYFP N I G A F A      
YFP 0 YFP YFP(505,535,direct) ( ,505) ( ,535)AYFP N I G A F A   
FRET 0 FRET FRET(440,535,direct) ( , 440) ( ,535)AYFP N I G A F A   
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Direct excitation of donor molecules 
To model the fluorescence emission of donor molecules when evaluated through the CFP 
cube, we first consider the CFPX(ex,x, em,x, direct) branch (pathway 1) of the complete state 
transition diagram shown in Fig. Sxe. Here, to obtain the total CFP emission due to direct 
excitation, we must consider two populations of CFP molecules: (1) the fraction of free donor 
molecules and (2) the fraction of donor molecules bound to an acceptor. As with acceptor 
molecule, we assume a low excitation limit such that there is minimal ground state depletion for 
donor (D) fluorophores (PD ~ 1). Thus, for free donor molecules, the steady-state probability of 
occupying the excited state follows the relation,  
 (pathway 1) (S1.5) 
However, as donor molecules bound to an acceptor can de-excite through FRET, the probability 
that such fluorophores are excited is governed by the equation,  
 (pathway 2) (S1.6) 
 
 
Next, we consider the emission-detection subsystem to estimate the rate of emission of photons 
from an excited donor and the efficacy by which such photons are detected. The rate of excited 
donor relaxations that result in the emission of a photon is in general given by         . Thus, the 
total fluorescence output by both free and bound donor molecules is given by,  
  (S1.7) 
Given that the quantum yield of the donor fluorophore is given by,  
 
and by defining X em,x D X em,xˆ( , ) ( , )F D QY F D   , Eq. S1.7 simplifies to yield the equation,  
  (S1.8) 
  
*
0 ex,x* *
0 ex,x D D,nr
D D,nr
( )
( ) ( ) 0
( )
DD
D D D D
I GdP
I G P k k P P
dt k k



      
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0 x ex,x* *
0 x ex,x D D,nr T
D D,nr T
( , )
( , ) ( )
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D
D D D
I G DdP
I G D P k k k P P
dt k k k



       
*
D Dk P
0 ex,x 0 x ex,x
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Excitation of acceptor molecules as a result of FRET 
 The third key quantity of concern is YFP fluorescence output as a result of excitation by 
FRET or the YFPx(ex,x, em,x, FRET) branch (pathway 2) of the complete state transition 
diagram in Fig Sxe. In order for YFP molecules to be excited by FRET, they have to be 
associated with CFP molecules. Moreover, as before we assume ‘low-exciation limit’ (PD ~ 1, 
PA ~ 1) and that the data acquisition time is long enough for the system to reach steady-state. 
First, we consider the probability of exciting a donor molecule,  
 (S1.9) 
Next, we consider the rate of excitation of the bound acceptor molecule. At steady state,    
 (S1.10) 
Substituting Eq. S1.9 in S1.10 yields,  
 (S1.11) 
Next, we consider the emission-detection subsystem to estimate the rate of emission of photons 
from an excited acceptor and the efficacy by which such photons are detected. The rate of 
excited acceptor relaxations that result in the emission of a photon is in general given by         . 
Thus, the total fluorescence output by YFP molecules excited by FRET is given by,   
 (S1.12) 
 
Importantly, the total number of bound complexes is given by ND·Db = NA·Ab. Moreover, the 
output transfer function is also defined as X em,x A X em,xˆ( , ) ( , )F A QY F A   . Substituting these 
identities into S1.12 yields,  
 (S1.13) 
Equations S1.4, S1.8, and S1.13 form three master equations that could be used to deduce either 
the 33-FRET efficiency or the E-FRET efficiency as outlined in subsequent section.  
Deducing 33-FRET efficiency 
The 33-FRET efficiency measures sensitized emission or the fractional increase in acceptor 
intensity due to FRET. The term sensitized emission in Box 1 Eq. 5 corresponds to YFPx(ex,x, 
em,x, FRET). Thus,  
  (S1.14) 
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Notice, the factor GA(ex,x)/GD(ex,x) is an instrument specific parameter that normalizes for the 
differences in the propensity for the donor and acceptor to absorb light. Substituting Eq. S1.13 
and S1.4 into S1.14 yields,  
  (S1.14) 
 
Simplifying this relation yields, 
  (S1.15) 
Thus, the apparent 33-FRET efficiency is the true FRET efficiency multiplied by the fraction of 
acceptor molecules that are bound. The experimental strategy to unscramble the parameter 
YFPx(ex,x, em,x, FRET) from corrupting factors is described in Box 1.  
  
T
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Deducing E-FRET efficiency 
E-FRET is a donor centric measure that estimates the fractional quenching of donor fluorescence 
due to FRET. Thus, the E-FRET efficiency corresponds to   
 (S1.16) 
where CFPFRET|before is the quenched CFP fluorescence intensity before acceptor molecules are 
photobleached and CFPFRET|after is the intensity after all acceptor molecules are photobleached.  
Importantly, CFPFRET|after is an indirect measure that corresponds to the modified state transition 
diagram shown in Fig. 1f. For this modified system, 
 (S1.17) 
The fluorescence output for a single donor fluorophore would be proportional to        the rate of 
excited donor relaxations that result in the emission of a photon. Accordingly, the total 
fluorescence output of CFPFRET|after is given by,  
 (S1.18) 
Utilizing the fact that X em,x D X em,xˆ( , ) ( , )F D QY F D   , Eq. S1.17 simplifies to  
 (S1.19) 
By contrast, CFPFRET|before is a direct measure that corresponds to CFPX(ex,x, em,x, direct) branch 
of state transition diagram in Fig. S1e. To relate CFPFRET|after with CFPFRET|before, we reconsider 
Eq. S1.8, 
 
 
 
Simplifying this relation, we obtain 
  (S1.20) 
 
Substituting Eq. S1.19 to S1.20 yields,  
 
 (S1.21) 
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Also recall that the total number of bound complexes must be the same, therefore ND·Db = 
NA·Ab. Thus,  
 
 (S1.22) 
 
Now, substituting S1.13 into Eq. S1.22 yields,  
 (S1.23) 
 
Rearranging this equation yields,  
 (S1.24) 
Importantly, Eq. S1.24 confirms the intuition that CFP intensity after photobleaching is the sum 
of the quenched CFP intensity before photobleaching and amount of quenching reported as the 
sensitized emission corrected for emission properties of YFP molecules versus CFP molecules.  
Substituting Eq. S1.24/S1.23 into S1.16, yields  
 
 
 
Defining the microscope specific gain factor, 
 (S1.25) 
yields the E-FRET equation shown in Box 1 Eq. 7,  
 (S1.26) 
 
To deduce ED in terms of fundamental parameters in Fig. Sxe, we substitute Eq. S1.13 and Eq 
S1.8 into Eq. S1.26 and further simplify to obtain,  
 
 (S1.27) 
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Supplementary Note 3| Determination of binding affinities from FRET measurements 
As elaborated in Box 1, the 33-FRET and E-FRET efficiencies depend on the fraction of acceptor 
(Ab) and fraction of donor molecules (Db) that are bound respectively. Both Db and Ab in fact 
depend on the total number of donor and acceptor molecules and relative binding affinity. For 
typical FRET experiments, we consider a binding interaction with a 1:1 stoichiometry. 
Moreover, the bound state is assumed to conform to a unique with a characteristic FRET 
efficiency (E). These assumptions allow for fitting a simple Langmuir isotherm to the 
experimental data yielding an estimate for the binding affinity. Though more complex binding 
models can be evaluated using FRET, the increased number of states often implies the lack of a 
unique solution and multiple parameter sets may fit the data.  
Consider the simple 1:1 binding model with dissociation constant Kd,  
 
As FRET experiments are typically conducted at steady-state,  
 
 (S2.1) 
Since, the total concentration of acceptor molecules T free[ ] [ ] [ ]A A AD  , the fraction of bound 
acceptor molecules is given by,  
 
 (S2.2) 
The 33-FRET efficiency is thus,  
 
 (S2.3) 
where Emax is the FRET efficiency when all acceptor molecules are bound.  
 
Similarly, since the total concentration of donor molecules T[ ] [ ] [ ]D D AD  , the fraction of 
bound donor molecules is given by,  
 
 (S2.4) 
Thus, the E-FRET efficiency is given by,  
 (S2.5) 
In both cases to obtain a binding relation, we must deduce the free concentration of donor and 
acceptor molecules.  
  
dK
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d
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[ ]
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Importantly, fluorescence measurements from single cells are proportional to the total number of 
fluorophores. Accordingly, we restate Eq. S2.3 and Eq. S2.5 in terms of number of fluorophores. 
Thus,  
 (S2.6) 
Similarly,  
 (S2.7) 
 
Indeed, for a 1:1 stoichiometry interaction, the fraction of acceptors bound is given by, Ab = (ND 
– NDfree)/ NA. Note that ND – NDfree corresponds to the number of bound donor-acceptor 
complexes. Thus, Eq. S2.6 can be rewritten as  
 
 (S2.8) 
Rearranging this equation,  
 (S2.9) 
Solving this equation yields,  
 
 (S2.10) 
 
 
Since the number of bound complexes are the same,                                      .  Thus,  
 (S2.11) 
Substituting Eq. S2.10 into Eq. S2.11 yields,  
 
 
 (S2.12) 
 
 
Importantly, the total number of acceptor (NA) and donor (ND) molecules in a cell can be 
estimated based on fluorescence measurements as outlined below.   
 
First, for YFP molecules the fluorescence intensity due to direct excitation viewed through the 
FRET cube can be obtained from Eq. S1.4 as,  
 (S2.13) 
The number of acceptor molecules is then,  
 (S2.14) 
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The factors, GFRET(A,440) and FFRET(A,535) correspond to microscope specific calibration 
factors. In cells that express both YFP and CFP, YFPFRET(440,535, direct) can be estimated from 
the YFP cube measurement by the relation,  
 (S2.15) 
Thus,  
 (S2.16) 
 
Similarly the total number of donor molecules (ND) could be estimated based on the fluorescence 
intensity of CFP molecules through the FRET cube. However, one confounding factor is 
quenching of CFP fluorescence as a result of FRET to nearby YFP molecules. The amount of 
quenching could be corrected for based on Eq. S1.19. Here,   
 (S2.17) 
 
Note that,   
 (S2.18) 
where ED is the E-FRET efficiency. Thus, Eq. S2.17 simplifies to, 
 (S2.19) 
This expression can be rearranged to obtain, 
 (S2.20) 
 
Note once again the denominator corresponds to microscope specific calibration factors. 
Moreover, CFPFRET(440, 535, direct) could be estimated based of fluorescence measurement 
from the CFP cube as follows: 
 (S2.21) 
Eq. S2.21 could be substituted into Eq. S2.20 to obtain,  
 (S2.22) 
 
An alternative formulation is shown in main text Eq. 13 where the CFP signal lost due to FRET 
is added as a correction term.  
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Both Eq. S2.16 and Eq. S2.22 provide experimentally determined estimates for total number of 
acceptor and donor molecules respectively. Thus, we now reconsider Eq. S2.10 by multiplying 
both RHS and LHS by I0,  
 
 
 (S2.23) 
 
Now, we could redefine, Eq. S2.23 based on parameters experimentally determined (i.e. Eq. 
S2.16 and Eq. S2.22). If we define, 0 Dfree freeI N D  , an effective concentration of free donor 
molecules and d,EFF 0 d cell avoK I K V N    , then 
 (S2.24) 
 
Similarly, if 0 Afree freeI N A  then Eq. S2.11 could be rewritten as,  
 (S2.25) 
These two equations, namely Eq. S2.24 and Eq. S2.25 allows one to determine the free 
concentrations of donor and acceptor molecules and effective binding affinities through the 
iterative procedure described in Box 2.  
Notice that the computation of CFPEST and YFPEST requires the knowledge of both
D FRET FRET( ,436) ( ,535)M G D F D   and A FRET FRET( , 436) ( ,535)M G A F A  . However, only the 
ratio MA/MD can be reliably determined experimentally using various CFP-YFP dimers. The 
individual values MA and MD are, in fact, calculated from the parameters of optical elements in 
the microscope. Reassuringly, our theoretical calculation yielded an MA/MD ratio that was highly 
similar to the experimentally determined value. Even, since these values are computed based on 
manufacturer’s specifications for various optical elements, they are only approximate. In our 
experiments, we followed a simple procedure whereby we computed the MD value based on 
specifications of our optical elements, and then set the MA value by multiplying this theoretically 
determined MD value by the experimentally determined ratio MA/MD (from dimer experiments). 
Here, we explore how a miscomputation of the theoretical MD value may affect the measured 
Kd,EFF.  
Suppose the true MD value (
true
DM ) relates to the estimated MD value (
*
DM ) by 
 true *D DM M    (S2.26) 
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Here  is an error term. Since the MA/MD can be experimentally determined and therefore 
assumed to be ratio of the true MA and MD values (i.e. 
true true
A D/M M  ), the estimated MA value is 
given by,  
 
true true
* * *A A A
A D D true
D experimental D
M M M
M M M
M M 
   
       
   
 (S2.27) 
 
Reconsidering Eq. S2.16 and substituting in Eq. S2.27, we can relate the experimentally 
estimated YFPEST (
*
ESTYFP ) to the true value 
true
ESTYFP as follows: 
 
  (S2.28) 
 
Similarly, we can relate the experimentally computed CFPEST (
*
ESTCFP ) to the true value 
true
ESTYFP
by substituting Eq. S2.26 into Eq. S2.22,  
 
  (S2.29) 
 
 
Now substituting Eqs. S2.28 and S2.29 into S2.23, we could determine the true free 
concentration of donor molecules, truefreeD , by the following equation: 
 
 
 
  (S2.30) 
 
 
 
 
Rearranging this equation,  
 
 
  (S2.31) 
 
 
 
We could in fact redefine * trued,EFF d,EFFK K   and 
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free freeD D  , yielding 
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Experimentally, then the error in estimation of MD by factor  would simply result in a scaled 
relative dissociation constant, 
 * trued,EFF d,EFF 0 cell avo dK K I V N K         (2.33) 
But this ambiguity is computationally no different than lacking knowledge of the I0 value. In the 
extreme case, if we do not have an estimate of MD, we could simply set  *D 1M  . Thus, 
true
DM 
, and the measured relative affinity is * trued,EFF D 0 cell avo dK M I V N K     . Finally to compare across 
experimental setups, we could compare measured affinities for a robust construct and deduce the 
pertinent scaling factors.  
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Supplementary Note 4 | Theoretical basis of concentration-dependent FRET 
One important challenge for robust analysis of binding interactions using FRET 2-hybrid is that 
of concentration-dependent or spurious FRET. If the bulk concentrations of expressed 
fluorescent proteins are high, then a freely-diffusing donor molecule may, by chance, be 
sufficiently close to a freely-diffusing acceptor molecule to elicit FRET despite the absence of a 
specific binding interaction. How do we account for concentration dependence of spurious 
FRET? Empirically, if CFP and YFP fluorophores are co-expressed in HEK293 cells, the 33-
FRET and E-FRET efficiencies appear to be linearly dependent on the total concentration of CFP 
(CFPEST) or YFP (YFPEST) respectively (Supplementary Fig. 1). In this section, we furnish a 
theoretical analysis that supports the linear dependence of spurious FRET efficiency on the total 
concentration of fluorophores. This discussion follows the derivation presented in Erickson et 
al1. 
For 33-FRET, consider an acceptor molecule at position r = 0 as shown in Supplementary Note 4 
Fig. 1a. The probability that a donor molecule (D) resides within a spherical shell of radius r and 
r + dr of the acceptor molecule is given by,  
 2 27D avo
3( ) [D] 4 (10  L Å )/P r dr N r dr        (S3.1) 
Here, [D] denotes the (molar) concentration of donor molecule, Navo represents Avogadro’s 
number. The shell radius r is assumed to be in units of angstrom. The expected FRET efficiency 
(E̅A) for randomly dispersed donors at all distances is given by,  
 
6
0
A D 6 6
00
( )
R
E P r dr
R r

  
  (S3.2) 
Note that the two fluorophores are assumed to be of negligible molecular size and therefore can 
be infinitesimally close to each other. Substituting S3.1 into S3.2 yields,  
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
 (S3.3) 
Simplifying this expression,  
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As shown in main text Eq. 24, the fluorescence intensity of the donor fluorophore is proportional 
to concentration of donors ([D] = ND / (Navo·Vcell) = ((RD1 ·SCFP) / MD) / (Navo·Vcell), thus, 
 3
2 27 3
2 27 30
D1 CFP D1 0
A CFP CFP 3 -FRET
D cell D cell
2
(10 ) )2 (103
3
RR S R R
E S S m
M V M V
 

    
     
 
 (S3.5) 
Hence, the spurious FRET efficiency is linearly proportional to the fluorescence intensity of the 
donor molecules in the given cell.  Note that the estimate here is an upper limit for the spurious 
FRET efficiency as the donor and acceptor molecules were assumed to be of negligible size. 
Nonetheless, the slope of the spurious FRET curve could be estimated experimentally.  
A similar relation could be determined for spurious FRET between a membrane-localized 
acceptor fluorophore and a cytosolic donor fluorophore. Consider the fluorophore arrangement 
shown in Supplementary Note 4 Fig. 1b. By symmetry, the probability of finding a donor 
fluorophore within distance r and dr would be exactly half as in Supplementary Note 4 Fig. 1a. 
Therefore, the spurious FRET slope would be half that of Eq. S3.5 but nonetheless linear with 
respect to the fluorescence intensity of the donor molecule.  
Finally, in the case that both donor and acceptor fluorophores are tethered to membrane proteins, 
these molecules are restricted to the membrane as shown in Supplementary Note 4 Fig. 1c. Thus, 
the probability of finding a donor molecule within the distance r and r + dr can be obtained by 
considering the thin cylindrical shell,  
 8 2D surface
2( ) 2 (10  Å )m /P r dr D r dr       (S3.6) 
Note that Dsurface is the surface density of the donor fluorophore in the membrane (units of 
number of molecules / m2). The expected FRET efficiency (E̅A) for randomly dispersed donors 
at all distances is given by,  
  (S3.7) 
   
 
 
 
  (S3.8) 
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The fluorescence intensity of the donor fluorophore is proportional to the number of donors in 
the membrane, thus Dsurface = ND / SAmem = ((RD1 ·SCFP) / MD) / SAmem,  
 
  (S3.10) 
 
Again, notice that the spurious 33-FRET efficiency is linearly proportional to the fluorescence 
intensity of the CFP molecule. Importantly, as the molecules are constrained to the membrane 
the slope of the spurious FRET efficiency may be prohibitively large. Intuitively, this result 
stems from the enhanced crowding of fluorophores as a result of restricted planar diffusion. 
Experimentally, this large spurious FRET may be estimated by localizing donor and acceptor 
fluorescent proteins to the membrane by lipidation.  
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Uncoupling PIP2-calmodulin regulation of Kv7.2 channels by an
assembly destabilizing epileptogenic mutation
Araitz Alberdi1,*, Carolina Gomis-Perez1,*, Ganeko Bernardo-Seisdedos1, Alessandro Alaimo1,
Covadonga Malo1, Juncal Aldaregia1, Carlos Lopez-Robles1, Pilar Areso2, Elisabeth Butz3,
Christian Wahl-Schott3 and Alvaro Villarroel1,‡
ABSTRACT
We show that the combination of an intracellular bi-partite calmodulin
(CaM)-binding site and a distant assembly region affect how an ion
channel is regulated by a membrane lipid. Our data reveal that
regulation by phosphatidylinositol(4,5)bisphosphate (PIP2) and
stabilization of assembled Kv7.2 subunits by intracellular coiled-coil
regions far from the membrane are coupled molecular processes.
Live-cell fluorescence energy transfer measurements and direct
binding studies indicate that remote coiled-coil formation creates
conditions for different CaM interaction modes, each conferring
different PIP2 dependency to Kv7.2 channels. Disruption of coiled-
coil formation by epilepsy-causing mutation decreases apparent
CaM-binding affinity and interrupts CaM influence on PIP2 sensitivity.
KEY WORDS: Coiled-coil, Leucine zipper, Calmodulin, PIP2, KCNQ,
Epilepsy, M-current, Allosteric
INTRODUCTION
Phosphatidylinositol(4,5)bisphosphate (PIP2) is aminor (<1%) acidic
phospholipid found in the inner leaflet of the cellmembrane and plays
a vital part in cellular signaling by directly interacting with membrane
proteins, including Kv7 potassium channels (Gamper and Shapiro,
2007; Suh and Hille, 2008; Hille et al., 2014; Zaydman and Cui,
2014). Function of Kv7 channels is absolutely dependent on PIP2
(Zaydman and Cui, 2014) and activation of phospholipase C, and
subsequent PIP2 hydrolysis causes downregulation of their activity,
which in turn lowers the threshold for activity (Brown et al., 2007),
orchestrating excitability in brain, heart, skeletalmuscle and inner ear.
Related diseases encompass epilepsy, autism, schizophrenia, cardiac
arrhythmias, hearing loss and sudden death (Soldovieri et al., 2011;
Dvir et al., 2014a; Maljevic and Lerche, 2014).
The five members of the Kv7 family of non-inactivating voltage-
dependent potassium channels share a common architecture,
differing from that of Kv1–Kv4 channels in lacking an N-terminal
T1 tetramerization domain. Instead, and in common with a large
group of channels, such as Eag, Erg, SK, CNG and TRP channels,
present multiple calmodulin (CaM; Uniprot P62161)-binding
domains followed by a tetrameric coiled-coil segment (Jenke et al.,
2003; Tsuruda et al., 2006). Kv7 channels have a large intracellular
C-terminal region, ranging from 320 to 500 residues in size,
containing four helical regions (A–D), which can be conceptually
divided into three parts. Immediately after the last S6 transmembrane
segment, the intracellular membrane proximal half (AB) is important
for CaM binding and channel gating. Three-dimensional (3D)
reconstitution locates the intracellular distal part (helixD) far from the
membrane (Dvir et al., 2014b), which directs oligomerization and
partner specificity (Yus-Nájera et al., 2002; Howard et al., 2007;
Haitin and Attali, 2008). The AB and D helices are connected by
helix C, indispensable for function, and a linker of variable length.
Mutagenesis suggests that, in addition to the S4–S5 linker and the
proximal C-terminus, helix C contributes to PIP2 regulation (Dvir
et al., 2014b; Zaydman and Cui, 2014). CaM binding is essential for
Kv7 channels to exit from the endoplasmic reticulum, and influences
heteromeric assembly of Kv7.2/3 channels and subsequent
enrichment at the axonal initial segment (Yus-Nájera et al., 2002;
Devaux et al., 2004; Chung et al., 2006; Etxeberria et al., 2008;
Haitin and Attali, 2008; Alaimo et al., 2009; Cavaretta et al., 2014;
Chung, 2014; Liu and Devaux, 2014). CaM regulatory mechanisms
that change the gating behavior proceed through an effect on
sensitivity to PIP2 (Kosenko et al., 2012; Kosenko and Hoshi, 2013;
Zaydman et al., 2013; Kang et al., 2014). The interlinker between
helices A and B is not essential for function, although it plays a
critical role in PIP2 regulation for Kv7.3, but not in Kv7.1 and
Kv7.2 channels (Hernandez et al., 2008; Aivar et al., 2012; Sachyani
et al., 2014).
In contrast to the obligatory role of helices ABC for Kv7.2
channel function, helix D is dispensable (Schwake et al., 2006;
Nakajo and Kubo, 2008). The helix D coiled-coil bundle has been
largely considered as a passive stitch, with little active role other
than to convey stability to the tetramer and specificity during the
formation of heteromeric assemblies (Schmitt et al., 2000; Jenke
et al., 2003; Maljevic et al., 2003; Schwake et al., 2006; Howard
et al., 2007). Whilst this is undoubtedly part of its function, we find
that this structure has a more active role by indirectly influencing
PIP2 dependency.
Here, we identified a mechanism to modulate, at a distance,
regulation by PIP2. We monitored the relative distance/orientation
of the ABCD domain by live-cell fluorescence resonance energy
transfer (FRET) assays in conjunction with analysis of whole-cell
currents. The observations we made explain how the tetrameric
conformation of helix D can functionally influence CaM binding to
a distal site, and, in turn, how a pathological mutation affecting
tetramer stability modifies Kv7.2 activity.
RESULTS
Calmodulin binds to Kv7.2 AB with a 1:1 stoichiometry
Calmodulin is a bi-functional protein, with two highly homologous
lobes (N and C) joined by a flexible linker, each capable of engagingReceived 24 June 2015; Accepted 9 September 2015
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targets adopting an α-helix configuration (Villarroel et al., 2014).
Helix A of Kv7.2 presents a marked preference for fetching the
C-lobe, whereas helix B anchors more favorably to the N-lobe
(Alaimo et al., 2014) and these features are present on the
crystallographic Kv7.1 [AB/CaM] complex (Sachyani et al.,
2014). To place the data of this report into physical perspective,
Fig. 1 shows a tentative disposition of CaM on Kv7.2 forming a ring
under the pore that complies with numerous restrictions from
different studies (Mruk et al., 2012; Xu et al., 2013; Alaimo et al.,
2014; Sachyani et al., 2014) (see Materials and Methods). One
important feature derived from the 3D structure of the Kv7.1
[ABCD/CaM] complex is that the helix D coiled-coil is separated
from the membrane by the CaM ring (Sachyani et al., 2014)
(Fig. 1A).
To investigate in more detail the interaction with the Kv7.2
CaM-binding domain, we co-expressed CaM and a construct
bearing the Kv7.2 CaM-binding elements (helices A and B,
residues G313–R530) to produce the recombinant complex in
bacteria. The intervening A–B linker (residues Y372–T501), which
is not essential for Kv7.2 function (Aivar et al., 2012), was
removed to improve protein yield. We found by size exclusion
chromatography (SEC) that the purified material migrated with an
apparent molecular mass of 35.3 kDa, which is close to the
expected size for a 1:1 [CaM/AB] globular complex (16.7
+13.6=30.3 kDa; Fig. 1C). Thus, similar to Kv7.1 or Kv7.4 [AB/
CaM] complexes studied in vitro (Wiener et al., 2008; Xu et al.,
2013), the Kv7.2 [AB/CaM] complex adopts a 1:1 stoichiometry
in solution.
The helix D L609R mutation disrupts coiled-coil formation
We studied next the consequences of the helix D L609R mutation
[equivalent to L637R in the long Kv7.2 splice variant (Richards
et al., 2004)] found in patients with hereditary benign familial
convulsions (Richards et al., 2004), which is predicted to interrupt
coiled-coil formation (Lupas and Gruber, 2005; Schwake et al.,
2006) (Fig. 1B). To this end, non-tagged CaM and ABCD
C-terminally tagged with a fluorescent protein were co-expressed
in bacteria, and the resulting complexes were purified and analyzed.
The SEC elution volume was consistent with a 4:4 [ABCD/CaM]
globular complex. In contrast, the larger elution volume of the
L609R mutant indicated that no stable tetramers were formed
(Fig. 1C). In addition, the fastest non-denaturing electrophoretic
pattern of [ABCD-L609R/CaM] compared with [ABCD/CaM]
indicates disruption of the complex (Fig. 1D). Thus, the L609R
mutation impedes the adoption of a stable tetrameric coiled-coil
configuration.
Helices CD do not interact with calmodulin and the [ABCD/
calmodulin] complex is compact
It has been suggested that FRET results between isolated domains of
Ca2+ voltage-dependent channels and CaM can be applied to the
entire protein (Ben Johny et al., 2013). Inspired by this precedent,
100 140 180 220
Elution Volume
ABCD-YFP
L609R-YFP
AB
+CaM
1
2
3
4
5
A
C
B
-Lobe
C-Lobe
K+
D
L609
D
C
oi
le
d-
co
il 
pr
op
en
si
ty
Amino acid position
560 600 640
0.4
0.8
Helix C Helix D
WT
L609R
PIP2
B
A
N
S4
Fig. 1. The L609R mutation disrupts coiled-coil formation. (A) Structural model of the CaM ring under the membrane based on the crystallographic co-
ordinates and synchrotron X-ray data of the [AB/CaM] Kv7.1 and [ABCD/CaM] Kv7.1 complexes, respectively (Sachyani et al., 2014), the [B/CaM] Kv7.4 complex
(Xu et al., 2013), helix D Kv7.4 and Kv7.1 tetrameric bundles (Howard et al., 2007; Wiener et al., 2008), and the model derived from internal TEA-CaM blockade
(Mruk et al., 2012). The disposition of helix C and the CD linker are unknown (dashed lines). Only the selectivity filter, the S4 (salmon), S5 and S6 segments
(green), S4–S5 linker (salmon) and post-S6 segment (salmon) of two potassium channel subunits are shown for clarity. The distance between the inner leaflet of
themembrane and L609 is∼10 nm in this model. (B) Coiled-coil probabilities of helices C and D for wild-type Kv7.2 and the L609Rmutant computed using COILS
(http://www.ch.embnet.org/software/COILS_form.html). (C) Size exclusion chromatographyof the indicated constructs. Normalized absorbance is plotted against
elution volume. All samples were loaded at a concentration of 20 µM. Theoretical molecular masses (in kDa) are: 103 for [ABCD-YFP/CaM], 412 for [ABCD-YFP/
CaM]4, 206 for [ABCD-YFP/CaM]2 and 30 for [AB/CaM]. (D) Gel electrophoresis of the indicated samples in the absence of SDS. YFP (29 kDa) and BSA
(66.5 kDa), which present different degrees of oligomerization, served as a ruler for molecular mass. On top of the BSA bands the presumed number of molecules
in the oligomer is indicated (Friedman et al., 1993). The computed molecular mass of the ABCD-YFP construct is 57 kDa and that of CaM is 17 kDa. The
fluorescence image of the same gel is shown on the right.
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the interaction between CaM and the C-terminal Kv7.2 domain was
analyzed by FRET in living cells. Cyan fluorescent protein (CFP)
and yellow fluorescent protein (YFP) exhibit 50% energy transfer at
a distance of ∼5 nm and measurable transfer up to 8 nm (Patterson
et al., 2000). The ratio of the integral of CFP/YFP emission isolated
after spectral unmixing is directly proportional to the FRET
efficiency. The FRET index between CaM and helices AB was
important (Fig. 2A,E), whereas between helices CD and CaM it was
insignificant (Fig. 2B,E,G). These data reinforce the initial
conclusion, based on yeast two-hybrid interaction trap and pull-
down assays, that helices CD do not contribute directly to CaM
binding (Yus-Nájera et al., 2002). Similarly, a role of CD helices has
been discarded for CaM binding to Kv7.4 and Kv7.1 channels (Xu
et al., 2013; Sachyani et al., 2014). In contrast, an increased FRET
index compared with that of AB was observed between CFP-CaM
and YFP-ABCD (Fig. 2C,E), which is an expected consequence of
having multiple donors and acceptors within the FRET distance
[<8 nm (Patterson et al., 2000; Vogel et al., 2006); Fig. 2F]. Based
on the structure of the related Kv1.2 channel (Long et al., 2005), two
fluorescent proteins in the same channel should be ∼5.6 nm apart
(assuming they are in adjacent subunits) or 7.9 nm apart (assuming
they are in non-adjacent subunits). In agreement with this
interpretation, disruption of helix D coiled-coil by the L609R
mutation resulted in a FRET index comparable to that of AB
(Fig. 2D,E). The differences in FRET efficiency were apparent at
low free donor or acceptor concentrations, where collisional or
spurious FRET is negligible (Fig. 2G; Figs S1, S2). Thus CaM and
AB from different subunits are within FRET distance in the
tetrameric complex brought together by helix D.
Tetramerization of the distal helix D positions A helices from
different subunits within FRET distance
To gain further insights into the [Kv7.2/CaM] complex, the impact
of tetramerization on the separation between A helices of
neighboring subunits was gauged by FRET analysis, attaching
CFP or YFP at the N-terminus, upstream of helix A. This
configuration allowed the assessment of the transfer of energy
between adjacent subunits, which was virtually undetectable
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Fig. 2. FRET between calmodulin and ABCD is reduced by the helix D L609Rmutation. (A–D) Emission spectra (green) after excitation at 405 nm from cells
expressing CFP-CaM and YFP-target protein. The orange trace is the computed FRET emission from the YFP-tagged target protein and the cyan plot is the
reference emission of CFP. Note in B the negligible bleed through due to direct excitation of YFP at 405 nm. (E) FRET indexes between CFP-CaM and the
indicated constructs. (F) Cartoon illustrating how, as a result of tetramerization, each donor could be within FRET distance of two or more acceptors. Disruption of
coiled-coil formation would cause separation/re-orientation of the donor–acceptor pairs, which now would function as independent entities. (G) Binding curve in
which the FRET strength between CFP-CaM and the indicated YFP-labeled proteins is plotted versus concentration of free CFP-CaM from each individual cell
(Ben et al., 2013) (n>25). EA, acceptor-centric FRET efficiency; Dfree, free donor concentrations in arbitrary units.
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between CFP-AB and YFP-AB (Fig. 3A, compare cyan and green
traces). In contrast, a clear FRET signal was detected between
CFP-ABCD and YFP-ABCD (Fig. 3B,E), indicating that the
separation of the N-termini is below 8 nm in the tetrameric
complex. Disruption of the helix D coiled-coil formation by the
L609R mutation resulted in a large reduction of the FRET index
(Fig. 3C,D), reinforcing the view that helix D is critical for bringing
A helices close together.
Calmodulin re-orients the A helices of neighboring subunits
Three-dimensional structural data indicate that the ABCD domain
can be envisioned as a flower bouquet with the tetrameric coiled-
coil helix D corresponding to the pedestal (Sachyani et al., 2014)
(Fig. 1). We can imagine the bunch in two extreme situations: in a
compact arrangement or with flaccid stacks positioning the flowers
towards the periphery (Fig. 3G). FRET can distinguish between
closed and spread configurations, because in the first case donors
and acceptors from neighboring [CaM/AB] complexes will be
within FRET distance. With this idea in mind, the impact of
elevating CaM levels was monitored. The FRET index recorded
after disruption of tetramerization by the L609R mutation was low,
and increased after CaM elevation (Fig. 3C,D; compare green and
salmon plots), whereas no significant changes were revealed when
helix D was missing (Fig. 3A). In contrast, a prominent FRET index
was obtained for the CFP-ABCD and YFP-ABCD pair, which
almost doubled with elevated CaM levels (Fig. 3B). Thus CaM
leads to a rearrangement, probably by compaction (Fig. 3G), of the
disposition of helix A in the ABCD complex. This compaction also
takes place for the L609R mutant, but it does not reach the distant/
orientation values of the ABCD complex. Furthermore, the FRET
index was significantly reduced in cells overexpressing
neurogranin, an apo-calmodulin-binding protein (Villarroel et al.,
2014) that is expected to diminish CaM availability (Fig. 3F). These
results suggest that CaM favors, by mass action, the adoption of a
novel organization of the ABCD domain, and that this new
configuration is favored by helix D acquiring a tetrameric coiled-
coil formation.
Coiled-coil formationbyhelixD increasescalmodulin-binding
affinity
The changes on FRET suggest that CaM can bind to ABCD in at
least two different configurations, resulting in an equilibrium
scheme between a minimum of three states (Fig. 4A). A testable
consequence of the incorporation of an additional binding mode is
that the apparent binding affinity should decrease after disruption of
helix D-mediated tetramer formation by L609R (Fig. 4). Using
e-FRET methodology (Chen et al., 2006) we resolved the binding
curve in which the FRET strength between CFP-CaM and
YFP-ABCD is plotted cell-by-cell versus concentration of free
YFP-ABCD (Ben Johny et al., 2013). This revealed that, besides
decreasing maximal FRET, the L609Rmutation led to a reduction in
apparent binding affinity (Fig. 4B). To further evaluate the impact of
this mutation in CaM binding in a more controlled in vitro setting,
recombinant ABCD and ABCD-L609R proteins were produced in
bacteria and purified in the absence of CaM (Alaimo et al., 2009).
The refolded monodisperse CaM-binding domains were
subsequently assayed in vitro for binding to dansylated CaM
(D-CaM) (Alaimo et al., 2013b; Bonache et al., 2014). In
accordance with theory and with results obtained by using live
cells, the elimination of the presumed additional binding mode was
accompanied by a clear decrease in apparent binding affinity for the
L609R mutant (Fig. 4C,D). In the tetramer, the packing suggests
that binding of one CaM might affect binding to another CaM.
However, the Hill coefficient (Edelstein and Le, 2013) of the dose–
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Fig. 3. Elevation of calmodulin levels leads to increased FRET in tetrameric ABCD. (A–D) Comparison of the impact of elevation of CaM levels on the
emission spectra (green versus salmon) after excitation at 405 nm from cells co-expressing the indicated regions of Kv7.2 tagged with CFP and YFP at the
N-termini. The reference CFP emission spectrum is plotted in blue. The deviation of the green and salmon traces from the blue plot provides a visual indication of
changes in FRET. (E) Summary of FRET indexes measured under normal (gray) and elevated (salmon) CaM conditions. (F) Comparison of the impact of
overexpression of Neurogranin (Nrg, green) to reduce CaM levels on spectral FRET between CFP-ABCD and YFP-ABCD. (G) Cartoon illustrating how CaM
engaging AB in an additional binding mode could form a sort of ‘lock washer’ that compacts the proximal region of ABCD, bringing together donors and acceptors
from different subunits.
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responses did not change as a consequence of coiled-coil disruption,
suggesting that tetramerization has minor or no effect on potential
co-operativity between CaM molecules (Fig. 4C).
The effect of elevated calmodulin on PIP2 dependency
differs between WT and L609R mutant channels
Cells expressing Kv7.2, complemented or not with CaM, were
examined by whole-cell recording (Fig. 5A,B) to explore the
functional consequences of the tetramerization-disrupting mutation
on CaM-dependent function, such as current density and PIP2
dependency. Current density was not significantly affected by this
mutation (Fig. 5), whereas there was a remarkable 18 mV right shift
of the conductance–voltage relationship (Fig. 5C). The decrease in
CaM-binding affinity caused by the L609R mutation should tend to
reduce the ensemble occupancy of the four CaM-binding sites on a
Kv7.2 channel. A similar decline in the steady-state occupancy
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Fig. 4. Disruption of coiled-coil formation results in
reduced calmodulin-binding affinity. (A) Scheme
illustrating how coiled-coil formation can lead to a three-
state binding model (top) compared with a two-state model
in the absence of tetramerization (bottom). (B) The binding
curve in which the FRET strength between CFP-CaM and
YFP-ABCD (black line) or YFP-ABCD-L609R (red line) is
plotted cell-by-cell versus concentration of free YFP-
ABCD. The shaded boxes indicate the concentration
range in arbitrary units producing half-maximal e-FRET.
ED, donor-centric FRET efficiency; Afree, free acceptor
concentrations in arbitrary units. (C) Dose–response
relationship of normalized D-CaM fluorescence emission
increases with purified monodisperse recombinant GST-
ABCD proteins in the absence of Ca2+. The lines are the
result of fitting aHill equation to the data, and the EC50 from
the fit is indicated in the figure. Hill coefficients for ABCD
and L609R were 1.80±0.15 and 2.15±0.17, respectively
(n=3). (D) Dose–response relationship of normalized
D-CaM fluorescence emission increase in the presence of
3.9 µM free Ca2+. The lines are the result of fitting a Hill
equation, and the EC50 values from the fit are indicated in
the figure. Hill coefficients for ABCD and L609R were
3.07±0.39 and 2.83±0.18, respectively (n=3).
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should occur when the concentration of free CaM is critically low.
To test this idea, the properties of Kv7.2 channels in a low CaM
environment were evaluated. Under reduced CaM conditions there
was a significant decrease in current density, consistent with the role
of CaM on Kv7.2 trafficking (Etxeberria et al., 2008). Remarkably,
there was a 17 mV right shift of the conductance–voltage
relationship (Fig. 5). Similar effects were observed in cells
expressing neurogranin (n≥12, not shown). Thus both disruption
of coiled-coil formation and low CaM availability led to similar
changes in the conductance–voltage relationship, with a strong
correlation with the impact on the proximity/orientation of the
ABCD domains.
The voltage-dependent phosphatase Danio rerio voltage sensing
phosphatase (DrVSP) was used to address the impact on PIP2
dependence. To avoid voltage errors associated with the large
currents evoked at the extreme voltages required to activate DrVSP
(see Fig. 6A), series resistance compensation for the patch electrode
was set to >95% (Sherman et al., 1999). The comparison of current
relaxations before and after DrVSP activation demonstrated that the
L609R mutant was more resistant to activation of the voltage-
dependent phosphatase (Fig. 6B). Furthermore, a similar increase in
resistance to DrVSP activation was observed for wild-type channels
under low CaM conditions, which is comparable to that in channels
carrying the L609R mutation. Importantly, in contrast to wild-type
channels, the response of the mutant channel to activation of DrVSP
was insensitive to CaM elevation (Fig. 6C). Thus disruption of helix
D coiled-coil changes voltage dependency and perturbs the
adoption of additional CaM-binding modes and subsequent
change on PIP2 dependency in Kv7.2 channels.
DISCUSSION
Despite their fundamental importance in regulation and signaling,
allosteric mechanisms are, in general, poorly understood (Motlagh
et al., 2014). Here, we show that PIP2 dependency is affected at a
distance by the formation of a coiled-coil tetrameric bundle. The
data are consistent with a mechanism involving different CaM-
binding modes, which confer differential PIP2 sensitivity to Kv7.2
channels.
The data reveal that the pathogenic L609R mutation [equivalent to
L637R in the long Kv7.2 splice variant (Richards et al., 2004)]
destabilizes the helix D-dependent tetramerization of the C-terminal
region of Kv7.2. In addition, this mutation reduces the apparent
affinity for CaM binding, and leads to increased resistance to the
action of a voltage-dependent phosphatase that reduces PIP2
concentration at the plasma membrane. A plausible consequence of
the reduction of CaM affinity is that CaM occupancy of the channel is
diminished, and, on average, not all four sites of the tetrameric
channel would be engaged in a given instant. A similar reduction in
the number of resident CaM molecules can be achieved by lowering
CaM availability, which led to increased resistance to DrVSP action,
similar to that seen for the helixD-mutated channels. In addition, both
wild-type channels when CaM is scarce and L609Rmutant channels
under resting CaM levels present a >17 mV right shifted
conductance–voltage relationship, meaning that two different
situations that lead to low CaM occupancy converge towards a
similar voltage dependency and increased resistance to PIP2
depletion. Although results obtained with isolated domains may not
apply to the full-length channel, the agreement between in vitro data
and those obtained by using live cells favor the argument that these
events are related, and are consistent with the idea that the effect on
PIP2 sensitivity is a consequence of the changes on CaM residence.
How can helix D affect CaM binding? Neither our new FRET
data, nor previous studies using yeast two hybrid assays, or studies on
Kv7.1 or Kv7.4, have exposed any hint of direct CaM interaction
with helices CD (Yus-Nájera et al., 2002; Howard et al., 2007;
Wiener et al., 2008; Xu et al., 2013). In addition, small angle X-ray
scattering of the related Kv7.1 subunit (Sachyani et al., 2014) reveals
that there is no physical contact between helix D and the [AB/CaM]
complex. Therefore, we conclude that the impact of helix D in CaM
binding is indirect. In addition to previous functional and structural
data (Alaimo et al., 2013a; Sachyani et al., 2014), the helix
D-dependent changes in CaM-binding affinity unveiled here support
the concept of the occurrence of more than one binding mode. The
decrease in FRET for the L609R mutant underscores the importance
of coiled-coil formation by helix D in this process. The changes in
homo-FRET efficiency between ABCD modules are a clear
indication that the A helices re-orient, come closer, or both, when
more CaM is available. Either new CaM molecules are entering the
complex, or existing CaM molecules are engaging in new binding
modes, such as intrasubunit and intersubunit binding modes.
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The CaMN-lobe has a significant preference to anchor to helix B,
whereas the C-lobe binds more favorably to the IQ site located in
helix A (Alaimo et al., 2014). In the context of the full-length
channel, both helices in the [AB/CaM] complex could originate from
the same subunit (intrasubunit binding) or from two adjacent
subunits (intersubunit binding). Intersubunit binding requires
placing AB helices from contiguous subunits within CaM reach,
i.e. <4 nm (Villarroel et al., 2014). Indeed, Kv7.2 models derived
from trigonometric restrictions obtained with pore blockers tethered
to CaM as calipers, position the lobe anchoring sites of nearby CaM
molecules under 4 nm (Mruk et al., 2012) (Fig. 1A). In addition,
besides the precedents for bridged configurations in other channels
(Schumacher et al., 2001; Sarhan et al., 2012; Villarroel et al., 2014),
the crystallographic structure of Kv7.1 [AB/CaM] has been trapped
with CaM embracing helices A and B from different subunits
(Sachyani et al., 2014). We have previously shown by whole-cell
recording that precluding CaM binding to helix A or to helix B
results in non-functional channels, but, remarkably, both mutant
channels complement each other, restoring function when co-
expressed (Alaimo et al., 2013a). Furthermore, at submicromolar
concentrations, CaM links two Kv7.2 AB domains in vitro,
anchoring helix A of one subunit to helix B of another subunit
(Alaimo et al., 2013a). Therefore, we consider reasonable the
hypothesis that, by bringing together the AB helices from
adjacent subunits thanks to helix D coiled-coil formation, each
CaM lobe can engage with the complementary helix from a
neighboring subunit.
Consideration of our new data together with prior work leads us to
propose an extension of the CaMmodulation hypothesis to include a
switch betweenCaMbinding-modes, whichmay correspond to intra-
and intersubunit engagement or different degrees of occupancyof the
multiple CaM-binding sites, providing distant control of PIP2
sensitivity by the tetramerization domain. The structures of many
configurations are presently unknown, but homology modeling
confirms the plausibility of these arrangements. In the context of the
full-channel, with the restrictions imposed by the pore-forming
regions preceding helix A, the approximation of these helices caused
by CaM elevation should translate in a movement of the whole
[ABCD/CaM] complex relative to the pore. A doubling in FRET
index in the presence of elevatedCaM (Fig. 3) could be accounted for
by less than 6% reduction in the separation of the fluorophores, i.e. a
displacement <0.5 nm, a magnitude comparable to the vertical
translation of the cytoplasmic domain observed between the
structures of Kir2.2 channels with and without PIP2 (Hansen et al.,
2011).
It is not known if the helix D tetramer de-oligomerize and re-
oligomerize as part of the normal channel function, allowing for
physiological allosteric control of channel activity. Beyond
supporting different CaM-binding modes and affecting channel
assembly, the helix D coiled-coil domain may also serve as a
scaffold for interactions with other proteins that regulate channel
activity (Marx et al., 2002; Kass et al., 2003; Wiener et al., 2008).
Thus, helix D may act as an antenna, funneling relatively distant
interactions towards the pore by changing indirectly the way the
channel engages with CaM.
The data provide a basis for theoretical generalization of an
allosteric mechanism. Many ion channels, such as Kv7, Eag, Erg,
SK, CNG and TRP, present multiple CaM-binding domains
followed by a tetrameric coiled-coil bundle (Jenke et al., 2003;
Tsuruda et al., 2006), but other elements could assume the
equivalent conceptual roles. The ingredients are two bi-functional
target–receptor components, plus a mechanism that brings two or
more targets in close vicinity. By controlling at a long distance the
proximity between the binding sites, the receptor could engage the
target in different configurations, ultimately affecting activity.
PIP2 is strictly required for the operation of Kv7 channels, and it
is currently thought that parts of the channel from well-separated
regions of the linear sequence fold to bring together several basic
residues to create a binding pocket (Zaydman and Cui, 2014). The
concept is that the interacting basic residues do not represent a
structurally selective binding site; rather they form positively
charged clouds that would attract any acidic lipid. PIP2 would be the
principal target because it is the most abundant multiply-
phosphorylated lipid of the plasma membrane (Suh and Hille,
2008). By reconfiguring the CaM ring underneath the pore, the
cloud envelope in contact with PIP2 at the inner leaflet of the
membrane could change, such that the orientation of lysine, arginine
or histidine residues making electrostatic contacts with the charged
phosphate groups will be controlled at a distance by helix D. A
fuzzy organization of the PIP2-binding surface like this may help to
explain the puzzling similar effects in channel-PIP2 sensitivity of
low and elevated CaM levels. Defects in channel-PIP2 sensitivity
through interfering mutations can lead to disease (Logothetis et al.,
2010). It is attractive to hypothesize that mutations not located at the
binding site that disrupt channel-PIP2 dependency, such as L609R
described here and which was found in a patient with an epileptic
condition (Richards et al., 2004), could also lead to disease.
MATERIALS AND METHODS
Molecular biology
The human isoform 3 Kv7.2 (Y15065) cDNA was provided by T. Jentsch
(Leibniz-Institut für Molekulare Pharmakologie, Berlin, Germany) and the
cDNA encoding rat CaM was provided by the group of J.P. Adelman
(Vollum Institute, Portland, OR, USA). The subunits tagged at the
N-terminal with CFP or YFP were cloned into pCDNA3.1 and we
previously confirmed that these N-terminal tags have no impact on the
electrophysiological properties of the channel (Soldovieri et al., 2006;
Gómez-Posada et al., 2010; Gómez-Posada et al., 2011). Point mutations
were constructed by polymerase chain reaction (PCR)-based mutagenesis.
Dr-VSP-IRES-GFP from zebrafish was provided by Y. Okamura (Osaka
University, Osaka, Japan). The CaM sponge, which has CFP and YFP
flanking the apoCaM-binding site of neuromodulin, was provided by
D.J. Black (University of Missouri, Missouri, USA). For in vitro
co-expression experiments, CaM was subcloned into the pOKD4 vector.
C-terminal channel sequences were fused to a custom-made circularly
permuted Venus variant of YFP (Shinege; China) and subcloned into
pPROEX-HTc vector. Rat neurogranin (NM_024140.2) tagged with a myc
epitope at the N-terminus was cloned into pcDNA3.1 hys/myc A vector.
Homology modeling
The portrayed structure in Fig. 1 is an extension of model 3 proposed by
Mruk et al., which places key residues of the CaM N- and C-lobes at a
distance relative to the Kv7.2 pore compatible with the effects of a pore
blocker tethered to CaM with chains of varying length (Mruk et al., 2012),
and adequate for it being linked to S6, assuming that the IQ site adopts a
similar disposition as that in the Kv7.1 [AB/CaM] complex (Sachyani et al.,
2014), and presents a kink as predicted by sequence analysis (Alaimo et al.,
2014). The structural models of [N-lobe/helix B] complexes fromKv7.1 and
Kv7.4 nicely superimpose, and are consistent with nuclear magnetic
resonance (NMR) data obtained for the Kv7.2 [AB/CaM] complex (Xu
et al., 2013; Alaimo et al., 2014; Sachyani et al., 2014). In turn, the structural
crystallographic X-ray-based model for the Kv7.1 [C-lobe/helix A] complex
is compatible with NMR observations of the Kv7.2 [AB/CaM] complex
(Alaimo et al., 2014; Sachyani et al., 2014), and is almost identical to every
other solved complex of apo-C-lobe (Ca2+ free) with peptides containing an
IQ motif (IQxxθR, θ=bulky apolar residue), a motif that is present in helix A
of every Kv7 channel (Yus-Nájera et al., 2002; Villarroel et al., 2014).
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Finally, helix D has been placed at a distance from the CaM-binding site,
according to the envelope observed by small-angle X-ray scattering (SAXS)
for the Kv7.1 [ABCD/CaM] complex in solution (Sachyani et al., 2014).
This disposition places PIP2 and L609 of helix D more than 10 nm apart.
Fluorescence spectroscopy
Recombinant proteins ABCD, ABCD-L609R (both fused to GST) and CaM
were produced as described previously (Alaimo et al., 2009). Fluorometric
experiments using dansyl-CaM (D-CaM), CaM dansylation, sample and
buffers preparation and fluorescent measurements were performed as
described previously (Alaimo et al., 2013b; Bonache et al., 2014).
Recombinant protein production, purification and native gel
electrophoresis
Fusion proteins were expressed in Escherichia coli [BL21(DE3)] grown in
lysogeny broth (LB) medium at 37°C and induced at OD600 nm=0.6–0.8 with
0.5 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) for 5 h. Cells were
harvested by centrifugation at 5000 g for 20 min at 4°C, and cell pellets were
frozen at −20°C. Thawed cell pellets were lysed in lysis buffer (mM: 120
KCl, 3 imidazole, 1 phenylmethylsufonyl fluoride (PMSF), 10 K-HEPES;
pH 7.4), and one tablet of protease inhibitor without EDTA (Roche Applied
Science, Penzberg,Germany), and passed three times through a homogenizer
(Emulsiflex). Insoluble material was precipitated by centrifugation for
30 min at 25,000 g at 4°C. The resulting soluble fraction, which contained
the fusion protein, was applied to a 5 ml cobalt-charged column (no. 28-
9537-67, GE Healthcare, Little Chalfont, UK), and pre-equilibrated in wash
buffer (mM: 120 KCl, 10 K-HEPES; pH 7.4). Increasing amounts of
imidazole were used for washing. Sample elution proceeded on a linear
gradient from 30 to 300 mM imidazole on an ÄKTA fast protein liquid
chromatography (FPLC) system. Imidazole was removed by dialysis
overnight at 4°C in cellulose membrane tubing (no. D927-100FT, Sigma-
Aldrich, St Louis, MO, USA) with agitation against 1 litre of fluorescence
buffer (mM: 125 KCl, 5 NaCl, 1 MgCl2, 10 EGTA, 10 Tris; pH 7.4. Fusion
proteins were then applied to a Superdex 200 pg 26/600 column (no. 28-
9893-36, GE Healthcare) and eluted in the same buffer. Positive fractions
were pooled together and concentrated using a 3 kDa cut-off Amicon ultra-
15 concentrator (no. UFC900308, EMDMillipore, Billerica, MA, USA) in a
fixed angle rotor at 3500 g. Protein concentration was measured at 462 nm,
equalized to 4 µM and samples with 5% of glycerol were run in 7% non-
denaturing (‘native’) gels (without SDS).
Cell culture and transfection
HEK293T cells (HEK 293T/17, ATCC, CRL-11268) were maintained in
5% CO2 at 37°C in Dulbecco’s modified Eagle’s medium (DMEM, Sigma-
Aldrich), supplemented with non-essential amino acids (Sigma, Madrid,
Spain) and 10% fetal bovine serum (FBS; Lonza, Madrid, Spain). Transient
transfection for imaging was performed using polyethylenimine (PEI)
25 kDa (no. 23966-22g, PolySciences, Eppelheim, Germany), whereas for
electrophysiology experiments lipofectamine 2000 (Invitrogen) was used
following manufacturer’s instructions. All experiments were performed
48 h after transfection.
Electrophysiological measurements
Whole-cell patch recordings of HEK293T cells were obtained at room
temperature (21–25°C). Cells were bathed in the following solution (mM):
140 NaCl, 4 KCl, 2 CaCl2, 2 MgCl2, 10 Na-HEPES and 5 D-glucose,
adjusted to pH 7.4 with NaOH. The osmolarity was adjusted with mannitol
to ∼315 mosmol/l. Pipettes were pulled from borosilicate glass capillaries
(Sutter Instruments, USA) using a Narishige micropipette puller (PC-10;
Narishige Instrument Company, Japan). All experiments to test the impact
of DrVSP (0.5 µg cDNA per 35 mm dish) were carried out with 100% series
resistance compensation using a VE-2 amplifier (Alembic Instruments,
Canada) equipped with an Rs Compensator (Sherman et al., 1999).
We applied the traditional voltage protocol as in the original description
of the M-current (Adams et al., 1982). This protocol takes advantage of the
lack of inactivation of the M-channels, and allows removing potential
‘invasion’ of the signal by other inactivating currents. Our protocol to study
the sensitivity to DrVSP activation is similar to that used by Hille and
collaborators (Falkenburger et al., 2010). DrVSP was activated by a 200 ms
jump to +100 mV, and the voltage was returned to the holding potential of
−20 mV. Jumps to−110 mV, beyond the K+ reversal potential, were applied
to close the channels. Upon returning to the holding potential, an
instantaneous current jump (corresponding to leak current) followed by a
slowly developing outward relaxation (corresponding to the opening of the
M-channels) was recorded. The size of the outward relaxation before and
after the +100 mV jump was used to estimate the effect of DrVSP activation
on M-current size (Adams et al., 1982; Villarroel, 1994).
Pipettes were filled with an internal solution containing (mM): 125KCl, 5
MgCl2, 5 EGTA, 5 Na2ATP and 10 K-HEPES, adjusted to pH 7.2 with KOH
and the osmolarity adjusted to ∼300 mosmol/l with mannitol (Gómez-
Posada et al., 2010). The amplitude of the Kv7 current was defined as the
peak difference in current relaxation measured at −30 mV after 500–
1500 ms pulses to −110 mV (all channels closed) and to +30 mV (all
channels opened). The data were acquired and analyzed using pCLAMP
software (version 8.2), normalized in Excel (Microsoft, Madrid, Spain) and
plotted using SigmaPlot (SPSS Corporation, Madrid, Spain). Data are
shown as means±s.e.m. The differences between the means were evaluated
using Student’s unpaired t-test, where values of P≤0.05 were considered
significant. The number of cells in each experiment is indicated in
parentheses in the figures. The results are from two or more independent
batches of cells. In all figures *, ** and *** indicate significance at P<0.05,
P<0.01 and P<0.001, respectively.
Spectral FRET measurements
Single transiently transfected HEK293 cells were maintained in buffer
solution composed of (mM): 140 NaCl, 5 KCl, 1 MgCl2, 2 CaCl2, 10
glucose and 10 Na-HEPES; pH 7.4 at room temperature. For CFP-CaM
binding to YFP-tagged KV7.2 C-terminal region (devoid of any membrane
anchoring region) the transfection ratio used was 1:5 with a total of 0.6 µg
DNA per M35 dish. Control experiments expressing CFP alone or CFP
together with YFP at a 1:5 ratio demonstrated that contamination of the CFP
emission signal due to direct YFP excitation at 405 nm was <1% (Fig. S1).
For assembly experiments, the ratio was 1:1 (1 µg of each FCP-tagged
ABCD and 2 µg of CaM or 2 µg of empty pcDNA3.1 his/myc C vector).
Images were recorded 48 h after transfection using a Nikon D Eclipse
TE2000-U fluorescence microscope (Nikon Instruments, Tokyo, Japan)
equipped with a confocal scanning head and a spectral detector module.
Images were captured using a 60× oil objective (numerical aperture 1.43),
with the pinhole opened (150 µm) and using the 405 nm laser line
(Coherent, Santa Clara, CA, USA) or the 488 nm line (Melles-Griot,
Rochester, NY, USA) for direct CFP or YFP excitation, respectively.
Cytosolic regions of interest (ROI) from cells displaying a clear signal after
excitation with the 488 nm laser line were included in the analysis. The
spectral detector allows simultaneous recording of 32 images, each
registering a 5 nm band of the spectrum, covering 450–610 nm. After
spectral unmixing, the area under the spectra was measured and a FRET
index was calculated as FRET index=YFP405/CFP405.
e-FRET measurements
Fluorescence intensities of YFP and CFP were recorded from single cells
using a Leica DMI6000B inverted epifluorescence microscope and a dual
emission photometric system (Till Photonics, Gräfelfing, Germany).
Excitation was done at 436±7.5 nm or 500±7.5 nm, applied at 2 Hz using
a Polychrome V as light source. Epifluorescence emission was detected by a
photodiode, digitized (Mini Digi1B; Molecular Devices) and acquired using
Clampex 10 software (Molecular Devices). FRET filter cubes were
(excitation, long-pass beam-splitter, emission): CFP (ET436/20x; T455lp;
ET480/40m), YFP (ET500/20x; T515lp; ET535/30m) and FRET (ET436/
20x; T455lp; ET535/30m) (Chroma Technology). e-FRET efficiencies
(ED) were determined using ED=(SFRET−RD1×SCFP−RA×SYFP)/
(SFRET−RD1×SCFP−RA×SYFP+G×SCFP). SFRET, SCFP and SYFP denote
fluorescence intensities derived from measurements in individual cells co-
expressing YFP- and CFP-tagged proteins with the respective filter cube
(excitation, emission): SFRET (500±7.5 nm, 535±15 nm), SCFP (436±
7.5 nm, 480±20 nm) and SYFP (500±7.5 nm, 535±15 nm). RD1 and RA
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are experimentally predetermined constants from measurements applied to
single cells expressing only CFP- or YFP-tagged molecules that correct for
donor bleed trough and acceptor cross excitation. G factor represents the
ratio of sensitized acceptor emission to quenched donor emission due to
FRET, and was experimentally determined to be 4.13 using CFP fused to
YFP with linkers of varying length (4, 40 and 80 amino acids). The CFP/
YFP ratio was between 1:5 and 5:1, which is expected to yield reliable
results.
d-FRET measurements
Fluorescence intensities of YFP and CFP were recorded from single cells
using a Leica DMI6000B inverted epifluorescence microscope and a 914
photomultiplier detection system (PTI, Canada). Excitation was done at
436±7.5 nm or 500±7.5 nm, applied with a DeltaRam X monochromator
including an arc lamp (PTI, Canada) as light source. Epifluorescence
emission was acquired using FelixGX software (PTI, Canada).
FRET efficiency for d-FRET (EA), which is defined as the fractional
increase in YFP emission caused by FRET, was calculated using EA=
{[SFRET−(RD1)(SCFP)]/[(RA1)(SYFP)]−1}×(εYFP/εCFP); SFRET, SCFP and
SYFP denote fluorescence intensities derived from measurements in
individual cells co-expressing YFP- and CFP-tagged proteins with the
respective filter cube.
FRET data were analyzed using Clampfit 10.0 (Molecular Devices), and
Microsoft Office Excel software. Data plotting, curve fitting and statistical
analysis were performed using Sigma-Plot 12 software (SPSS Corporation).
All values are presented as means±s.e.m. for the indicated number (n) of
experiments. Student’s t-test was used to compare means of two groups from
data with a normal distribution. Statistical analysis was performed using
SigmaPlot software. *P<0.05, **P<0.01 and ***P<0.001 indicate
significance.
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Fig. S1. Emission spectra of the different fluorophores excited at 405 nm (donor excitation
wavelength, cyan trace, left image) or 488 nm (acceptor excitation wavelength, yellow trace, 
right image). The regions of interest selected to generate the spectra are indicated with red 
squares. Note that the presence of helices CD prevents the constructs from reaching the nucleus. 
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Fig. S2. The binding curve in which the FRET strength between CFP-CaM and YFP-AB or
YFP-CD is plotted cell-by-cell versus concentration of free YFP-tagged acceptor (n >25).  
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High susceptibility to fatty liver disease in two-pore
channel 2-deficient mice
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Endolysosomal organelles play a key role in trafficking, breakdown and receptor-mediated
recycling of different macromolecules such as low-density lipoprotein (LDL)-cholesterol,
epithelial growth factor (EGF) or transferrin. Here we examine the role of two-pore channel
(TPC) 2, an endolysosomal cation channel, in these processes. Embryonic mouse fibroblasts
and hepatocytes lacking TPC2 display a profound impairment of LDL-cholesterol and
EGF/EGF-receptor trafficking. Mechanistically, both defects can be attributed to a dysfunction
of the endolysosomal degradation pathway most likely on the level of late endosome to
lysosome fusion. Importantly, endolysosomal acidification or lysosomal enzyme function are
normal in TPC2-deficient cells. TPC2-deficient mice are highly susceptible to hepatic
cholesterol overload and liver damage consistent with non-alcoholic fatty liver hepatitis.
These findings indicate reduced metabolic reserve of hepatic cholesterol handling. Our results
suggest that TPC2 plays a crucial role in trafficking in the endolysosomal degradation
pathway and, thus, is potentially involved in the homoeostatic control of many macro-
molecules and cell metabolites.
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E
ndo/lysosomal vesicle trafficking is important for many cells
and organ systems. In the liver, receptor-mediated uptake of
low-density lipoproteins (LDLs) and subsequent intra-
cellular transport is essential for hepatic cholesterol homoeostasis
and plasma lipoprotein metabolism. Dysfunction within this
pathway results in liver disease such as non-alcoholic fatty liver
disease (NAFLD), which is associated with increased cardio-
vascular and liver-related mortality1. NAFLD is the most
common cause of chronic liver disease in Western Europe and
the United States2,3. It has been estimated that as many as 30% of
adults in these countries have NAFLD2. This liver disease has
thus emerged as a substantial public health concern. The
spectrum of NAFLD ranges from simple lipid accumulation in
hepatocytes (steatosis) in absence of alcohol, which is considered
relatively benign, to steatosis with liver damage, inflammation
and fibrosis (non-alcoholic steatohepatitis (NASH)) and
progressive liver disease, including cirrhosis and hepatocellular
carcinoma4. The hallmark of NAFLD is hepatic neutral lipid
accumulation, mainly triacylglycerol and cholesterol ester (CE).
The roles of both triglycerides and free fatty acid accumulation in
NAFLD have been elucidated in many studies5. By contrast, the
role of cholesterol in NAFLD has been less extensively studied but
is gaining increasing attention1,6–8.
Recent studies have demonstrated that cholesterol metabolism
and trafficking might play an important role in the pathogenesis
of NAFLD and NASH1. Cholesterol is highly enriched in LDLs
and is taken up by the liver via receptor-mediated endocytosis of
the LDL–LDL receptor complex at the plasma membrane. After
internalization, membrane vesicles containing this complex fuse
to early endosomes. Subsequently, LDL receptors and its ligand
LDL are separated in the sorting endosome and distributed by
two major routes: the recycling pathway transports LDL receptor
proteins back to the plasma membrane; the degradation pathway
traffics LDL to late endosomes and lysosomes. This pathway
involves maturation of early endosomes into multivesicular
bodies/late endosomes which finally fuse with lysosomes9–15.
LDL-cholesterol exits from late endosomes and lysosomes and is
either metabolized to bile acids (BAs) and excreted, stored as CEs
in lipid droplets or exported from hepatocytes into the plasma.
While the principle pathways of LDL transport in the
endolysosomal vesicle system are well characterized, the distinct
proteins involved in these processes are largely unknown.
Interesting candidate proteins, which might regulate endolysoso-
mal trafficking, and fusion processes are cation channels present
in the membrane of endolysosomal vesicles. Recently identified
cation channels that may generate Ca2þ signals during
endolysosomal fusion events and thereby vesicle trafficking are
the two-pore channels (TPCs)16,17. Two different TPC subtypes
exist in mouse and man, TPC1 and TPC2. There is evidence
that TPC1 is mainly present in the proximal endosomal system,
and TPC2 is predominantly expressed on late endosomes and
lysosomes16,18,19. The activation mechanism of TPCs is complex
and has been suggested to involve the second messenger nicotinic
acid adenine dinucleotide phosphate (NAADP) and the
endolysosomal membrane lipidphosphatidylinositol (3,5)-
bisphosphate (PI(3,5)P2)17,18,20–24. Independent of what the
nature of the endogenous ligand of these channels might be,
there is substantial evidence that on activation TPCs mediate the
release of Ca2þ from lysosomal stores. Patch-clamp21,22,24, lipid
bilayer and calcium imaging experiments18,25,26 indicate that
TPCs are Ca2þ permeable channels and, hence, may directly
confer Ca2þ release from endosomes/lysosomes.
Here, we demonstrate that TPC2-deficient cells display
profound trafficking defects in the endolysosomal degradation
pathway. We provide evidence that TPC2 cation channels
may directly be involved in Ca2þ signalling necessary for
endolysosomal fusion processes. On the whole-animal level, we
demonstrate that loss of TPC2 leads, as a result of the observed
trafficking defects, to enhanced hepatic cholesterol accumulation,
hyperlipoproteinaemia, and to NASH. These findings indicate a
reduced metabolic reserve of hepatic cholesterol handling. Our
results suggest that TPC2 plays a crucial role in endolysosomal
trafficking in the endolysosmal degradation pathway and, thus, is
potentially involved in the homoeostatic control of many
macromolecules and cell metabolites.
Results
Loss of TPC2 impairs trafficking in the degradation pathway.
To test whether TPC2 is implicated in endolysosomal trafficking,
we disrupted the Tpc2 gene in the mouse (Fig. 1a). In this mouse
line, exon 7 of TPC2, which encodes TMD5 and part of the
pore-loop of domain I, is globally deleted (Fig. 1a). This targeting
strategy results in non-functional ion-channel proteins and is
different from the strategies used for two mouse lines published
before17,18. The deletion of the TPC2 gene was confirmed
by genomic DNA analysis using Southern blot (not shown),
PCR strategies, immunocytochemistry and western blotting
(Supplementary Fig. 1a,b). Reverse-transcription PCR (RT–PCR)
revealed the absence of exon 7 of TPC2 in TPC2 / murine
embryonic fibroblasts (MEFs) and hepatocytes (Supplementary
Fig. 1b). In addition, we generated a TPC2 antibody to detect
TPC2 protein. In agreement with the RT–PCR results,
TPC2 protein was totally absent in TPC2 / MEFs in
Figure 1 | Generation and characterization of TPC2 knockout mice. (a) Targeting strategy for the generation of TPC2 / mice and validation. The
targeted exon 7 of the mTPC2 gene encodes TMD5 and part of the pore-loop of domain I. Exons 6–8 are represented by boxes. The targeting vector
contains two loxP sites (green triangles), and a neo cassette flanked by two FLP recombination target (FRT) sites (blue triangles). (b) Representative
immunofluroscence (IF) images of WT and TPC2 / MEFs (stained with anti-TPC2 and Cy5) as well as WT and TPC2 / liver cryosections (stained
with anti-TPC2 and Alexa-488). Cell nuclei were visualized with Hoechst (MEFs) or 4’,6-diamidino-2-phenylindole (DAPI) (liver). Scale bars, 20 mm.
(c) Current–voltage relations of currents recorded from single-WT and -TPC2 / lysosomes in the presence of 50 nM NAADP or 10mM PI(3,5)P2.
Lysosomes were isolated from vacuolin-treated WT and TPC2 / MEFs before measurements. (d,e) Population data for current amplitudes at  200 mV
obtained from experiments as shown in a; **Po0.01, ***Po0.001, two-way analysis of varicane (ANOVA) followed by Bonferroni’s post hoc test (d) or
unpaired Student’s t-test (e). (f) Expression and distribution of selected marker proteins for endosomes and lysosomes were unaffected in TPC2 /
compared with WT MEFs. Shown are representative confocal images of WT and TPC2 / MEFs labelled with anti-EEA1, LAMP1 or LAMP2 and
Alexa-488. Nuclei were visualized with DAPI. Scale bar, 20mm. For additional markers, see Supplementary Fig. 1. (g) Representative electron microscope
images of WT and TPC2 / liver sections. BC, bile canaliculus; LY, lysosome; Mito, mitochondrion; RER, rough endoplasmic reticulum. Scale bars,
500 nm. (h,i) Measurement of endolysosomal pH in WTand TPC2 / cells. Late endocytic compartments of WT and TPC2 / MEFs were labelled with
dextran-Oregon Green 514. (h) Fluorescence intensity ratios were calculated for defined pH values as described in the Methods section. (i) Lysosomal
pH values in WT and TPC2 / MEFs were calculated using the calibration curves presented in h and determined under basal conditions, without amino
acids ( aa, EBSS), and without both, aa and glucose ( aa,  glc). Baf. A1 was used as positive control; n.s., not significant, unpaired Student’s t-test.
Data points in d,e,h and i are given as mean±s.e.m.
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immunocytochemistry experiments, while it could be detected
in wild-type (WT) MEFs (Fig. 1b). Western blot analysis of WT
and TPC2 / liver samples confirmed absence of TPC2 protein
in TPC2 / livers (Supplementary Fig. 1b). In lysosomes
prepared from TPC2 / MEFs, currents elicited by postulated
activators of TPC2, NAADP and PI(3,5)P2 were strongly reduced
(Fig. 1c–e). NAADP-dependent currents in WT lysosomes
displayed a bell-shaped dose-response relationship (Fig. 1d) as
reported previously25,26.
Expression and distribution of the early endosomal markers
EEA1, Rab4 and Rab5, the late endosomal/lysosomal markers
LAMP1, LAMP2, LIMP2 and CD63 or the recycling endosomal
markers TfR, Rab4 and Rab11 were comparable in WT
and TPC2 / cells (Fig. 1f and Supplementary Fig. 1c–e).
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Overexpression of the constitutively active Rab5 variant
Rab5(Q79L) induced the formation of characteristic enlarged
Rab5-positive vesicles both in WT and TPC2 / MEFs,
indicating that early endosomal fusion is functioning normally
(Supplementary Fig. 1f). Ultrastructural analyses of WT and
TPC2 / liver samples using electron microscopy revealed no
obvious alterations in the endolysosomal system (Fig. 1g). In
particular, the number of endolysosomal vesicles did not show
any deviations between the two genotypes. Notably, lysosomal
deposits which have been reported in lysosomal storage diseases
such as mucolipidosis type IV27,28 could not be detected in
TPC2 / mice.
Finally, steady-state endolysosomal pH values were similar in
TPC2 / and WT MEFs. This result was obtained in two
different, independently generated WT and TPC2 / batches
of MEFs: 5.08±0.1 for WT versus 4.93±0.06 for TPC2 /
(batch-1) and 4.87±0.03 for WT versus 4.89±0.02 for TPC2 /
(batch-2) (Fig. 1h,i and Supplementary Fig. 1g–i). Even under
starvation conditions (EBSS buffer ( aa) or starvation buffer
( aa/ glc)), no significant differences in endolysosomal
pH between WT and TPC2 / were observed (again two
independently generated MEF cell lines (batch-1 and batch-2)
were tested) (Fig. 1i and Supplementary Table 1). In addition, the
pH dependent, endolysosomal processing of cathepsin D and
cathepsin L was examined. In the acidic environments of late
endosomes and lysosomes, the mature forms of cathepsin D and
cathepsin L are produced after proteolytic removal of the
propeptide. We found that the generation of mature forms of
cathepsin D and L was not impaired in TPC2 / MEFs
compared with WT (Supplementary Fig. 1j). Specificity of the
detected bands was controlled by analysing lysates from the
respective cathepsin / MEFs in parallel.
Next, we assessed the functional consequences of a loss of
TPC2 for trafficking processes in the endolysosomal degradation
pathway (Fig. 2a), the main subcellular localization of TPC2. This
pathway can be tested by using labelled LDL which binds to its
receptor and is internalized into the cell via endocytosis10.
Subsequently, LDL dissociates from the receptor and is passed on
to late endosomes and lysosomes, from where cholesterol is
released into the cytosol (Fig. 2a). A trafficking or fusion defect
within this pathway would lead to accumulation of LDL in
vesicles proximal to the defect. We used LDL-BodipyFL to test
this hypothesis and found that the number of LDL-positive
vesicles per cell was significantly increased in TPC2 /
compared with WT MEFs (Fig. 2b–d). This effect was observed
at a broad range of LDL concentrations and after different pulse/
chase times (Fig. 2c,d). LDLR expression in WT and TPC2 /
MEFs was found to be similar as determined by quantitative
western blot experiments (normalized to glyceraldehyde
3-phosphate dehydrogenase) (Fig. 2e and Supplementary
Fig. 2a). As an independent test for the same pathway, we
performed experiments using labelled EGF (epithelial growth
factor; AlexaFluor488-EGF)29. These experiments revealed that
EGF accumulation is increased in TPC2 / compared with WT
MEFs (Fig. 2f–h). This finding was confirmed in independently
generated MEFs (batch-2) (Supplementary Fig. 2b,c). In addition,
in primary hepatocytes isolated from TPC2 / mice, the
number of EGF-positive vesicles per cell was also significantly
increased compared with WT hepatocytes, whereas EGFR
expression in WT and TPC2 / livers was not significantly
different (Fig. 2i and Supplementary Fig. 2d,e). To further assess
whether the increased accumulation was caused by decreased
degradation, the time course of EGF degradation after uptake was
measured. MEFs were incubated with a saturating concentration
of EGF (4 mg ml 1), followed by defined chase times before
fixation (Fig. 2j,k). In TPC2 / MEFs, the fluorescence
decreased significantly slower compared with WT MEFs.
To further determine the identity of the endolysosomal vesicles
where EGF accumulates in TPC2 / cells, we co-labelled cells
with markers for early endosomes (Rab5), late endosomes (Rab7),
and late endosomes/lysosomes (LAMP1), and found that about
57% of the EGF-positive vesicles showed co-labelling with Rab7
and 41% with LAMP1, but only about 5% with Rab5, indicating
that accumulation occurs rather in the late section of the
endolysosomal system than in early endosomes (Fig. 2l,m).
Taken together, these results suggested that EGF/EGFR and
LDL-cholesterol transport and degradation are impaired in
TPC2 / cells, and the endolysosomal transport machinery
appeared to be saturated significantly faster in TPC2 / than in
WT cells.
Calcium and TPC2 channels are critical for trafficking.
Endolysosomal trafficking defects can be caused by multiple
factors. They can result from defects in enzymatic degradation of
macromolecules, which is the underlying cause of most lysosomal
storage disorders. Impaired trafficking can also be caused by
defects in the acidification of endolysosomal organelles, defective
ionic homoeostasis or defects in endolysosomal fusion and fission
processes. Defects in acidification of endolysosomal vesicles have
been reported before to be the primary cause for the observed
trafficking abnormalities for example, in mucolipidosis type IV,
which is caused by mutations in the lysosomal cation channel
TRPML1 (refs 27,30,31). However, endolysosmal pH appears
normal in TPC2 / cells. Another attractive hypothesis for
impaired endolysosomal trafficking is a defect in vesicle fusion or
Figure 2 | TPC2 deletion leads to LDL and EGF/EGFR trafficking defects in the degradation pathway. (a) Cartoon illustrating endolysosomal degradation
and recycling pathways. In the degradation pathway (endo/lysosomal axis) EGF/EGFR and LDL are degraded. In the recycling pathway LDLR and Tf/TfR
are recycled. Cholesterol can exit the endolysosomal system from late endosomes or lysosomes. LE, late endosome; LY, lysosome; C, free cholesterol.
(b) Representative confocal images of WT and TPC2 / MEFs incubated with 3mg ml 1 LDL-BodipyFL. Cell nuclei were visualized with Hoechst.
(c) Average numbers of LDL-positive vesicles per cell after an incubation time of 30 min at concentrations as indicated. (d) Average numbers of LDL-
positive vesicles per cell after different incubation times at a concentration of 1 mg ml 1. (e) Quantitative western blot data showing average protein levels
of LDLR in WT and TPC2 / MEFs. (f) Representative confocal images of WT and TPC2 / MEFs incubated with 0.3 mg ml 1 AlexaFluor488-EGF.
(g) Average numbers of EGF-positive vesicles per cell after an incubation time of 30 min at concentrations as indicated. (h) Average numbers of
EGF-positive vesicles per cell after different incubation times at a concentration of 0.3mg ml 1, followed by a 2-h chase period. (i) Average numbers of
EGF-positive vesicles per cell from similar experiments with freshly prepared WT and TPC2 / hepatocytes. (j) Representative confocal images of
TPC2 / and WT MEFs incubated with 4mg AlexaFluor488-EGF for 30 min and chased for defined time intervals in EGF-free DMEM before fixation.
(k) Time course of EGF degradation obtained from experiments as shown in j. (l) Representative confocal images of WT and TPC2 / MEFs incubated
with 1mg ml 1 AlexaFluor488-EGF for 30 min, fixed and stained with anti-LAMP1, anti-Rab5 and anti-Rab7 antibody, respectively, and Cy5 as secondery
antibody. (m) Quantification of experiments as shown in l. All data points are given as mean±s.e.m. of at least three independent experiments, each.
At least two independently generated WT and TPC2 / MEF cell lines were analysed; n.s., not significant, ***Po0.001, **Po0.01, *Po0.05 (c,d,g,h and
k: two-way anlysis of variance (ANOVA) followed by Bonferroni’s post hoc test; e and i: unpaired Student’s t-test). All scale bars, 20mm.
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fission processes. It has been postulated before that Ca2þ is
required for vesicular fusion processes and thereby regulates
trafficking of vesicular cargo proteins30,32,33. In accordance
with this hypothesis, we found that in WT MEFs chelation of
cytosolic Ca2þ by 1,2-bis(2-aminophenoxy)ethane-N,N,N0,N0-
tetraacetic acid tetrakis(acetoxymethyl ester) (BAPTA-AM)
mimics the effect on EGF trafficking observed in TPC2 /
MEFs (Fig. 3a,b). This effect was dose dependent (Fig. 3a,b).
By contrast, in TPC2 / MEFs, EGF accumulation was not
significantly changed by BAPTA-AM (Fig. 3a,b). Ethyleneglycol-
bis(b-aminoethyl)-N,N,N0,N0-tetraacetoxymethyl ester (EGTA-
AM), which has much slower binding kinetics than
EGF
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Figure 3 | Effects of BAPTA-AM or TPC2 overexpression on endolysosomal trafficking in WT and TPC2 / MEFs. (a) Representative images of WT
and TPC2 / MEFs incubated with 0.1 mg ml 1 AlexaFluor488-EGF (5 min), followed by an incubation with 0.1 mg ml 1 AlexaFluor488-EGF in the
presence of either 0.03 mM or 0.3 mM BAPTA-AM (25 min) in PBS. Cell nuclei were visualized with Hoechst. Scale bar, 20mm. (b) Average numbers of
AlexaFluor488-EGF-positive vesicles per cell after incubation with BAPTA-AM at different concentrations as described in a. (c,d) Effect of 2 mM
bafilomycin A1 (Baf. A1; c) or 10mM nigericin (Nig.; d) on cytosolic calcium levels in WT and TPC2 / MEFs loaded with fura-2. Shown are representative
calcium imging experiments (mean of n¼ 10 cells, each). Measurements were performed in the presence of 2 mM EGTA. (e) Summary of Baf. A1 and
Nig. experiments; bars represent values 150 s (bafilomycin) or 450 s (nigericin) after compound application (n¼ at least five experiments with 5–10 cells,
each). (f) TPC2 WT, the inactive TPC2 mutant TPC2(N257A), or TRPML1 WT were fused to green fluorescent protein (GFP), overexpressed in TPC2 /
MEFs and incubated with 1mg ml 1 AlexaFluor555-EGF (red). Shown are representative images after fixation of the respective MEF cell line as indicated.
Cell nuclei were visualized with Hoechst. Scale bar, 20mm. (g) Average numbers of EGF-positive vesicles per cell taken from experiments as shown in e.
Non-transfected (NT) TPC2 / cells in close proximity to cells transfected with the respective cDNAs served as positive controls for each experiment.
All data points are given as mean±s.e.m. *Po0.05, **Po0.01, unpaired Student’s t-test.
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BAPTA-AM, had no significant effect on EGF accumulation
(Supplementary Fig. 2).
Bafilomycin A1 (Baf. A1)—a cell-permeant inhibitor of the
vacuolar-type Hþ -ATPase, results in loss of the lysosomal/late
endosomal proton gradient and eventually leads to the depletion
of luminal calcium34. By using Baf. A1 (in the absence of
extracellular calcium), we demonstrate that loss of TPC2
(TPC2 / MEF) causes a significant elevation in cytosolic
calcium compared with WT, suggesting that loss of TPC2 may
lead to an increased retention of calcium in the endolysosomal
lumen (Fig. 3c,e). Similar results were obtained when the
Kþ /Hþ exchanger nigericin was used instead of Baf. A1
(ref. 35) (Fig. 3d,e). Taken together, these results suggest that a
significantly higher amount of calcium is retained in intracellular
acidic compartments in TPC2 / compared with WT cells. To
confirm that the Ca2þ required for EGF trafficking depends on
the presence of TPC2, we performed rescue experiments in
TPC2 / MEFs and found that overexpression of WT TPC2 in
TPC2 / MEFs leads to a rescue of the EGF-trafficking defects
(Fig. 3f,g). The remaining EGF accumulation was not significantly
different from the amount of EGF accumulating in WT MEFs at
the respective EGF concentration (Fig. 2g). Notably, a non-
conducting TPC2 mutant (TPC2-N257A)21 was not sufficient to
rescue trafficking defects, suggesting that ion flux through TPC2
is necessary for the rescue. Furthermore, the rescue is specific for
TPC2 because TRPML1, another Ca2þ permeable and PI(3,5)P2-
activated cation channel in lysosomes36, did not rescue EGF-
trafficking defects observed in TPC2 / MEFs (Fig. 3f,g).
In vivo cholesterol accumulation in TPC2-deficient mice. Given
the pronounced impairments in LDL and EGF trafficking
observed in TPC2 / MEF cell lines and hepatocytes, we
hypothesized that defects might also be present in an in vivo
model. Therefore, WT and TPC2 / mice were fed with a
standard diet (SD) or a Western-type diet rich in cholesterol (CD)
for 6 weeks, respectively37. Analysis of TPC2 / mice fed with
SD indicated that these mice appeared identical to their WT
littermates as determined by morphological and histological
studies. The lack of a gross phenotype in TPC2 / mice on SD
is not surprising, since SD contains relatively little cholesterol
(r0.02% w/w). On this diet, the cholesterol requirement of the
animals is achieved primarily through de novo biosynthesis38.
We next tested the effect of a diet rich in cholesterol (1.25%
cholesterol; CD). The intake of cholesterol per day on this
diet is approximately 20–30 times above the amount an
average animal synthesizes to maintain homoeostasis when its
dietary needs are not being met38. The average liver weight/body
weight ratio of TPC2 / on CD was significantly increased
compared with WT on CD (Fig. 4a), while this parameter
was similar in WT and TPC2 / on SD. Importantly, there was
no difference in total body weight between the two groups of
mice, suggesting the absence of obesity in the TPC2 / mice.
On macroscopic examination, more than 95% (n¼ 21) of
TPC2 / livers (CD) displayed changes in colour ranging
from slightly yellow to strongly yellow (Fig. 4b,c). Only
about 5% of the livers looked normal. In contrast, 76% of WT
livers (CD) looked normal while 24% displayed a light yellow
colour (n¼ 21). Livers from WT and TPC2 / mice on SD did
not display visible changes in colour (n¼ 13 and n¼ 21,
respectively).
The prominent yellow colour of the livers from TPC2 /
mice on CD is highly suggestive for hepatosteatosis (fatty liver).
An analysis of the free and total hepatic cholesterol levels (free
cholesterol and CEs) revealed that in SD-fed WT and TPC2 /
mice, there was no difference in free and total liver cholesterol
levels (Fig. 5a–c). After CD treatment, free and total cholesterol
levels were elevated in both mouse lines. In TPC2 / mice,
cholesterol levels were significantly higher than in WT mice
(Fig. 5a–c). In particular, total cholesterol levels including
CEs were dramatically increased in TPC2 / liver samples
(Fig. 5a–c). In line with the biochemically observed hepatic
overload of cholesterol and CEs in TPC2 / mice on CD, liver
paraffin sections from TPC2 / mice on CD displayed strong
accumulation of lipid droplets of different sizes predominantly in
periportal hepatocytes (Fig. 5d). The histologic pattern is
consistent with/resembles non-alcoholic fatty liver disease which
is characterized by a microvesicular periportal hepatosteatosis.
Signs of periportal and pericellular fibrosis were seen in liver
sections from TPC2 / mice on CD (Fig. 5e). The strong
accumulation of lipid droplets was further confirmed by electron
microscopy of liver sections from TPC2 / mice on CD
compared with WT on CD (Fig. 5f). Filipin39–42 stainings further
confirmed a strong accumulation of cholesterol in TPC2 /
hepatocytes after CD treatment (Fig. 6a). A macroscopic analysis
of gallbladders isolated from WT and TPC2 / mice on CD
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revealed the presence of large gallstones in TPC2 /
gallbladders (Supplementary Fig. 3a).
To test whether the severe cholesterol overload of TPC2 /
livers causes compensatory hepatic changes, a pathway analysis of
differentially regulated genes was performed in TPC2 /
and WT mice on SD and CD diet. This analysis revealed
significant enrichment of genes involved in lipid metabolism and
molecular transport (Supplementary Table 2). In line with an
increased hepatic pool of free cholesterol, transcriptional
upregulation of hepatic enzymes involved in BA and CE
synthesis as well as BA efflux was observed in TPC2 /
compared with WT mice on CD, while enzymes involved in
hepatic cholesterol synthesis were downregulated (Fig. 6b)43–45.
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and TPC2 / mice on SD (data not shown), while a significant
downregulation was observed in livers from TPC2 / mice on
CD compared with WT on CD (Fig. 6b). Expression of the
ABC transporters ABCA1, ABCG5 (sterolin-1) and ABCG8
(sterolin-2) was not significantly upregulated (Fig. 6b). An
analysis of faecal BA content and composition revealed an
increase in BA excretion in CD compared with SD-fed animals,
which was, however, independent of the genotype
(Supplementary Fig. 3b). In liver, only one type of BA was
consistently detectable: cholic acid. While desoxycholic acid was
not detectable in liver samples of SD-fed animals, it was
detectable in 40% of the investigated CD-fed TPC2 /
animals (Supplementary Fig. 3c).
We further assessed functional hepatic consequences of the
measured cholesterol accumulation by determining liver-specific
enzyme levels in the peripheral blood. While no differences in
enzyme levels indicating liver damage such as glutamate
dehydrogenase or alanine transaminase were found in mice on
SD, significantly increased glutamate dehydrogenase and alanine
transaminase values (Fig. 6c and Table 1) were detected in
TPC2 / mice compared with WT on CD. Taken together,
these findings indicate that in addition to hepatic cholesterol
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mean±s.e.m.
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overload, liver damage was present in TPC2 / mice after CD
treatment.
Since the liver is the key organ in regulating lipoprotein
metabolism, we next determined systemic changes in lipopro-
teins. In WT and TPC2 / mice fed with SD, we found no
differences in total cholesterol as well as HDL- (high-density
lipoprotein), LDL- or VLDL-cholesterol (very low-density
lipoprotein cholesterol) plasma levels (Fig. 6d,e). However, in
mice on CD, total blood cholesterol levels as well as LDL- and
VLDL-cholesterol levels were strongly elevated. Notably, LDL-
and VLDL-cholesterol levels were significantly more increased in
TPC2 / than in WT mice. Serum HDL-cholesterol levels as
well as protein, triglyceride and glucose levels were similar within
both groups (Table 1). Finally, faecal total cholesterol levels were
increased in CD compared with SD-fed animals. However, here
no significant differences were detectable between the genotypes
(Supplementary Fig. 3d).
Discussion
Here, we show that TPC2 / mice are more susceptible to
cholesterol and CE accumulation in the liver than WT mice. This
accumulation is not caused by extrahepatic factors, because
similar accumulation is seen in single-cell experiments. The
macroscopic and histological presentation of TPC2 / livers,
the increased cholesterol accumulation and increase in hepatic
transaminases indicate fatty liver and liver damage, and are
consistent with the clinical picture of NAFLD and NASH.
The clinical phenotype can be explained by specific defects in
vesicle trafficking along the endolysosomal degradation pathway
in the TPC2 / mouse. In the absence of TPC2, receptors and
cargoes such as LDL or EGF/EGFR, which are transported along
the degradation pathway, accumulate rapidly in intracellular
vesicles of TPC2 / but not WT cells. This finding suggests that
TPC2 channels are critically involved in the regulation of
endolysosomal trafficking along this pathway. Since TPC2
channels are specifically expressed on late endosomes and
lysosomes, it is likely that TPC2 regulates or enhances the final
transport or fusion step between these two organelles. Consistent
with this hypothesis, deletion of TPC2 leads to a partial block in
transport and accumulation of LDL-cholesterol and LDL CEs
proximal to the fusion defect in the prelysosomal vesicle pool, in
particular late endosomes (Fig. 6f). LDL-derived CEs are
normally hydrolysed to free cholesterol by lysosomal and late
endosomal acid lipase and subsequently exported from the
endolysosomal system. Due to prelysosomal accumulation, more
cholesterol may exit via late endosomes in TPC2 / mice and
thus increase the free cholesterol pool in the cytosol. It is well
known that an increased free cholesterol pool at the endoplasmic
reticulum (ER) induces CE formation and deposition in lipid
droplets as well as downregulation of endogenous cholesterol
synthesis (Fig. 6f)43,44. In line with this theory, we found that CEs
are increased in TPC2 / mice. CEs are generated from free
cholesterol by Soat1 and Soat2 (sterol O-acyltransferase 1 and 2).
These enzymes are upregulated in livers of TPC2 / mice. ER
enzymes involved in endogenous cholesterol synthesis are
downregulated. Finally, serum VLDL levels are elevated in
TPC2 / mice on CD (Fig. 6e). While this elevation could be
caused by an increase in hepatic VLDL production, the possibility
of a reduced VLDL clearance cannot completely be ruled out.
Together, these results indicate that in TPC2 / hepatocytes,
secondary ER-dependent processes are induced. This could either
be caused by a globally increased free cholesterol pool or
alternatively by misrouting of free cholesterol to the ER. Such a
misrouting effect could be caused by a decreased flux of
cholesterol from late endosomes to lysosomes with an upregula-
tion of alternative trafficking pathways from late endosomes to
the ER. In support of this notion, there is increasing evidence of
contact sites between late endosomes and the ER46–48, as well as
evidence for direct vesicular and non-vesicular transport of
cholesterol to the ER from late endosomes49,50.
How could a proposed role of TPC2 for vesicular trafficking
and fusion be explained mechanistically? We demonstrate that in
MEFs, TPC2 is critically involved in the generation of a current
specifically activated by the known TPC2 activators NAADP and
PI(3,5)P2. It has been shown that PI(3,5)P2 concentrations
increase from early to late endosomes9,11,15. Thus, in the
absence or in the presence of very low levels of PI(3,5)P2, TPC2
may conduct only very small currents and progressively start to
open on maturation toward late endosomes as PI(3,5)P2 gradually
rises. Opening of TPC2 channels in late endosomes could initiate
the final fusion between late endosomes and lysosomes. Here, we
demonstrate that vesicle trafficking in the endo/lysosomal
degradation pathway requires Ca2þ and ion flux through
TPC2. The most likely interpretation is that Ca2þ flows
directly through TPC2 channels. TPC2 has been shown
previously to conduct Ca2þ (refs 18,21,22,24) and we confirm
here that endogenous TPC2 channels are permeable to calcium
(Supplementary Fig. 4). Opening of TPC2 channels may lead to
Ca2þ efflux from vesicles directly into microdomains
surrounding Ca2þ -dependent proteins of the fusion machinery
and thereby induce fusion. Anchoring of TPC2 within the cellular
fusion machinery is supported by interactions with specific
SNARE proteins such as STX7 and additional protein
components of SNARE complexes which were identified by
proteomics-based interaction screens, and confirmed by
fluorescence resonance energy transfer analyses and co-
immunoprecipitation experiments (Supplementary Fig. 5a–g
Table 1 | Summary of serum parameters.
WT SD TPC2 / s.d. ANOVA WT CD TPC2 / CD ANOVA
Mean±s.e.m. Mean±s.e.m. Mean±s.e.m. Mean±s.e.m.
Total cholesterol (mg dl 1) 78±5.8 72.0±5.7 n.s. 139.5±9.6 210.3±18.0 ***
GLDH (U l 1) 14.9±2.8 17.1±2.9 n.s. 32.3±4.8 49.4±5.0 *
ALAT (U l 1) 33.7±9.6 44.9±11 n.s. 34.9±8.4 60.8±7.7 *
ASAT (U l 1) 145.3±34 199.4±6.7 n.s. 118.6±23 155.4±34.5 n.s.
Total protein (g dl 1) 4.4±0.2 4.1±0.2 n.s. 4.4±0.1 4.2±0.2 n.s.
Glucose (mg dl 1) 163.9±12.0 170.7±12.0 n.s. 186.7±14.0 183.2±16.9 n.s.
Triglycerides (mg dl 1) 42.1±3.4 41.1±6.8 n.s. 33.8±2.9 28.3±5.0 n.s.
ANOVA, analysis of variance; ALAT, alanine transaminase; ASAT, aspartate transaminase; CD, cholesterol; GLDH, glutamate dehydrogenase; n.s. not significant; SD, standard diet; TPC, two-pore channel;
WT, wild type.
Table summarizing data shown in Fig. 6 c,d and additional serum parameters in WT and TPC2 / mice on SD and CD. Values are given as mean±s.e.m. (two-way ANOVA followed by Bonferroni’s post
hoc test, *Po0.05, ***Po0.001).
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and Supplementary Table 3)51–53. Alternatively, ionic flux
through TPC2 channels could also be part of an indirect
mechanism which provides Ca2þ . In this scenario, cations
other than Ca2þ flowing through TPC2 would act on a
downstream channel, which in turn provides Ca2þ . Naþ and
Kþ have also been shown to permeate through TPC2
channels17,20. Given the proposed close structural assembly of
TPCs and the fusion machinery (Supplementary Fig. 5g),
depolarization by Naþ efflux through TPC2 may also
electrostatically facilitate fusion between two vesicular
membranes as suggested by the model of Wang et al.17 Similar
events may be relevant for TPC1 within the proximal endosomal
pathway.
Defects in the endolysosomal trafficking and cellular proces-
sing of LDL-cholesterol have been implicated in human diseases
such as Niemann Pick disease and Wolman’s disease (CE storage
disease) where CEs accumulate in late endosomes and lysosomes
due to a severely diminished activity of cholesterol export
proteins NPC1 and NPC2 or lysosomal acid lipase54. Here, we
demonstrate that loss of TPC2 results in a defect which is more
distally located in the endolysosomal LDL-cholesterol trafficking
pathway. Loss of TPC2 increases the risk of developing NAFLD
and NASH. These diseases themselves are independent of
traditional cardiovascular risk factors and the metabolic
syndrome associated with increased risk for cardiovascular
disease. Furthermore, in obese individuals these diseases are
markers of insulin resistance and diabetes. Notably, TPC2 /
mice are highly susceptible to NAFLD and NASH, while obesity
and impaired glucose tolerance are not observed. This finding
suggests that TPC2 / mice have a reduced metabolic reserve in
hepatic cholesterol handling, which leads to NAFLD even in the
absence of obesity and impaired glucose tolerance. The increased
susceptibility of TPC2 / mice to NAFLD is clinically highly
relevant because this disease affects up to one-third of the
population worldwide and may cause adverse cardiovascular
outcome and increased cardiovascular mortality.
Methods
Generation of TPC2 / knockout mice. TPC2 / mice were generated by
deleting exon 7 and introducing an early stop codon. We generated a targeting
vector that, after homologous recombination, resulted in a modified TPC2 allele
carrying two loxP sites flanking exon 7. A neoR cassette, which was used for
G418/geneticin selection, was removed with Flp recombinase before the ES cells
were injected into host blastocysts to generate chimeric mice. After germline
transmission and continued breeding, PCR with genomic DNA from progeny of
WT, heterozygous and homozygous animals showed proper recombination and
inheritance of the TPC2lox allele. Subsequently, exon 7 was deleted by pairing
TPC2lox mice with mice expressing Cre-recombinase under a cytomegalovirus
promoter. Exon 7 encodes TMD5 and part of the pore-loop in domain I of TPC2.
Animals were used under approved animal protocols and University of Munich
(LMU) Institutional Animal Care Guidelines.
Whole-lysosome planar patch-clamp experiments. For whole-lysosome planar
patch-clamp recordings, isolated intact lysosomes from HEK293 cells or MEFs
were prepared by differential centrifugation as described previously21,22,55.
HEK293 cells stably expressing murine TPC2 or the TPC2 mutant TPC2(N257A),
both N-terminally fused to green fluorescent protein and subcloned into
pcDNA5FRT vector with hygromycin resistance (Invitrogen) were used. To
investigate STX7 effects on TPC2, a double stable HEK293 cell line was generated
coexpressing murine STX7, N-terminally fused to mCherry (in pcDNA3 vector
with geneticin (G418) resistance) and TPC2 as described above. The planar patch-
clamp technology combined with a fast internal perfusion system (Port-a-Patch,
Nanion Technologies) was applied as described previously21,22,55. Currents were
recorded using an EPC-10 patch-clamp amplifier and PatchMaster acquisition
software (HEKA). Data were digitized at 40 kHz and filtered at 2.8 kHz. Mean
endolysosomal capacitance was 1.01±0.04 pF (n¼ 47). For all experiments,
salt-agar bridges were used to connect the reference Ag-AgCl wire to the bath
solution to minimize voltage offsets. Unless otherwise stated, cytoplasmic solution
contained 60 mM KF, 70 mM K-MSA (methanesulfonate), 0.2 mM Ca-MSA, 4 mM
Na-MSA, 10 mM HEPES (pH adjusted with KOH to 7.2). Luminal solution was
60 mM Ca-MSA, 85 mM Na-MSA, 1 mM MgCl2, 10 mM HEPES (pH adjusted
with NaOH to 4.6 (refs 17,20)). Mannitol was used to adjust osmolarity.
For the application of PI(3,5)P2 (A.G. Scientific) or NAADP (Tocris Bioscience),
cytoplasmic solution was completely exchanged by PI(3,5)P2- or NAADP-
containing solution.
Endolysosomal trafficking experiments. For trafficking experiments,
AlexaFluor488-EGF, AlexaFluor555-EGF or LDL-BodipyFL (Life Technologies)
were used. MEFs from WT and TPC2 / mice were seeded on glass coverslips in
24-well plates and grown in Dulbeccos modified eagles medium (DMEM) with
10% fetal bovine serum at 37 C and 5% CO2 for 48 h. Cells were treated with
varying concentrations of labelled LDL or EGF and incubated for different time
intervals at 37 C and 5% CO2. Cells were subsequently washed in DMEM
containing no fetal bovine serum and fixed with ice-cold methanol for 5 min at
 20 C or chased before fixation for defined time intervals at 37 C and 5% CO2 in
DMEM containing no fetal bovine serum, as indicated in the respective figure
legends. Hoechst nuclear staining (Hoechst 33342) was performed in PBS buffer
(5 mg ml 1). Cells were incubated at room temperature for another 30 min, washed
twice with PBS and embedded in Cell Lab Fluoromount-G Slide Mounting
Medium (Beckman Coulter). In the degradation format, cells were incubated as
described above with a saturating concentration of AlexaFluor488-EGF
(4 mg ml 1) for 30 min, washed and incubated for different chase times as
indicated. For data quantification, ImageJ software was used. In each experiment,
numbers were calculated based on the total number of vesicles (dots) per image
divided by the number of cells (nuclei) per image. The term ‘cell’ is used instead of
‘confocal cell section’.
Endolysosomal pH measurements. Endolysosomal pH measurements were
performed by ratiometric fluorescence imaging as described previously56. MEFs
were seeded on imaging dishes (145 mm glass bottom, PAA Laboratories, Germany)
and grown overnight in DMEM supplemented with 1 g l 1 bovine serum albumin
in the presence of 500mg ml 1 of the pH-sensitive fluorophore Oregon Green 514
conjugated to dextran (70,000 MW, Life Technologies). In order to allow clearance
of early endocytic compartments and ensure specific localization of the dye in the
late endocytic pathway, cells were chased in DMEM at 37 C for 1 h in the presence
of bovine serum albumin followed by 1-h incubation in serum-free medium before
imaging for basal pH determination. To assess lysosomal pH under starvation
conditions, the chase procedure was replaced by either 2-h incubation without
amino acids (EBSS) or 2-h incubation without both, amino acids and glucose
(110 mM NaCl, 45 mM NaHCO3, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2,
pH 7.4)20. As a control for increased lysosomal pH, 200 nM Baf. A1 (Sigma
Aldrich) were applied during the 1-h incubation in serum-free medium under basal
conditions. Ratiometric imaging was performed using an Olympus FV1000
confocal laser scanning microscope. Cells were excited alternately by light
transmitted from a 440-nm laser diode or a multiline argon laser at 488 nm (Showa
electronics model GLS3135). In both cases, images were acquired at an emission
wavelength of 535±20 nm using a charge-coupled device-camera. At the end of
every experiment, an in situ calibration was performed for each genotype by
incubating the cells with isotonic Kþ buffer solutions (145 mM KCl, 10 mM
glucose, 1 mM MgCl2 and 20 mM of either HEPES, MES or acetate, pH ranging
from 4.0 to 7.0), containing 10 mg ml 1 of the ionophorenigericin. The resulting
fluorescence intensity ratios (488/440) were fitted to the Boltzmann equation to
interpolate pH values from the experimental ratio data.
Calcium imaging experiments. Calcium imaging experiments were performed
using fura-2 as described previously57. Briefly, WT and TPC2 / MEFs cells were
plated onto glass coverslips, and after 24 h, cells were loaded for 1 h with the
fluorescent indicator fura-2-AM (4 mM; Invitrogen) in a standard bath solution
containing (in mM) 138 NaCl, 6 KCl, 2 MgCl2, 2 CaCl2, 10 HEPES and 5.5
D-glucose (adjusted to pH 7.4 with NaOH). Cells were washed in 2 mM EGTA for
30 min before measurement. Calcium imaging was performed using a
monochromator-based imaging system (Polychrome IV monochromator, TILL
Photonics). Compounds were applied in the presence of 2 mM EGTA.
Immunocyto- and immunohistochemistry, electron microscopy.
Immunocytochemistry was performed as described previously58. Histology,
immunohistochemistry and electron microscopy experiments were performed
according to standard protocols. For further details, please refer to Supplementary
methods.
Serum cholesterol levels and expression profiling in liver. Male TPC2 / and
WT mice were fed with standard chow diet (SD) or a high-cholesterol containing
Western-type diet (1.25% cholesterol, 15% fat, 0.5% Na-cholate; ssniff GmbH,
Soest, Germany) for 6 weeks. Throughout the text, we refer to this diet by calling it
cholesterol diet or CD. On the day of euthanasia, food was removed from the cage
and approximately 8 h later, mice were killed as described59 and blood was drawn
by left-ventricular puncture in EDTA-containing syringes. Cell counting was
performed after 1:4 dilution with PBS in an automated hematology analyzer
(Sysmex). Lipoproteins were isolated by sequential ultracentrifugation from 60 ml
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of plasma at do1.006 g ml 1 (VLDL) 1.006rdr1.063 g ml 1 (intermediate- and
low-density lipoprotein (IDL and LDL, respectively)) and d41.063 g ml 1 (high-
density lipoprotein (HDL)) in a TL100 ultracentrifuge (Beckman). Cholesterol was
determined enzymatically by using a colorimetric method (Roche).
RNA from liver samples of TPC2 / and WT mice fed with SD (WT n¼ 4;
TPC2 / n¼ 4) or CD (WT n¼ 4; TPC2 / n¼ 4) was isolated as described
previously60. RNA was labelled and hybridized to Illumina Mouse Ref-8 v2.0
Expression Bead Chips and arrays were scanned with an Illumina iScan microarray
scanner. Bead level data pre-processing was done in Illumina Genome Studio
followed by quantile normalization and background reduction according to
standard procedures in the software. Of the 425,600 annotated RefSeq transcripts
that were covered by the arrays, a total of 4,598 transcripts were upregulated or
downregulated in TPC2 / mice with fold changes 420% compared with
WT control. Of these, 2,159 transcripts were differentially regulated in livers of
mice on SD and 3,288 partially overlapping transcripts were differentially regulated
in livers of mice on CD. Using the Ingenuity Pathways Analysis software
(www.ingenuity.com), most significantly enriched biological functions in WT and
TPC2 / mice were identified and levels of significance were determined using
Fisher’s exact tests implemented in the software61. Alternatively, expression of Ldlr
(50-primer 50-TGGGTCATCGCCCTGCT-30 , 30-primer 50-TTCCTGCTGCATGA
GTCTTCT-30, probe 50FAM-50-CTGGCTGCTGCCGGAGTTGCA-30TAMRA),
Egfr (50-primer 50-CCTATGCCACGCCAACTGTAC-30, 30-primer 50-GATGGCC
ACACTTCACATCCT-30 , probe 50FAM-50-TATGGATGTGCTGGGCCAGGTC
TTC-30TAMRA) was assessed in liver samples by quantitative RT–PCR and
normalized to glyceraldehyde 3-phosphate dehydrogenase (50-primer 50-TGTCCG
TCGTGGATCTGACG-30 , 30-primer 50-CCAAGATGCCCTTCAGTGGG-30 ,
probe 50FAM-50-CGCCTGGAGAAACCTGCCAAGTATGATGAC-30TAMRA).
Determination of hepatic cholesterol by gas chromatography mass
spectrometry. Gas chromatography mass spectrometry analysis was performed
on a Varian 3800 gas chromatograph coupled with a Varian Saturn 2200 ion trap.
The stationary phase was an Agilent VF-5 ms capillary column with 30 m 0.25
mm inner diameter and 0.25 mm film thickness. The mobile phase was helium at a
constant flow rate of 1.4 ml min 1. The inlet temperature was 250 C, injection
volume 1 ml (split ratio 3 for free liver cholesterol and 15 for total liver cholesterol
after alkaline ester hydrolysis). The GC oven started at 70 C, ramped up to 270 C
(heating rate 50 C min 1), followed by a gradient of 5 C min 1 up to 310 C.
Transfer line temperature was 270 C and the ion-trap temperature was 200 C. MS
scanned from 8.5 to 12.0 min at a mass range of 100–550 m/z (electron ionization,
70 eV). The peak areas of characteristic ions forcholesterol tetramethylsilane ether
(368 m/z) and for cholestane (217 m/z) were used for data analysis. The mean value
of each double-injected sample (n¼ 5) was used for statistical analysis. For details
of sample preparation, please refer to Supplementary methods.
Statistical analysis. Details of statistical analyses and n values are provided in
the methods subsections or the figure legends. Statistical analyses were carried
out using Origin 7.5 and GraphPad Prism 5. All error bars are depicted as
mean±s.e.m. Statistical significance was determined via Student’s t-test, one-way
analysis of variance followed by Tukey’s post test, or two-way analysis of variance
followed by Bonferroni’s post hoc test, unless stated otherwise. Significance is
denoted on figures as outlined in the legends. Statistics were derived from at least
three independent experiments.
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Supplementary Fig. 1. Characterization of TPC2 knockout mice. (a) Representative 
genotyping results obtained from samples prepared from tails and MEFs of WT, TPC2-/- 
and heterozygous mice. (b) RT-PCR (left) and Western blot (right) results obtained from 
WT and TPC2-/- samples prepared from MEFs, primary hepatocytes, or liver tissue lysates 
(membrane preparations). (c) Expression and distribution of selected marker proteins for 
endosomes and lysosomes were unaffected in TPC2-/- compared to WT MEFs. Shown are 
confocal images of WT and TPC2-/- MEFs labeled with antibodies against CD63 antigen, 
LIMP2, and TfR visualized with Alexa488 as secondary antibody. Nuclei were visualized 
with DAPI. Scale bar = 20 µm. (d) Average numbers of vesicles positive for selected 
markers shown in c and in Fig.1f. (e) Expression and distribution of different Rab proteins 
in TPC2-/- and WT MEFs. Antibodies against Rab4, 5, and 11 were used and  proteins 
were visualized with Cy5 as secondary antibody. Nuclei were stained with DAPI. Scale bar 
= 20 µm. (f) Overexpression of the constitutively active Rab5(Q79L) variant in TPC2-/- and 
WT MEFs showing characteristic enlarged Rab5 positive vesicles. (g-i) Measurement of 
endolysosomal pH. Late endocytic compartments of WT and TPC2-/- MEFs were labeled 
with dextran-Oregon Green 514. In situ calibration procedure: Cells were bathed in 
extracellular solution of defined pH. After extracellular application of the ionophore 
nigericin intracellular pH was clamped to the pH value of the extracellular solution. (g) 
Fluorescence images are presented as overlay of fluorescence emission at 535 nm upon 
excitation at 440 nm (blue) and 488 nm (green), respectively. Scale bar = 20 µm. (h) 
Fluorescence intensity ratios were calculated for defined pH values and a calibration curve 
was constructed. (i) Lysosomal pH values in WT and TPC2-/- MEFs were calculated using 
calibration curves presented in f (Batch-2 MEFs; for Batch-1 MEFs see Fig.1h-i) and 
determined under basal conditions, without amino acids (-aa, EBSS), and without amino 
acids and glucose (-aa, -glc); n.s. not significant, unpaired Student’s t-test. (j) Proteolytic 
processing of cathepsin D and cathepsin L in WT and TPC2-/- MEFs was analyzed by 
Western blotting. CathD-/- and CathL-/- MEFs were used as controls. All data points are 
given as mean ± SEM. For Western blotting the anti-TPC2 antibody was used as 
described in Fig.1b. For RT-PCR the following oligonucleotides were used for genotyping: 
5’-atgcctaatccagatggctc-3’ (sense), 5’-cctcagcctcaagatgagtg-3’ (sense), and 5’-
tggacatgcaacaggctctc-3’ (antisense). Using a second forward primer that binds within the 
loxP sites, and therefore does not work in knockout mice/cells, results in three bands: 1827 
bp (WT), 379 (TPC2-/-), and 290 bp (WT). PCR conditions were chosen so that only the 
two shorter bands were amplified. The following oligonucleotides were used for RT-PCR: 
5’-ctgctgcagaattcctccatgat-3’ (forward) and 5’-aacaagcttcctatcaaggtgaa-3’ (reverse) 
(PCR1: expected fragments: 322 bp for WT and 246 bp for TPC2-/-), 5’-
aacctgtggctgctggcctactt-3’ (forward) and 5’- ggtagccacggaactgattatag-3’ (reverse) (PCR2: 
expected fragments: 493 bp for WT and 417 bp for TPC2-/-), and 5’-
atccacctgtgtctcttcaccat-3’ (forward) and 5’-ggtagccacggaactgattatag-3’ (reverse) (PCR3). 
The latter forward primer binds to exon 7 which is lost in TPC2-/- animals. Expected 
fragment size for WT: 283 bp. 
 
 
    
     
 
 
 
 
 
 
 
 
 
    
     
 
Supplementary Fig. 2. LDLR expression in MEFs, confocal images of EGF 
accumulation in TPC2-/- hepatocytes, Egfr levels in liver samples from TPC2-/- and 
WT mice, and effect of EGTA-AM on EGF trafficking. (a) Representative Western blot 
showing expression of LDLR protein in WT and TPC2-/- MEFs (calculated band size = 93 
kDa; actual band size of 120 kDa is expected according to manufaturer’s guidelines 
(http://www.abcam.com/ldl-receptor-antibody-ab14056.html)). Quantification was repeated 
in 3 independent experiments using GAPDH expression as reference. Western blot 
quantification was performed using ImageLab software (Bio-Rad Laboratories). (b) 
Confocal images of WT and TPC2-/- MEFs (Batch-2; MEFs were generated independently 
from MEFs used in Fig.2 (Batch-1)) incubated with 0.3 µg/ml AlexaFluor488-EGF for 30 
min before fixation. Cell nuclei were visualized with Hoechst. Scale bar = 20 µm. (c) 
Average numbers of EGF positive vesicles/cell from experiments as shown in b. (d) 
Quantitative RT-PCR results showing average expression levels of Egfr in liver samples 
from WT and TPC2-/- mice, normalized to Gapdh. (e) Confocal images of WT and TPC2-/- 
primary hepatocytes incubated with 0.1 µg/ml AlexaFluor488-EGF for 30 min before 
fixation. Cell nuclei were visualized with Hoechst. Scale bar = 20 µm. Data points in c and 
d are given as mean ± SEM. **p<0.01, unpaired Student’s t-test. (f) Representative 
images of WT and TPC2-/- MEFs incubated with 0.1 µg/ml AlexaFluor488-EGF (5 min), 
followed by an incubation with 0.1 µg/ml AlexaFluor488-EGF in the presence of either 0.1, 
0.5 mM, 1.5 mM EGTA-AM, or 0.3 mM BAPTA-AM (25 min) in PBS. Cell nuclei were 
visualized with Hoechst. Scale bar = 20 µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
     
 
 
 
Supplementary Fig. 3. Macroscopic analysis of gallbladders, analysis of cholesterol 
content in feces, and analysis of BA content and composition in liver and feces. (a) 
Representative image of gallstone containing gallbladder isolated from CD fed TPC2-/- 
mice. Scale bar = 1 mm. (b-c) Average fecal (b) and liver (c) BA levels in WT and TPC2-/- 
mice on SD or CD as indicated; n.d. = not detectable. Unknown BA = ketocholic acid or 
cholic acid with an additional double bond. (d) Average fecal levels of unesterified free 
cholesterol in WT and TPC2-/- mice on SD or CD as indicated. All data points are 
presented as mean ± SEM.  
 
 
 
 
 
 
 
 
    
     
 
 
 
Supplementary Fig. 4. NAADP-activated TPC2 currents in WT MEFs are Na+ and Ca2+ 
permeable. (a) Whole-lysosome recordings of NAADP-evoked TPC2-like currents (50 nM 
NAADP) under bi-ionic conditions with 107 mM luminal Ca2+, 165 mM cytoplasmic K+ or 
165 mM cytoplasmic Na+ at pH 4.6. (b) Current recordings revealed that Erev is 77 ± 4 mV 
(n = 8) and -14 ± 7 mV (n = 6), respectively. Data are presented as mean ± SEM. The 
relative permeability of TPC2 for monovalent and divalent cations was assessed by 
determining the reversal potential with 107 mM luminal Ca2+ and 165 mM cytoplasmic K+ 
or Na+. NAADP evoked TPC2-like current recordings under these bi-ionic conditions 
revealed that the estimated permeability ratios for PCa/PK and PCa/PNa were about 340 (n = 
8) and 0.7 (n = 6), respectively. These ion substitution analyses demonstrate that 
endogenous TPC2 is permeable for Ca2+ and Na+ but much less for K+. For further details 
see Supplementary Methods. 
 
 
    
     
 
 
 
 
 
 
 
 
 
 
 
 
 
    
     
 
Supplementary Fig. 5. Identification of proteins associated with TPC2. (a) 
Logarithmized and normalized ratios of forward and reverse SILAC immunoprecipitation 
experiments of GFP-tagged murine TPC2 versus their corresponding control cell lines; 
annotated proteins shown as black dots were more abundant in the pull-down of the 
tagged cell line with p<0.05 (Significance B) in both the forward and reverse experiments. 
Grey dots represent proteins that were not significant interaction partners. For more details 
refer to Supplementary Table 2. (b) Confocal images showing colocalization of TPC2 and 
STX7 in a subset of intracellular vesicles of transiently transfected WT MEFs. For 
comparison, STX7 and STX12/13 did not colocalize in the same vesicles confirming that 
these proteins are confined to distinct vesicle pools. Scale bars = 20 µm. (c) FRET ratios 
between Cer-tagged TPC2 and Cit-tagged STX7 or STX6, and control combinations. 
Positive control: Cit-tagged STX7 and Cer-tagged Vamp7. Negative controls: Cit-tagged 
STX7 or Cit-tagged STX6 and Cerulean vector, respectively. ***p<0.001, one-way ANOVA 
followed by Tukey’s post test, n = number of measured cells. (d) Representative co-
immunoprecipiation experiment of HEK293 cells coexpressing myc-TPC2 and mCherry-
STX7. Lysates (L) were immunoprecipitated (E) with anti-myc, blotted and probed with 
anti-mCherry or anti-myc. (e) Current-voltage relations of TPC2 currents from single 
lysosomes stably coexpressing TPC2 and STX7 in the presence of 10 µM PI(3,5)P2 or 50 
nM NAADP. Lysosomes were isolated from HEK293 cells pretreated with vacuolin (1 µM 
for 2 h). Further shown are control TPC2 currents activated by 10 µM PI(3,5)P2, 10 µM 
PI(4,5)P2, (negative control), or 50 nM NAADP, recorded from lysosomes expressing 
TPC2 only. These results suggest that TPC2 channel properties remain unaltered by the 
interaction with STX7, while close proximity to or direct interaction with endolysosomal 
SNARE proteins such as STX7 would allow spatially and temporally restricted Ca2+ 
signalling through TPC2 at the fusion complex. (f) Population data for current amplitudes 
at -200 mV obtained from experiments shown in f; n = number of measured cells, unpaired 
Student’s t-test. (g) Cartoon displaying potential model of TPC2 involvement in fusion 
processes between late endosomes (LE) and lysosomes (LY) by directly or indirectly 
interacting with components of the fusion machinery such as syntaxins. Besides interaction 
with STX7, the proteomics and FRET results suggest possible interactions of TPC2 with 
other SNARE proteins and complexes containing e.g. STX6. Data points in c and f are 
presented as mean ± SEM. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
     
 
Lysosomal 
pH 
Batch-1  
WT 
Batch-1  
TPC2-/- 
Batch-2  
WT 
Batch-2  
TPC2-/- 
basal 4.93 ± 0.06 5.08 ± 0.1 4.89 ± 0.02 4.87 ± 0.03 
-aa 5.1 ± 0.08 5.15 ± 0.23 4.79 4.79 
-aa -glc 4.97 ± 0.01 5.05 ± 0.15 4.96 ± 0.01 5.01 ± 0.13 
Baf.A1 > 6.5 > 6.5 > 6.5 > 6.5 
 
Supplementary Table 1. Lysosomal pH measurements. Summary (mean ± SEM) for 
the conditions described in Fig. 1i and Supplementary Fig. 1i. Bafilomycin A1 (Baf. A1) 
was used as positive control. 
 
 
 
 
 
Molecular and  
cellular functions 
CD (p-value) Molecules (n) SD (p-value) Molecules (n) 
Lipid Metabolism 1.47x10-09 399 2.36x10-08 281 
Molecular Transport 1.47x10-09 397 1.17x10-06 340 
Small Molecule Biochemistry 1.47x10-09 485 2.36x10-08 331 
Cell Death and Survival 1.61x10-08 740 5.88x10-08 512 
Cell-To-Cell Signaling and 
Interaction 1.59x10-06 347 3.11x10-04 102 
Cellular Movement 2.67x10-06 454 1.21x10-05 325 
Carbohydrate Metabolism 2.86x10-06 275 9.57x10-08 195 
Cellular Function and 
Maintenance 4.14x10-05 292 2.56x10-04 319 
Cellular Development 8.44x10-05 561 2.80x10-05 301 
Cellular Growth and 
Proliferation 8.44x10-05 711 2.80x10-05 501 
Protein Synthesis 1.18x10-04 370 3.03x10-04 201 
Cell Morphology 4.82x10-04 165 2.33x10-05 266 
 
Supplementary Table 2. Gene set enrichment data. Gene set enrichment analysis of 
differentially regulated genes in livers isolated from TPC2-/- and WT mice on SD and CD, 
respectively. Molecular and cellular functions with ≥200 molecules are given. Data are 
sorted according to most significant p-value of enrichment in CD mice. 
 
 
 
 
 
 
 
 
 
 
    
     
 
 
 
 
 
Gene name 
  
Forward experiment Reverse experiment 
log2 ratio H/L Significance B log2 ratio L/H Significance B 
TPC2 4.7 3.74E-13 3.6 1.69E-02 
SYNGR2 3.9 8.76E-10 5.7 6.99E-05 
BCAP31 4.2 5.83E-11 5.0 5.99E-04 
ARL8B 3.9 1.36E-09 5.0 6.00E-04 
VAMP3;VAMP2 3.7 5.68E-09 4.7 1.14E-03 
RTN4 3.0 3.26E-06 4.6 1.50E-03 
STX12 4.9 2.58E-14 4.6 1.76E-03 
RPN1 3.9 9.28E-10 4.5 2.18E-03 
VTI1B 4.2 4.04E-11 4.4 2.39E-03 
LMAN1 4.0 7.21E-10 4.0 6.38E-03 
BAT3;BAG6 2.9 7.66E-06 3.9 8.01E-03 
TMX1 4.0 2.99E-10 3.8 9.80E-03 
HMGB2 4.0 5.48E-10 3.6 1.43E-02 
RAB14 3.2 8.42E-07 3.5 1.72E-02 
VPS45 4.8 9.18E-14 3.5 1.98E-02 
RAB1A 3.6 2.26E-08 3.5 2.01E-02 
TFRC 5.4 6.32E-17 3.5 2.03E-02 
STX6 4.2 4.15E-11 3.4 2.19E-02 
RAB1B;RAB1C 3.4 9.32E-08 3.3 2.90E-02 
STX7 4.0 3.30E-10 3.2 3.18E-02 
TMED10 4.0 6.21E-10 3.2 3.40E-02 
RAB11A;RAB11B 3.3 2.72E-07 3.2 3.46E-02 
SYNGR1 4.1 2.26E-10 3.1 3.76E-02 
TMED9 3.7 6.36E-09 3.1 3.81E-02 
ATP6V0D1 4.1 1.23E-10 3.1 4.23E-02 
CPD 2.6 4.49E-05 3.1 4.26E-02 
SCAMP3 4.1 1.29E-10 3.0 4.33E-02 
 
Supplementary Table 3. Results of SILAC immunoprecipitation experiments. 
Logarithmized and normalized ratios of forward and reverse SILAC immunoprecipitation 
experiments of GFP-tagged murine TPC2 versus their corresponding control cell lines; 
Listed are the hits shown in Supplementary Fig. 3a as black dots. SNARE proteins 
including endolysosomal syntaxins are highlighted in red. 
 
 
 
 
 
 
 
 
 
    
     
 
 
 
 
Supplementary Methods 
 
Isolation of hepatocytes and MEFs from TPC2-/- and WT mice.  
To generate primary hepatocyte cultures, livers from 8- to 12-week-old male TPC2-/- and 
WT mice were digested by a standard in situ 2-step retrograde collagenase-perfusion 
technique (Liberase-Blendzyme-3; Roche, Penzberg, Germany). Hepatocytes were 
separated from nonparenchymal cells by subsequent low-speed centrifugation (4x at 50 g 
for 2 minutes at 4°C). Isolated hepatocytes were seeded on collagen-coated glass cover 
slips in 24-well plates at a density of 2.5 x 105 cells/ml in Williams Medium-E (Sigma) 
supplemented with 5% FBS, 2 mmol/L L-glutamine, 100 U penicillin/ml, and 100 μg 
streptomycin/ml. Immortalized MEFs were generated as previously described1, 2.  
 
FRET measurements.  
Measurements of single-cell FRET, based on aggregate (nonspatial) fluorescence 
recordings were performed and analyzed using the Three-Cube-FRET method as 
described previously3.  
For measurements, transiently transfected HEK293 cells were maintained in buffer 
solution composed of 140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 10 mM 
Glucose, 10 mM Na-HEPES pH 7.4 at RT. Fluorescence intensities of the GFP variants 
Citrine and Cerulean were recorded using an Axiovert 200 inverted epifluorescence 
microscope and a dual emission photometric system (Till Photonics). Excitation was done 
at 440 ± 7.5 nm or 505 ± 7.5 nm, applied with a frequency of 2 Hz with light from a 
Polychrome V. Epifluorescence emission was detected by a photodiode, digitized (MINI 
DIGI1B; Molecular devices) and analysed using Clampex 10 software. The FRET ratio, 
which is defined as the fractional increase in YFP emission caused by FRET, was 
calculated using FR = [SFRET-(RD1)(SCFP)]/[(RA1)(SYFP)]. SFRET, SCFP and SYFP denote 
fluorescence intensities derived from measurements in individual cells coexpressing 
Citrine- and Cerulean-tagged proteins with the respective filter cube (excitation, emission): 
SFRET (440 ± 7.5 nm, 542 ± 13.5 nm), SCFP (440 ± 7.5 nm, 483 ± 16 nm) and, SYFP (505 ± 
    
     
 
7.5 nm, 542 ± 13.5 nm). RD1 and RA1 are experimentally predetermined constants from 
measurements applied to single cells expressing only Cerulean- or Citrine-tagged 
molecules. 
Co-immunoprecipitation and Western blotting.  
For co-immunoprecipitation experiments, TPC2 and STX7 were N-terminally tagged with 
c-myc or mCherry, respectively. Anti c-myc MicroBeads (μMACS c-myc Isolation Kit) were 
used for co-immunoprecipitation and experiments were performed according to the 
manufacturer’s protocol (Miltenyi Biotec GmbH). HEK293 cells were transiently transfected 
with single plasmids or with combinations of the expression vectors using calcium 
phosphate. Transfected cells were washed with cold PBS 48 h after transfection and lysed 
in ice-cold precipitation assay buffer consisting of Tris-HCl (50 mM), NaCl (150 mM), 
EDTA (1 mM), and Triton X-100 (1%). Western blots were incubated for 1 h at RT in 5% 
(w/v) dry milk powder (AppliChem GmbH) in TBST (milk). Subsequently the blots were 
incubated overnight at 4 °C with antiserum diluted in milk. The following antiserum dilutions 
were used: 1:1000 for monoclonal 9E10 anti c-myc antibody and 1:1000 for anti mCherry 
antibody (Clontech). The blots were washed four times for 10 min each at RT in TBST. 
Detection was performed with HRP coupled anti mouse secondary antibodies (1:1000; 
SantaCruz) and ECL solution using the BioRad ChemiDoc MP imaging system. 
For detection of LDLR and GAPDH in WT and TPC2-/- MEFs the following antibodies were 
used in a dilution 1:1000, each: anti LDLR (abcam ab52818) and anti GAPDH (Cell 
signaling D16H11). For detection of TPC2 and Na+/K+-ATPase in WT and TPC2-/- liver 
membrane preparations the following antibodies were used in a dilution 1:1000, each: anti 
TPC2 (generated as described below) and anti Na+/K+-ATPase (Developmental Studies 
Hybridoma Bank).  
 
Proteomics-based TPC2 interaction screens.  
Cell Culture for SILAC experiments: For stable isotope labeling, HEK293 cells were 
cultured in SILAC-DMEM media (DMEM devoid of arginine and lysine) with 10% FBS, 100 
U penicillin/ml and 100 µg streptomycin/ml. “Light” and “heavy” media were prepared by 
adding 84 mg/ml 13C6/
15N4 L-arginine and 146 mg/l 
13C6/
15N2 L-lysine (Sigma Isotec) or the 
corresponding non-labeled amino acids, respectively4. Cells were grown for seven 
passages to ensure full labeling and “heavy” labeled cells were transfected with GFP-
    
     
 
TPC2. In parallel, a “reverse” experiment was performed by transfecting the “light” cells 
with GFP-TPC2 instead. Immunoprecipitation and in-gel digestion: Immunoprecipitation 
was performed using Chromotek’s GFP Trap according to manufacturer’s protocol. 
Immunoprecipitations of the corresponding SILAC conditions were combined, bound 
proteins eluted from beads by heating with 2x LDS-Sample buffer (NuPAGE, Invitrogen) at 
70 °C for 10min and separated by 1D-SDS PAGE (4-12% Bis-Tris Mini Gel, Invitrogen). 
After visualization using Colloidal Blue Staining Kit (Invitrogen), gel pieces were excised 
from the gel and subjected to reduction, alkylation and in-gel digestion with sequence 
grade modified trypsin (Promega) as described5. After digestion, peptides were extracted 
with 30% acetonitrile/3% trifluoroacetic acid in water, concentrated in a speedvac, and 
desalted using StageTips before analysis by MS6. LC-MS/MS analysis: Peptides were 
separated by reverse phase chromatography using in house-made C18 microcolumns (75 
µm ID packed with ReproSil-Pur C18-AQ 3 µm resin, Dr. Maisch GmbH) in a 130 min 
gradient from 9% to 45% acetonitrile in 0.5% acetic acid at a flow rate of 200 nl/min using 
a Proxeon EASY-nLC II, which was directly connected to a LTQ-Orbitrap VELOS mass 
spectrometer via a nanoelectrospray ion source (Thermo Fisher Scientific). The LTQ-
Orbitrap VELOS was operated in the data-dependent mode to simultaneously measure full 
scan MS spectra in the Orbitrap and the ten most intense ions in the LTQ part by 
collisionally induced dissociation, respectively. Background ions were reduced by using an 
ABIRD device (ESI Source Solutions). Data processing and analysis: Raw files were 
analyzed with the in-house built software MaxQuant7. The derived peak list was searched 
with Andromeda8 as a database search engine for peptide identifications against the 
human Uniprot database containing mouse TPC2 protein sequences combined with 248 
common contaminants and concatenated with the reversed version of all sequences. Fixed 
modification of cysteine carbamidomethylation and variable modifications for methionine 
oxidation and protein N-acetylation were specified. Full tryptic specificity was required and 
a maximum of two missed cleavages accepted. The minimum peptide length was set to 6 
amino acids. Parent MS masses and fragment MS/MS ions were searched with an initial 
mass tolerance of up to 7 ppm and 0.5 Da, respectively. Search results were processed 
with MaxQuant and filtered with a false discovery rate of 0.01. The re-quantification feature 
was enabled. Protein identification required at least one unique peptide for each protein 
group. Forward and reverse experiments were analyzed together and ratios of the 
    
     
 
reversed experiment were inverted. Specific interactors were determined by using 
Significance B statistics as indicated in the figure. The p-value for the significance of 
enrichment had to be <0.05 in both the forward and reverse experiment.  
Immunocytochemistry, histology, immunohistochemistry, and electron microscopy. 
The following primary antibodies were used in immunocytochemistry experiments to label 
endo/lysosomal markers: anti EEA1 (C45B10, Cell Signaling), anti Rab4 (abcam 
ab13252), anti Rab5 (2143S, Cell Signaling or abcam ab18211), anti Rab7A (NBP1-
87174, Novus Biologicals), anti Rab11 (abcam ab3612), anti CD63 antigen9, anti LAMP1 
(1D4B; Developmental Studies Hybridoma Bank), anti LAMP2 (ABL93; Developmental 
Studies Hybridoma Bank), anti LIMP210, and anti TfR (H68.4, Invitrogen). Briefly, cells 
grown on coverslips were fixed in 4% (w/v) paraformaldehyde in PBS and permeabilised 
with 0.2% saponin. Alternatively, cells were fixed with ice-cold methanol for 5 min at -20 
°C. Alexa488 (MoBiTec) or Cy5 (Jackson ImmunoResearch) were used as secondary 
antibodies for detection. Nuclei were visualised with DAPI (4,6-diamidino-2-phenylindole, 
Sigma-Aldrich) that was included into the mounting medium containing Mowiol 4-88 (EMD 
Millipore) and the anti-fading reagent DABCO (1,4-diazabicyclo[2,2,2]octane, Sigma-
Aldrich) or with Hoechst as indicated in the respective figure legend. Images from optical 
sections were acquired with an FV1000 confocal laser scanning microscope (Olympus) or 
with a Zeiss LSM 510.  
For macroscopic analysis livers from TPC2-/- and WT mice were removed and imaged 
using the Zeiss Stemi SV11 microscope. Images were processed with Adobe Photoshop 
by extracting livers automatically and placing them on a black background.  
For histological analysis, livers were removed, fixed in 4% PFA for 20 hours, embedded in 
paraffin, and sectioned. Serial 3.5 μm thick sections were stained with hematoxylin-eosin.  
For immuohistochemical analysis, livers were fixed in 4% PFA for 2 hours at 4ºC, washed 
in PBS, cryoprotected with increasing concentrations of 10%, 20%, and 30% sucrose 
solutions prepared in PBS, and embedded in O.C.T. Tissue Tek. Serial 10 µm thick 
cryosections were stained with 0.05 mg/ml Filipin (Sigma F-9765) in PBS for 2h at RT, 
followed by nuclei co-staining with ToPro-3 (Invitrogen). Samples were washed in PBS and 
viewed by fluorescence microscopy using a UV filter set. Images were taken with a Zeiss 
Axiowert 200M microscope or confocal Olympus FV10i microscope.  
    
     
 
For electron microscopic examination, tissues from TPC2-/- and WT mice were perfused 
transcardially with glutaraldehyde (6% in PBS). Tissue blocks of liver were rinsed in 
phosphate buffer, postfixed in OsO4 for 2 h, and embedded in araldite according to routine 
procedures. Semithin sections were stained with toluidine blue. Ultrathin sections were 
stained with uranyl acetate and lead citrate, and examined with a Zeiss EM 900 
microscope.  
 
Generation of a TPC2 specific antibody. 
To raise an antibody specific for TPC2, rabbits were immunized with a C-terminal peptide 
of the TPC2 protein (N-Cys_Phe[705]-His[726]-C). After immunization, complete serum 
was affinity purified against the peptide using the SulfoLink® Immobilization Kit for 
Peptides (Thermo Scientific) according to the manufacturer’s protocol and an ÄKTAprime 
(GE Healthcare) plus chromatography system. Antibody elution was performed by applying 
a linear acid gradient starting from pH 7 to pH 2. 
 
Sample preparation for the determination of hepatic cholesterol by GC-MS. 
Sodium hydroxide solution (2 M) was added to aliquots of liver (40-120 mg) to obtain a 
final tissue concentration of 10 mg/ml. The vials were stored at 80° C for 2 h, and 
occasionally shaken. After cell lysis the content of every vial was partitioned into 50 µl 
samples for analysis of hepatic unesterified cholesterol and 100 µl samples for hepatic 
total cholesterol content analysis (n = 5). For alkaline hydrolysis aliquots were transferred 
into 4 ml glass vials containing 900 µl ethanolic NaOH solution (1 M) and stored at 60° C 
for 2 h. After saponication, 500 µl were transferred into 15 ml centrifuge tubes, and 5 ml 
water, 100 µl of internal standard solution (cholestane in MTBE, 10 µg/ml), and 900 µl 
MTBE were added. The mixtures were shaken and centrifuged at 2,500 x g for 5 min. The 
organic layer was transferred into 2.0 ml microcentrifuge tubes containing 40 mg of a 
mixture (7:1) of anhydrous sodium sulphate and PSA (Agilent Technologies). The lysate 
was extracted a second time with another 800 µl of MTBE. The second organic extract 
was also added to the microcentrifuge vial and the mixture was shaken and centrifuged at 
9,000 x g for 5 min. Finally 900 µl of the purified organic phase were transferred into an 
autosampler vial and 100 µl of silylation reagent mixture MSTFA/TSIM (9:1) (Macherey-
Nagel) was added.  
    
     
 
 
Determination of bile acids in liver by gas chromatography-mass spectrometry.  
Sample preparation: 1 ml of the cell lysate (n = 3) was transferred into 4 ml glass vials 
containing 1 ml ethanolic NaOH solution (1 M) for alkaline hydrolysis and stored at 60° C 
for 2 h. After saponication 1 ml was transferred into a 15 ml centrifuge tube, and 5 ml 
hydrochloric acid (1 M), 500 µl of internal standard solution (ergosterol in MTBE, 50 µg/ml), 
and 500 µl MTBE were added. The mixture was shaken and centrifuged at 2,500 x g for 
5 min. Each lysate was extracted with another 1 ml of MTBE. The organic extracts were 
combined, 1 ml was transferred into an autosampler vial and evaporated to dryness under 
a gentle stream of nitrogen. The butyl ester formation of the free carboxylic group of bile 
acids was arranged according to literature17. Thus, the dried extract was mixed with 50 µl 
HCl (36%) and 200 µl n-butanol. The mixture was stored at 60 °C for 4 h. After 
esterification the solvents were removed under a stream of nitrogen. The silyation of free 
hydroxyl groups was carried out with 200 µl TSIM at 60 °C for 30 min. The resulting 
mixture was mixed with 300 µl MTBE and 1 µl was injected into the GC-MS system (see 
below). 
 
Determination of bile acids and unesterfied cholesterol in feces by gas 
chromatography-mass spectrometry.  
Sample preparation: the collected feces were comminuted after drying at 60 °C for 1 h. 
The samples (30-90 mg) were weighed into 4 ml glass vials and 4 M NaOH (water:ethanol; 
1:1) was added to obtain a final solution of 25 mg/ml. The vials were stored at 80° C for 2 h 
and occasionally shaken. The mixtures were centrifuged at 2,500 x g for 5 min. Aliquots of 
500 µl were transferred into 15 ml centrifuge tubes containing 5 ml HCl (1 M). The further 
work-up steps are described above. 
Instrumental conditions: the inlet temperature was 270 °C, injection volume 1 µl (split ratio 
3 for feces analyses and splitless for liver analyses). The GC oven started at 70 °C ramped 
up to 270 °C (heating rate 50 °C/min), followed by a gradient of 1 °C/min up to 290 °C, and 
of 50 °C/min to 310 °C (total run time 30 min). The MS was switched on for feces analyses 
after 14 min and for liver samples after 16 min (cholesterol cut-off). Transfer line 
temperature was 270 °C and the ion trap temperature was 200 °C. The MS scanned from 
a mass range of 70 to 650 m/z (EI, 70 eV). The peak areas of characteristic ions of TMS 
    
     
 
ethers/butyl esters of bile acids and sterols were used for data analysis: cholesterol 
368 m/z, ergosterol (internal standard) 468 m/z, cholic acid 410 m/z, chenodesoxycholic 
acid 412 m/z, desoxycholic acid 255 m/z, lithocholic acid 414 m/z, β/γ/ω-muricholic acid 
195 m/z, and unkown BA (keto cholic acid or cholic acid with additional double bond). The 
muricholic acids were identified according to literature18. The mean value of each double 
injected sample was used for statistical analysis. 
 
Calculation of relative cation permeabilites. 
The reversal (zero-current) potential, Erev, for NAADP-mediated currents in enlarged 
lysosomes was determined from current-voltage relations measured in response to 
NAADP during voltage-clamp ramp protocols (+100 to -200 mV, 500 ms). The relative 
permeability of PCa/Px, where x is a monovalent ion (Na
+ and K+), was estimated by the 
following bi-ionic equation (I)11-13, derived from the Goldman-Hodgkin-Katz (GHK) voltage 
equation:  
 
PCa/Px = γX[X]Cyto/(γCa 4[Ca
2+]Luminal){exp(ErevF/RT)}{1+exp(ErevF/RT)}            (I) 
 
where R, T, Erev, and γ are, respectively, the gas constant, absolute temperature (RT), 
Faraday constant, reversal potential, and activity coefficient. Activity coefficients of KF (γK) 
and NaF (γNa) were 0.75
14. Activity coefficients of KMSA (γK’) and NaMSA(γNa’) were 
likewise 0.7515. Activity coefficient of CaMSA was 0.52 similar to CaCl2
16. All results are 
presented as mean ± SEM. An unpaired t-test was performed for the comparison between 
two groups. Values of p < 0.05 were considered significant. 
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Two-pore channels (TPCs) are endolysosomal cation channels.
Two members exist in humans, TPC1 and TPC2. Functional roles
associated with the ubiquitously expressed TPCs include VEGF-
induced neoangiogenesis, LDL-cholesterol trafficking and degra-
dation, physical endurance under fasting conditions, autophagy
regulation, the acrosome reaction in sperm, cancer cell migration,
and intracellular trafficking of pathogens such as Ebola virus or
bacterial toxins, e.g. cholera-toxin. In a genome-wide association
study for variants associated with human pigmentation character-
istics two coding variants of TPC2, rs35264875 (encoding M484L)
and rs3829241 (encoding G734E), have been found to be associ-
ated with a shift from brown to blond hair color. In two recent
follow-up studies a role for TPC2 in pigmentation has been further
confirmed. However, these human polymorphic variants have not
been functionally characterized until now. The development of
endolysosomal patch-clamp techniques has made it possible to
investigate directly ion channel activities and characteristics in iso-
lated endolysosomal organelles. We applied this technique here to
scrutinize channel characteristics of the polymorphic TPC2 variants
in direct comparison with wild-type. We found that both polymor-
phisms lead to a gain of channel function (GOF) by independent
mechanisms. We next conducted a clinical study with more than
100 blond and brown/black haired individuals. We performed a
genotype/phenotype analysis and subsequently isolated fibrob-
lasts from WT and polymorphic variant carriers for endolysosomal
patch-clamp experimentation to confirm key in-vitro findings.
TPC | TPC2 | two-pore channel | polymorphism | pigmentation
Two-pore channels (TPCs) are endolysosomal cation chan-
nels which are distantly related to the endolysosomal TRP chan-
nels of the TRPML subfamily on the one hand and the voltage-
gated calcium channels on the other hand. Two members exist
in humans, TPC1 and TPC2. Functional roles associated with
the ubiquitously expressed TPCs include VEGF-induced neoan-
giogenesis (1), endolysosomal LDL-cholesterol trafficking and
degradation (2), physical endurance under fasting conditions (3),
autophagy regulation (4-5), the acrosome reaction in sperm (6),
intracellular trafficking of certain pathogens such as filoviridae,
e.g. Ebola or Marburg virus (7), bacterial toxins, e.g. cholera-
toxin (8), and a role in cancer cell migration (9). A few years
ago, Sulem and colleagues (10) presented results from a genome-
wide association study for variants associated with human pig-
mentation characteristics among 5,130 Icelanders, with follow-
up analyses in 2,116 Icelanders and 1,214 Dutch individuals from
which they claimed that two coding variants of hTPC2 (SNPs),
rs35264875 (encoding M484L) and rs3829241 (encoding G734E),
were associated with a shift from brown to blond hair color. Very
recently, Ambrosio and colleagues (11) as well as Bellono et al.
(12) confirmed a role for TPC2 in pigmentation by showing that
TPC2 regulates the pH and size of melanosomes, thus controlling
the amount of melanin produced. Consequently, loss of TPC2
activity by knockout or knockdown leads to a strong increase of
melanin production and melanosomal pH.
Hence, it seemed intriguing to functionally investigate these
polymorphic TPC2 variants. We investigated the activity of WT
hTPC2 side-by-side with hTPC2(G734E) and hTPC2(M484L) as
well as the double mutant isoform (M484L/G734E). First, we
applied the endolysosomal patch-clamp technique in combina-
tion with small molecule activators and blockers of TPC2 to di-
rectly assess channel activity. Secondly, we performed molecular
dynamics simulations of TPC2 based on the recently published
structures of TPC1 (13-14) to investigate structural changes due
to the SNPs. These results were corroborated by ion substitution
experiments to assess pore sizes. Furthermore, we genotyped
more than 100 blond and brown/black haired human individuals
and isolated fibroblasts from selected donors to confirm key in-
vitro findings and the results of the genome-wide association
study by Sulem and colleagues (10).
Results
Human TPC2 WT and polymorphic variants show comparable
subcellular distribution but differences in basal activity and
their response to PI(3,5)P2. Wild-type (WT) hTPC2 and the
polymorphic variants containing either M484L, G734E, or both
M484L and G734E show similar subcellular distribution when
overexpressed in HEK293 cells (SI Fig. S1A). All variants localize
Significance
Polymorphisms in the endolysosomal cation channel TPC2
have been suggested to lead to a shift in human hair color
from brown to blond. In two further studies a role for TPC2 in
melanosomal pH-regulation was postulated. Electrophysiolog-
ical data on how these polymorphisms affect channel gating
and activity are however missing. We show here that both
polymorphisms lead to a gain of channel function by different
mechanisms. In M484L sensitivity to its endogenous ligand
PI(3,5)P2 is strongly increased while in G734E channel inacti-
vation by ATP is reduced. These findings are corroborated by
molecular dynamics and ion substitution experiments. Further-
more, >100 blond and brown/black haired human individuals
were genotyped and fibroblasts isolated from selected donors
to confirm key in-vitro findings.
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Fig. 1. Effect of PI(3,5)P2 on endolysosomal vesicles expressing either human TPC2 WT or polymorphic variants. (A) Cartoon showing the estimated positions of
the polymorphisms (SNPs) M484L and G734E. (B-E) Shown are representative basal and PI(3,5)P2 (1 μM) activated currents in vacuolin enlarged endolysosomal
vesicles expressing either hTPC2 WT, hTPC2(M484L), hTPC2(G734E), or hTPC2(M484L/G734E) C-terminally fused to YFP. (F) Statistical summary of data as
shown in b-e. Shown are average current densities at -100 mV. (G) PI(3,5)P2 dose-response curves for hTPC2 WT and hTPC2(M484L) and hTPC2(G734E). In all
experiments, currents were elicited by applying 500-ms voltage ramps from -100 to +100 mV every 5 s. In all statistical analyses mean values of at least 5-10
independent experiments are shown, each. To test for statistical significance the one-way ANOVA test followed by Tukey’s post-test was applied. ***,indicates
p<0.001, **, indicates p<0.01.
Fig. 2. Effect of ATP on human TPC2 WT and poly-
morphic variants using the respective EC50 values of
PI(3,5)P2 as activating concentrations. (A-C) Represen-
tative PI(3,5)P2 (diC8) activated currents in vacuolin
enlarged hTPC2 WT and hTPC2 SNP expressing en-
dolysosomal vesicles using the respective EC50 values
as activating PI(3,5)P2 concentrations and different
concentrations of ATP as indicated to block the cur-
rents. (D) ATP dose response curves from experiments
as shown in A-C. In all experiments currents were
elicited by applying 500-ms voltage ramps from -100
to +100 mV every 5 s. To test for statistical significance
the Student’s t-test, unpaired was applied. * indicates
p<0.05.
to intracellular vesicular structures which are positively stained
with Lysotracker (SI Fig. 1A). A calculation of the Pearson cor-
relation coefficients (PCC) resulted in similar numbers for colo-
calization with Lysotracker for all variants (SI Fig. 1B). Western
blot analysis demonstrated that expression levels of the different
variants in endolysosomal membranes are not significantly differ-
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Fig. 3. Effect of rapamycin and torin-1 on human TPC2 WT and G734E. (A-B) Representative PI(3,5)P2 (1 μM) activated currents in vacuolin enlarged hTPC2
WT and hTPC2(G734E) expressing endolysosomal vesicles and the respective blocking effects of 2 μM torin-1 or 1 μM rapamycin. Cells were incubated with
torin-1 for 12 hours or with rapamycin for 10 minutes before experimentation. Currents were measured in the absence of ATP. (C) Statistical summary of data
as shown in A-Bincluding respective basal currents. Shown are average current densities at -100 mV. To test for statistical significance the one-way ANOVA
test followed by Tukey’s post-test was applied to basal and PI(3,5)P2 conditions, respectively. ***, ### indicate p<0.001, ## indicates p<0.01.
Fig. 4. Ion substitution experiments and molecular dynamics simulations. (A-D) Endolysosomal patch-clamp experiments showing PI(3,5)P2-activated hTPC2
WT (A-B) or hTPC2(M484L) (C-D) currents under bi-ionic conditions with luminal Na+ and bath solutions containing the following monovalent cations,
respectively: Li+, K+, Rb+ and Cs+. (B, D) Expanded view of A and C, showing that the reversal potentials are shifted to negative voltage in M484L variant. (E)
Summary of data as shown in A-D. Shown are the relative permeabilities (PX/PNa) of the different cations plotted against the diameter of cations. The dashed
lines are fitted to Equation 1 (see method section for details). (F) Schematic representation of the TPC2 simulation system. The channel (grey) is embedded in
a fully solvated POPC bilayer (transparent surfaces). As the channel has a conic shape the bilayer is bent locally. To cope with this effect always two channel
models were embedded in antiparallel fashion into a larger bilayer patch. (G) Enlargement of the selectivity filter omitting part of the protein. D276, N273
and A272 which are present symmetrically on both subunits are shown in VdW representation. (H) The pore radius of TPC2 is shown at the height of A272
for WT (blue) and the M484L variant (red) simulated in presence of PI(3,5)P2. A representative window at the end of the independent simulations was chosen
which presumably resembles an opening event. One of two M484L pores showed a dilation of more than 1 Å for almost 10 ns.
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Fig. 5. Characterization of human fibroblasts isolated from TPC2 WT donors or donors carrying TPC2 polymorphisms. (A-B) Data summarizing sequencing
results obtained from human genomic DNA samples. Shown in A is the genotype distribution (in %) of individuals with either blond hair or brown/black
hair, e.g. 23.9% of the brown/black hair donors but only 5.8% of the blond hair donors are genotype WT. In contrast, 26.1% of the blond hair donors are
homozygous for E (homE) at position 734 while only 10.4% of the brown/black hair donors are homE. Shown in B is the phenotype distribution (in %) of
all genotyped individuals, e.g. 80% of all individuals with the genotype WT have brown/black hair while only 20% have blond hair. In contrast, 72% of all
individuals with the genotype homE at position 734 and 71.4% of all individuals with the genotype L homozygous (homL) at position 484 are blond. The
total numbers of donors were 67 (brown/black hair) and 69 (blond hair), respectively. (C) Examples of human donor genotyping results. Shown are respective
sequences around position 484 (Leu/Met) and 734 (Gly).(D-E) Representative endolysosomal patch-clamp experiments showing PI(3,5)P2 (10 μM) activated
currents in vacuolin enlarged fibroblast endolysosomes isolated from donors homozygous for WT, M484L, and G734E. The TRPML channel activator ML-SA1
was used to demonstrate that TRPML currents were comparable in size in all fibroblast lines, in contrast to PI(3,5)P2 mediated currents. (F) Statistical summary
of data shown in D-E. Two independent donor fibroblast samples were used for each WT and M484L. One sample was used for G734E. Shown are the pooled
average current densities at -100 mV of at least 5 independent experiments, each. To test for statistical significance one-way ANOVA test followed by Tukey’s
post-test was applied. ***,indicates p<0.001, *, indicates p<0.05.
ent (SI Fig. 1C and D). Treatment with vacuolin increased the
size of endolysosomal vesicles to a similar extent in all variants
(SI Fig. 1E). Finally, dimerization efficiencies of TPC2 WT and
the polymorphic variants were comparable as assessed by FRET
experimentation (SI Fig. 2).
The two polymorphisms are found in very different parts of
the protein. While M484L resides in the second transmembrane
domain of the second channel domain, G734E is found in the C-
terminus of the protein (Fig. 1A), suggesting different functional
consequences.
We next performed endolysosomal patch-clamp experiments.
Here, we found striking differences between the respective vari-
ants. The polymorphic variant M484L as well as the double
polymorphic variant showed, compared to WT, a significantly
increased basal channel activity as well as a significantly increased
channel activity after stimulation with PI(3,5)P2 (3, 15). In con-
trast, G734E showed similar mean basal and stimulated activation
levels as WT. (Fig. 1B-F and SI Fig. 3A). Average capacitance
values were comparable for all variants indicating that differences
in channel activity were not due to differences in the size of
the patched vesicles (SI Fig. 3B). Dose-response measurements
revealed an EC50 of 1138 ± 376 nM for WT compared to 216 ± 55
nM for M484L while G734E was not significantly different from
WT with an EC50 of 827 ± 183 nM (Fig. 1G; increased potency).
In addition, the maximum response level was increased by two to
three fold, depending on the PI(3,5)P2 concentration, in M484L
compared to WT or G734E (Fig. 1G; increased efficacy).
Differences in ATP inhibition between TPC2 WT and poly-
morphic variants. We next assessed the inhibition of activated
TPC2 WT and polymorphic variants by ATP. Block of TPC
activity by ATP has been demonstrated before and was shown
to be physiologically relevant during cell starvation (3). We con-
firm here that the channel activities of WT TPC2 and also the
polymorphic variants M484L and G734E are efficiently blocked
by applying high concentrations of ATP (1 mM). However, dose-
response measurements revealed significant differences in the
IC50 values which were generated for each variant based on their
individual PI(3,5)P2 EC50 values (Fig. 2A-D). When we used
the individual PI(3,5)P2 EC50 values to activate we obtained the
following IC50 values for the ATP block: WT (91 ± 19 μM), G734E
(351 ± 37 μM), and M484L (102 ± 6 μM). These data demonstrate
that significantly less ATP is necessary to block WT TPC2 or
M484L variant activities compared to the G734E variant. Similar
results were obtained when we used the individual PI(3,5)P2 EC80
values or a fixed concentration of 1 μM PI(3,5)P2 to activate. The
respective IC50 values for the ATP block were: WT (179 ± 15 μM)
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and G734E (384 ± 39 μM) for PI(3,5)P2 EC80 as well as WT (4 ±
2 μM) and G734E (133 ± 71 μM) for the fixed concentration of 1
μM PI(3,5)P2 (SI Fig. 4).
In summary these data suggest that both M484L and G734E
variants are gain of function (GOF) polymorphisms.
Effect of mTOR inhibitors. ATP is known to activate mTOR
(mechanistic target of rapamycin (16)) and mTOR is the medi-
ator that inhibits TPC2 by direct protein-protein interaction as
recently shown (3). To further investigate the cross-talk between
channel activity and ATP inhibition, we tested the effect of mTOR
inhibitors such as rapamycin and torin-1 on TPC2 channel ac-
tivity. Both compounds were found previously to enhance TPC2
channel activity by blocking the TPC2 inhibitor mTOR (3). We
found that inhibition of mTOR increased TPC2(G734E) channel
activity more efficiently than WT activity, suggesting a stronger
effect of mTOR on WT compared to G734E. In contrast, the
channel activity of the M484L isoform could not be further
enhanced under the same conditions (for M484L a PI(3,5)P2
concentration of 1 μM is a saturating concentration; EC50 = 216
± 55 nM) (Fig.3A-C and SI Fig. 5A-B).
Ion substitution experiments. To further corroborate the
findings obtained for the M484L variant, we performed ion sub-
stitution experiments and molecular dynamics simulations based
on the recently published structures of AtTPC1 (13-14). In ion
substitution experiments using the endolysosomal patch-clamp
technique, we found differences in the estimated pore diameters
between WT and M484L while there were no obvious differences
between WT and G734E (Fig. 4A-E and SI Fig. 5C-E). We used
monovalent cations (sodium, lithium, rubidium, and cesium) in a
concentration of 160 mM, each, to estimate the pore diameters
of TPC2 WT and the M484L variant (Fig. 4A-E). We determined
permeability ratios relative to Na+ (PX/PNa) from the bionic
reversal potentials, which resulted in estimations of 3.7 Å and 3.9
Å for the minimum pore diameter of TPC2 WT and the M484L
variant, respectively. The estimation for the G734E variant diam-
eter resulted in the same value as for WT (3.7 Å) (SI Fig. 5E).
These data suggest that M484L not only contributes to larger
current amplitudes but also influences channel conformation and
the narrowest part of the pore region.
Molecular dynamics simulations confirm dilated pore in
hTPC2(M484L) variant. Multiple models of the TPC2 channel
were submitted to prolonged molecular dynamics simulations of
at least 100 ns, each. WT and M484L variant were simulated with
PI(3,5)P2 resembling the experimental layout. As each simulation
system contained two channel models a total of over 800 ns was
available for analysis. All models showed a high degree of stability
preserving their overall structure and a continuous water column
through the pore. For one of the two M484L models a dilation of
the pore could be observed in the presence of PI(3,5)P2 for ∼10
ns around position A272. The pore radii of the dilated M484L
pore were compared with the WT pore (Fig. 4F-H). This finding
suggests that the M484L mutation affects pore dynamics, further
corroborating the data presented on the estimation of the pore
sizes of TPC2 WT and M484L by ion substitution experimenta-
tion. Notably, Schieder et al. (17) had reported previously that
TPC2 mutant isoform N273A (next to A272) shows a pore block
and Wang and colleagues (15) reported that the D276K mutation
likewise leads to a pore block and loss of PI(3,5)P2 response,
emphasizing the importance of this region for channel activity.
Endogenous TPC2 channel activity in human donor fibrob-
lasts. Next, we screened, more than 100 blond and brown/black
haired human donors for TPC2 polymorphisms and identified
individuals which were either homozygous for WT, M484L, or
G734E, or individuals which were heterozygous for the respec-
tive polymorphisms (Fig. 5A-B). The obtained genotyping results
were found to correlate well with the data published by Sulem
et al. (10). Thus, the percentage of DNA samples isolated from
blond haired individuals which are homozygous for either M484L
or G734E was 7.2% and 26.1% (n = 69), respectively, while
DNA samples isolated from brown, dark brown, or black haired
individuals were in only 2.9% of the cases homozygous for M484L
and in only 10.4% of the cases homozygous for G734E (n = 67).
Among the blond haired donors we found only 5.8% to be ho-
mozygous for WT. Vice versa among individuals with brown/black
hair 23.9% were found to be homozygous for WT (Fig. 5A).
We subsequently isolated fibroblasts from selected individ-
uals and analysed them using the endolysosomal patch-clamp
technique (Fig. 5C-F). While we found only small endogenous
PI(3,5)P2 currents in WT or G734E fibroblast endolysosomes,
significantly increased PI(3,5)P2-mediated channel activity was
detectable in endolysosomes isolated from donor fibroblasts ho-
mozygous for M484L, essentially confirming the in-vitro findings.
For ATP dose-response measurements the PI(3,5)P2-mediated
currents in G734E endolyosomes were too small. As an activation
control we used the TRPML-channel activator ML-SA1 (18).
TRPML channel currents activated with ML-SA1 were not sig-
nificantly different between M484L, G734E, and WT endolyso-
somes, suggesting that the differences in PI(3,5)P2 response are
not due to differences in TRPML channel activity (Fig. 5C-E).
In summary, these data confirm the strong GOF found for the
M484L variant in overexpressing HEK293 cells and the data fur-
ther confirm the increased association of the M484L and G734E
variants with blond hair color compared to the WT TPC2 isoform.
Discussion
We show here that the TPC2 variants M484L and G734E, re-
ported previously to be associated with a shift in human hair
color from brown to blond display distinct functional differences
compared to WT. We used overexpressing HEK293 cells and en-
dogenously expressing fibroblasts to functionally characterize the
respective variants. In endolysosomal patch-clamp experiments
we found that both variants show a gain of channel function com-
pared to WT (SI Fig. 6). While basal activity and activation with
PI(3,5)P2 was increased in M484L, affecting both efficacy and
potency of PI(3,5)P2, inhibition of channel activity by ATP was
less sensitive in G734E compared to WT (SI Fig. 6). The M484L
polymorphism leads to structural changes affecting the pore di-
ameter of TPC2. Thus, M484L displays a significant pore dilation
compared to WT as demonstrated by molecular dynamics simula-
tions and ion substitution experiments. The G734E variant is less
responsive to ATP and more sensitive to mTOR inhibitors than
WT, the latter one suggesting that the weaker ATP effect may be
mediated by mTOR. While torin-1 is a selective ATP-competitive
inhibitor of mTOR which effectively blocks phosphorylation of
mTOR, rapamycin and related inhibitors form a complex with the
intracellular immunophilin FKBP12; the resulting complex then
interacts with and inhibits mTOR (19-20). Despite these different
mTOR inhibitory mechanisms, both torin-1 and rapamycin result
in a stronger increase in G734E activity compared to WT, further
emphasizing that the differences in ATP block may be directly
mediated via mTOR and downstream effects. Nevertheless, we
cannot fully exclude the possibility of mTOR independent ATP
effects.
Remarkably, human TPC2 cDNAs used for functional studies
in past publications were often polymorphic variants. Thus, for
example Calcraft et al. (21) had used a TPC2 variant cloned
from HEK293 cells containing both polymorphisms: M484L and
G734E. Pitt et al. (22) had used a variant of human TPC2
containing the G734E polymorphism (GenBank accession no.
AY029200) and Brailoiu et al. (23) had used the IMAGE clone
5214862 (GenBank accession no. BC063008) which also contains
the polymorphism G734E. Thus, it seems that WT hTPC2, at least
in its recombinant form has not always been used as a reference
in the existing publications.
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In accordance with recent findings by Ambrosio et al. (11)
as well as Bellono et al. (12), claiming that loss of TPC2 leads
to increased melanin production, an increase in TPC2 channel
activity as found here for the two SNPs would be expected to
result in the opposite effect, a decrease in melanin production.
Located in the basal epidermis and in hair follicles, melanocytes
of the integument are responsible for hair coloration through pro-
duction of melanin pigments in melanosomes (24). Two types of
pigment are known to give hair its color: eumelanin and pheome-
lanin. Eumelanin has two subtypes, black and brown, which de-
termine the darkness of the hair color. A low concentration of
brown eumelanin results in blond hair, whereas a higher con-
centration of eumelanin will color the hair brown/black. Melanin
production is strongly dependent on the activity of the enzyme
tyrosinase (TYR). TYR activity is optimal at neutral pH (25-
27). To achieve neutralization of melanosomal pH, the proper
function of a cascade of ion transporters seems to be required
(27). Consequently, polymorphisms in any of such transporters
or ion channels rendering them dys- or malfunctional may lead
to changes in melanosome pH and thus to changes in melanin
production as suggested recently by Ito et al. (27). For TPC2
this hypothesis has now been supported by works published by
Ambrosio and colleagues (11) and Bellono et al. (12). Thus, loss
of TPC2 leads to an increase in melanosomal pH and melanin
production while overexpression of TPC2 leads to a decrease
in melanin production. Like TPC2 overexpression, an increase
in TPC2 activity would be expected to result, in a decreased
melanosomal pH and thus a decrease in melanin production. This
would consequently explain the shift in hair color from brown to
blond.
In addition to hair coloration, altered TPC2 channel activity
may also impact human health, in particular under challenging
conditions such as physical stress or infections. TPC2 knockout
mice show an increased susceptibility to hypercholesterinemia
and fatty liver hepatitis compared to WT when fed with a high
cholesterol diet (2), they show a decreased physical endurance
under fasting conditions (3), and they are less susceptible to
distinct viral infections (7). Migration of cancer cells and the
formation of metastases was recently found to be reduced in
TPC2 knockdown cells or after pharmacological inhibition of
TPC2 (9). We therefore speculate that humans carrying the GOF
polymorphisms M484L or G734E or both may have, in particular
under stress conditions, an altered susceptibility for diseases
that are associated with the endolysosomal system. In addition,
it may also be possible that changes in TPC2 activity affect
melanosomes differently than lysosomes, e.g. due to differences
in pH regulatory mechanisms with different consequences for
human physiology and pathophysiology.
Materials and Methods
Molecular biology. All human TPC2 variants were generated from hTPC-
2(M484L/G734E)-mCherry, a kind gift by Prof. Dr. Michael Zhu (Houston).
Point mutations were removed from constructs by site-directed mutagenesis
using QuikChange (Agilent) according to the procedures outlined in the
manufacturer’s manual or by overlap PCR-experimentation. C-terminally
fused YFP versions of WT and the polymorphic TPC2 variants were generated
from the respective mCherry constructs and subcloned into pcDNA3.1 vector.
Constructs used for FRET experiments are described in the methods section
and the figure legend in more detail.
Endolysosomal membrane preparations. To evaluate expression levels
of TPC2 WT and variants in endolysosomal membranes, HEK293 cells were
transfected with TPC2-constructs (YFP-tagged), respectively. Preparation of
endolysosomes was performed as described previously (17, 28). For im-
munoblotting, antibodies were used in the following dilutions: rabbit anti-
Rab7, 1:500 (cell signaling, 2094S); mouse anti-GFP, 1:2000, mouse anti-
HRP 1:2000 (sc-2031, Santa Cruz), and rabbit anti HRP, 1:1000 (NA934V, GE
Healthcare).
Molecular modeling. A model for TPC2 was constructed using
Schrödinger Prime based on PDB ID 5E1J (14) with the UniProt sequence
Q8NHX9 (21). Default settings were used employing the multichain protocol
modeling both subunits simultaneously. Always two of the resulting models
were embedded into a POPC bilayer in antiparallel orientation to reduce
lateral stress following protocols described earlier (29-30) and solvated with
SPC water. CaCl2 was added to balance the overall charge and to achieve
nearly physiological ion concentrations. Employing GROMACS-5.1 the pe-
riodic system was energy minimized and constraints on the protein were
gradually reduced (31-33). A total of 100 ns each were simulated with a time
step of 2 fs for the WT, WT with PI(3,5)P2, M484L and M484L with PI(3,5)P2.
Two equivalents per pore were placed in vicinity of M484L into the bilayer
for the corresponding simulations. Neighbor searching was performed every
40 steps. The PME algorithm was used for electrostatic interactions with a
cut-off of 1.2 nm and verlet cut-off scheme. A reciprocal grid of 192 x 120 x
120 cells was used with 4th order B-spline interpolation. A single cut-off of
1.2 was used for van der Waals interactions. Temperature coupling to 310
K was done with the V-rescale algorithm. Semiisotropic pressure coupling
to 1 bar in the plane and perpendicular to it was done with the Berendsen
algorithm. For all simulations the 53a6 force field were used with parameters
for POPC adapted from (29) and adapted for PI(3,5)P2 from (34). The analysis
was performed using GROMACS tools, VMD, Schrödinger and hole2 (31, 35-
37).
FRET experiments. Measurements of single-cell FRET, based on aggre-
gate (nonspatial) fluorescence recordings were performed and analyzed
using the three-cube-FRET method as described previously (38). For mea-
surements, transiently transfected HEK293 cells were maintained in buffer
solution composed of 140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2,
10 mM Glucose, 10 mM Na-HEPES pH 7.4 at room temperature (RT). Fluo-
rescence intensities of YFP or the GFP variants Citrine and Cerulean were
recorded using a LEICA DMI6000B inverted epifluorescence microscope and
a photomultiplier detection system (PTI, Canada). Excitation was done at
436nm ± 2.5 or 500 nm ± 2.5 with a DeltaRam monochromator (Horiba,
Canada). Epifluorescence emission was detected by a photomultiplier (PMT
914) and acquired on a personal computer using FelixGX software (Horiba,
Canada). Three cube FRET filter cubes were as follows (excitation, long-
pass beamsplitter, emission): CFP/Cerulean (ET436/20x; T455lp; ET480/40m),
YFP/Citrine (ET500/20x; T515lp; ET535/30m) and FRET (ET436/20x; T455lp;
ET535/30m) (Chrome technology). The FRET ratio, which is defined as the
fractional increase in YFP emission caused by FRET, was calculated using FR
= [SFRET-(RD)(SCer)]/[(RA)(SCit)]. SFRET, SCer and SCit denote fluorescence inten-
sities derived from measurements in individual cells co-expressing Citrine-
or Cerulean-tagged proteins with the respective filter cube (excitation,
emission): SFRET (436 nm ± 10, 535 nm ± 15), SCFP (436nm ± 10, 480 nm ± 20)
and, SYFP (500nm ± 10, 535 nm ± 15). RD and RA are experimentally predeter-
mined constants from measurements applied to single cells expressing only
Cerulean- or Citrine-tagged molecules that correct for donor bleed through
or acceptor cross excitation. FRET efficiencies (EA) can be calculated from FRs
using the following equation (39):
ɛcitrine and ɛcerulean are the setup specific average molar extinction coefficients
for citrine and cerulean, respectively, over the precise bandwidth of the
FRET cube excitation filter. In our setup, the calculated molecular extinction
coefficient ratio is ɛcitrine (436) / ɛcerulean (436) = 0.0563. Data were analyzed
using FelixGX (Horiba PTI, Canada) and Microsoft Excel (Microsoft).
Whole-endolysosomal patch-clamp experiments. For whole-
endolysosomal patch-clamp recordings, isolated intact endolysosomes
from HEK293 cells were manually isolated after vacuolin treatment for at
least 2 hours. Human TPC2 WT and polymorphic TPC2 variants (C-terminally
fused to YFP) were transiently transfected into HEK293 cells using TurboFect
Transfection Reagent (ThermoFisher). Currents were recorded using an
EPC-10 patch-clamp amplifier and PatchMaster acquisition software (HEKA).
Data were digitized at 40 kHz and filtered at 2.8 kHz. Cytoplasmic solution
contained 140 mM KMSA, 5 mM KOH, 4 mM NaCl, 0.39 mM CaCl2, 1 mM
EGTA and 20 mM HEPES (pH adjusted with KOH to 7.2). Luminal solution
was 140 mM NaMSA, 5 mM KMSA, 2 mM CaMSA, 1 mM CaCl2, 10 mM
HEPES and 10 mM MES (pH adjusted with MSA to 4.6). For the application
of PI(3,5)P2 (A.G. Scientific) and ATP-Mg (Sigma), cytoplasmic solution
was completely exchanged by compound containing solution. Torin-1 and
rapamycin were purchased from Tocris and LC Laboratories, respectively.
All recordings were performed at 23-25 °C. For experiments using ATP and
mTOR inhibitors, cell density was 50-60 % and the time spent outside the
incubator was 30 minutes.
To estimate the pore diameter of TPC2 WT and M484L, the relative
permeability ratios of cations relative to Na+ were plotted against the
diameter of the respective monovalent cations as indicated in Fig.4. The
following equation was applied (40):
where a is the diameter of the permeating cation, k is a constant factor, and
d is the pore diameter (41). The ionic radii of Li+, K+, Rb+ and Cs+ are 0.6,
1.33, 1.48 and 1.69 Å (42). To calculate the permeability ratios the following
equation was used:
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where V is the reversal potential, R is the gas constant, F is the Faraday
constant, and T is the temperature in Kelvin. To determine the relative
Na+ (PX+/PNa+) permeabilities of TPC2 WT and M484L, whole-endolysosome
recordings were performed using ramp protocols (+100 to -100 mV with 500
ms increments). The bath solution contained 160 mM (pH 7.2, HEPES 5 mM)
of the respective cations (as indicated in the Fig.) and the pipette solutions
contained 160 mM NaCl (pH 7.2, HEPES 5 mM). The recordings were started
with symmetric Na+ solutions. The cytoplasmic solution was then exchanged
with the respective monovalent cation containing solution.
Human donor DNA purification and sequencing. Human genomic DNA
was obtained from adult male and female individuals using the Gentra
Puregene Buccal Cell Kit (Qiagen), according to manufacturer’s instructions.
Briefly, buccal cells were collected by scraping the inside of the mouth
10 times. For cell lysis, the collection brush was incubated in lysis solu-
tion at 65 °C for at least 15 min. Proteins were precipitated and cen-
trifuged. To precipitate DNA, the supernatant was added to isopropanol
and glycogen solution. The pellet was washed with 70 % ethanol and
air-dried before resuspension in DNA hydration solution. Samples were
incubated at 65 °C for 1h, followed by incubation at RT overnight to
dissolve the DNA. Genomic DNA fragments were amplified using gene-
specific primers (hTPC2(M484L) genomic DNA-forward: 5’-GGTGTTCCTGGT-
GCTGGA-3’; hTPC2(M484L) genomic DNA-reverse: 5’-ACAGCCTCTAGTCCTCA-
GGG-3’; hTPC2(G734E) genomic DNA-forward: 5’-GGCCACCTACCAGATGACT-
3’; hTPC2(G734E) genomic DNA-reverse: 5’-CGGACGTCACCTGCACAG-3’. All
DNA sequencing services were done by Eurofins MWG Operon.
Isolation of human fibroblasts. Human genomic DNA sampling and
human fibroblast isolation were approved by the LMU Ethics Committee
(headed by Prof. Dr. Eisenmenger; reference number: 254-16). Acquisition
of human material was performed after obtaining written informed consent
by the donors. Primary fibroblasts were isolated by Prof. Dr. Carola Berking
and colleagues, Department of Dermatology, LMU Munich from the skin of
healthy adult donors. Epidermis was separated from dermis using dispase
II (10 mg/ml in PBS pH 7.2 -7.4; Sigma #D4693) and dermis was digested
in collagenase (1 mg/ml in DMEM Medium; Sigma #C0130) for 22 h at
room temperature. Fibroblasts were cultured in DMEM with glutamine (Life
Technologies, Inc.) and 10% FBS (FBS Superior, Biochrom #S0615). They were
used for experiments at passage 3-7.
Statistical analysis. Details of statistical analyses and n values are pro-
vided in the methods subsections or the figure legends. Statistical analyses
were carried out using Origin 7.5 and GraphPad Prism 5. All error bars are
depicted as mean ± SEM. Significance is denoted on figures as outlined
in the legends. Statistics were derived from at least three independent
experiments.
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SI Figure 1  
Human TPC2 WT and polymorphic variants: expression, subcellular distribution 
and vacuolin effect. (A) Shown are representative laser scanning images of hTPC2 
WT and the polymorphic variants hTPC2(G734E), hTPC2(M484L), and 
hTPC2(M484L/G734E), all C-terminally fused to YFP and overexpressed in HEK293 
cells using TurboFect. All isoforms showed a punctuated pattern and colocalized with 
Lysotracker DR (deep red). Scale bars = 10 μm (zoom-in images: scale bars = 5 μm). 
(B) PCC (Pearson correlation coefficients) calculated from images as shown in A using 
ImageJ software and the JACoP colocalization plugin (images were taken from n = 3 
independent experiments). (C-D) Depicted in C are representative western blot data 
showing specific bands for hTPC2 WT and the polymorphic variants hTPC2(G734E), 
hTPC2(M484L), and hTPC2(M484L/G734E) fused to YFP, respectively, and detected 
with an anti-GFP antibody in lysosomal membranes (LM). LM were purified from whole 
cell lysates. The bands recognized with anti-Rab7 antibody were used as reference for 
the lysosomal preparations. Shown in D is the quantification of the data presented in 
C (n = 3 independent experiments) using Image Lab Software. All variants showed no 
significant differences in their relative expression levels. (E) The effect of vacuolin on 
all isoforms was comparable. Shown are representative laser scanning images of the 
respective variants overexpressed in HEK293 cells. Cells were treated for 4 hours with 
1 μM vacuolin. Scale bars = 10 μm.  
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SI Figure 2 
FRET experiments to assess TPC2 WT and polymorphic variant dimerization. (A) 
Shown are the respective FRET efficiencies (EA) for binned groups of HEK293 cells 
overexpressing hTPC2 WT or the polymorphic variants hTPC2(G734E), 
hTPC2(M484L), or hTPC2(M484L/G734E), N-terminally fused to Citrine or Cerulean, 
respectively, plotted versus Dfree, forming a binding curve. As negative control the 
lysosomal transmembrane protein hTMEM192 C-terminally fused to Cerulean was co-
transfected with Citrine-hTPC2 WT. As a second negative control co-transfection of 
Cerulean-hTPC2 WT with empty Citrine-vector was used. (B) Statistical summary of 
data as shown in A using Dfree > 0.5 as cutoff. In all statistical analyses mean values 
of at least 3 independent experiments (n = 10-15 cells each) are shown, each. To test 
for statistical significance one-way ANOVA test followed by Tukey’s post-test was 
applied. No significant differences were found between the TPC2 variants.  
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SI Figure 3 
Effect of PI(3,5)P2 on endolysosomal vesicles expressing either human TPC2 WT 
or polymorphic variants. (A) Single values of current densities (at -100 mV) 
measured in endolysosomal patch-clamp experiments as shown in Fig.1. Currents 
were elicited with PI(3,5)P2 (1 μM). To test for statistical significance the one-way 
ANOVA test followed by Tukey’s post-test was applied. ***, indicates p<0.001, **, 
indicates p<0.01. (B) Single capacitance values for the vesicles measured in the 
experiments presented in Fig.1. 
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SI Figure 4 
Effect of ATP on human TPC2 WT and G734E using the respective EC80 values 
of PI(3,5)P2 as activating concentrations or a fixed concentration of 1 μM. (A-B) 
Representative PI(3,5)P2 (diC8) activated currents in vacuolin enlarged hTPC2 WT 
and hTPC2(G734E) expressing endolysosomal vesicles using the respective EC80 
values as activating PI(3,5)P2 concentrations and different concentrations of ATP as 
indicated to block the currents. (C) ATP dose response curves from experiments as 
shown in A-B. (D-E) Similar experiments as in A-B using a fixed PI(3,5)P2 
concentration of 1 μM as activating concentration and different concentrations of ATP 
as indicated to block the currents. (F) ATP dose response curves from experiments as 
shown in D-E. In all experiments currents were elicited by applying 500-ms voltage 
ramps from -100 to +100 mV every 5 s. To test for statistical significance the Student’s 
t-test, unpaired was applied. * indicates p<0.05.  
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SI Figure 5 
Effect of mTOR inhibitors on M484L and ion substitution experiments for G734. 
(A) Representative PI(3,5)P2 (1 μM) activated currents in vacuolin enlarged 
hTPC2(M484L) expressing endolysosomal vesicles and the respective blocking effects 
of 2 μM torin-1 or 1 μM rapamycin. Cells were incubated with torin-1 for 12 hours or 
with rapamycin for 10 minutes before experimentation. Currents were measured in the 
absence of ATP. (B) Statistical summary of data as shown in A including respective 
basal currents. Shown are average current densities at -100 mV. (C) Endolysosomal 
patch-clamp experiments showing PI(3,5)P2-activated hTPC2(G734E) currents under 
bi-ionic conditions with luminal Na+ and bath solutions containing the following 
monovalent cations, respectively: Li+, K+, Rb+ and Cs+. (D) Expanded view of C. (E) 
Summary of data as shown in C-D. Shown are the relative permeabilities (PX/PNa) of 
the different cations plotted against the diameter of cations. The dashed lines are fitted 
to Equation 1 (see method section for details). 
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Model for the different channel properties in TPC2 variants. (A) Shown are 
schematic PI(3,5)P2 dose-response curves (DRCs) of WT versus M484L (A, left) and 
WT versus G734E (A, right). (B) Schematic ATP DRCs of WT versus M484L (B, left) 
and WT versus G734E (B, right) using the respective EC50 concentrations of PI(3,5)P2 
to activate. Compared to WT the DRC for PI(3,5)P2 is changed in the M484L variant 
while the ATP inhibition curve is not. The opposite effect can be seen when comparing 
WT with the G734E variant: Compared to WT the DRC for PI(3,5)P2 is unchanged in 
the G734E variant while the ATP inhibition curve is changed. Therefore, the overall 
system response is determined by the difference in DRC for PI(3,5)P2 in the M484L 
variant while it is determined by the ATP inhibition curve in the G734E variant. Gain of 
function in the M484L variant is evident by the increased maximal PI(3,5)P2 activation 
current density (increased efficacy) and by the lower EC50 for PI(3,5)P2 (increased 
potency) compared to WT (A). At a fixed ATP concentration one would expect the same 
fractional block in WT and the M484L variant (inhibition curve is identical; B, left). 
However, this fractional block is determined by the DRC for PI(3,5)P2 and depends on 
the PI(3,5)P2 concentration. Inhibition of mTOR which likely mediates the ATP effect 
on TPC2 would revert the block and increase current density in both channel variants. 
The fractional increase would likewise be determined by the DRC for PI(3,5)P2 and 
depend on the PI(3,5)P2 concentration. The dashed grey lines and red double arrows 
(A, left) indicate the range for further increase in channel activity at the EC50 of WT. At 
this concentration M484L has almost reached its activation plateau. If the activating 
PI(3,5)P2 concentration is at the EC50 of WT, then mTOR inhibition would result in a 
smaller increase in activity in M484L compared to WT. (A, right) In WT and G734E the 
DRC and EC50 values for PI(3,5)P2 are similar. By contrast, the ATP inhibition curve is 
shifted to higher ATP concentrations in G734E (B, right). Thus, at the same ATP 
concentration (= activation of mTOR) WT would be blocked more efficiently than 
G734E. Inhibition of mTOR would increase channel activity in both WT and G734E. 
However, at the same PI(3,5)P2 concentration (see Fig. 3) the increase in activity would 
be expected to be stronger in G734E than in WT. (C) Model of the effects shown in A 
and B. Left panel, WT: In the absence of PI(3,5)P2, the channels can open but the 
openings are very rare. This is indicated by the equilibrium constant biased toward the 
closed state. Upon binding to PI(3,5)P2, the channels can open much better as the 
equilibrium is biased towards the open state. Thus, addition of PI(3,5)P2 will increase 
the currents substantially. Inactivation: ATP binding to mTOR triggers channel 
inactivation, possibly via a two-step process. First activated mTOR binds to an effector 
interface, and then that triggers a conformational change that manifests as inactivation. 
Moreover, channels unbound to PI(3,5)P2 will preferentially enter the inactivated state. 
Center panel, M484L: C1 to O1 and C0 to O0 are enhanced as a result of the pore-
dilation. Right panel, G734E: Activation process is not affected but the ATP sensitivity 
is reduced with no effect on the activation. 
 
 
  
 
 
 
 
  
Peripherin-2 couples rhodopsin to the CNG
channel in outer segments of rod photoreceptors
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Outer segments (OSs) of rod photoreceptors are cellular compartments specialized in the conversion of light
into electrical signals. This processrelies on the light-triggered change in the intracellular levels of cyclic guano-
sine monophosphate, which in turn controls the activity of cyclic nucleotide-gated (CNG) channels in the rod OS
plasma membrane. The rod CNG channel is a macromolecular complex that in its core harbors the ion-conduct-
ing CNGA1 and CNGB1a subunits. To identify additional proteins of the complex that interact with the CNGB1a
core subunit, we applied affinity purification of mouse retinal proteins followed by mass spectrometry. In com-
bination with in vitro and in vivo co-immunoprecipitation and fluorescence resonance energy transfer (FRET),
we found that the tetraspanin peripherin-2 links CNGB1a to the light-detector rhodopsin. Using immunoelectron
microscopy, we found that this peripherin-2/rhodopsin/CNG channel complex localizes to the contact region be-
tween the disk rims and the plasma membrane. FRET measurements revealed that the fourth transmembrane
domain (TM4) of peripherin-2 is required for the interaction with rhodopsin. Quantitatively, the binding affinity
of the peripherin-2/rhodopsin interaction was in a similar range as that observed for rhodopsin dimers.
Finally, we demonstrate that the p.G266D retinitis pigmentosa mutation found within TM4 selectively abolishes
the binding of peripherin-2 to rhodopsin. This finding suggests that the specific disruption of the rhodopsin/per-
ipherin-2 interaction in the p.G266D mutant might contribute to the pathophysiology in affected persons.
INTRODUCTION
Outer segments (OSs) of rod photoreceptors harbor all essential
proteins of the phototransduction cascade including the
G-protein-coupled receptor rhodopsin, the guanylyl cyclase,
the phosphodiesterase and the rod cyclic nucleotide-gated
(CNG) channel. Most of these proteins localize to highly struc-
tured intracellular membrane stacks (disks), which are physical-
ly separated from the plasma membrane (1). One exception is the
CNG channel, which is exclusively found in the plasma mem-
brane (2). Moreover, the periphery of disks facing the plasma
membrane, referred to as disk rims, contains a set of proteins
that differ from that of the remaining part of the disks. Previous
studies revealed that the rod CNG channel is directly connected to
the disk rims via a direct protein–protein interaction of the glu-
tamic acid-rich (GARP) domain of the CNGB1a subunit and the
disk rim-specific tetraspanin peripherin-2 (3,4). Peripherin-2 is a
scaffolding protein reported to be responsible for the disk
morphogenesis and for membrane fusion processes (5,6). Muta-
tions in peripherin-2 are associated with severe retinal diseases
(http://www.retina-international.org last accessed 26 June
2014). The vast majority of these mutations are linked to auto-
somal dominant retinitis pigmentosa (adRP), a degenerative
retinal disease that affects rod photoreceptors and often results
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in complete blindness. Here, we combined in vivo and in vitro
biochemical, imaging and immunoaffinity methods to show that
peripherin-2 in rod OSs binds to rhodopsin and the CNGB1a
subunit of the CNG channel. Moreover, we demonstrate that the
fourth transmembrane domain (TM4) of peripherin-2 is essential
for its interaction with rhodopsin and that a single adRP-
associated point mutation in TM4 of peripherin-2 abolishes this
interaction while leaving the binding to CNGB1a unaffected.
These results indicate that peripherin-2 operates as an adaptor
protein in the disk rims that physically couples the rod CNG
channel to the phototransduction cascade. This physical coupling
between rhodopsin and the CNG channel suggests that photo-
transduction in rod OS is more spatially confined than it has
been known so far and could help to gain new insights on the func-
tional and structural role of the disk rim microcompartment in the
rod OS. Finally, we conclude that the adRP phenotype in patients
carrying a mutation in TM4 of peripherin-2 most probably results
from the specific disruption of the peripherin-2/rhodopsin
interaction in the disk rims.
RESULTS
Identification of CNGB1a-interacting proteins
To identify novel components of the rod photoreceptor, CNG
channel complex of retinal lysates of light-adapted 6-week-
old-mice were immunopurified using an antibody directed
against the C-terminus of the CNGB1a subunit of the rod CNG
channel and analyzed by quantitative mass spectrometry.
Lysates of age-matched, CNGB1-deficient mice served as nega-
tive control. Among the list of OS-specific CNGB1a-interacting
proteins, we identified rhodopsin and peripherin-2 (Supplemen-
tary Material, Table S1). Reciprocal co-immunoprecipitations
(co-IPs) from retinal lysates using either an anti-rhodopsin anti-
body (Fig. 1A) or an anti-CNGB1a antibody (Fig. 1B) confirmed
that rhodopsin, peripherin-2 and CNGB1a are present in the
same channel complex. Importantly, no specific bands were
observed when performing the co-IPs with retinal lysates from
CNGB1-knockout mice (Fig. 1B, lane 2) or when a control
IgG was used instead of the anti-CNGB1a antibody (Fig. 1A,
lane 2). In addition to monomeric rhodopsin, the anti-rhodopsin
antibody detected bands corresponding to rhodopsin oligomers
(i.e. dimers, trimers and tetramers) pointing to a very tight inter-
action between rhodopsin molecules, which persisted under
SDS–PAGE conditions. To get a more direct view on the local-
ization of rhodopsin and CNGB1a in rod OSs, we employed
immunoelectron microscopy in retinal sections (Fig. 1C). Immu-
nogold particles of different diameters co-labeled with the anti-
rhodopsin and anti-CNGB1a antibodies, respectively, revealed
that CNGB1a is localized in close proximity to rhodopsin.
Analysis of the rod opsin/peripherin-2/CNGB1a complex
in HEK293 cells
In previous studies, it was shown that peripherin-2 binds to the
N-terminal GARP domain of CNGB1a (3,4). However, an inter-
action between peripherin-2 and rhodopsin or between rhodop-
sin and CNGB1a has not been reported so far. To address this
issue, we performed co-IPs in HEK293 cells expressing different
combinations of the chromophore-free rod apo-opsin (herein
referred to as rod opsin), peripherin-2 and the rod CNG
channel subunits (Fig. 2A and B). Surprisingly, in the absence
of peripherin-2, rod opsin did not assemble with CNGB1a nor
did it interact with this subunit when both subunits of the
native CNG channel (CNGB1a + CNGA1) were present
(Fig. 2A). In contrast, when peripherin-2 was co-expressed
together with rod opsin and CNGB1a, the CNGB1a subunit
could be co-immunoprecipitated with the anti-rhodopsin anti-
body (Fig. 2B). Moreover, peripherin-2 was binding to rod
opsin in the absence of CNGB1a (Fig. 2B). Taken together, the
co-IP experiments indicate that rod opsin requires peripherin-2
to interact with CNGB1a. We therefore postulated that
peripherin-2 physically links rod opsin and CNGB1a by simul-
taneously binding to both proteins.
To test this hypothesis, we applied fluorescence resonance
energy transfer (FRET) that allows detection and quantification
of protein–protein interactions (Fig. 2C). We tagged the proteins
C-terminally with either citrine or cerulean and then used the
respective fusion protein pairs for FRET measurements. In
agreement with the immunoprecipitation data, we obtained
robust FRET signals for rod opsin/peripherin-2 and as well as
for peripherin-2/CNGB1a. Quantitatively, FRET ratios (FRs)
of these pairs were in a similar range. However, they were some-
what lower than FRs obtained for rod opsin or peripherin-2
homodimers (see also Fig. 1A and B). In agreement with previ-
ous findings (3,4), our FRET data also revealed a robust inter-
action between peripherin-2 and the soluble GARP2, which
corresponds to the N-terminal portion of CNGB1a. Importantly,
the FR obtained for the rhodopsin/CNGB1a FRET pair was only
slightly above background confirming that there is no specific
interaction between these two proteins.
In vitro FRET unveils binding characteristics
of rod opsin and peripherin-2
To narrow down the region in peripherin-2 that is required for the
interaction with rod opsin, we determined the FRs between the
cerulean-tagged rod opsin and citrine-tagged peripherin-2 har-
boring C-terminal truncations (Fig. 3A). While deletion of the
C-terminus downstream of the fourth transmembrane segment
(Prph2_C1-citr) had no effect on the interaction with rod
opsin, additional truncation of the TM4 domain (citr-Prph2_C2)
abolished binding to rod opsin (Fig. 3A). In the latter truncation
mutant (containing only three transmembrane segments), citrine
was fused to the N-terminus to ensure that (like in C-terminally
tagged peripherin-2 variants containing four transmembrane
domains) citrine faces the cytoplasmic side of the cell. Import-
antly, the position of the tag did not interfere with the principal
interaction with rod opsin because FRs of the peripherin-2/rod
opsin pairs were in a comparable range for either N- or
C-terminally tagged peripherin-2 (Fig. 3A).
In order to specifically examine protein interactions in the
plasma membrane and to determine binding curves of the rod
opsin/peripherin-2 interaction, confocal FRET experiments
were performed in HEK293 cells (Fig. 3B and C). Maximal
FR values (FRmax) obtained with this approach for rod opsin/
peripherin-2 and rod opsin/rod opsin pairs, respectively, were
in good agreement with the FR obtained in standard (non-
confocal) FRET (Fig. 3A). As expected, confocal FRmax
values were consistently higher than the corresponding
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non-confocal FRs. On the basis of confocal FRET measure-
ments, the relative binding affinity of the rod opsin/peripherin-2
interaction was calculated to be 80% of the rod opsin/rod opsin
interaction.
FRET measurements in isolated rod OSs
To demonstrate that rhodopsin is bound to peripherin-2 in native
rod photoreceptors, FRET constructs were expressed in the
murine retina using AAV8-vectors, which contain the human
rhodopsin promoter (Fig. 4A).Three to four weeks after subret-
inal injection of viral vectors, robust expression of individual
constructs was observed (Fig. 4B). The expression was restricted
to rod OSs indicating that the fluorophores did not interfere with
the ciliary transport (Fig. 4B). OSs isolated using a self-designed
quick protocol appeared to be intact with regard to their structure
and shape (Fig. 4C). Figure 4D shows co-expression of a
representative FRET pair (rhodopsin-cerulean and peripherin-
citrin) in an isolated rod OS. As expected for a native system,
FRs were throughout smaller as found upon heterologous
expression in HEK293 cells (Fig. 4E). This difference most
probably can be ascribed to the fact that the unlabeled wild-type
proteins in vivo interfere with the FRET constructs leading to the
reduction of the absolute FRET signal. Qualitatively, however,
results in rod OSs were consistent with the results in HEK293
cells. Highest FRs were observed for the rhodopsin homomer.
Importantly, there was also clear FRET between rhodopsin
and peripherin-2 with the FR being slightly higher for the
N-terminally as compared with the C-terminally tagged
peripherin-2. In contrast, in good agreement with previous
studies (4,7), no FRET was observed for rhodopsin and
rod-specific GARP2 protein.
An adRP-linked mutation in TM4 of peripherin-2 disrupts
binding to rhodopsin
As mentioned before, mutations in peripherin-2 have been asso-
ciated with adRP. Thus, we were wondering whether some of
these mutations may lead to an impaired rhodopsin binding.
To address this issue, we analyzed whether some adRP-linked
mutations are localized in TM4 of peripherin-2, the domain
that we found to be crucial for binding to rhodopsin (cf.
Fig. 3A). Indeed, one adRP-associated mutation (p.G266D) (8)
was found in TM4 and was located in the transmembrane
region most proximal to the intradiskal portion of peripherin-2
(Fig. 5A). Consequently, we tested whether this mutation inter-
feres with the binding of peripherin-2 to rhodopsin. Using FRET
(Fig. 5B) and co-IP (Fig. 5C) experiments from HEK293 cells,
we demonstrate that the p.G266D mutant abolishes binding to
rod opsin. To further demonstrate the specificity of this
finding, we analyzed the effects of two additional peripherin-2
mutations on rhodopsin binding. Interestingly, the exchange of
the glycine residue at position 266 and glutamate at position
276 by the neutral amino acid alanine (p.G266A and p.E276A,
respectively) did not affect the binding to rhodopsin (Fig. 5B
and C). Importantly, the interaction of single peripherin-2
mutants with CNGB1a was not affected as shown by additional
co-IP experiments from HEK293 cells (Fig. 5D). This indicates
that the lack of binding of the p.G266D mutant most probably is
not due to its overall folding deficiency. Notably, for co-IP
experiments, we used membrane preparations, and in the re-
spective input controls, we could not observe any difference in
the membrane expression levels of the mutants compared with
the wild-type peripherin-2 (Fig. 5C and D, input controls),
which argues against the lack of the membrane expression or
transport deficits for any of the mutants analyzed.
DISCUSSION
In this study, we show that peripherin-2 forms a stable protein
complex with both rhodopsin and the rod CNG channel in rod
OS. Several lines of evidence support this conclusion. First, anti-
bodies specific for the rod CNGB1a subunit immunoprecipitated
rhodopsin from murine retinal lysates. Similarly, immunopreci-
pation with rhodopsin-specific antibodies pulled down
CNGB1a. In both sets of experiments, peripherin-2 was
Figure 1. CNGB1a, peripherin-2 and rhodopsin are assembled in a protein
complex in rod OS. (A) Retinal lysates of wild-type (WT) mice were immunopre-
cipitated with an anti-rhodopsin antibody (a-Rho) or a nonspecific control IgG
(a-IgG). Precipitated samples were analyzed in immunoblots (IB) using a-Rho
and antibodies directed against the CNGB1a subunit (a-B1a) and peripherin-2
(a-Prph2) as indicated. (B) Left, retinal lysates of WT and CNGB1-knockout
mice (B12/2) were immunoprecipitated with a-B1a and probed with a-Rho,
a-B1a and a-Prph2. Right, loading control containing 10% of the protein
lysate used for the co-IP in the left panel. (C) Immunoelectron microscopy
images of longitudinal (left) and transversal (right) sections of rod OS co-stained
with small-diameter immunogold particles coupled toa-B1a and large-diameter
particles coupled to a-Rho, respectively. Co-localization of large and small par-
ticles is marked by arrows. Scale bar, 100 nm.
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identified in the immunoprecipitated complex. Experiments in
HEK293 cells revealed that rhodopsin does not directly bind to
the CNG channel but rather requires peripherin-2 as a molecular
linker to form a complex with the channel. FRET experiments
strongly supported this ‘bridging’ function of peripherin-2.
Based on our confocal FRET measurements, the relative
binding affinity for the peripherin-2/rhodopsin interaction was
in the similar range as for the rhodopsin/rhodopsin homomer.
To the best of our knowledge, the absolute binding affinity of
rhodopsin homomers was not determined so far. However, in
our co-IP experiments, rhodopsin dimers and oligomers could
be detected even under stringent SDS–PAGE and reducing con-
ditions. Based on this, we expect the absolute binding affinity of
rhodopsin homomers to be rather high. These results indicate
that rhodopsin binds to peripherin-2 with a high affinity that is
comparable with that of the rhodopsin homomer. Our biochem-
ical and FRET experiments in isolated OSs strongly support the
presence of rhodopsin dimers and oligomers in the native tissue.
This is in line with recent studies providing strong evidence for
the existence of rhodopsin dimers and oligomers in the native
environment (9–11). In this study, we also identified the
molecular determinants required for the rhodopsin/peripherin-2
interaction. As the major portion of both proteins is residing in
the disk membrane of rod OS, it seems reasonable to assume
that the interaction occurs via the transmembrane helices. In
support of such a model, deletion of transmembrane domain 4
in peripherin-2 abolished binding to rhodopsin. Moreover, a
single glycine to aspartate exchange at the position 266 in the
TM4 of peripherin-2 that was previously reported in patients suf-
fering from adRP (8) resulted in loss of binding to rhodopsin.
Importantly, binding to CNGB1a was unaffected in the G266D
mutant suggesting that the pathophysiological impact of this mu-
tation relies on the impairment of the interaction with rhodopsin.
The functional role of intradiskal and intracellular domains
of peripherin-2 was examined in numerous studies (12).
However, to our best knowledge, only one study addressed the
role of a transmembrane domain of this protein showing that
the glutamate residue at position 276 in TM4 was crucial for
disk morphogenesis (13). Interestingly, the exchange of this
charged amino acid to alanine (E276A) did not affect the inter-
action with rhodopsin. Similarly, the G266A mutation also had
no effects on the peripherin-2/rhodopsin complex formation.
These results suggest that introduction of charged residues on
position 266 disrupts the binding of peripherin-2 to rhodopsin
Figure 2. Peripherin-2 binds to both rod apo-opsin and CNGB1a. (A) Lysates from HEK293 cells co-transfected with rod apo-opsin (rOps), CNGB1a (B1a) and
GFP-tagged CNGA1 (A1_GFP) were immunoprecipitated with a-Rho and probed with antibodies as indicated. (B) Co-IP from HEK293 cells co-expressing myc-
tagged Prph2, rOps and B1a as indicated. Immunoprecipitates were analyzed witha-myc,a-Rho anda-B1a antibodies. Single transfection of peripherin-2 served as
negative control for nonspecific binding to the beads (third lane from right). (C) FRET measurements from HEK293 cells co-transfected with different OS-specific
proteins to monitor homomeric and heteromeric protein–protein interactions. Fret ratios for the single FRET pairs are as follows: rOps/rOps, FR ¼ 3.03+0.14;
Prph2/Prph2, FR ¼ 2.84+0.17; rOps/Prph2, FR ¼ 2.45+0.13; Prph2/B1a, FR ¼ 2.30+0.33; Prph2/GARP2, FR ¼ 2.03+0.17; rOps/B1a, FR ¼ 1.29+
0.13. Numbers of independent measurements (n) are given in brackets.
5992 Human Molecular Genetics, 2014, Vol. 23, No. 22
 at U
niversitaetsbibliothek M
uenchen on D
ecem
ber 22, 2016
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
whereas neutral amino acids at the same position do not affect
this interaction. Taken together, our data point to a key role of
TM4 for the peripherin-2/rhodopsin interaction and suggest
that impaired binding to rhodopsin may contribute to the patho-
physiology of peripherin-2 mutations.
As is evident in Figure 5C and D, two bands for wild-type
peripherin-2 are detected in the inputs and co-IP experiments.
The upper band of peripherin-2 is most likely not a result of gly-
cosylation because our protein samples were deglycosylated
prior to the SDS–PAGE. Intriguingly, the relative intensities
of the two bands correlate with the number of negative charges
in TM4. In the G266D mutant that contains two negative
charges (E276 and D266), the upper band is stronger than the
lower band. In contrast, in G266A and wild type containing
one negative charge in TM4 (E276), the lower band is stronger
than the upper band. Finally, in the E276A mutant containing
no negative charge, only the lower band is visible. A potential
effect of charges on the conformation and relative mobility of
peripherin-2 would be in agreement with previous findings
showing that single mutants can lead to a differential electro-
phoretic mobility of the corresponding protein (14).
Finally, we used FRET and immunoelectron microscopy to
directly demonstrate that rhodopsin and CNGB1a are located
in close proximity in rod OS. Overall, our results are consistent
with the model shown in Figure 6. The novel aspect of this model
is that peripherin-2 by binding to both, rhodopsin and the CNG
channel, physically couples the most proximal protein of the
light transduction cascade (rhodopsin) with the most distal
protein (the CNG channel) in a narrow spatial microcompart-
ment encompassing the disk rims and the neighboring plasma
membrane. One could imagine two principal scenarios where
the supramolecular organization of these proteins might be
relevant. First, the complex could play a structural role in the for-
mation and maintenance of rod OS structure. Mutations in
peripherin-2 as well as in rhodopsin are associated with impaired
disk morphogenesis and stability resulting in shortened and
deteriorated rod OS (15–18). Structural impairments of OS are
also seen upon mutation of ROM1, another photoreceptor-
specific protein that binds to peripherin-2 (19), and in CNGB1a-
knockout mice lacking the peripherin-2-binding GARP domain
(20). Taken together, these findings imply that the integrity of the
rhodopsin/peripherin-2/ROM1/CNG channel complex is crucial
formorphogenesisand long-termstabilityof rodOS.Loss or func-
tional impairment of any of the constituents of the complex will
thus lead to more or less severe structural defects. In support to
a structural roleof the rhodopsin/peripherin-2 interaction, the add-
ition of rhodopsin to the reconstituted peripherin-2/ROM1
complex in lipid vesicles was recently reported to induce the
formation of disk rim-like structures in vitro (21).
Thesecond scenario refers to a functional role of the complex in
visual transduction. By binding to both, rhodopsin and the CNG
channel, peripherin-2 helps to generate a microcompartment in
Figure 3. FRET-based determination of the binding characteristics of the rod opsin/peripherin-2 interaction. (A) Left, schematic representation of peripherin-2 con-
structs used to determine the FRs shown in the right panel. Citrine was fused to either the N- or C-terminus of peripherin-2. Numbered black boxes (1–4) represent the
transmembrane domains of peripherin-2. Right, FR of the peripherin-2 constructs co-expressed with rOps-cerulean. Numbers of independent measurements (n) are
given in brackets. Fret ratios for the single FRET pairs are as follows: rOps/Prph2-citr, FR ¼ 2.45+0.13; rOps/Prph2_C1-citr, FR ¼ 2.19+0.23; rOps/
citr-Prph2_C2, FR ¼ 1.29+0.11; rOps/citr-Prph2, FR ¼ 2.73+0.15. (B) Representative confocal images of FRET channels (Donor, FRET, Acceptor and
Merge) of single HEK293 cells used for the calculation of the FRs are shown in C. Scale bar ¼ 3 mm. (C) Results of the confocal FRET imaging obtained from mea-
surements of plasma membrane-restricted regions of single cells (black squares). FR was plotted against the cerulean/citrine molar ratio (cer/citr MR) to obtain FRmax
and the binding curves.
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the rim disk region that could have evolved to optimize the sensi-
tivity and precision of light transduction. Recently, it was reported
that a substantial portion of the rod phosphodiesterase (PDE6) is
located at the disk rims of rod OS (22). GARP2 that was shown
to bind PDE6, peripherin-2, and the CNG channel subunits
(3,23,24) could serve as an adaptor protein that anchors PDE6
to the disk rim. Another study also reported a physical interaction
of PDE6 and the rod CNG channel (25). The proposed complex
would be exquisitely efficient because the distance between the
light harvesting rhodopsin, the guanosine monophosphate
(cGMP)-hydrolyzing PDE6 and the channel that translates
changes in cGMP in changes of the Na+/Ca2+ flux would be
extremely short. In contrast to rhodopsin, the CNG channel
and peripherin-2 were reported to be absent in the central
disk region (2,26,27). Consequently, in this region, rhodopsin
is physically uncoupled from the CNG channel. At the
moment, only one can speculate about the exact functional
role of the differential microcompartmentalization of rhodop-
sin in the central and peripheral part of the disks. Owing to
the shorter diffusion distance for cGMP, however, the disk
rim-associated complex is expected to operate at lower light in-
tensities and faster kinetics. Such an optimization could be im-
portant in rods, which are tailored to detect extremely low light
levels. In contrast, in the less light-sensitive cones, coupling of
the light sensor to the channel seems less important. In agree-
ment with this hypothesis, the cone CNG channel subunits
lack the GARP domain that is required for the interaction
with peripherin-2 (3,28,29).
MATERIALS AND METHODS
Animals
All procedures concerning animals were performed with permis-
sion of local authorities (Regierung von Oberbayern).
Molecular biology
Full-length CNGB1a, GARP2, peripherin-2 and rhodopsin were
PCR-amplified from mouse retinal cDNA and subcloned into the
pcDNA3.1Myc/His expression vector (Invitrogen). For FRET
measurements and for in vitro co-IP studies, the FRET-opti-
mized YFP and CFP derivatives citrine or cerulean (30–32)
were introduced N- or C-terminally to the respective constructs
by standard cloning procedures. Peripherin-2 deletion mutations
were obtained by site-directed mutagenesis (QuikChange Light-
ning Mutagenesis Kit, Agilent Technologies) and overlap PCR
techniques. All constructs amplified by PCR were completely
sequenced prior to use. For the FRET studies on rod OS, the
appropriate FRET constructs were subcloned to the previously
described single-stranded pAAV2.1 vector (33) containing a
human rhodopsin (hRHO) promoter.
Retina preparation and protein biochemistry
For in vivo co-IPs and for quantitative mass spectrometry,
freshly dissected retinas were homogenized in 1% Triton
X-100 solution under normal daylight illumination, which
Figure 4. FRET in isolated rod OS from WT mice injected with different rAAV constructs. (A) Schematic view of the constructs used for the rAAV-mediated trans-
duction of retinas from P14 C57/Bl6N WT mice. hRHO, human rhodopsin promoter. (B) Representative confocal images of retinal sections from mice expressing
rhodopsin-cerulean (left) and citrin-peripherin-2 (right). OS, outer segment; IS, inner segment; ONL, outer nuclear layer. (C) Bright-field images of an isolated
OS isolated from mouse retina. (D) Representative confocal image of a single OS used for FRET measurements and co-expressing rhodopsin-cerulean (donor)
and peripherin-2-citrin (acceptor), respectively. Scale bar ¼ 2 mm. (E) Results of the FRET measurements for different FRET pair combinations. Numbers of inde-
pendent measurements (n) are given in brackets. FRET ratios for the single FRET pairs are as follows: Rho/Rho, FR ¼ 2.14+0.09; Rho/citr-Prph2, FR ¼ 1.49+
0.09; Rho/Prph2-citr, FR ¼ 1.30+0.07; Rho/GARP2, FR ¼ 0.97+0.07.
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results in bleached rhodopsin. Subsequently, cell debris was
removed by 5000×g centrifugation for 15 min, and protein con-
centration of the supernatant was determined by Bradford. For
mass spectrometry, 50 ml of the magnetic beads (Dynabeadsw
Protein A, Invitrogen) were pre-incubated with 5 mg of the
CNGB1 antibody (34) in a total volume of 500 ml of PBS for
2 h at 48C. After the removal of PBS, the pre-coupled beads
were incubated over night at 48C with 500 mg of total retinal
protein per single reaction. Next steps were performed according
to manufacturer’s instructions. After the removal of magnetic
beads, the immunoaffinity purified proteins were analyzed via
LC MS/MS as described previously (35).
For in vivo co-IP experiments, anti-B1a, anti-rhodopsin
[mouse anti-Rho 1D4, Thermo Scientific) and anti-peripherin-2
(mouse anti-Prph2 2B7 (36)] antibodies were used followed by
the same protocol as described earlier for the mass spectrometry.
The anti-B1a antibody recognizes the distal C-terminus of the
rod-specific CNGB1a and the olfactory-specific CNGB1b
subunit (34). Immunopurified proteins were separated on a
6–12% SDS–PAGE gradient gel and proceeded for western
blotting. Antibodies were used in the following dilutions:
rabbit anti-B1a, 1 : 1000; mouse anti-Prph2, 1 : 1000; mouse
anti-Rho, 1 : 2000; mouse anti-myc, 1 : 2000 (Cell Signaling);
mouse anti-GFP (Clontech), 1 : 2000. In vitro co-IPs were
performed as described previously (23). Rod opsin signals
from untreated HEK293 protein lysates are detected as a smear
on western blot owing to an extensive rod opsin glycosylation.
Hence, prior to the sample loading to the SDS–PAGE gel, a
deglycosylation step was included using PNGase F (New
England Biolabs) according to the instructions of the manufac-
turer. For in vitro co-IPs with the anti-myc or anti-GFP antibody,
the mMACS GFP or myc-tagged beads were used (Miltenyi
Biotec). All steps were performed in accordance with the
manufacturer’s protocol.
Photometric FRET measurements
Digital FRET measurements were performed as described (37).
For confocal FRET measurements, HEK293 cells were grown in
5-cm cell culture dishes (Greiner bio-one) and transiently trans-
fected using the calcium phosphate method. After 24–48 h, the
cells were washed and maintained in buffer solution composed
of 140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 10 mM
glucose, 10 mM Na-HEPES, pH 7.4, at room temperature.
Figure 5. adRP-associated mutation in TM4 of peripherin-2 abolishes binding to rhodopsin. (A) Schematic view of the positions of the mutations in the TM4 of
peripherin-2 analyzed in B–C (black arrows). (B) FRET experiment from HEK293 cells co-transfected with rod opsin and peripherin-2 wild-type (WT) or
mutant constructs, respectively. FRET ratios for the single FRET pairs are as follows: Rho/G266D, FR ¼ 1.58+0.05; Rho/G266A, FR ¼ 1.98+0.09; Rho/
E276A, FR ¼ 2.14+0.14; Rho/WT, FR ¼ 2.26+0.08. (C) Co-IP from HEK293 cells co-expressing rhodopsin and GFP-tagged wild-type or mutant peripherin-2
constructs. (D) Co-IP from HEK293 cells co-expressing CNGB1a and GFP-tagged wild-type or mutant peripherin-2 constructs. All peripherin-2 constructs in C and D
were detected with the GFP-specific antibody (a-GFP).
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Cells were imaged using a Leica TCS SP8 confocal microscope
with a 20× water objective (1.0 numerical aperture). Excitation
of cerulean was performed with a 448-nm laser followed by
emission measurements between 483+ 16 nm. Citrine was
excited with a 514-nm laser beam, and emission was measured
between 542+ 17 nm. FRET images were obtained by
448-nm excitation and 542+ 17-nm emission. Cerulean,
FRET and citrine images were acquired simultaneously, and
all images were performed under the same laser intensity, photo-
multiplier gain and pinhole settings. The intensities of the signals
were subtracted from the background, and FRs were calculated
according to the three cube FRET equations described in (37).
Cell membrane was defined as region of interest, and images
of cells with over- or under-saturated cerulean or citrine
signals were omitted from further analysis. For the conversion
of fluorescence intensities obtained from measurements in
cells expressing separate cerulean- and citrine-labeled proteins
into molar cer/citr ratios, we used a correction factor, R ¼ 3
(37). To calculate FRmax and to obtain the binding curves, FRs
of the respective FRET pairs were plotted versus the cer/citr
ratios and fitted to a hyperbolic function: (P1 × X)/(P2 + X). X
is the FRET values of the single cells and P1 and P2 were calcu-
lated by 100 iterations for each FRET pair. P1 is the limiting
value of the function and equals FRmax. For the determination
of the relative binding affinity, the following equation was
used: (FRmaxPrph2/FRmaxrOps) × 100.
Statistics
All values are given as mean+SE, and n is the number of
animals or trials. Unless stated otherwise, an unpaired student’s
t-test was performed for the comparison between two groups.
Statistical significance is given as follows: ∗P , 0.05; ∗∗P ,
0.01; ∗∗∗P , 0.001. If multiple comparisons were made, signifi-
cance was tested by analysis of variance followed by Dunnett’s
test. For analysis of the LC MS/MS data, one-way ANOVA
was used.
Preparation of OSs
Single retinas were dissected and transferred to 200 ml of PBS.
The OSs were mechanically separated by mixing the solution
for 10–20 s on a standard shaking device. The solution was
spun for few seconds to remove cell debris. The supernatant con-
taining the OSs was transferred to cell culture dishes (ibiTreat,
ibidi, Martinsried, Germany). Prior to the FRET measurements,
the OSs were allowed to sediment for 15 min.
rAAV preparation and subretinal injections
The production of single-strand AAVs and the procedure of
subretinal injections were described previously (33). A total of
108–1010 rAAV particles were delivered by a single injection.
Immunoelectron microscopy
The preparation for immunoelectron microscopy was performed
as previously described (38). Labeled LRWhite ultrathin
sections were analyzed in a transmission electron microscope
(Tecnai 12 BioTwin; FEI, Eindhoven, The Netherlands).
Images were obtained with a charge-coupled device camera
(SIS Megaview3; Surface Imaging Systems), acquired by ana-
lySIS (Soft Imaging System) and processed with Adobe Photo-
shop CS. Antibodies used were as follows: anti-B1a, anti-Rho
and anti-Prph2 (PER5H2) (39).
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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Figure 6. Peripherin-2 couples the CNG channel to the phototransduction cascade in rod OS. (A) Simplified paradigm of protein–protein interactions in the disk rim
region of OS. Peripherin-2 simultaneously binds to its homolog ROM1, to CNGB1a and to rhodopsin. The soluble GARP2 undergoes multiple protein–protein inter-
actions with CNGB1a, CNGA1, phosphodiesterase (PDE6) and peripherin-2 as indicated by the dashed line. Gt, transducin. (B) Tentative model of the CNGB1a/
peripherin-2/rhodopsin complex. Note that the exact portion of rhodopsin that binds to TM4 of peripherin-2 is not known and is only tentatively assigned in this
cartoon.
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Abstract
Peripherin-2 is a glycomembrane protein exclusively expressed in the light-sensing compartments of rod and cone
photoreceptors designated as outer segments (OS). Mutations in peripherin-2 are associated with degenerative retinal
diseases either affecting rod or cone photoreceptors. While peripherin-2 has been extensively studied in rods, there is only
little information on its supramolecular organization and function in cones. Recently, we have demonstrated that
peripherin-2 interacts with the light detector rhodopsin in OS of rods. It remains unclear, however, if peripherin-2 also binds
to cone opsins. Here, using a combination of co-immunoprecipitation analyses, transmission electron microscopy (TEM)-
based immunolabeling experiments, and quantitative fluorescence resonance energy transfer (FRET) measurements in cone
OS of wild type mice, we demonstrate that peripherin-2 binds to both, S-opsin and M-opsin. However, FRET-based
quantification of the respective interactions indicated significantly less stringent binding of peripherin-2 to S-opsin
compared to its interaction with M-opsin. Subsequent TEM-studies also showed less co-localization of peripherin-2 and S-
opsin in cone OS compared to peripherin-2 and M-opsin. Furthermore, quantitative FRET analysis in acutely isolated cone OS
revealed that the cone degeneration-causing V268I mutation in peripherin-2 selectively reduced binding to M-opsin without
affecting the peripherin-2 interaction to S-opsin or rhodopsin. The differential binding of peripherin-2 to cone opsins and the
mutant-specific interference with the peripherin-2/M-opsin binding points to a novel role of peripherin-2 in cones and might
contribute to understanding the differential penetrance of certain peripherin-2 mutations in rods and cones. Finally, our
results provide a proof-of-principle for quantitative FRET measurements of protein-protein interactions in cone OS.
Introduction
Rod and cone photoreceptors are the light sensing cells of the
retina conferring dim and daylight/color vision, respectively.
The tetraspanin peripherin-2 (PRPH2) is a glycosylated mem-
brane protein localized in the light detecting compartments of
rods and cones referred to as outer segments (OS). Mutations in
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PRPH2 are among the leading causes of autosomal dominant
degenerative retinal disorders, which can either affect rod or
cone photoreceptors (1,2). PRPH2 mutations primarily affecting
the rods almost exclusively lead to autosomal dominant retini-
tis pigmentosa (adRP), a disease characterized by a progressive
rod degeneration. In contrast, PRPH2 mutations primarily af-
fecting the cones often result in adult vitelliform macular dys-
trophy (AVMD). Recently, we demonstrated that the differential
penetrance of PRPH2 mutations in rods and cones can partially
be explained by differential effects of the single mutations on
mRNA splicing in the affected photoreceptors (3). However,
some of the mutants did not exert an effect on mRNA splicing
suggesting additional disease mechanisms. In another study,
we identified the rod-specific light detecting G-protein coupled
receptor rhodopsin as a novel PRPH2 interacting protein in OS of
rods. In addition, we showed that the adRP-causing G266D mu-
tation in transmembrane domain 4 (TM4) of PRPH2 specifically
disrupted this binding (4). Other studies identified the soluble
variant of the glutamic acid-rich protein (GARP2), the GARP-
region containing rod cyclic nucleotide-gated (CNG) channel
B-subunit (CNGB1a), the PRPH2 homologue ROM-1 and melanor-
egulin as proteins interacting with PRPH2 in rods (5–7).
However, with the exception of ROM-1 (8,9), no additional
PRPH2 interacting proteins were found in cones.
Comprehensive analysis of protein-protein interactions in
cones has been hampered by technical limitations as cones ac-
count for a very small percentage of photoreceptors in mam-
mals (3%, (10)). Furthermore, compared with rods, OS of cones
are smaller in both, length and diameter (http://webvision.med.
utah.edu/book/part-v-phototransduction-in-rods-and-cones/
phototransduction-in-rods-and-cones/). Cone OS often contain
phototransduction proteins which are homologous to the mem-
bers of the rod phototransduction cascade. The rhodopsin ho-
mologous proteins in cones are referred to as cone opsins.
Cones of most mammals express two different types of opsins,
which differ in their light absorption spectra: the middle wave-
length absorbing M-opsin and the short wavelength absorbing
S-opsin (10). Based on the relatively low homology between rho-
dopsin and cone opsins, it is unclear whether PRPH2 binds to
cone opsins in vivo. Here, using different methodological
approaches including quantitative fluorescence resonance
energy transfer (FRET) measurements in transduced cone
OS, we provide evidence that PRPH2 binds to both, M-opsin and
S-opsin, albeit the binding to M-opsin was significantly stronger
throughout all experiments. We also show that the AVMD-
linked V268I mutant in TM4 of PRPH2 selectively attenuates
binding to M-opsin. These results provide novel insights into
the physiology and pathophysiology of PRPH2 in cones. Finally,
our study shows that FRET-based approaches are well suited to
quantitatively analyze protein-protein interactions in vivo in
small cellular compartments like cone OS.
Results
Co-immunoprecipitation analysis of the PRPH2/opsin
interaction in transiently transfected HEK293 cells
In an attempt to examine the interaction of PRPH2 with cone
opsins, we transiently co-expressed murine C-terminally
myc-tagged PRPH2 with murine C-terminally GFP-tagged M-
or S-opsin in HEK293 cells (Fig. 1A). Reciprocal co-immuno-
precipitations (co-IPs) on membrane preparations with either
a GFP- or myc-specific antibody revealed robust interaction of
PRPH2 with both opsins (Fig. 1B–E). Importantly, no interac-
tion was observed when co-expressing PRPH2 with C-termi-
nally GFP-tagged HCN2, (hyperpolarization-activated cyclic
nucleotide-gated cation channel, subunit 2), another unre-
lated transmembrane protein shown to be expressed in the
retina (Fig. 1F and G) (11).
Given the high structural homology of photoreceptor opsins,
it appeared reasonable to assume that cone disease-linked mu-
tations in TM4 of PRPH2 might also interfere with binding to
cone opsins. Screening of TM4-specific PRPH2 mutations identi-
fied one AVMD-associated mutant very close to the adRP-linked
G266D mutation. This mutation leads to a valine to isoleucine
exchange at position 268 (V268I, Fig. 2A). Cross-species align-
ment revealed a 100% conservation of this valine residue among
mammals and birds, whereas zebrafish and Xenopus laevis con-
tain methionine or leucine at this position (Fig. 2B). However,
isoleucine is not present at position 268 in any of the species.
Figure 1. Reciprocal co-IPs from transfected HEK293 cells indicate stable PRPH2/cone opsin interaction. (A) Scheme of the C-terminally myc-tagged WT PRPH2 (P-WT)
and C-terminally GFP-tagged M-opsin, S-opsin and HCN2 constructs used for the co-IPs shown in B–G. B–G, co-IPs using membrane preparations from HEK293 cells co-
transfected P-WT/S-opsin (B and C), P-WT/M-opsin (D and E), and P-WT/HCN2 (F and G) combinations and the single transfected respective controls. For co-IPs, myc (a-
myc, B, D and F) or GFP (a-GFP, C, E and G) specific antibodies were used. IB, immunoblotting; IP, immunoprecipitation.
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Given that the cone dominant symptoms of the V268I mutant in
affected individuals are caused by changes in binding to opsins,
we hypothesized that such changes should be restricted to cone
opsins and should not affect the PRPH2/rhodopsin interaction.
To test this assumption, we co-expressed wild type (WT) PRPH2
and the V268I mutant with chromophore-free S-opsin, M-opsin
and rod apo-opsin (herein referred to as rod opsin) in HEK293
cells and conducted another set of co-IP experiments. As ex-
pected, no differences in binding of WT and V268I mutant to
rod opsin could be detected (Fig. 2C). However, this mutation re-
vealed differential effects on the binding to cone opsins.
Interestingly, whereas the interaction of the V268I mutant to M-
opsin was significantly reduced, no significant changes could be
observed with respect to its binding to S-opsin. In addition to
these mutant-specific differences, we also detected differences
in the binding of WT PRPH2 to the single opsins. In this context,
the strongest binding was detectable for the PRPH2/rod opsin
interaction followed by the PRPH2/M-opsin and PRPH2/S-Opsin
interaction (Fig. 2C). Together, these results indicate that PRPH2
differentially binds to cone opsins and that the V268I mutant
specifically deteriorates the PRPH2/M-opsin binding.
FRET-based quantification of WT and V268I PRPH2/
opsin binding in transiently transfected HEK293 cells
To quantify the single interactions, we performed FRET mea-
surements of the respective PRPH2/opsin combinations in
transfected HEK293 cells. For this purpose, we used WT or mu-
tant PRPH2 constructs C-terminally tagged with cerulean and
C-terminally citrine-tagged opsins, respectively (Fig. 3A). The
single PRPH2 and opsin constructs were robustly expressed and
largely co-localized in HEK293 cells (Fig. 3B). Importantly, subse-
quent results of the FRET measurements in living HEK293 cells
nicely confirmed our observations obtained from co-IP experi-
ments. First, robust FRET signals, plotted as FRET ratios (FRs) (4),
could be measured for all WT PRPH2/opsin interactions (Fig. 3C).
Very similar to the co-IP results, the highest FR could be
detected for the PRPH2/rod opsin interaction (FR¼ 2.57 6 0.15)
and the lowest FR for the PRPH2/S-opsin FRET pair
(FR¼ 1.53 6 0.04). Second, compared to the WT PRPH2/M-opsin
FR (FR¼ 2.01 6 0.11), the V268I/M-opsin FR was significantly re-
duced (FR¼ 1.34 6 0.14). In contrast, no significant changes
could be obtained when comparing WT and V268I mutant with
regard to their binding to rod opsin or S-opsin (V268I/rod opsin,
FR¼ 2.54 6 0.18, V268I/S-opsin, FR¼ 1.13 6 0.10). Taken together,
FRET measurements from transfected HEK293 cells consistently
confirm the co-IP results showing differential effects of WT and
V268I mutant PRPH2 binding to rod or cone opsins.
In vivo co-IP and TEM studies of the PRPH2/opsin
interaction in cones
To analyze if cone opsins also interact with PRPH2 in vivo, we
conducted co-IPs from membrane preparations of 8-week old
WT mice using the PRPH2-specific antibody (Prph2 2B7, (12)).
This approach led to a robust enrichment of the M-opsin band
and to a faint, but detectable band for S-opsin (Fig. 4A). This re-
sult is compatible with our data from HEK293 cells suggesting
Figure 2. WT and V268I mutant differentially bind to cone opsins. (A) Schematic illustration of the mutant position in TM4 of PRPH2. (B) clustal cross-species sequence
alignment (Clustal Omega 1.2.1) of TM4 shows high conservation of the valine at position 268 among representative mammals and birds. In Xenopus laevis and
zebrafish, this position is occupied by methionine and leucine, respectively. (C) co-IPs using membrane preparations from HEK293 cells co-transfected with different
combinations of C-terminally myc-tagged WT or V268I PRPH2 mutant and C-terminally GFP-tagged cone opsins or untagged rod opsin as indicated. PRPH2 constructs
co-transfected with cone opsins were immunoprecipitated with a GFP antibody (left panel), those co-transfected with rod opsin were immunoprecipitated with a rho-
dopsin-specific antibody (a-Rho, Rho1D4). The IP showing the reduced binding of the V268I mutant to M-opsin is highlighted in a red dashed box.
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strong binding of PRPH2 to M-opsin and weaker binding to
S-opsin. To confirm this finding with another method, we per-
formed immunogold TEM-based staining on cone OS from 8-
week old WT mice using the same PRPH2, M-opsin and S-opsin
antibodies as for co-IPs (Fig. 4B). The specificity of each antibody
was tested on post-embedded sections of photoreceptor OS us-
ing single antibodies coupled to immunogold particles. In line
with previous studies, PRPH2 staining was almost exclusively
observed in the rim regions of photoreceptor OS
(Supplementary Material, Fig. S1A) (13,14). However, given the
fact that PRPH2 is expressed in rods and cones, this approach
does not allow to undoubtedly discriminate between the OS of
these two photoreceptor types. Moreover, the identification of
cone OS is strongly hampered by a very low number of this pho-
toreceptor type in the mammalian retina. Hence, to identify
cone OS among the photoreceptor OS, we performed immuno-
gold stainings using M-opsin and S-opsin antibodies. In contrast
to PRPH2, staining was restricted to few clearly shaped regions
in the OS layer most likely representing cones (Supplementary
Material, Fig. S1B and C). Having shown the specificity of the
single antibodies, we next set out to identify and quantify
PRPH2 and opsin co-localization in cone OS. To this end, we per-
formed co-labeling experiments using immunogold particles of
different size. Large particles were coupled to the PRPH2 anti-
body and small particles to M-opsin or S-opsin antibodies, re-
spectively. Importantly, using this approach we could observe
co-staining of PRPH2 with both opsin types (Fig. 4B). However,
quantitative analysis of PRPH2 co-localizing with cone opsins
revealed a co-labeling percentage of 49% 6 0.04% for PRPH2/M-
opsin, which was significantly higher than the percentage of
the PRPH2/S-opsin co-localization (29% 6 0.08%, Fig. 4C). Of
note, our TEM data suggest that PRPH2 is present on both,
opened and closed sites of the cone OS rims. This strongly indi-
cates that PRPH2 localization in mammalian cone OS is not
identical to that in Xenopus laevis, showing unilateral PRPH2 lo-
calization exclusively in the closed OS rims of cones (2,15).
Taken together, in vivo co-IP and TEM data strongly support the
results from HEK293 cells suggesting lower binding affinities for
the PRPH2/S-opsin interaction compared with the PRPH2/M-op-
sin binding.
Ciliary transport and mRNA splicing of the V268I
mutant in photoreceptors
The results from transfected HEK293 cells indicated that the V268I
mutation selectively deteriorates the binding of PRPH2 to M-opsin.
However, it is conceivable that the potential pathogenetic effects
of this mutation are different in vivo. Some PRPH2 mutations have
been shown to influence the transport of PRPH2 to the OS of rods
or cones (3,8,16). To analyze the effects of the V268I mutant on
protein transport, we expressed the mutant in rods and cones us-
ing recombinant adeno-associated virus (rAAV)-mediated gene
transfer. The rAAV particles containing the C-terminally cerulean-
tagged V268I mutant driven by rod- or cone-specific promoters
(human rhodopsin, hRHO and mouse short wavelength opsin,
mouse SWS (mSWS), respectively) were subretinally injected in 2-
week old WT mice. Three weeks post injection, retinas were dis-
sected and used for subsequent immunolabeling with the CNGB1a
antibody as marker for rod OS and M-opsin and S-opsin antibodies
as marker for cone OS, respectively. Importantly, the V268I mu-
tant fully co-localized with rod or cone OS markers indicating no
transport deficits for this mutant (Fig. 5A and B, Supplementary
Material, Fig. S2A).
Figure 3. FRET-based quantification of WT and V268I mutant interactions with rod opsin and cone opsins. (A) Scheme of PRPH2 and opsin constructs used to determine
the FRs shown in C. The FRET donor cerulean was C-terminally fused to WT or mutant PRPH2. The opsins were C-terminally fused to the FRET acceptor citrine. (B)
Representative live confocal images showing FRET channels (Donor, FRET, Acceptor and Merge) from HEK293 cells co-transfected with one combination of the PRPH2
and opsin constructs shown in A. Scale bar represents 3 mm. (C) FRET-based quantification of the single combinations as indicated. The mean values of the single mea-
surements are plotted as FRs with the number of independently measured cells for each construct given in brackets. Statistical analysis was performed using one way
ANOVA followed by the Tukey’s multiple comparison test. FRs and FRET efficiencies (EA) for the single FRET pairs are as follows: P-WT/S-opsin, FR¼1.53 6 0.04;
EA¼2.98% 6 0.08%; P-V268I/S-opsin, FR¼1.13 6 0.10; EA¼0.73% 6 0.06%; P-WT/M-opsin, FR¼2.01 6 0.11; EA¼5.69% 6 0.31%; P-V268I/M-opsin, FR¼1.34 6 0.14;
EA¼1.91% 6 0.20%; P-WT/rod opsin, FR¼2.57 6 0.15; EA¼8.84% 6 0.52%; P-V268I/rod opsin, FR¼2.54 6 0.18; EA¼8.67% 6 0.61%;. P-values between the single FRET com-
binations are as follows, P-WT/S-opsin and P-V268I/S-opsin, P¼0.0626; P-WT/M-opsin and P-V268I/M-opsin, P¼0.0002; P-WT/S-opsin and P-WT/M-opsin, P¼ 0.0106;
P-WT/rod opsin and P-V268I/rod opsin, P¼0.8786. *, P<0.05; **, P<0.01; ***, P<0.001. n.s., not significant.
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Recently, we demonstrated that the cone dominance of
some PRPH2 mutants goes along with their specific effects on
mRNA splicing. In this context, we provided evidence for three
different splice isoforms of PRPH2 to exist in rods and cones,
which include the unspliced, the intron 1 retention, and the cor-
rectly spliced variant. In particular, some of the mutants associ-
ated with cone diseases led to increased splice efficiencies of
the correctly spliced PRPH2 variant in cones, which represents
the only splice isoform translated into protein (3). To exclude
any effects of the V268I mutant on mRNA splicing, we per-
formed splicing analysis in cones of WT mice transduced with
the same PRPH2 minigenes under the same conditions as de-
scribed (3). The analysis of mRNA splicing of all three PRPH2 iso-
forms revealed no changes between the V268I mutant and its
WT counterpart (Supplementary Material, Fig. S3A–D). Taken to-
gether, we could exclude effects of the V268I mutation on
Figure 4. In vivo co-IP and TEM images of cone OS co-immunolabeled with PRPH2 and cone opsin antibodies. (A) co-IPs using membrane preparations from isolated ret-
inas of light-adapted 8-week old C57/BL6J WT mice. Immunoprecipitation was conducted with the PRPH2-specific antibody (a-Prph2, Prph2 2B7). Control co-IP was per-
formed with IgGs (a-IgG). (B) Representative TEM images of post-embedded longitudinal cone OS sections from 8-week old light-adapted WT mice co-labeled with large
diameter gold particles coupled to the PRPH2 antibody and small diameter gold particles coupled to M-opsin (a-M-opsin) or S-opsin (a-S-opsin) specific antibody, re-
spectively. The specificity of the antibodies was proven in Supplementary Material, Figure S1 showing TEM images of photoreceptor OS labeled with the single antibod-
ies. White arrows indicate co-localization of large and small gold particles. Scale bar¼100 nm. (C) quantification of the PRPH2/cone opsin co-localization. Shown are
the co-localization percentages of PRPH2/S-opsin and PRPH2/M-opsin gold particles originating from 6 (PRPH2/S-opsin) or 11 (PRPH2/M-opsin) different cone OS. The
total number of gold particles counted was 58 for PRPH2/S-opsin and 178 for PRPH2/M-opsin, respectively. Statistical analysis was done with the unpaired Student’s
t-test, P¼0.0195.
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protein transport and mRNA splicing suggesting other disease
mechanisms for this mutant.
FRET measurements of WT and V268I PRPH2/opsin
interactions in murine photoreceptors
In our previous study, we demonstrated that quantitative FRET
can in principle be used for analysis of protein-protein interac-
tions in acutely isolated rod OS (4). Given the very low percent-
age of cones (3%) and the smaller size of cone OS in the
mammalian retina, it is unclear whether FRET measurements
are also suitable for detection and quantification of protein-
protein interactions in cone OS. Hence, we set out to establish
FRET-based analysis of protein-protein interactions in isolated
cone OS. To this end, we transduced cones with the same
PRPH2/cone opsin FRET combinations as shown in Figure 3A us-
ing the rAAV-mediated gene transfer. All PRPH2/cone opsin
FRET constructs were driven by the mSWS promoter. To analyze
the effects of the V268I mutant on rhodopsin binding in rod OS,
the respective WT and V268I FRET constructs were virally trans-
duced to rods using the hRHO promoter. The titer-matched
rAAV particles (1010 particles/injection) containing the FRET
pairs were subretinally injected in 2-week old WT mice. Four
weeks post injection, the OS of four pooled retinas for each
FRET pair were isolated with the self-designed quick protocol as
Figure 5. Expression of the V268I mutant in murine cones and FRET-based quantification of WT and V268I mutant interactions in isolated cone OS. (A and B)
Representative confocal images of co-immunolabeled retinal sections from subretinally rAAV-injected C57/BL6J WT mice expressing C-terminally cerulean-tagged
V268I mutant (V268I_cer) under the control of the mSWS promoter. Immunolabeling was performed on retinal cryosections of light-adapted animals 3 weeks post in-
jection using M-opsin (A) or S-opsin (B) antibodies described in Figure 4. The expression of the mutant was visualized by cerulean fluorescence. OS, outer segment. IS,
inner segment. ONL, outer nuclear layer. Scale bar¼5 mm. C, Representative confocal FRET channel images from isolated cone OS of rAAV-injected C57/BL6J WT mice
co-expressing one combination of the FRET constructs described in Figure 3A under the control of the mSWS promoter. Scale bar¼1 mm. D, FRET-based quantification
of the single combinations as indicated. The mean values of the single measurements are plotted as FRs with the number of independently measured cone OS for each
combination given in brackets. Statistical analysis was performed using one way ANOVA followed by the Tukey’s multiple comparison test. FRs and FRET efficiencies
for the single FRET pairs are as follows: P-WT/S-opsin, FR¼2.17 6 0.15; EA¼6.59% 6 0.46%; P-V268I/S-opsin, FR¼1.59 6 0.10; EA¼3.32% 6 0.21%; P-WT/M-opsin,
FR¼3.31 6 0.37; EA¼13.01% 6 1.45%; P-V268I/M-opsin, FR¼1.74 6 0.16; EA¼4.12% 6 0.38%; P-WT/rod opsin, FR¼1.46 6 0.16; EA¼2.59% 6 0.28%; P-V268I/rod opsin,
FR¼1.48 6 0.18; EA¼ 2.70% 6 0.33%. P-values between the single FRET combinations are as follows, P-WT/S-opsin and P-V268I/S-opsin, P¼0.4263; P-WT/M-opsin and
P-V268I/M-opsin, P¼ 0.0001; P-WT/S-opsin and P-WT/M-opsin, P¼0.0126; P-WT/rod opsin and P-V268I/rod opsin, P¼0.9323. *, P<0.05; **, P<0.01; ***, P<0.001. n.s., not
significant.
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described (4). Importantly, to ensure for comparability, FRET
measurements of all constructs were conducted on the same
day under the same conditions. The FRET approach addressing
the PRPH2 WT or V268I/rhodopsin interaction in rods
(Supplementary Material, Fig. S2B) led to a large number of la-
beled rod OS showing high co-expresssion rates of citrine and
cerulean fluorophores up to 90%. Similar co-transduction rates
in rods were observed in our recent study (4). As expected, in ex-
periments addressing PRPH2 WT or V268I/cone opsin interac-
tion, the vast majority of the isolated OS originated from rods
and did not show any fluorescence (data not shown).
Occasionally, we observed citrine or cerulean fluorescence in
small-sized OS-like structures most likely representing the OS
of cones (Fig. 5C). In contrast to rods, the percentage of cone OS
co-expressing both FRET fluorophores was markedly lower (up
to 30%). Despite the lower co-transduction efficiency of the
FRET fluorophores, this approach led to the identification of a
sufficient number of cone OS, enabling a comparative and quan-
titative analysis of the single protein-protein interactions.
Overall, the resulting FRET measurements from isolated OS are
largely comparable to those obtained from the HEK293 cells
(Fig. 5D). First, for WT PRPH2, a robust FRET signal could be ob-
tained with both M-opsin and S-opsin indicating that these pro-
teins indeed interact in vivo. Quantitatively, however, the FR of
PRPH2/M-opsin (FR¼ 3.31 6 0.37) was significantly higher than
that of the PRPH2/S-opsin (FR¼ 2.17 6 0.15) FRET pair. Second,
the FR of the V268I PRPH2/M-opsin (FR¼ 1.73 6 0.16) was signifi-
cantly attenuated compared with the FR of WT PRPH2/M-opsin.
By trend, but not significantly, a reduction of the FR was also ob-
served for the V268I PRPH2/S-opsin FRET pair (FR¼ 1.59 6 0.10).
Third, in rod OS, no significant differences could be measured
when comparing the FRs between the WT PRPH2/rhodopsin
(FR¼ 1.46 6 0.16) and the V268I PRPH2/rhodopsin FRET pairs
(FR¼ 1.48 6 0.18). Notably, compared to the FRET results from
HEK293 cells, the FRs were consistently higher for PRPH2/cone
opsin interaction, and consistently lower for the PRPH2/rhodop-
sin FRET pair. The latter finding is in line with the results from
our previous study (4). The consistently higher FRs for the
PRPH2/cone opsin binding in vivo (in particular that for the
PRPH2/M-opsin FRET pair) indicate that these interactions could
have strong physiological relevance.
Discussion
In this study, we provide evidence for a stable interaction be-
tween PRPH2 and cone opsins. This finding is supported by sev-
eral methodological approaches in living HEK293 cells and in
cone OS. Consistently, co-IPs and quantitative FRET measure-
ments in transiently transfected HEK293 cells and in cone OS
suggested more stringent binding of PRPH2 to M-opsin in com-
parison to the PRPH2/S-opsin interaction. This was confirmed
by TEM-studies on WT murine cone OS showing a significantly
higher percentage of co-localization for PRPH2 and M-opsin
when compared to PRPH2 and S-opsin. Overall, these findings
are consistent with the model shown in Figure 6. The physiolog-
ical importance of this differential interaction of PRPH2 with
cone opsins remains unclear. Most cones express both opsin
types, however, some of them contain either S- or M-opsin (10).
Interestingly, S-opsin and M-opsin expressing cones are un-
equally distributed in the retina with M-opsin expressing cones
(referred to as M-cones) being preferentially found in the dorsal
part and S-opsin expressing cones (also known as S-cones) be-
ing present predominantly in the ventral part of the retina (10).
It remains to be clarified if the differential binding of PRPH2 to
cone opsins is related to the dorso-ventral gradient of M- or
S-cones. In a recent study, it was shown that M-opsin and S-
Opsin are mislocalized throughout the cone photoreceptor of a
cone-dominant mouse model expressing a PRPH2 mutant that
exhibits localization deficits (C150S) (8). Similar effects on pro-
tein localization were not reported for rhodopsin. One possible
explanation for these observations is that the PRPH2/cone opsin
interaction is specifically required for the concurrent transport
of these proteins to the cone OS. The potential relevance of the
PRPH2/M-opsin interaction in cone OS is supported by the fact
that the V268I AVMD-linked mutant in TM4 of PRPH2 selectively
attenuates the binding of PRPH2 to M-opsin without affecting
other possible disease-causing parameters like protein localiza-
tion or mRNA splicing. Interestingly, this mutant did not signifi-
cantly alter the binding to rhodopsin or S-opsin. Given the same
evolutionary origin and the resulting structural homology of
photoreceptor opsins, it is not surprising that their binding to
PRPH2 is mediated by the same domain. However, even though
the V268I mutant is in very close proximity to the G266D muta-
tion, only the latter interferes with the PRPH2/rhodopsin inter-
action. This finding implies that different molecular
determinants within the same domain have evolved to ensure
for the specificity of the PRPH2 binding to rhodopsin or cone op-
sins. The V268I mutant is associated with AVMD, a disease
characterized by late onset degeneration of cones. In contrast to
the adRP-linked G266D mutation, which almost completely
abolishes binding of PRPH2 to rhodopsin (4), the V268I mutation
results only in a moderate attenuation of its binding to M-opsin
indicating that a portion of M-opsin still is able to form protein
complexes with PRPH2. This finding is consistent with the mild
and late-onset symptoms reported in AVMD patients carrying
the V268I mutation (17). Transgenic mice expressing different
PRPH2 mutations have been proven as a valid model to analyze
the structural and functional importance of PRPH2 in rods and
cones (9,18–21). The exact course of retinal degeneration caused
by the V268I mutation requires the generation of appropriate
transgenic mouse models and is beyond the scope of this study.
Comparative analysis of FRs from HEK293 cells and rod or
cone OS revealed an inverse correlation between the PRPH2/
rhodopsin and PRPH2/cone opsin interaction. Although the
PRPH2/cone opsin FRs were higher in cone OS compared with
HEK293 cells, the opposite was the case for the PRPH2/rhodop-
sin FRET pairs. The latter finding is in line with the results from
our previous study (4). These differences in FRET between
HEK293 cells and photoreceptor OS might be explained by the
specific molecular composition of rod and cone OS. First, in our
recent study using reverse transcriptase-polymerase chain re-
action (RT-PCR) from fluorescence-activated cell (FAC)-sorted
native rods, we demonstrated that the relative rhodopsin/
PRPH2 mRNA expression is 9:1 (3). Given the overwhelming
evidence showing that rhodopsin forms dimers and high-order
oligomers in rod OS (4,22,23) most of the labeled rhodopsin mol-
ecules used for FRET in our study most probably do not bind to
PRPH2, but rather are assembled to rhodopsin di- and oligo-
mers, leading to an overall reduction of the FRET signal. In con-
trast, RT-PCR from FAC-sorted native cones revealed that the
mRNA expression levels for PRPH2 and cone opsins are very
similar (3,24). This more or less balanced PRPH2/cone opsin
mRNA expression is expected to result in similar PRPH2 and
cone opsin protein levels and might explain the higher FRs for
the PRPH2/cone opsin interaction in isolated cone OS when
compared with the PRPH2/rhodopsin interaction in rod OS.
Second, several studies have shown that PRPH2 interacts with
the rod CNG channel B-subunit CNGB1a in the disc rim regions
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of rod OS (4,7,25). In contrast, PRPH2 does not bind to the
CNGB1a homologous CNG B-subunit in cones (CNGB3) that lacks
the N-terminal GARP domain (26). Based on this, it is tempting
to speculate that PRPH2 is spatially less flexible in rods than in
cones, thus allowing only a small portion of rhodopsin mole-
cules to interact. Similar molecular constraints are not expected
to occur in transiently transfected HEK293 cells, which are not
known to express any of the OS-specific proteins analyzed
herein. This might explain the higher FRs for the PRPH2/rhodop-
sin interaction obtained in these cells. Rods and cones show re-
markable differences with respect to their light sensitivity or
light response and adaptation kinetics. So far, the molecular de-
terminants of the functional differences between these two cell
types are not fully understood (27). This raises the option that
the PRPH2/opsin interaction may also partially contribute to
shaping the typical physiological features of cones.
Conclusively, using different methodological approaches, this
study identified cone opsins as novel interaction partners of
PRPH2 in cone OS suggesting a novel physiological role of PRPH2
in these cells. In addition, the selective reduction of the PRPH2/
M-opsin binding observed for the AVMD-linked, TM4-specific
V268I mutant might contribute to explain the differential pene-
trance of some PRPH2 point mutations in rods and cones.
Materials and Methods
Animals
All procedures concerning animals were performed with per-
mission of local authorities (Regierung von Oberbayern).
Anesthesia was performed by subcutaneous injection of keta-
mine (40 mg/kg body weight) and xylazine (20 mg/kg body
weight). Euthanasia was performed by cervical dislocation.
Molecular biology
Full-length sequences for M-opsin and S-opsin were RT-PCR
amplified from mouse retinal cDNA and subcloned into the
pcDNA3.1 expression vector (Invitrogen). For FRET measure-
ments and for in vitro co-IP studies, GFP and the FRET optimized
YFP and CFP derivatives citrine or cerulean (28–30) were C-ter-
minally introduced to the respective constructs by standard
cloning procedures. PRPH2 and rhodopsin FRET constructs were
previously described (4). PRPH2 V268I mutation was obtained by
site directed mutagenesis (QuikChange Lightning Mutagenesis
Kit, Agilent Technologies). For mRNA splicing analysis, WT and
V268I mutant PRPH2 minigene constructs were cloned as previ-
ously described (3). All constructs amplified by PCR were com-
pletely sequenced prior to use. For the FRET studies on rod or
cone OS and the mRNA splicing analysis in cones, the respective
FRET or PRPH2 minigene constructs were subcloned to the pre-
viously described single stranded pAAV2.1 vector (pAAV2/8 YF,
(31)) containing a hRHO or mSWS promoter.
Protein biochemistry
For co-IPs in transiently transfected HEK293 cells (calcium phos-
phate transfection), cells were harvested 48 h post transfec-
tion and membrane preparations were conducted as described
(32). co-IPs were performed with the anti-myc (9B11, Cell
Signaling), anti-GFP (JL-8, Clontech) or anti-Rhodopsin (Rho1D4,
ThermoScientific) antibody using Protein A or Protein G mag-
netic beads (novex by life technologies). All steps were per-
formed in accordance to the manufacturer’s protocol. Rod and
cone opsin signals from untreated HEK293 membrane prepara-
tions are detected as a smear on western blot due to an exten-
sive opsin glycosylation. Hence, prior to the sample loading to
the SDS–PAGE gel, a deglycosylation step was included using
PNGase F (New England Biolabs) according to the instructions of
the manufacturer.
For in vivo co-IPs, freshly dissected retinas of light adapted
WT C57 BL/6J animals were homogenized in membrane prepa-
ration buffer using the Potter S homogenizer (B. Braun).
Subsequently, membrane preparations were performed fol-
lowed by co-IPs using the anti- PRPH2 (mouse anti-Prph2 2B7,
Figure 6. PRPH2 differentially interacts with M-opsin and S-opsin in cone OS. (A and B) Simplified paradigm of PRPH2 protein-protein interactions in the cone OS based
on the results of this and previous studies. (A) In lamellar rim regions of S-opsin expressing cones (S-cones), PRPH2 presumably simultaneously binds to its homolog
ROM-1 and to S-opsin. However, a large portion of the PRPH2/ROM-1 complexes probably remains unbound to S-opsin. (B) In lamellar rim regions of M-opsin expressing
cones (M-cones), larger portions of the PRPH2/ROM-1 complexes are expected to be bound to M-opsin. Similar to S-opsin, M-opsin molecules outside of the rim regions
are very likely not bound to PRPH2 complexes.
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(12)) antibody. The membrane preparation and co-IP protocols
were identical to those described above for the HEK293 cells.
For immunoblotting, antibodies were used in following dilu-
tions: mouse anti-Prph2, 1:1000; mouse anti-Rho, 1:2000; mouse
anti-myc 1:2000; mouse anti-GFP, 1:2000.
Photometric FRET measurements
FRET measurements were performed as described (33). In short,
HEK293 cells were transiently transfected using the calcium
phosphate method. Twenty four to 48 h post-transfection, the
cells were washed and maintained in buffer solution composed
of 140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 10 mM glu-
cose, 10 mM Na-HEPES, pH 7.4, at room temperature (RT).
Isolated rod and cone OS were maintained in the same buffer
solution at RT for 20 min to let the OS attach to the dish.
Fluorescence intensities of cerulean and citrine were recorded
using a Leica DMI6000B inverted epifluorescence microscope
and a 914 photomultiplier detection system (PTI, Canada).
Excitation was performed at 436 6 2.5 nm or 500 6 2.5 nm with a
DeltaRam monochromator (Horiba, Canada) and emission was
detected by a photomultiplier (PMT 914) and acquired on a per-
sonal computer using FelixGX software (Horiba, Canada). Three
Cube FRET filter cubes were as follows (excitation, longpass
beamsplitter, emission): CFP/cerulean (ET436/20; T455lp;
ET480/40m), YFP/citrine (ET500/20; T515lp; ET535/30m) and
FRET (ET436/20; T455lp; ET535/30m) (Chroma technology). The
fluorescence intensities (S) were measured in individual cells
co-expressing cerulean-and citrine-tagged proteins with the re-
spective filter cube (excitation, emission): SFRET (436 6 10 nm,
535 6 15 nm), Scerulean (436 6 10 nm, 480 6 20 nm) and Scitrine
(500 6 10 nm, 535 6 15 nm). The intensities of the signals were
subtracted from the background and FRs were calculated ac-
cording to the three cube FRET equation described in (33). FRET
efficiencies (EA) can be calculated from FRs using the following
equation:
EA ¼ FR 1½  
ecitrineð436Þ
eceruleanð436Þ
ecitrine and ecerulean are the setup specific average molar extinc-
tion coefficients for citrine and cerulean, respectively, over the
precise bandwidth of the FRET cube excitation filter. In
our setup, the calculated molecular extinction coefficient ratio
is ecitrine (436)/ecerulean (436)¼ 0.0563. FRET data were analyzed
using FelixGX (Horiba PTI, Canada) and Microsoft Excel
(Microsoft).
Preparation of OS
Preparation of rod OS was conducted as described (4). Cone OS
were isolated using the same protocol.
rAAV preparation and subretinal injections
The production of single-strand AAVs (rAAV 2/8 YF) containing
either the hRHO or mSWS promoter and the procedure of subre-
tinal injections were described previously (31). 1010 rAAV parti-
cles were delivered by a single injection on postnatal day 14.
Three weeks post injection, all injected retinas were analyzed
for the fluorescence using scanning laser ophthalmoscopy
(Spectralis, Heidelberg Eye Instruments).
Immunohistology
For immunohistology, WT C57 BL/6J mice were injected on P14
with the respective rAAV particles. Three weeks post injection,
the retinas were dissected and processed for immunohistology
as described (34). We used the rabbit anti-CNGB1a (1:2000, (35)),
rabbit anti-M-opsin (1:300, EMD Millipore) or rabbit S-opsin
(1:300, EMD Millipore) antibody as marker for rod and cone OS,
respectively. Retinal images were obtained by the TCS SP8 con-
focal scan microscope (Leica), acquired with the LASAF software
(Leica) and processed with the ImageJ software (National
Institutes of Health).
Post-embedding immunoelectron microscopy
The isolated retinae were fixed in 0.1% glutaraldehyde and 4%
paraformaldehyde for 3 h at RT and processed further as de-
scribed previously (36). After dehydration and embedding in LR
White Resin (Plano, Agar Scientific), retinas were briefly poly-
merized at 4 C under indirect ultraviolet light (350 nm) for 48–
60 h. After being sectioned on an ultramicrotome (Reichert
Ultracut E), retina sections (60–70 nm) were collected on
Pioloform coated nickel grids and etched with saturated sodium
periodate solution (Sigma-Aldrich) at RT for 3–5 min. Following
pre-incubation in 0.1% Tween 20 (Sigma-Aldrich), the sections
were blocked in 50 mM NH4Cl (Sigma-Aldrich) and blocking solu-
tion (0.5% cold-water fish gelatine and 0.1% ovalbumin, both
Sigma-Aldrich). After incubating the retina in primary antibod-
ies (4 C, 60 h), the sections were washed once with PBS and
twice in IgG-gold buffer (blocking solution including 0.01%
Tween 20, 0.5 M NaCl) and incubated for 2 h with corresponding
Fab-conjugated nanogold antibodies prepared with gold parti-
cles (Science Services, Aurion; diluted in IgG-gold buffer).
Post-fixation in 1% glutaraldehyde for 10 min and air-drying
was followed by silver intensification as described (37). All pri-
mary antibodies used for post-embedding (anti-Per 2B7, anti-M-
opsin and anti-s-opsin) were described above.
Image preparation
Post-embedded immunoelectron sections were stained with
uranylacetate and lead citrate (Leica). Ultrathin sections were
examined and photographed by using a Zeiss EM10 electron mi-
croscope (Zeiss) and a Gatan SC1000 OriusTM CCD camera
(Gatan) in combination with DigitalMicrographTM software
(Gatan). Representative images were chosen based on the in-
spection of several hundred slices from independent experi-
ments. Micrographs were adjusted for contrast and brightness
by using Adobe Photoshop CS6 (Adobe Systems).
mRNA splicing analysis in cones
Splicing analysis of PRPH2 minigenes was performed as described
(3). Briefly, WT C57 BL/6J mice were injected on P14 using respec-
tive WT or V268I PRPH2 minigenes. Three weeks post injection,
the retina fluorescence was confirmed by fundus photography
(see above). Subsequently, four of the dissected fluorescent ret-
inas for each PRPH2 minigene were pooled and used for RNA iso-
lation with the RNeasy Mini Kit (Qiagen) according to the
instructions of the manufacturer. Equal concentrations (1 mg) of
the isolated total RNA from each sample were applied for the sub-
sequent cDNA synthesis (Revert Aid First Strand cDNA Sythesis
Kit, Life Technologies). All experiments were performed on the
same day under the same conditions. For semi-quantitative
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analysis of the single PRPH2 minigenes, three RT-PCR reactions
were conducted with variable number of cycles ranging between
30 and 33 cycles. The absolute intensities of the single splice
bands were determined using the Image Lab software (BioRad).
Statistics
All values are given as mean 6 SEM, and n is the number of tri-
als. Unless stated otherwise, an unpaired Student’s t-test was
performed for the comparison between two groups. Statistical
significance is given as follows: *, P< 0.05; **, P< 0.01; ***,
P< 0.001. If multiple comparisons were made, significance was
tested by analysis of variance (one way ANOVA) followed by the
Tukey’s multiple comparison test.
Supplementary material
Supplementary Material is available at HMG online.
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Suppl. Fig. 1 Immunogold TEM labeling of photoreceptor OS confirms the specificity of 
peripherin-2 and cone opsin antibodies. A-C, Representative TEM images of post-
embedded rod and cone OS sections from 8-week old light-adapted C57/BL6J WT mice 
labeled with gold particles coupled to peripherin-2 (A), M-opsin (B), or S-opsin (A) specific 
antibodies. Note that the concentrations for S-opsin and M-opsin antibodies were higher than 
those used for co-labeling experiments shown in Fig. 2, resulting in stronger staining of cone 
OS. However, even under these high concentrations of M-opsin and S-opsin antibodies, no 
staining of rod OS was detectable, demonstrating the specificity of the respective antibodies. 
 
 
 
Suppl. Fig. 2 Immunolabeling of the V268I mutant in murine rods and confocal images 
of FRET channels in isolated rod OS. A, Co-immunolabeling of retinal sections from WT 
mice subretinally injected with rAAV particles containing C-terminally cerulean-tagged 
V268I mutant (V268I_cer) under the control of the human rhodopsin (hRHO) promoter. 
CNGB1a antibody (B1a) was used as marker for rod OS. Scale bar = 10 µm. B, 
Representative confocal FRET channel images from isolated rod OS of WT mice co-injected 
with rAAV particles containing the P-V268I_cer/Rhodopsin_citr FRET pair as described in 
Fig. 3A under the control of the hRHO promoter. Scale bar = 1 µm. 
 
 
 
 
 
 
 
 
Suppl. Fig. 3 mRNA splicing of the V268I mutant in cones. A, Representative RT-PCR 
from retinal cDNA generated from total RNA of WT animals injected on P14 with rAAV 
PRPH2 minigene constructs harboring the mSWS promoter. The respective minigenes, RT-
PCR primers, and detailed experimental conditions were recently described (1). Ctrl, control 
containing the cDNA from non-transduced retina. The single bands of the relevant splice 
products are highlighted by arrows: i) unspliced, ii) intron 1 retention, and iii) correctly 
spliced, respectively. (B-D) Semi-quantitative analysis of the relative signal intensity 
percentages of the unspliced (B), intron 1 retention (C), and correctly spliced (D) PRPH2 
transcripts. For both, WT and V268I peripherin-2 minigenes, the mean percentage of the 
intensities of these three splice variants relative to the total intensity (given as sum of the 
single intensities) was calculated from five RT-PCR analyses. Significance was calculated 
using the unpaired student’s t-test. P-values are as follows: unspliced, p = 0.2075; intron 1 
retention, p = 0.1332; correctly spliced, p = 0.8654. 
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Fluorescence resonance energy transfer (FRET) is a powerful method for the
detection and quantification of stationary and dynamic protein-protein interactions.
Technical limitations have hampered systematic in vivo FRET experiments to study
protein-protein interactions in their native environment. Here, we describe a rapid and
robust protocol that combines adeno-associated virus (AAV) vector-mediated in vivo
delivery of genetically encoded FRET partners with ex vivo FRET measurements. The
method was established on acutely isolated outer segments of murine rod and cone
photoreceptors and relies on the high co-transduction efficiency of retinal photoreceptors
by co-delivered AAV vectors. The procedure can be used for the systematic analysis of
protein-protein interactions of wild type or mutant outer segment proteins in their native
environment. Conclusively, our protocol can help to characterize the physiological and
pathophysiological relevance of photoreceptor specific proteins and, in principle, should
also be transferable to other cell types.
Keywords: fluorescence resonance energy transfer, FRET, adeno-associated viral vectors, AAV, protein-protein
interaction, photoreceptor, outer segment
INTRODUCTION
The outer segments (OS) of rod and cone photoreceptors are highly specialized cilia harboring all
proteins involved in light-induced phototransduction (Arshavsky and Burns, 2012). Mutations in
genes encoding these proteins lead to untreatable diseases that severely impair rod and/or cone
structure and/or functionality (Berger et al., 2010). The majority of these genes encode proteins
that are organized in large macromolecular complexes assembled by networks of homomeric
and/or heteromeric protein-protein interactions (Roepman and Wolfrum, 2007). To decipher
pathomechanisms underlying the retinal disorders and to develop appropriate treatments, the
identification and characterization of these networks is inevitable. So far, the vast majority of OS
protein-protein interaction studies in photoreceptors were performed using classical biochemical
techniques (Goldberg et al., 1995; Loewen and Molday, 2000; Poetsch et al., 2001; Jastrzebska et al.,
2004; Michalakis et al., 2011; Knepp et al., 2012). However, the biochemical techniques have several
limitations: (i) They strongly rely on the availability of antibodies with high affinity and specificity,
(ii) they do not necessarily reflect “true” interactions since, due to the tissue homogenization, some
Becirovic et al. AAVs for FRET in Photoreceptors
proteins may randomly interact even though they are spatially
separated in vivo, (iii) they do not allow for dynamic
measurements, and (iv) exact quantification of interactions is
rather difficult as many different technical parameters which
might influence the interaction must be controlled rigorously.
With regard to these obstacles, FRET is superior to the
biochemical approaches. One important constraint of FRET is
the fact that it requires the co-expression of the fluorescently
tagged molecules in a given cell type. This can be easily
handled in heterologous expression systems, however, in complex
organisms like mammals the application of FRET has been
hampered by the laborious and time consuming generation of
transgenic animals. Therefore, only a few FRET-based studies
were performed in vivo, most of them using FRET biosensors for
analysis of spatiotemporal dynamics of small signaling molecules
(Hovan et al., 2010; Hirata et al., 2012; Wen et al., 2013;
Kumagai et al., 2014). Here, we describe a protocol for systematic
monitoring of protein-protein interactions without the necessity
of generating transgenic animals. The technique utilizes adeno-
associated virus (AAV) vectors that are valuable tools for in vivo
gene transfer into brain and retinal neurons (Schön et al.,
2013; Murlidharan et al., 2014; Trapani et al., 2014; Zacchigna
et al., 2014). AAVs lead to long-term ectopic expression of the
transgene in mammals and thus can be used as a rapid alternative
to the generation of transgenic animals. We have already used
AAV mediated viral gene expression in retinal neurons in our
previous studies (Becirovic et al., 2014, 2016; Nguyen et al.,
2016).
The protocol allows for rapid and robust measurements
of sensitized acceptor emission FRET on isolated virally
transduced murine photoreceptor OS. The complete procedure
can be performed within 3 weeks on wild type animals
and requires only limited expertise and special equipment
(Figure 1). We show that this method is suitable for the
detection and quantification of protein-protein interactions of
proteins involved in the pathogenesis of hereditary degenerative
retinal diseases. We propose the application of this method for
FRET-based protein-protein interaction studies in other primary
cilia of many cell types to study the pathogenesis of other
ciliopathies.
Experimental Procedure
The genes of interest encoding each of the protein-protein
interaction partners are C- and/or N-terminally fused to
the genes encoding citrine or cerulean, two FRET-optimized
derivatives of YFP and CFP, respectively (Griesbeck et al.,
2001; Rizzo et al., 2004). Each of these constructs is then
cloned into the multiple cloning site of a rAAV cis-plasmid
containing the rod photoreceptor specific human rhodopsin
(hRHO) (Allocca et al., 2007) or murine short wavelength opsin
(mSWS) promoter (Michalakis et al., 2010a), a Woodchuck
hepatitis virus posttranscriptional regulatory element (WPRE),
and a bovine growth hormone polyadenylation signal (BGH
pA). Subsequently, each rAAV cis plasmid is co-transfected
with the trans (AAV helper and Adeno helper) plasmids
into HEK293T cells using triple Ca2+ phosphate transfection.
rAAV particles are then purified in a multistep procedure
that yields high titers of approx. 1013 vector genomes (vg)
per ml. For FRET measurements, 1 × 109 total vg of each
construct is delivered into the subretinal space of anesthetized
mice. For co-transduction experiments of two titer-matched
constructs a total number of 2 × 109 total vg is injected.
The co-transduction efficiency was up to 90% in rods and
up to 30% in cones after co-delivery of mixtures of two
rAAVs. The isolation of rod or cone OS was performed
10–14 days post-injection using a modified version of the
mechanical share method (Mitchell et al., 2009). Three cube
FRET measurements were carried out using a slightly modified
version of the protocol described previously (Erickson et al.,
2003; Shaltiel et al., 2012; Ben Johny et al., 2013). The isolated
OS were stable for several hours after isolation, which in
principle also allows for dynamic FRET measurements of single
interactions.
Using this method, we were able to confirm several
homomeric and heteromeric protein-protein interactions in rod
OS that had been previously observed using other (biochemical)
methods. In addition, we also identified novel protein-protein
interactions in OS of rods and cones. Furthermore, we
demonstrate that FRET is applicable to quantify the effects
of disease associated point mutations on protein-protein
interactions in these compartments. Conclusively, we show that
our FRET protocol enables robust qualitative and quantitative
measurements of protein-protein interactions in small cellular
compartments like photoreceptor OS.
Advantages of the Method
Compared to FRET and other ex vivo measurements of protein-
protein interactions, which are currently widely used, this
method has several advantages:
(i) It can be performed within 3 weeks including the
production of specific rAAVs. The isolation of OS can be
carried out within a few minutes and yields a high quantity
of OS of adequate quality and purity.
(ii) It allows for systematic analysis of protein-protein
interactions ex vivo in a specialized small compartment
with preserved native morphology.
(iii) It is principally transferable to analyses of protein-protein
interactions in ciliary compartments of other tissues (e.g.,
respiratory cilia and olfactory cilia). This is of special
importance for deciphering the disease mechanisms of a
large group of diseases known as ciliopathies.
(iv) As isolated OS are stable for up to 6 h, the method can also
be used for dynamic FRET measurements.
(v) The protocol was established in wild type mice. Thus, it
allows for systematic analysis of disease mechanisms of
single disease associated point mutations without the time
consuming generation of transgenic animals.
(vi) It can in principle be used to determine the relative binding
affinities of single interactions.
(vii) The co-transduction efficiency for two constructs was up
to 90% for rod OS and up to 30% for cone OS. Hence,
a sufficient number of OS co-expressing both proteins of
interest can be isolated from a single animal.
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FIGURE 1 | Schematic overview of the main steps of the procedure. AAV vectors encoding the FRET fusion proteins are produced in HEK293T cells (day 1–10).
Single AAV vectors and combinations of AAVs encoding the FRET partners are delivered into the subretinal space of wildtype mice (day 11). Ten days later, OS are
isolated for ex vivo FRET measurements.
(viii) In principle, it can be adapted for the establishment of
FRET measurements on retinas of living animals.
(ix) Due to its easy handling our protocol should also be
transferable to other tissues or organisms.
Limitations of the Method
There are a few limitations of themethod, which can be overcome
by appropriate techniques or conditions:
(i) With respect to the packaging capacity of rAAVs (5 kb)
(Trapani et al., 2014), this method seems less suitable for
analysis of protein-protein interactions of large proteins.
However, there are several approaches showing that larger
transcripts can also be packaged into rAAVs, even though
with lower efficiencies (Trapani et al., 2014).
(ii) The endogenous wild type proteins in the OS of transduced
photoreceptors interfere with the labeled constructs and
lead to overall lower FRET efficiencies than expected
from in vitro experiments (incomplete labeling) (Becirovic
et al., 2014). This limitation should be of relevance only
if weak interactions are expected. This issue could be
overcome by using appropriate single or double knock-
out animals, which lack expression of the endogenous
(unlabeled) proteins of interest.
(iii) So far, we found no short or long term toxic effects
of the fluorophores on the structural integrity of the
retina, which is consistent with previous studies (Bennett
et al., 1999; Becirovic et al., 2014). However, we cannot
exclude that large amounts of specific cerulean- or
citrine-tagged proteins could have toxic effects that
influence photoreceptor function and morphology.
Therefore, to exclude any toxic effects, we suggest using
histological analysis of retinal cross sections prior to the
actual FRET measurements for each construct.
(iv) In the case of three cube FRET, in addition to the
simultaneous delivery of two FRET partners, injections of
single FRET constructs are also necessary. They serve as
bleed-through and crosstalk controls for the determination
of the FRET efficiencies.
(v) Overexpression of the tagged proteins by strong promoters
might result in an artefactual FRET signal. To exclude
this possibility, additional controls might be necessary.
In this context, the most eligible control is to use point
mutations within the protein-protein interaction site of one
(or both) FRET partners. If the protein interaction interface
is not known, artefactual FRET signal can be excluded by
overexpressing other proteins not expected to interact with
the respective FRET partner.
(vi) Bulky fluorescent tags could possibly hinder proper
trafficking or localization of the fusion protein (Feilmeier
et al., 2000). In addition, they might influence the proper
folding and the stability of the protein. In turn, incorrect
folding may also affect the fluorophore itself and lead
to little or no fluorescence (Waldo et al., 1999). If
these problems occur, they can be overcome by varying
the position of the fluorescent tag within the protein
or by placing a short linker sequence between tag and
protein.
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MATERIALS AND EQUIPMENT
Animals
All procedures were performed on P14-21 C57BL/6J mice
with permission from local authorities (District Government
of Upper Bavaria). Anesthesia was performed by subcutaneous
injection of ketamine (40mg/kg body weight) and xylazine
(20mg/kg body weight). Euthanasia was performed by cervical
dislocation.
Reagents
• Sodium chloride (NaCl; VWR, cat. no. 27810.364)
• Potassium chloride (KCl; Carl Roth, cat. no. 6781.1)
• Magnesium chloride hexahydrate (MgCl2 × 6H2O; Carl Roth,
cat. no. 2189.1)
• Calcium chloride dihydrate (CaCl2 × 2H2O; VWR, cat. no.
22317.230)
• Glucose monohydrate (Carl Roth, cat. no. 6887.1)
• HEPES sodium salt (VWR, cat. no. A16516.22)
• Sodium hydroxide, 5M (NaOH; VWR, 28244.295)
• KAPA SYBR FAST Universal x2 qPCRMasterMix (peqlab, cat.
no. 07-KK4600-01)
• Poly-L-lysine, 1mg/ml (Sigma, cat. no. P2636)
• Polybrene/Hexadimethrine bromide (Sigma, cat. no. 107689)
• Dextran (Sigma, cat. no. 95771)
• BES sodium salt (Sigma, cat. no. B2891)
• AAV cis (for cloning of the expression cassette) and trans
plasmids (encoding for Cap, Rep and adenoviral helper genes)
can be obtained from various sources including Penn Vector
Core (http://www.med.upenn.edu/gtp/vectorcore) or from
UNC Vector Core (http://www.med.unc.edu/genetherapy/
vectorcore,seealsoRef. Grieger et al., 2006)
• Benzonase (VWR, cat. no. 1.01695.0001)
• OptiPrep (Progen, cat. no. 1114542)
• Disodium hydrogen phosphate (Na2HPO4; Sigma, cat. no.
S9763)
• Sodium dihydrogen phosphate (NaH2PO4; Sigma, cat. no.
S5011)
• Tris(hydroxymethyl)aminomethane (TRIS; VWR, cat. no.
71003-490)
• Phenol red (Sigma, cat. no. P3532)
• Tween 20 (Sigma, cat. no. P2287).
Equipment for rAAV Preparation and
Subretinal Injection
• Vortexer
• Microcentrifuge tubes, 1.5ml
• Microcentrifuge tubes with screw cap, 1.5ml
• ibidi µ-dish, 35mm, low (ibidi, cat. no. 80131)
• Room temperature bench top centrifuge (1.5ml tube rotor)
• Petri dishes, 3 cm
• Forceps
• Polystyrene tubes, 50ml
• Cell culture dishes, 15 cm
• Cell scraper (VWR, cat. no. 734-1111)
• Liquid nitrogen
• Quick-Seal polypropylene tubes, 39ml (Beckman, cat. no.
342141)
• Glass pipettes
• Peristaltic pump MINIPULS 3 (Gilson, cat. no. n/a)
• Quick-Seal Cordless Tube Topper kit, 50Hz (Beckman, cat.
no. 358313)
• Beckman Coulter J2-MC high speed centrifuge (Beckman, cat.
no. n/a)
• JA-10 Rotor, Fixed Angle, Aluminum, 6× 500ml, 10,000 rpm,
17,700× g (Beckman, cat. no. 369687)
• Beckman Coulter Optima LE-80K ultracentrifuge (Beckman,
cat. no. n/a)
• 70 Ti Rotor, Fixed Angle, Titanium, 8 × 39mm, 70,000 rpm,
504,000× g (Beckman, cat. no. 337922)
• Syringe needle, 21-gauge
• Syringe, 5ml
• Sterile syringe filters with acrylic housing, 0.2µm, cellulose
acetate (VWR, cat. no. 28145-477)
• HiTrap Q FF sepharose column, 5ml (GE Healthcare, cat. no.
17-5156-01)
• Superloop, 50ml (GE Healthcare, cat. no. 19-7850-01)
• ÄKTAprime plus chromatography system (GEHealthcare, cat.
no. 11-0013-13)
• PrimeView 5.31 software (GE Healthcare, cat. no. 28-9949-61)
• Amicon Ultra-4 centrifugal filter units, 100 kDa (Millipore,
cat. no. UFC810024)
• LightCycler 480 multiwell plate 96 (Roche, cat. no.
04729692001)
• LightCycler 480 Sealing Foil (Roche, cat. no. 04729757001)
• LightCycler 480 Instrument II real-time PCR amplification
and detection instrument (Roche, cat. no. 05015278001)
• NanoFil syringe, 10µl (World Precision Instruments, cat. no.
NANOFIL)
• NanoFil 34-gauge beveled needle (World Precision
Instruments, cat. no. NF34BV-2)
• Nanodrop 2000c UV-Vis spectrophotometer (peqlab, ca. no.
91-ND-2000C)
• Dexpanthenol eye and nose salve, 5% (Bepanthen, Bayer Vital
GmbH, cat. no. 1578681)
• OPMI 1 FR pro surgical microscope (Zeiss, cat. no. n/a)
• Gentamicin 5 mg/g and dexamethasone 0.3 mg/g eye
salve (Dexamytrex, Dr. Gerhard Mann GmbH, cat. no.
2747789)
• Dissection stereomicroscope Stemi 2000 (Zeiss, cat. no.
495005-0022-000)
• Epifluorescence microscope Axioplan 2 imaging (Zeiss, cat.
no. n/a).
Equipment for Three Cube FRET
Measurements
• Inverted fluorescent microscope (Leica, cat. no. DMI6000B)
• HC PL APO 63x/1.40-0.60 oil immersion objective (Leica, cat.
no. 11506349)
• Cerulean filter cube, excitation: ET436/20x, Dichroic: T455lp,
emission: ET480/40m, transmission rate 93–97% (Chroma
Technology, cat. no. 49001)
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• Citrine filter cube, excitation: ET500/20x, Dichroic: T515lp,
emission: ET535/30m, transmission rate 93–97% (Chroma
Technology, cat. no. 49003)
• FRET filter cube, excitation: ET436/20x, Dichroic: T455lp,
emission: ET535/30m, transmission rate 93–97% (Chroma
Technology, cat. no. 49052)
• DeltaRamX monochromator (Horiba, cat. no. n/a)
• D-104 B microscope photometer (Horiba, cat. no. n/a)
• Xenon short arc lamp type UXL-75XE (Ushio Inc. Japan, cat.
no. n/a)
• PMT housing 914 (Horiba, cat. no. n/a)
• R1527 photomultiplier (Horiba, cat. no. n/a)
• FelixGX software (Horiba, cat. no. n/a)
• MATLAB R© R2014b (MathWorks. Inc., cat. no. n/a)
• Excel software (Microsoft Corporation, cat. no. n/a).
Buffers and Solutions
2x BBS transfection solution Final component concentrations
are 45mMBES, 280mMNaCl, 1.5mMNa2HPO4. Adjust the pH
to 6.95 and sterile filtrate. Prepare 50ml aliquots and store them
at 4◦C for up to 1 year.
Lysis Buffer Final component concentrations are 150mM
NaCl, 50mM TRIS. Adjust the pH to 8.5 and sterile filtrate.
Prepare freshly before use.
15% iodixanol solution Final component concentrations are
1x PBS (phosphate buffered saline), 1mM MgCl2, 2.5mM KCl,
1M NaCl, 15% Optiprep. Add phenol red (use 1% solution) ad
libitum until the solution is visibly colored. Store at 4◦C for up to
1 week.
25% iodixanol solution Final component concentrations are
1x PBS, 1mM MgCl2, 2.5mM KCl, 25% Optiprep. Add phenol
red (use 1% solution) ad libitum until the solution is visibly
colored. Store at 4◦C for up to 1 week.
40% iodixanol solution Final component concentrations are
1x PBS, 1mMMgCl2, 2.5mMKCl, 1MNaCl, 40%Optiprep. The
solution remains uncolored. Store at 4◦C for up to 1 week.
60% iodixanol solution Final component concentrations are
1mM MgCl2, 2.5mM KCl, 60% Optiprep. Add phenol red (use
1% solution) ad libitum until the solution is visibly colored. Store
at 4◦C for up to 1 week.
PBS-MK solution Final component concentrations are 1x
PBS, 1mM MgCl2, 2.5mM KCl. Sterile filtrate and store at 4◦C
for up to 1 week.
Buffer A Final component concentrations are 20mM TRIS,
15mMNaCl. Adjust the pH to 8.5. Store at 4◦C for up to 1 week.
Buffer B Final component concentration is 2.5M NaCl.
Adjust the pH to 8.5. Store at 4◦C for up to 1 week.
FRET imaging solution Final component concentrations are
140mM NaCl, 5mM KCl,
1mM MgCl2, 2mM CaCl2, 10mM glucose, 10mM HEPES
sodium salt. Adjust the pH with 5M NaOH to 7.4. Prepare 50ml
aliquots and store them at −20◦C for up to 1 year. Store thawed
aliquots at 4◦C for up to 1 week.
FRET Imaging Setup
Imaging dishes We recommend the use of commercially
available glass-bottomed cell-culture dishes for imaging. They
should be coated with Poly-L-lysine to ensure complete
adherence and immobilization of OS. In our hands, the use of
pre-coated dishes (e.g., ibiTreat, ibidi) resulted in insufficient OS
adherence.
Inverted epifluorescent microscope, excitation source, and
detection All measurements were performed using a Leica
DMI6000B inverted fluorescent microscope equipped with a
motorized turret and a 63x oil objective. Themicroscope contains
a motorized filter-wheel enabling rapid switching of filter cubes
within 300ms. Of note, the 40x oil objective is also suitable for
FRET measurements on isolated OS. The fluorescent intensity
is detected by a photomultiplier detection system including a
photomultiplier tube (Horiba). As excitation source, we use
a DeltaRam monochromator containing a 150W xenon high
stability lamp. The use of a conventional LED lamp is also
suitable. However, it is crucial to achieve a stable uniform
illumination.
Excitation filter, emission filter, and dichroic mirror
The following filter cubes are present in our microscope: A
donor cube containing a cerulean excitation filter, T455lp
dichroic mirror and a cerulean emission filter; an acceptor
cube with a citrine excitation filter, T515lp dichroic mirror,
and a citrine emission filter. Furthermore a FRET cube
containing a cerulean excitation filter, T455lp dichroic
mirror and a citrine emission filter. In case of using a
monochromator as excitation source, the excitation filters are
optional.
Software and data acquisition For photometric FRET
measurements, we employ the three cube FRET method
(Erickson et al., 2003; Shaltiel et al., 2012; Ben Johny et al.,
2013) that utilizes the detection of fluorescence intensities
from a specimen using three filter cubes. The excitation
source (DeltaRam monochromator) and appendant excitation
parameters (e.g., wavelength, pulse duration) are thereby
controlled via the software FelixGX, whereas the filter switch
is done manually. Fluorescence intensity signals are acquired
with the FelixGX software and deciphered with a custom-written
MATLAB script. Subsequent analysis is performed using Excel or
an adequate data processing software.
STEPWISE PROCEDURES
Production and Titer Determination of
rAAVs
Transfection, Harvesting, and Lysis of HEK293T Cells
The production and handling of recombinant pseudotyped
AAV2-derived vectors is subject to biosafety level 1. For a detailed
protocol on AAV production, see ref. (Grieger et al., 2006). 24 h
before transfection, confluent 15-cm-dishes of HEK293T cells
were split into 15 15-cm-dishes for each construct. For calcium
phosphate transfection, the components listed in Table 1 (the
amounts are adjusted for transfection of 15 15-cm-dishes) were
added in a 50-ml polystyrene tube. The following two equations
are used to calculate the amount of pAd Helper plasmid and
AAV2/8 Cap/Rep plasmid needed for the pre-transfection mix
described in Table 1, respectively:
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x (amount of pAd Helper) =
m (transgene AAV) × MM (pAd Helper)
MM (transgene AAV)
=
270 µg × 9509 g
mol
MM (transgene AAV)
y
(
amount of AAV 2/8 Rep/Cap
)
=
m
(
transgene AAV
)
×MM
(
AAV 2/8 Rep/Cap
)
MM
(
transgene AAV
) =
270 µg × 4523 g
mol
MM
(
transgene AAV
)
MM =molar mass of double stranded plasmid.
While vortexing the pre-transfection mix in the polystyrene
tube at maximum speed, 15ml 2x BBS was added dropwise. The
mixture was incubated at room temperature for 4–5min and
2ml of the transfection mix was added dropwise to each 15-
cm-dish of ∼80% confluent HEK293T cells. Transfected cells
were then incubated at 37◦C and 5% CO2 atmosphere for 24 h.
Subsequently, the medium from transfected cells was replaced
and the cells were incubated at 37◦C and 10% CO2 atmosphere
for additional 24 h. 48 h post transfection, the cells were harvested
by scraping them from each 15-cm-dish. Cell suspensions were
collected from 15 dishes in a 500-ml-centrifuge-tube. The cells
were centrifuged at 2000 × g for 15min at 4◦C (4000 rpm
in a J2-MC Beckman centrifuge using a JA-10 rotor). After
medium removal, the cell pellet was gently resuspended in
7.5ml lysis buffer (volume for cell pellet harvested from 15
15-cm-dishes) and transferred into 50-ml-polystyrene-tubes.
The cell suspension was shock-freezed in liquid nitrogen and
subsequently thawed at 37◦C. Freeze-thaw cycle was repeated two
additional times. The resulting cell suspension can be stored at
−80◦C overnight.
Gradient Centrifugation and Purification of rAAVs
Benzonase was added to the thawed cell suspension to a final
concentration of 50 U/ml followed by an incubation at 37◦C for
30min. Subsequently, the cells were pelleted via centrifugation
at 2000 × g for 25min at 4◦C. The virus-containing supernatant
was transferred into a Beckman Quick-Seal polypropylene tube.
To form the iodixanol gradient, a sterile, long glass pipette,
and a Gilson MINIPULS3 pump were used. First, the virus-
containing phase was underlaid with 7ml 15% iodixanol, then
with 5ml 25% iodixanol, followed by 5ml 40% iodixanol, and at
last with 6ml 60% iodixanol. To avoid mixing of the layers, the
pump should be run at the slowest speed. Polypropylene tubes
TABLE 1 | Reagents for a pre-transfection mix of one transgene AAV
construct.
Reagent Amount
Transgene AAV cis plasmid (Michalakis et al., 2010b;
Koch et al., 2012)
270µg
pAd Helper plasmid (pAdDeltaF6 Auricchio et al., 2001) x µg
AAV2/5 (Hildinger et al., 2001) or AAV2/8 (Gao et al.,
2002) Rep/Cap plasmid
y µg
Polybrene (8mg/ml) 15µl
Dextran (10mg/ml) 1500µl
2.5M CaCl2 1500µl
Double-distilled water ad 15ml
The listed amounts are for transfection of 15 15-cm-dishes of HEK293T cells.
were filled up and accurately balanced with PBS-MK. Prior to
centrifugation, the tubes were sealed with the Beckman Tube
Topper. Centrifugation was performed at 361.000 × g for 1 h
45min at 18◦C (70.000 rpm in an Optima LE-80K Beckman
ultracentrifuge using a 70 Ti rotor). During centrifugation, the
virus-containing fraction should accumulate in the 40% phase.
After centrifugation, the tube was pierced at the top near the
seal for pressurization. To collect the virus-containing phase, a
21-gauge-needle was used with a 5-ml-syringe to pierce the tube
through the side at the lower end of the 40–60% interface. During
this step, the open site of the needle tip should face the 40% phase.
Approximately 5ml of the 40% phase were collected. The virus-
containing phase can be stored in a 15-ml-polystyrene-tube at
−80◦C until proceeding with the purification step.
For purification, the virus-containing phase was thawed
on ice. HiTrap Q FF sepharose column and superloop were
connected with the ÄKTAprime plus chromatography system.
For collection of the purified fractions, 1.5-ml-centrifuge-tubes
were loaded into the tube rack. Dropsync unit was adjusted to
position 1. The HiTrap Q FF sepharose column was equilibrated
with 25ml of buffer A at 10ml/min flow rate. Manual run mode
was selected with 1.0ml/min flow rate, 1ml fraction size, and the
measuring curves were put to starting point via autozero. Virus
phase was diluted 1:1 with buffer A prior to application to the
ÄKTAprime plus systemwith a 10ml syringe to fill the superloop.
The virus dilution from the superloop was injected into the
ÄKTAprime plus system and 1ml fractions were collected in
1.5-ml-tubes. During this step, the UV and conductance curves
should be monitored via the Äktaprime software. When the
conductance curve has reached basal values, the ÄKTAprime plus
system was switched to 100% buffer B at 10ml/min flow rate
and 0ml fraction size to purge the sepharose column from the
remaining virus dilution. To wash out the remaining salt from
the system, sterile, double-distilled water was used at 10ml/min
flow rate.When the conductance curve reached zero, the washing
step was continued for additional 5min. All of the collected 1-ml
fractions within the plateau phase of the conductance curve were
pooled. The purified and pooled virus fractions can be stored in a
15-ml-polystyrene-tube at−80◦C until continuing with the virus
concentration step.
Concentration of rAAVs
For virus concentration, the purified virus fraction was first
thawed on ice. 4ml of the fraction was then transferred to an
Amicon centrifugal filter unit and was centrifuged at 2000 × g
for 10min at 20◦C (4000 rpm in a Beckman centrifuge using a
JA-10 rotor). The flow-through was discarded and the cycles of
4ml virus fraction transfer and subsequent centrifugation were
repeated until the complete virus was loaded to the column and
∼500µl remained in the filter unit. The concentrated virus was
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washed with 1ml 0.014% Tween/PBS-MK by pipetting up and
down five times. The virus suspension was then centrifuged at
2000 × g at 20◦C until 100µl of concentrated virus suspension
remained in the filter unit. The supernatant was aliquoted and
stored in 1.5-ml screw cap tubes. Virus suspensions were stored at
−80◦C until determination of virus titer and subretinal injection.
Titer Determination of rAAVs
For titer determination, the virus suspension was diluted
1:500 with double-distilled water. 5µl of virus dilution, a
standard sample, and double-distilled water were used for
quantitative real-time PCR according toTables 2, 3. For standard
preparation, a small fragment within the WPRE (woodchuck
hepatitis virus posttranscriptional regulatory element) of the
pAAV2.1 vector was amplified via PCR. The corresponding
primers are listed in Table 4. The PCR product was purified after
gel electrophoresis and DNA concentration was determined with
a spectrophotometer (Nanodrop 2000c). The concentration of
the standard for 1010 copies per 5µl was calculated according to
the following equation:
c
(
pg
µl
)
=
1010 × 660× 1012 pg
mol
× fragment size
6.022× 1023 1
mol
× 5µl
c is the concentration of the standard for 1010 copies per 5µl;
660 × 1012 pg/mol is the mean molar mass of a base
pair (deoxyribosyladenosine with deoxyribosylthymidine or
deoxyribosylcytidine with deoxyribosylguanosine);
6.022× 1023/mol is the Avogadro constant;
The size of the amplified WPRE fragment is given in base
pairs.
A 10-fold serial dilution was made to obtain standards
at different concentrations. 5µl of a standard were used
to determine the virus titer via quantitative real-time PCR.
Standards were stored at−20◦C until use.
Subretinal Injection of rAAV Vectors
The procedure of subretinal rAAV injection was carried out as
described by (Mühlfriedel et al., 2013) with slight modifications.
The NanoFil 34-gauge beveled needle was sterilized before each
experiment. The 10-µl NanoFil syringe was preloaded with the
virus suspension under exclusion of air bubbles. The mouse was
anesthetized via intraperitoneal injection of xylazine (20mg/kg)
and ketamine (40mg/kg). Five percent dexpanthenol eye salve
was applied to the non-injected eye and the anesthetized mouse
TABLE 2 | Pipetting scheme for quantitative real-time PCR.
Reagent Volume (µl)
Template plasmid (50–100 ng)/standard/double-distilled water
(negative control)
5,0
KAPA SYBR FAST Universal x2 qPCR MasterMix 10,0
WPREqF (10 pmol/µl) 1,0
WPREqR (10 pmol/µl) 1,0
Double-distilled water ad 20,0
was placed on a 37◦C heating plate. The eye was dilated with
1% atropine and 0.5% tropicamide solution. The eye fundus
was focused with a stereomicroscope until blood vessels became
clearly visible. The outer layers of the eye (sclera, choroidea,
and retinal pigment epithelium) were then penetrated with the
needle in a 60◦ angle. When the needle was visible beneath the
retina, 1µl (containing approx. 109 rAAV particles) of virus
suspension was gradually applied freehand. For the co-delivery
of two constructs, a 1:1 mixture of titer matched rAAVs was
used. The formation of a clearly visible injection bleb indicated
a correct application to the subretinal space. The needle was
slowly removed from the eye, which was subsequently treated
with gentamicin 5 mg/g and dexamethasone 0.3 mg/g eye salve.
The anesthetized mouse was placed under a heat lamp and
was monitored until awaking from narcosis. If available, optical
coherence tomography (OCT) was conducted immediately after
subretinal injection to monitor the injection procedure and the
degree of subretinal detachment (Mühlfriedel et al., 2013).
Dissection of Murine Retinas and Isolation
of Photoreceptor Outer Segments
The mouse was sacrificed 10 days post injection and the injected
eye was proptosed by placing blunt forceps around the optic
nerve close to its exit from the eye. The globe was then transected
along the equator with a sharp razor blade or scalpel and the
vitreous body was removed by carefully pushing it out of the
incision with a thin needle. The forceps was pushed upwards to
detach the retina from the optic nerve and from the pigment
epithelium. The upward movement was gradually continued
until the retina lay free on the forceps. The isolated retina
was transferred into a petri dish filled with phosphate buffered
saline (PBS). The expression or co-expression of fluorescent
fusion proteins was analyzed by an epifluorescence microscope
(Axioplan 2 imaging, Zeiss). As described in Figure 2A, the retina
was transferred into a 1.5-ml-microcentrifuge-tube containing
100µl PBS. In case of weak expression or in case of isolating
cone OS, two (or more) retinas can be pooled at this stage
TABLE 3 | Program steps of quantitative real-time PCR for titer
determination.
Step Phase Temperature (◦C) Time Cycle numbers
1 Initial Denaturation 95 10min 1
2 Denaturation 95 10 s 40
3 Annealing 60 5 s
4 Elongation 72 20 s
5 Final elongation 72 5min 1
TABLE 4 | Primer sequences for quantitative real-time PCR and standard
preparation.
Primer for amplification of standard
fragment
Sequence (5′ to 3′)
WPREqF AGTTCCGCCGTGGCAATAGG
WPREqR CAAGGAGGAGAAAATGAAAGCC
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FIGURE 2 | OS preparation and FRET. (A) Overview of the protocol for the OS preparation and for the subsequent FRET measurements. (B) Representative
images of isolated OS at different time points after the isolation. Scale bar, 3µm.
to ensure a sufficient number of fluorescent OS. The OS were
separated from the retina by vortexing for 15–30 s. Vortexing
should not surpass 30 s as excessive shearing disrupts the
shape of OS. Afterwards, centrifugation was conducted at 500
× g for 30 s and the supernatant was carefully transferred
to a fresh 1.5-ml-microcentrifuge-tube without disturbing the
pellet. The supernatant contained the OS fraction suitable for
FRET measurements. If desirable, the quality and fluorescence
of purified OS can be analyzed (Figure 2B) on a standard
epifluorescence or confocal microscope by transferring 5–10µl
of supernatant on microscope slides topped with cover slips.
FRET Measurements on Isolated Outer
Segments
Setup of FRET Microscope, Software, and OS Sample
Calculation of three cube sensitized acceptor emission FRET
requires data for FRET donor (cerulean) only and acceptor
(citrine) only samples (Erickson et al., 2003; Shaltiel et al., 2012;
Ben Johny et al., 2013). Therefore, in addition to the fluorescence
signals from OS co-expressing cerulean and citrine constructs,
OS expressing cerulean- or citrine-tagged proteins only must be
imaged as well. For optimized signal acquisition, we recommend
to start the FRET measurements with OS co-expressing both
cerulean- and citrine-tagged FRET partners (hereinafter referred
to as FRET sample).
Purified OS solution was diluted in 400µl FRET imaging
solution and was transferred to the center of an imaging
dish. FRET measurements should be performed on single
OS as fluorescence from adjacent OS might interfere with
the measurements. Therefore, the density of OS should be
adjusted in order to allow for detection of single fluorescent
OS within the defined region of interest on the imaging setup
(image-plane pinhole). As the density of transduced OS varies
with transduction and purification efficiency, it is necessary to
individually adjust the amount of OS for each preparation. The
OS were allowed to sediment to the bottom for 10–15min at
room temperature. The fluorescence lamp was turned on at least
30min prior to the experiment to ensure stable illumination.
The image-plane pinhole was set to an appropriate size that
allows monitoring of a single OS, which was positioned in the
center of the axial beam path. This position must not be changed
throughout the entire FRET measurements performed on the
same day. The FelixGX software was started to acquire the
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fluorescence intensities. An oil-immersion and high-resolution
objective (40x or higher) was used and immersion medium was
applied. The imaging dish was placed onto the sample holder
and bright field illumination was used to focus on OS. Individual
OS were identified based on their characteristic morphology as
shown in Figure 2B.
Measurements on the FRET Sample
For measurements of FRET samples, OS that express sufficient
levels of both citrine and cerulean were used. A fluorescent OS
was placed in the center of the optic field and fluorescence from
adjacent cells invading the optic field was excluded. Gain and
fluorescence intensity settings were adjusted in order to achieve
an appropriate signal prior to the first signal acquisition. All
subsequent data must be acquired under the same conditions.
Fluorescence intensities were collected with the cerulean cube,
FRET cube, and citrine cube. The settings for the single cubes are
as follows:
For cerulean cube: 426–446 nm excitation filter, T455lp
dichroic mirror, and 460–500 nm emission filter; for citrine cube:
490–510 nm excitation filter, T515lp dichroic mirror, and 510–
550 nm emission filter; for FRET cube: 426–446 nm excitation
filter, T455lp dichroic mirror, and 510–550 nm emission filter.
The data for a single OS was acquired according to the
following sequence: cerulean excitation was started and the
signals with the cerulean cube followed by the FRET cube were
obtained. Then, citrine excitation was carried out and the signal
with the citrine cube was obtained. 25–35 individual OS were
measured. To subtract the OS autofluorescence, the same three
cube protocol as described above was applied to ∼10 OS that do
not express citrine or cerulean within the corresponding sample.
Cerulean-only Expressing Preparation
OS with varying expression levels of cerulean were used. For each
OS, the fluorescence intensity was measured with the cerulean,
FRET, and citrine filter cube according to the same protocol as
described above for the FRET sample. Data from at least 15 OS
were collected. To subtract the OS autofluorescence, the cerulean,
FRET, and citrine cube were measured for ∼10 OS that do not
express cerulean within the same sample.
Citrine-only Expressing Preparation
OSwith varying expression levels of citrine were chosen. For each
OS, the fluorescence intensity was measured with the cerulean,
FRET, and citrine filter cube according to the same protocol as
described above for the FRET sample. Data from at least 15 OS
were collected. To subtract the OS autofluorescence, the cerulean,
FRET, and citrine cube were measured for ∼10 OS that do not
express citrine within the same sample.
Data Analysis
The data set consists of three data points per OS, i.e., one
intensity value for each filter cube. As controls, we additionally
included data points measured from non-fluorescent OS for
background subtraction as well as from cerulean-only and
citrine-only expressing OS for donor bleed-through and cross-
excitation corrections, respectively. The data was transferred to
an Excel sheet or an adequate data processing program. For the
10 non-fluorescent OS measured for each of the preparations,
i.e. FRET, cerulean-only and citrine-only, the mean intensity
values were calculated. These mean values were subtracted from
each data point of the particular preparation to adjust for
background fluorescence. In order to correct for donor bleed-
through, the correction constant RD1 for each of the single data
points gathered from the cerulean-only expressing preparation
was calculated by dividing the intensities captured with the
FRET-cube by those obtained from the cerulean-cube. In order
to correct for acceptor cross-excitation, the correction constant
RA for each single data point gathered from the citrine-only
expressing preparation was calculated by dividing the intensities
captured with the FRET-cube by those obtained from the
citrine-cube. The mean value for both constants, RD1 and RA,
was calculated. Usually, a value of ∼0.25 for cerulean (donor-
bleed through) and 0.03 for citrine (acceptor cross-excitation)
was obtained in our setup. However, these values might differ
with fluorophore variant, protein tag, and imaging setup. The
calculated constants were used for donor bleed-through and
acceptor cross-excitation to evaluate the FRET ratio (FR) for each
single measurement according to the following equation:
FR =
SFRET − RD1 · Scerulean
RA · Scitrine
Scerulean, Scitrine, and SFRET are intensity signals acquired with
respective filter cubes (FRET, cerulean, and citrine) in a
FRET specimen and RA, RD1 are predetermined factors for
calibration issues (RA: Acceptor cross-excitation, RD1: Donor
bleed-through). Depending on the imaging setup and, in
particular, the filter set used for experiments, a considerable
amount of cerulean fluorescence may be detected by the citrine
cube. To correct for this, an additional donor bleed-trough
correction constant RD2 should be calculated by dividing the
cerulean fluorescence intensity obtained with the citrine cube by
the one detected with the cerulean cube. Accordingly, the FR
equation was adjusted to: (Erickson et al., 2003)
FR =
SFRET − RD1 · Scerulean
RA · (Scitrine − RD2 · Scerulean)
In our FRET setup, RD2 was negligibly small and could thus
be ignored. However, it should be rigorously tested for each
individual imaging setup. The mean value of the previously
obtained data was calculated. The mean value represents
the overall FR. Note that the FR values are instrumentation
dependent. FRET efficiencies (EA) (which are independent of
the setup used) can be easily calculated from the FR using the
following equation:
EA = [FR− 1] ·
εcitrine(436)
εcerulean(436)
εcitrine and εcerulean are the FRET setup specific average molar
extinction coefficients for citrine and cerulean, respectively.
Troubleshooting
Problems, possible underlying reasons and advices concerning
critical steps of the procedure can be found in Table 5.
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TABLE 5 | Troubleshooting.
Problem Possible Reason Solution
Low titer. Transfection reagents do not have sufficient transfection
efficiency.
Test transfection reagents for their efficiencies.
Requantify plasmid concentration used for transfection.
pH of HEK293T cell medium is not optimal for transfection. Remove HEK293T dishes from incubator immediately
before transfection.
The sequence of the ITRs (inverted terminal repeats) within
the plasmid is not intact, thus replication and packaging of
the rAAV vector is inefficient.
Check for the presence of SmaI and/or Eam1105I
restriction sites within the palindromic ITR sequence. In
case of unexpected restriction fragment band pattern,
repeat cloning using an intact rAAV vector.
The injection bleb in the subretinal
space is not visible under the
surgical/stereomicroscope.
The eye shows damages or opacity of the cornea. Make sure to choose only mice with clear, intact eyes for
subretinal injection. Check the eyes under the
stereomicroscope.
Virus suspensions diluted with double-distilled water to
adjust the particle concentration do not show optical
refraction as clear as the virus suspension in 0.014%
Tween/PBS-MK.
Dilute with 0.014% Tween/PBS-MK to adjust virus
particle concentration. If the suspension is too viscous,
dilute with double-distilled water at a maximum ratio of
1:2 (water-to-virus suspension).
The injection angle is not optimal. Adjust the injection angle to ∼60◦.
Loss of many OS. Removal of the pigment epithelium and ciliary body after
retina isolation with foreceps may result in loss of many OS.
Proceed with the next step without any removal of
undesirable tissue.
Protein expression level is too low, thus
leading to a too weak or absent
fluorescence signal.
Virus suspension is not (completely) injected into the
subretinal space.
Make sure to see a clear injection bleb as this indicates
the correct injection to the subretinal space. An injection
into the upper layers of the eye such as sclera or
choroidea causes a bleb outside at the globe. If the
needle is intravitreal, it can be clearly and sharply seen
under the stereomicroscope. By contrast, a needle in the
subretinal space (injection angle at ∼60◦) appears rather
blurred. Keep the injection needle for at least 20 s in the
bleb to ensure proper delivery of the desired volume. If
possible, perform OCT measurements on the
anesthetized mouse after injection to confirm
detachment of the retina at the injection position.
Virus titer has not been determined correctly. Double check the virus titer. Otherwise, repeat the virus
production.
Time Schedule
• Transfection of HEK293T cells: 48 h
• Isolation of rAAV: 2–4 h (varies depending on number of
dishes to be harvested)
• Gradient purification and rAAV concentration: 6 h (for 2
different rAAV constructs)
• Titer determination via quantitative real-time PCR: 2 h
• Preparation of standards for titer determination: 2 h
• Subretinal injection: 20min (per mouse)
• rAAV transduction of murine retina and protein expression:
10 days
• Isolation of photoreceptor OS: 10min (per eye)
• FRET imaging: 5–9 h (depending on number of retinas to be
analyzed)
• Data analysis: 2–3 h (depending on number of measurements
to be processed).
ANTICIPATED RESULTS AND DISCUSSION
In this protocol, we demonstrate that robust FRET signals
can be measured for well-known homomeric and heteromeric
interactions of different membrane and soluble proteins in OS
of rod and cone photoreceptors. Representative results are found
in our previous publications (Becirovic et al., 2014; Nguyen
et al., 2016). Selected data from these publications are presented
in the modified graphs shown in Figure 3. FRET is given as
FRET efficiencies (EA) which can be easily calculated from the
FRET ratios (FR) as shown in the “Data Analysis” Section. It
is noteworthy to mention that the mean value of EA may not
represent the maximal FRET efficiency (EA max). EA max can be
calculated if a relatively high variability of the cerulean/citrine
molar ratios is present in FRET measurements. If this is the case,
single FRET values can be plotted against the cerulean/citrine
intensity ratios to obtain the binding curves and to calculate
EA max. A comparison of EA max between different constructs
allows for the determination of relative binding affinities. Since
EA max is directly proportional to the binding affinity, ourmethod
in principle should also allow for comparisons of relative binding
affinities of single protein-protein interactions in an isolated
subcellular compartment.
Taken together, our protocol enables the measurement of
robust FRET signals ex vivo in small and highly specialized
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FIGURE 3 | FRET measurements in isolated photoreceptor OS. (A) Schematic depiction of the single constructs used for the subretinal injection and for the
determination of the FRET efficiencies (EA) shown in (C). (B) Representative confocal images of single isolated rod OS co-expressing C-terminally tagged peripherin-2
and rhodopsin. The excitation wavelength and emission filter settings used to obtain the single channels (Donor, FRET and Acceptor) are summarized in the “Stepwise
Procedures” section. Scale bar, 1.5µm. (C) Results of the FRET measurements for different FRET pair combinations given as mean values ± standard error of the
mean (SEM). Numbers of independent measurements (n) are given in brackets. EA values for the single FRET pairs are as follows: Rho-Rho, EA = 10.45 ± 0.78;
Rho-citr-P, EA = 4.52 ± 0.82; Rho-P-citr, EA = 2.76 ± 0.65; Rho-GARP2, EA = 0.26 ± 0.65; (D) Schematic view of the single constructs used for the subretinal
injection and for the determination of the FRET efficiencies (EA) shown in (F). (E) Representative confocal images of single isolated cone OS co-expressing C-terminally
tagged peripherin-2 and cone opsin. Scale bar, 1.5µm. (F) Results of the FRET measurements (given as mean values ± SEM) for different FRET pair combinations as
indicated. Numbers of independent measurements (n) are given in brackets. EA values for the single FRET pairs are described elsewhere (Nguyen et al., 2016).
cellular compartments of mammalian cells like OS of murine
photoreceptors. This allows for the systematic analysis of protein-
protein interactions in a physiological or pathophysiological
context of the photoreceptor biology. In particular, it can be used
to analyze the effects of disease-associated mutations on protein-
protein interactions. OS of photoreceptors are modified cilia.
Ciliopathies encompass a very large group of genetic disorders
compromising the functional or structural integrity of cilia.
Since the isolation of ciliary compartments from other tissues
(i.e. kidney, lung, brain, olfactory epithelium) is well-established
(Mitchell et al., 2009), our protocol should also be transferable
to analyses of protein-protein interactions in any other ciliated
tissue. In non-dividing cells, rAAVs lead to an episomal and
long-term expression of the respective gene for up to several
years (Trapani et al., 2014). Thus, FRET measurements can be
performed on several time points during the development of the
tissue. Finally, our protocol could also provide an experimental
basis for the establishment of FRET measurements in the retina
of living animals by means of fundus ophthalmoscopy combined
with e.g., conventional fluorescence imaging, 2-photon imaging,
multiphoton FLIM-FRET, or near infrared-FRET fluorescence
lifetime imaging (Abe et al., 2013; Johnsson et al., 2014).
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Peripherin-2 and Rom-1 have 
opposing effects on rod outer 
segment targeting of retinitis 
pigmentosa-linked peripherin-2 
mutants
Sybille Böhm1,2, Lisa M. Riedmayr1,2, O. N. Phuong Nguyen1,2, Andreas Gießl  3, Toni 
Liebscher1,2, Elisabeth S. Butz1,2, Christian Schön1,2, Stylianos Michalakis1,2, Christian Wahl-
Schott1,2, Martin Biel1,2 & Elvir Becirovic1,2
Mutations in the photoreceptor outer segment (OS) specific peripherin-2 lead to autosomal dominant 
retinitis pigmentosa (adRP). By contrast, mutations in the peripherin-2 homolog Rom-1 cause digenic 
RP in combination with certain heterozygous mutations in peripherin-2. The mechanisms underlying 
the differential role of peripherin-2 and Rom-1 in RP pathophysiology remained elusive so far. Here, 
focusing on two adRP-linked peripherin-2 mutants, P210L and C214S, we analyzed the binding 
characteristics, protein assembly, and rod OS targeting of wild type (perWT), mutant peripherin-2 
(perMT), or Rom-1 complexes, which can be formed in patients heterozygous for peripherin-2 mutations. 
Both mutants are misfolded and lead to decreased binding to perWT and Rom-1. Furthermore, both 
mutants are preferentially forming non-covalent perMT-perMT, perWT-perMT, and Rom-1-perMT dimers. 
However, only perWT-perMT, but not perMT-perMT or Rom-1-perMT complexes could be targeted to murine 
rod OS. Our study provides first evidence that non-covalent perWT-perMT dimers can be targeted to rod 
OS. Finally, our study unravels unexpected opposing roles of perWT and Rom-1 in rod OS targeting of 
adRP-linked peripherin-2 mutants and suggests a new treatment strategy for the affected individuals.
The tetraspanin peripherin-2 is exclusively expressed in outer segments (OS), specific light detecting compart-
ments of photoreceptors. Peripherin-2 forms homo- and heteromeric protein complexes in OS. The core homo-
meric peripherin-2 unit is the non-covalent tetramer, which can also assemble into covalently linked octamers 
and higher-order oligomers1–3. These homomeric peripherin-2 complexes are crucial for proper OS morphology 
and architecture4. Peripherin-2 also forms heteromeric complexes with its homolog Rom-1, however, the func-
tional importance of these complexes remained unclear2, 5, 6. Autosomal dominant retinitis pigmentosa (adRP) is 
the most frequent hereditary retinal disorder characterized by progressive loss of vision due to rod photoreceptor 
degeneration. Mutations in the peripherin-2 gene (PRPH2) are among the most common causes for adRP7, 8. 
Interestingly, despite the high sequence identity (approx. 35%) and the high structural conservation of Rom-1 
and peripherin-22, 9, mutations in Rom-1 are not clearly linked to monogenic adRP. Some homozygous Rom-1 
mutations, however, cause digenic RP in combination with a heterozygous mutation in PRPH2, suggesting that 
Rom-1 could function as genetic modifier that shapes the disease progression10, 11. Nevertheless, the molecular 
mechanisms underlying the postulated modifier function of Rom-1 have not been determined yet12. The majority 
of adRP-linked peripherin-2 mutants are located within the large loop domain connecting the transmembrane 
domain 3 and 4, also known as EC2 or D2 loop domain13, 14. Some adRP-linked peripherin-2 mutants in EC2 were 
shown to influence the subunit assembly15, 16. In this context, it was postulated that peripherin-2 tetramerization 
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is crucial for rod OS targeting. However, this conclusion was drawn from experiments addressing pure homo-
typic perMT complexes16. Nevertheless, due to the autosomal dominant fashion of PRPH2-linked adRP, different 
combinations of peripherin-2 protein complexes (perWT-perWT, perMT-perMT, perWT-perMT, Rom-1-perWT, and 
Rom-1-perMT) can be formed in heterozygous patients carrying wild type and mutant PRPH2 alleles. In addition, 
each of these complexes can exist in different equilibria of mono-, di- and tetramers and higher-order oligomers, 
respectively. This high complexity precluded a more accurate investigation of how subunit assembly might influ-
ence the rod OS targeting of the single peripherin-2 protein complexes.
In previous studies, we provided a proof-of-principle for FRET-based quantitative analysis of protein-protein 
interactions in isolated rod and cone OS17–19. Recently, we also reported that the two adRP-linked mutations 
(perP210L and perC214S) located within the highly conserved tetraspanin PxxCC motif are mislocalized to rod inner 
segments (IS) when expressed in wild type mice using adeno-associated virus (AAV) vectors20. Other studies 
demonstrated that perC214S affects homotypic mutant interactions and the heteromerization with Rom-121, 22. 
Despite these findings, little is known about the specific binding characteristics of this and other peripherin-2 
mutants to perWT or Rom-1 in their native environment (e.g. rod OS). Moreover, the precise contribution of 
perWT and Rom-1 on binding properties, subunit assembly, and rod OS targeting of the respective perWT-perMT 
and Rom-1-perMT complexes is not clear. Nevertheless, such information is crucial to understand the full com-
plexity of PRPH2-linked adRP and for developing successful treatments for the disease. Here, combining differ-
ent methods we provide novel insights into the binding characteristics, subunit assembly, and rod OS targeting 
of perP210L and perC214S mutants. We show that perWT and Rom-1 form heterodimers with both peripherin-2 
mutants. However, only perWT-perMT but not Rom1-perMT complexes could be targeted to rod OS suggesting 
unexpected opposing roles of peripherin-2 and Rom-1 in rod OS targeting of adRP-linked peripherin-2 mutants.
Results
perC214S and perP210L show reduced binding to perWT and Rom-1. In our recent work, we demon-
strated that, in contrast to perC214S and perP210L, eight additional disease-linked peripherin-2 D2 loop domain 
mutants did not affect rod OS targeting20 (Fig. 1a). One possible mechanism, which might explain the mislocali-
zation of perC214S and perP210L in rod photoreceptors, is that these mutants might affect binding to perWT and/or to 
Rom-1. To examine this possibility, we performed co-immunoprecipitation (co-IP) experiments from HEK293T 
cells co-transfected with the respective peripherin-2 mutants and perWT or Rom-1, respectively. Only perC214S 
and perP210L attenuated the binding to perWT, while binding of other peripherin-2 mutants to perWT remained 
unaffected (Fig. 1b). Very similar results were obtained in co-IPs addressing the binding of the single peripherin-2 
mutants to Rom-1 (Fig. 1c).
P210 and C214 are crucial for the proper folding of the distal D2 loop. The proline at position 210 
(P210) and the cysteine at position 214 (C214) are part of the highly conserved tetraspanin PxxCC motif, whose 
function has not been clearly determined yet. The reduced binding of perC214S and perP210L to perWT suggests that 
these residues could either i) be crucial for proper folding of peripherin-2 or ii) represent the protein-protein 
interaction interface. Using CD spectroscopy, a recent study suggested that C214S impedes protein folding 
by increasing the percentage of ß-sheets concomitant with a decrease in helices in the D2 loop23. However, it 
remained unclear which part(s) of the D2 loop is (are) affected by this mutation. To address this issue more 
directly, we established a protease digestion assay on membrane preparations from HEK293T cells expressing 
citrine-tagged WT and mutant peripherin-2 transgenes. For this purpose, we took advantage of the fact that 
endogenously expressed proteases are regularly present in these preparations. In addition, membrane prepa-
rations are expected to retain the native protein structure as they are isolated without detergents or reducing 
agents. Protein cleavage occurs on the exposed domain regions, which are accessible for endogenous pro-
teases. Accordingly, improper protein folding could lead to masking of existing or to an exposure of hidden 
protease cleavage sites. Using a GFP antibody that recognizes the N-terminal citrine tag of our peripherin-2 
constructs, we could detect three peripherin-2 bands at 61.5 kDa, 52.4 kDa and 42.5 kDa (Fig. 1d). The calculated 
size of full-length citrine-tagged peripherin-2 is 66.5 kDa, however, even in presence of protease inhibitors, the 
full-length perWT was always detected as a 61.5 kDa band. By contrast, the 52.4 kDa and 42.5 kDa could only be 
detected in the protease cleavage assay in the absence of protease inhibitors and upon incubation of the samples at 
37 °C. Using the 61.5 kDa band as reference, we calculated the cleavage sites for the 42.5 kDa and for the 52.4 kDa 
band. The cleavage site for the 42.5 kDa band corresponds to the peripherin-2 region around the highly conserved 
tetraspanin CCG motif (Fig. 1a). This band was also present in all peripherin-2 mutants suggesting proper folding 
at this part of the protein. By contrast, the 52.4 kDa band was completely absent for perC214S and perP210L, whereas 
other mutations did not show any considerable differences to perWT. The protease cleavage site for the 52.4 kDa 
band is calculated to be located within the distal part of the D2 loop domain next to the transmembrane domain 
4 (Fig. 1a). Hence, these results suggest that perC214S and perP210L lead to a structural rearrangement of the distal 
part of the D2 loop domain.
A recent study suggested that peripherin-2 residues 165–182 are crucial for homomeric interactions24. 
However, it remained unclear whether the perC214S and perP210L residues or flanking regions might also contribute 
to this type of interactions. To test this possibility, we performed a peptide competition assay using a peptide 
corresponding to the residues 201–220 of native human peripherin-2. Provided that the positions P210 and C214 
participate in peripherin-2 homomerization, this peptide should compete with the binding and, hence, result in 
a reduction of homomeric protein-protein interactions. However, in subsequent co-IP experiments even in the 
presence of a very high peptide concentration (10 mM), we could not detect any decrease in peripherin-2 binding 
compared to the peptide-free approach (Fig. 1e). This suggests that this region is not directly involved in homo-
meric peripherin-2 protein-protein interactions.
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Quantification of perWT, perMT, and Rom-1 protein-protein interactions in HEK293T cells using 
FRET. Recently, we reported that three cube FRET is suitable for quantification of homomeric and heteromeric 
interactions of different photoreceptor specific proteins including peripherin-2. In particular, it has been demon-
strated that FRET can be used to calculate the relative binding affinities of these proteins in HEK293T cells17. 
Consequently, using this approach we examined the binding properties of the different homo- and heteromeric 
perWT, perMT, and Rom-1 protein complexes. Binding curves can be calculated if the relative expression of the 
FRET fluorophores (given as molar ratio, MR) varies between the single FRET measurements. By plotting the 
FRET efficiency (EA) values against the corresponding cerulean/citrine MR, we observed a sufficient variability 
Figure 1. Effects of peripherin-2 mutants on protein-protein interactions and D2 loop folding. (a) left, Topology 
of peripherin-2. The dashed rectangle highlights the distal part of the D2 loop. Right, Schematical enlargement 
of the distal D2 loop showing the hitherto identified disease-linked peripherin-2 mutations in this region 
(highlighted in green). The position of mutants analyzed in (b–d) are marked by red arrows (for perP210L and 
perC214S) or by black arrowheads in case of the remaining mutants. The calculated protease cleavage sites from 
d are indicated by a white (corresponding to the 42.5 kDa band) or black (corresponding to the 52.4 kDa band) 
pacman. The position of the peptide (aa 201–220) used for the competition assay shown in (e) (pept201–220) is 
highlighted by the gray line. (b–c) Co-Immunoprecipitations (co-IPs) from membrane preparations of HEK293T 
cells transiently transfected with the respective N-terminally citrine-tagged mutants and C-terminally myc-
tagged perWT (perWT-myc) (b) or Rom-1 (Rom-1-myc) (c) using the myc-specific antibody (anti-myc). The single 
mutants were detected using the GFP-antibody, which also specifically recognizes citrine. IB, immunoblotting. 
(d) Protease cleavage experiments on membrane preparations from HEK293T cells transiently transfected with 
the single citrine-tagged peripherin-2 mutants as indicated. The molecular weight of the single bands (arrows) 
was calculated from five independent western blot experiments. (e) Co-IPs from membrane preparations of 
HEK293T cells co-transfected with myc- and citrine-tagged perWT in presence (left lane, 10 mM) or absence of 
the peptide.
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of the FRET fluorophore expression for each combination. The maximal FRET efficiency (EAmax) was calculated 
from the binding curve for saturable binding as described previously17 and is proportional to the binding strength 
of the respective protein complex in the equilibrium. Analysis of EAmax for the different perWT and perMT com-
binations allowed us to draw several important conclusions. First, robust and unusually high EAmax values could 
be observed for the perWT only FRET pair (34.2%, Fig. 2a and Supplementary Table 1). These values are close to 
the highest theoretically possible 40% FRET efficiency for proteins tagged with bulky fluorophores like citrine 
or cerulean and highlight the strength of protein-protein interactions in homomeric peripherin-2 complexes. 
Second, EAmax was only slightly decreased for the perP210L only (30.7%) and perC214S only (26.47%) FRET pairs 
when compared to perWT only (Fig. 2b,c and Supplementary Table 1), suggesting that mutants are still largely 
capable of self-interacting. By contrast, both, perWT-perP210L (9.44%) and the perWT-perC214S (8.58%) combina-
tions, led to a robust decrease in EAmax (Fig. 2d,e and Supplementary Table 1). Next, we also determined the EAmax 
values for Rom-1 co-expressed with each, perWT and perMT. When compared to perWT only, EAmax for the Rom-
1-perWT interaction was noticeably lower (15.64%) indicating that heteromeric Rom-1-perWT complexes bind less 
tight than their homomeric perWT only counterparts (Fig. 2f and Supplementary Table 1). Second, both, Rom-
1-perP210L and Rom-1-perC214S combinations, led to reduced EAmax values when compared to the Rom-1-perWT 
interaction (6.58% and 6.32%, respectively, Fig. 2g,h and Supplementary Table 1). Finally, we also calculated 
the percentage of EAmax reduction for both peripherin-2 mutants relative to perWT only and to the perWT-Rom-1 
FRET pair. When compared to perWT only, the EAmax values were reduced to 28% for the perWT-perP210L and to 
25% for the perWT-perC214S FRET pair, respectively. By contrast, relative to the Rom-1-perWT FRET pair, the EAmax 
values were reduced to 42% for the Rom-1-perP210L and to 40% for the Rom-1-perC214S combination, respectively 
(Supplementary Table 1). This suggests that binding of both peripherin-2 mutants to perWT is more strongly 
affected than binding to Rom-1.
Figure 2. Quantification of homo- and heteromeric perWT, perMT, and Rom-1 protein-protein interactions 
using FRET. (a–h) FRET experiments from living HEK293T cells transiently co-transfected with the respective 
citrine- (citr) or cerulean (cer)-tagged peripherin-2 or Rom-1 constructs as indicated. To obtain the binding 
curves, FRET efficiency (EA) was plotted against the cerulean/citrine molar ratio (cer/citr MR). The dots 
represent mean values of 1–7 single FRET measurements ± SEM. EAmax, maximal FRET efficiency. The single 
EAmax, values and the numbers of independent measurements (n) for each combination are summarized in 
Supplementary Table 1.
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Taken together, our FRET results indicate that, although with reduced efficiencies, both mutants in principle 
retain their ability to self-interact and to form complexes with perWT or with Rom-1.
Subunit assembly of homo- and heteromeric perWT, perMT, and Rom-1 complexes. Sucrose 
density gradient centrifugation (SDGC) allows for a separation of different covalently or non-covalently linked 
protein complexes across a sucrose gradient according to their specific molecular weight. Using SDGC, previous 
studies analyzed the impact of peripherin-2 mutants including perC214S on homotypic perMT-perMT or heterotypic 
Rom-1-perMT interactions on subunit assembly16, 21, 22, 25. To examine the complexes which can be formed in 
heterozygous patients more systematically, we performed a set of sedimentation velocity experiments of differ-
entially tagged perWT, perMT, and Rom-1 combinations (perWT only, perP210L only, perC214S only, perWT-perP210L, 
perWT-perC214S, Rom-1-perWT, Rom-1-perP210L, and Rom-1-perC214S) transiently expressed in HEK293T cells. 
In line with previous work, we found the perWT complexes only in sucrose gradient fractions containing the 
non-covalent tetramers as well as in fractions containing the disulfide-linked octamers under non-reducing con-
ditions (Fig. 3a). By contrast, when expressed alone, perP210L was primarily detected as monomer, non-covalent 
dimer, and aggregates, but some complexes were also found as disulfide-linked tetramers and octamers (Fig. 3b). 
Similar to perP210L, perC214S was predominantly detected in monomer, non-covalent dimer, and aggregate fractions 
when expressed alone (Fig. 3c). In presence of perWT, perP210L was primarily detected in the fractions containing 
monomers and non-covalent dimers, and only weak signal was found in the non-covalent tetramer fractions 
(Fig. 3d). Moreover, in this combination the SDGC pattern for perWT slightly differed from the perWT only situa-
tion. The most striking difference was that a substantial perWT signal could now also be seen in the non-covalent 
dimer fractions (Fig. 3d). Given that no considerable amounts of perWT were detectable in this fraction for perWT 
only (cf. Fig. 3a), we concluded that the non-covalent dimer fraction most likely consists of perWT-perP210L dimers. 
When co-expressed with perC214S, perWT reasonably decreased the percentage of perC214S aggregates (Fig. 3e). 
Moreover, in presence of perWT the majority of perC214S was found in the non-covalent dimer fractions and as 
perC214S monomers. However, in contrast to the perWT-perP210L combination, a strong perC214S signal could also 
be detected in the non-covalent tetramer fractions. Finally, in the perWT-perC214S combination, we could also 
robustly detect perWT in the non-covalent dimer fractions (Fig. 3e). Taking into account that perWT alone does 
not homodimerize (cf. Fig. 3a) and that perC214S alone does not form non-covalent tetramers (cf. Fig. 3c), we con-
cluded that the non-covalent dimer and tetramer fractions in the perWT-perC214S combination most likely contain 
perWT-perC214S dimers and tetramers, respectively (Fig. 3e).
Next, we analyzed the SDGC fractions from HEK293T cells co-expressing Rom-1-perWT, Rom-1-perP210L, and 
Rom-1-perC214S complexes. As expected, in the Rom-1-perWT combination a robust Rom-1 signal was found in 
non-covalent tetramer fractions (Fig. 3f). In addition, Rom-1 was also detected in non-covalent dimer and mon-
omer fractions. No considerable amounts of perWT were found in these fractions suggesting that no Rom-1-perWT 
heterodimers are present under these conditions (Fig. 3f). When analyzing Rom-1-perP210L and Rom-1-perC214S 
combinations, the perP210L and perC214S mutants were almost exclusively found in the non-covalent dimer and mon-
omer fractions (Fig. 3g,h). In contrast to the Rom-1 signal from the Rom-1-perWT combination, in presence of the 
perP210L and perC214S mutants Rom-1 was almost exclusively detected in dimer and monomer fractions (Fig. 3g,h). 
Based on this, we concluded that Rom-1 predominantly forms non-covalent dimers with both mutants.
Taken together, our SDGC results suggest that perWT-perMT and Rom-1-perMT protein complexes are mainly 
built of non-covalent dimers.
Rod OS targeting of homo- and heteromeric perWT, perMT, and Rom-1 complexes. Our FRET and 
SDGC experiments from HEK293T cells strongly suggest that both peripherin-2 mutants are in principle capable of 
forming complexes with perWT and Rom-1. This prompted us to analyze the protein targeting of these complexes in 
rod photoreceptors. For this purpose, we used rAAV vector gene delivery to express various combinations of perWT, 
Rom-1, and perMT and analyze their transport/localization in mouse photoreceptors. It has been shown previously 
that subretinal co-administration of two rAAVs encoding different transgenes results in very high co-transduction 
efficiencies in rods17. For delivery to rod photoreceptors, rAAV vectors with a rod specific human rhodopsin pro-
moter were used. To allow for discrimination between perWT or Rom-1 and perMT expression, we fused cerulean to 
the N-terminus of perWT and Rom-1, and citrine to the N-terminus of perMT, respectively. The rAAVs containing the 
different peripherin-2 and Rom-1 constructs were subretinally injected to P14 wild type mice. Subsequent analysis 
of peripherin-2 localization was examined four weeks post injection by detecting citrine and cerulean fluorescence 
on retinal slices from injected animals. When expressed alone, citrine and cerulean were retained in the rod IS 
(Suppl. Fig. 1). In accordance with our previous observations20, both mutants were also completely mislocalized 
to the IS (Fig. 4a,b). The localization pattern of perP210L and perC214S was remarkably different. perP210L showed a 
spotted large vesicular-like expression, whereas perC214S was distributed throughout the rod IS. Interestingly, how-
ever, simultaneous co-delivery of titer-matched perWT and perMT led to a noticeable rescue and substantial rod OS 
targeting of perP210L and perC214S (Fig. 4c,d). In addition, the rAAV-mediated co-delivery of perWT also rescued the 
vesicle-like expression pattern of perP210L in the rod IS (Fig. 4c). Finally, we also assessed whether co-administration 
of titer-matched rAAVs expressing transgenic Rom-1 together with perP210L or perC214S leads to a similar rescue 
effect. When co-expressed with perWT, both, Rom-1 and perWT were exclusively found in rod OS (Fig. 5a). However, 
transgenic Rom-1 did not noticeably promote perMT protein targeting to the OS. By contrast, a substantial amount 
of transgenic Rom-1, most likely the Rom-1-perMT heterodimers, was retained in the rod IS (Fig. 5b,c).
Taken together, these experiments demonstrate that simultaneous co-delivery of transgenic perWT rescues the 
targeting of the perP210L and perC214S mutants to rod OS. However, simultaneous co-delivery of transgenic Rom-1 
and perP210L or perC214S resulted in substantial retention of Rom-1 in the rod IS. In combination with the results 
obtained from SDGC experiments, these findings strongly indicate that perWT-perMT, but not Rom-1-perMT het-
erodimers, can be efficiently targeted to rod OS.
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Figure 3. SDGC of different perWT, perMT, and Rom-1 combinations. Shown are representative immunoblots 
(left panel) and the corresponding statistics (right panel) for each C-terminally myc- or flag-tagged combination 
as indicated. Each blot consists of 11 fractions collected across the 5–20% sucrose gradient. All fractions were 
normalized to the DNA standard mixed to the protein solution prior to SDGC as described in the methods 
section. The single peripherin-2 or Rom-1 complexes can be found in following fractions: octamers: fraction 
3–6; tetramers: fraction 6–8; dimers: fraction 9–10; monomers: fraction 10–11. Immunoblottings were 
performed with antibodies recognizing either the myc-tag (first row of the left panel) or the flag-tag (second 
row of the left panel), respectively. For quantification, the percentage of total immunoreactivity related to the 
number of single fractions for non-covalent or covalent complexes and aggregates was plotted against the 11 
collected fractions. The fractions containing the non-covalent dimers are highlighted by a dashed rectangle. The 
single values (percentages and numbers of independent experiments) for all combinations are summarized in 
Supplementary Table 2. Fractions containing the DNA standards (975 kDa, 325 kDa, 130 kDa and 49 kDa) are 
marked accordingly.
www.nature.com/scientificreports/
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Analysis of the perWT-perMT binding properties in rod OS using FRET. FRET and co-IP experiments 
in HEK293T cells revealed a reduced apparent binding of both peripherin-2 mutants to perWT. This finding could 
be best explained by decreased binding affinities of the perWT-perMT interaction and/or decreased initial binding 
kinetics of the mutants to perWT. However, in HEK293T cells co-transfected with perWT and perMT each mutant 
can also exist as monomers or could undergo self-interactions (i.e. as dimers or aggregates, cf. Fig. 3b–e). As all 
these combinations would contribute to the overall FRET signal, the apparent reduction of EAmax in HEK293T 
cells does not allow for discrimination between the mechanisms described above. To examine this issue directly, 
we took advantage of the fact that perMT targeting to rod OS is rescued only upon co-delivery of transgenic 
perWT. Consequently, in contrast to HEK293T cells, in rescued rod OS all perMT protein must be arranged in 
complexes with perWT. This happenstance allowed us to draw direct conclusions about the perWT-perMT binding 
properties under close-to-native conditions by measuring FRET in isolated “rescued” rod OS. For this purpose, 
we co-injected wild type mice on P14 with the respective perWT and perMT FRET pairs. At four weeks post injec-
tion we isolated the rod OS and measured FRET on single OS co-expressing both, cerulean-tagged perWT and 
citrine-tagged perMT (Fig. 6a–c). Robust FRET signals could be measured for all combinations. Importantly, the 
cerulean/citrine molar ratios substantially varied between the single rod OS, which also allowed us to calculate 
the binding curves. Remarkably, in contrast to the FRET results from HEK293T cells, the EAmax from isolated rod 
Figure 4. Rod OS targeting of perWT-perMT complexes. (a–d) Confocal images of immunostained retinas 
injected with citrine-tagged mutants (citr-perP210L (a) and citr-perC214S (b)), or co-injected with the respective 
mutants and the N-terminally cerulean-tagged perWT (cer-perWT, (c–d)). CNGB1a antibody (B1a, red) was used 
for specific staining of rod OS. Scale bar, 30 µm.
www.nature.com/scientificreports/
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OS was either increased in case of the perWT-perP210L pair or very close to that of the perWT only interaction for the 
perWT-perC214S combination (Fig. 6d–f and Supplementary Table 1). These findings indicate that the robust reduc-
tion in the perWT-perMT interaction observed from co-IP and FRET experiments in HEK293T cells does not result 
from reduced binding affinity, but is most likely caused by a decrease in initial binding kinetics of perMT to perWT.
Discussion
By analyzing the molecular mechanisms of two adRP-linked peripherin-2 mutants, we provide evidence for a 
novel role of peripherin-2 and its homolog Rom-1 in the pathophysiology of rod photoreceptors. We show for 
the first time that rod OS targeting of peripherin-2 mutants can be rescued in vivo by simultaneous co-delivery 
of perWT using rAAV-mediated gene transfer. This finding is important for understanding the peripherin-2 
Figure 5. Rod OS targeting of Rom-1-perWT/MT complexes. Confocal images of immunostained retinas co-
injected with C-terminally cerulean-tagged Rom-1 (Rom-1-cer) and citr-perWT (a), citr-perP210L (b), and citr-
perC214S (c). Scale bar, 30 µm.
Figure 6. FRET experiments in rod OS of retinas co-injected with perWT and perMT AAV-vectors. (a–c) 
Representative confocal images of FRET channels showing a single OS co-expressing cer-perWT and citr-
perWT(a), cer-perWT and citr-perP210L (b), or cer-perWT and citr-perC214S (c). Scale bar, 2 µm. (d–f) Binding 
curves of the corresponding FRET measurements for the single combinations displayed in (a–c). The dots 
represent mean values of 1–7 single FRET measurements ± SEM. The single EAmax, values and the numbers of 
independent measurements (n) for each combination are summarized in Supplementary Table 1.
www.nature.com/scientificreports/
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biology in photoreceptors and has implications for the development of future gene therapies for patients with 
PRPH2 mutations. Peripherin-2 is crucial for proper rod OS structure and development. This function was pro-
posed to be dose-dependent in rods suggesting that reduced dosage of peripherin-2 (less than 60–80% of the 
wild type level) induces retinal degeneration26, 27. In line with the postulated dose-dependency, transgenic mice 
expressing the perC214S mutant show reduced amounts of mutant protein in rod OS (due to mislocalization or 
protein degradation) which results in haploinsufficiency22. Interestingly, genetic supplementation of perWT on the 
perC214S mutant background led to a noticeable rescue of the retinal function28. Although helpful in initial stages 
of therapy development, the application spectrum of genetic supplementation is restricted to model organisms. 
By contrast, rAAV-mediated gene delivery has proven to be a very promising technique for therapeutic interven-
tion on retinal diseases like retinitis pigmentosa in mammals29–32. Our data suggest that rAAV-mediated gene 
supplementation of perWT could support a rescue of perMT targeting defects to rod OS in adRP patients carrying 
mislocalizing peripherin-2 mutations. We could not detect any detrimental effects on outer nuclear layer (ONL) 
thickness in fully developed retinas of WT animals co-injected with perWT and perMT transgenes six months post 
injection (Suppl. Fig. 2). However, we cannot exclude the possibility that rescue of perMT rod OS targeting by 
perWT gene supplementation would initiate retinal degeneration in patients heterozygous for these mutations. 
Consequently, prior to gene therapy, the long-term effects of the mutant rescue on retinal degeneration should be 
tested in appropriate animal models.
In mice co-injected with rAAVs expressing labeled peripherin-2 and Rom-1 transgenes, it is not possible to 
estimate the contribution of the endogenous murine peripherin-2 and Rom-1 on the perMT rescue. However, 
our observation that both mutants are mislocalized to the rod IS and lead to reduced protein expression suggests 
that the endogenous protein levels were not sufficient to rescue perMT localization. Of note, in heterozygous 
transgenic knock-in mice expressing perC214S, the mutant protein remains in the inner segments and is highly 
prone to degradation22. These results are very similar to our observations from wild type mice injected with the 
transgenic perC214S mutant. With respect to this finding, it can be concluded that the rAAV-mediated delivery 
of transgenic perC214S mutant to wild type mice largely reflects the native situation in mice heterozygous for this 
mutant. The fact that perC214S is not targeted to rod OS suggests that perWT-perC214S complexes most likely are not 
formed under these conditions. However, as discussed above, additional rAAV-mediated delivery of perWT pre-
sumably exceeds the critical levels necessary for perWT-perMT complex formation, highlighting the critical role of 
peripherin-2 dosage in pathophysiology of photoreceptors.
Our study also provides novel insights into the structural impacts of perP210L and perC214S on folding of the D2 
loop domain. We show that perP210L and perC214S lead to a structural rearrangement of the distal part of the D2 
loop domain around the aa position 260. It is conceivable that perP210L and perC214S may also lead to structural 
changes in other parts of the D2 loop, which could not be covered by our assay. However, our data suggest that 
folding changes induced by perP210L and perC214S most likely do not elicit structural rearrangements of the proxi-
mal half of the D2 loop close to the highly conserved tetraspanin CCG motif.
P210 and C214 are located within the PxxCC motif, which is conserved among most tetraspanins33. While 
both cysteine residues of the motif were shown to be involved in intramolecular peripherin-2 disulfide bond 
formation21, 34, the role of the proline residue remained unknown. Peripherin-2 belongs to the subfamily of 
non-conventional tetraspanins34, thus, it remains to be clarified if the PxxCC motif has a similar role on protein 
folding in other tetraspanins. Interestingly, other mutants in close proximity to the P210 and C214 position (i.e. 
perV209I or perS212T) did not change the accessibility of the proteases in our assay. This emphasizes the crucial 
role of the proline at position 210 and cysteine at position 214 for the proper folding of the D2 loop domain. 
Furthermore, our results suggest that the apparent reduction of perMT binding to perWT in co-IP and in FRET 
experiments from HEK293T cells is most likely caused by protein misfolding. Our FRET experiments on isolated 
rod OS indicate that this apparent decrease in binding to perWT does not result from reduced binding affinities, 
but rather seems to be a consequence of reduced initial binding kinetics of perP210L and perC214S to perWT. In other 
words, this suggests that the first step of perMT binding to perWT is impeded, however, once bound, the affinity of 
both mutants to perWT remains largely unchanged. These results are well matched on our peptide competition 
assay indicating that the PxxCC motif does not represent the interface for homomeric peripherin-2 interactions. 
EAmax values resulting from the transgenic perWT were higher in HEK293T cells compared to the rod OS. This dif-
ference could be caused by non-labeled endogenous peripherin-2 or Rom-1 in the retina, which are also expected 
to bind to transgenic perWT (incomplete labeling). However, the perWT EAmax values from isolated rod OS are still 
in a very high range highlighting the suitability of the FRET approach to addressing peripherin-2 oligomerization 
in these compartments.
When correlating our results from SDGC to those obtained from rod OS targeting experiments (Fig. 7 
and Suppl. Fig. 3), two very important conclusions could be drawn: 1) Non-covalent perWT-perMT dimers can 
be formed and targeted to rod OS. 2) Non-covalent Rom-1-perMT heterodimers are stacked in the inner seg-
ments. The first deduction is very surprising as non-covalent tetramerization was considered to be crucial for 
peripherin-2 targeting to rods16. This conclusion was drawn from different sets of experiments in previous studies: 
i) When analyzing perWT complexes isolated from OS, no dimers could be detected35. ii) Tetramerization-deficient 
peripherin-2 mutants could not be targeted to rod OS16. iii) Peripherin-2 mutants which preferentially form 
homodimers are not targeted to rod OS16. However, none of these experiments is sufficient to state if perWT-perWT 
or perWT-perMT dimers can also be targeted to rod OS. First, perWT does not form dimers in SDGC experiments 
when expressed alone, which explains its absence in rod OS under physiological conditions. Second, only rod 
OS targeting of pure perMT complexes was examined so far16. Consequently, to the best of our knowledge, this 
is the first study addressing the principle capability of perWT-perMT dimers to be targeted to rod OS. The finding 
that Rom-1-perMT heterodimers cannot be targeted to rod OS suggests that Rom-1 cannot fully compensate for 
the peripherin-2 function in rods under these conditions. Currently, one can only speculate about the physio-
logical role of these opposing effects of peripherin-2 and Rom-1 in terms of binding and targeting of misfolded 
www.nature.com/scientificreports/
1 0Scientific RepoRts | 7: 2321  | DOI:10.1038/s41598-017-02514-5
peripherin-2 mutants. A recent study revealed that Rom-1 promotes the trafficking of the Y141C peripherin-2 
mutant in vitro and converts the cone-dominant pattern dystrophy to RP phenotype in vivo12. Similar effects are 
not expected to occur for the C214S or P210L mutation, as Rom-1 cannot promote targeting of these mutants to 
rod OS. Together, these findings indicate that Rom-1 might play a yet undefined role in pathophysiology of retinal 
diseases as a mutation-dependent disease modifier.
Rom-1 and peripherin-2 are also expressed in cones and many mutations in peripherin-2 (but not in Rom-1) 
are linked to retinal diseases primarily affecting cone photoreceptors13. Despite some advances, the molecular 
mechanisms underpinning this differential penetrance of peripherin-2 mutants in rods and cones are still not 
fully understood. In light of our results, it is tempting to speculate that Rom-1 might be one of the key players 
shaping the penetrance of peripherin-2 mutants in rods and cones. Finally, in the context of gene therapy, the 
postulated novel function of Rom-1 raises the possibility that the efficiency of gene supplementation therapy of 
adRP-associated peripherin-2 point mutations could be improved by co-delivering peripherin-2 with Rom-1.
Methods
Animals. The studies were carried out in accordance with the approved guidelines of the local commit-
tee of laboratory animal care (District Government of Upper Bavaria) and German Laws on animal welfare 
(Tierschutzgesetz). Anesthesia was performed by intraperitoneal injection of ketamine (40 mg/kg body weight) 
and xylazine (20 mg/kg body weight). Euthanasia was performed by cervical dislocation.
Molecular biology. For expression in rods, the single human peripherin-220 and Rom-1 transgenes were 
subcloned to the pAAV2/8 YF vector30 containing the human Rhodopsin (hRHO) promoter using standard clon-
ing techniques. For expression in HEK293T cells (LentiX 293 T Cell Line, Clontech Laboratories, Mountain View, 
CA, USA), the peripherin-2 and Rom-1 transgenes were subcloned to the standard pcDNA3.1 vector (Invitrogen, 
Waltham, MA, USA). Peripherin-2 mutants were introduced by site directed mutagenesis (QuikChange 
Lightning Site-Directed Mutagenesis Kit, Agilent Technologies, Santa Clara, CA, USA). All transgenes were 
sequenced prior to use.
Protein biochemistry. For co-immunoprecipitations (co-IPs) transiently transfected HEK293T cells were 
harvested 48 hours post transfection and membrane preparations were conducted as described36. Co-IPs were 
performed with the anti-myc antibody (9B11, Cell Signaling Technology, Danvers, MA, USA) using Protein G 
magnetic beads (Novex, Thermo Fisher Scientific, Waltham, MA, USA) according to the manufacturer’s protocol.
For western blotting, injected retinas of light adapted wild type C57BL6/J animals were used four weeks post 
injection. The dissected retinas were homogenized in membrane preparation buffer using the Potter S homoge-
nizer (B. Braun Diessel Biotech, Melsungen, Germany).
For peptide competition assay, the peripherin-2 peptide (peptide sequence CDGRYLVDGVPFSCCNPSSPR) 
was obtained from jpt Innovative Peptide Solutions (Berlin, Germany). The peptide was added to the respec-
tive membrane preparation and the solution was incubated with the myc-antibody-coupled magnetic beads for 
30 min at room temperature. The co-IPs containing the peptide-free membrane preparations were processed 
under identical conditions. For the native protease cleavage assay, membrane preparations36 of transfected 
HEK293T cells were incubated for 5 h at room temperature (RT) and processed for western blotting. No protease 
inhibitors were added to the membrane preparations prior to the incubation. For immunoblotting, antibodies 
were used in following dilutions: mouse anti-myc (see above), 1:2000; mouse anti-GFP (Clontec, Takara Bio Inc., 
Shiga, Japan), 1:2000; mouse anti-ATPase (anti alpha3, ab2826, Abcam, Cambridge, UK), 1:2000.
Sucrose density gradient centrifugation. For sucrose density gradient centrifugation, HEK293T 
cells were transiently transfected with the respective peripherin-2 constructs. Cells were harvested 48 h post 
transfection and homogenized in a lysis buffer comprising 0.5% Triton X-100, 150 mM NaCl and 2 mM CaCl2 
using the Potter S homogenizer (see above). Continuous density gradients of 5–20% (wt/vol) sucrose were pre-
pared by underlayering 0.5 ml of 5%, 10%, 15% and 20% sucrose containing 0.1% Triton X-100 and 10 mM 
N-ethylmaleimide (Sigma-Aldrich, St. Louis, MO, USA). The gradient was left at RT for 1 h to facilitate diffusion 
Figure 7. Rod OS targeting of perMT dimeric complexes. The rod photoreceptor localization of different perMT-
containing dimers (perWT-perMT, Rom-1-perMT and perMT only) is symbolized by a dashed rectangle. The 
position of the D2 loop is highlighted in red and the D2 loop misfolding caused by perMT is symbolized by an 
incision.
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and chilled on ice for 30 min prior to sample application. To determine the weight of single peripherin-2 and 
Rom-1 protein complexes in each immunoblot, DNA standards of defined molecular weights (75 bp–20.000 bp, 
i.e. 49 kDa–13,000 kDa, GeneRuler 1 kb Plus (Thermo Fisher Scientific, Waltham, MA, USA)) were mixed to 
lysates containing 200 µg of the respective proteins. The mixture was carefully layered on top of the gradient and 
centrifuged at 46,700 rpm for 2 h at 4 °C in a Beckman Coulter Optima L-80K Ultracentrifuge (Beckman Coulter 
Biomedical GmbH, Munich, Germany). Afterwards, the centrifuge tube was punctured and fractions were col-
lected dropwise (5 drops/tube). Fractions from each sucrose gradient were separately used for immunoblotting 
with myc- or flag-specific antibodies and for agarose gel electrophoresis to detect the DNA standards. The suit-
ability of DNA standards was first validated for perWT only. As shown in Fig. 3a, perWT gives rise to well-defined 
fractions of non-covalent tetramers, covalent octamers, and high-order oligomers. The molecular weight of the 
DNA in the same fractions very nicely correlated with the molecular weights of the corresponding perWT com-
plexes. Therefore, for each of the remaining immunoblots, DNA standards were used to determine the fractions 
containing the different perWT, perMT, or Rom-1 complexes.
Photometric FRET Measurements. 3 cube FRET was performed as described in detail in Butz et al.37 
with modifications published in Becirovic et al. and Nguyen et al.18, 19. Briefly, transfected HEK293T cells and 
isolated rod OS were measured in a FRET imaging solution comprising 2 mM CaCl2, 10 mM glucose, 10 mM 
HEPES sodium salt, 5 mM KCl, 1 mM MgCl2, 140 mM NaCl, pH 7.4, at RT. 3 cube FRET measurements were 
conducted using a Leica DMI6000B inverted fluorescent microscope (Leica, Wetzlar, Germany) in combination 
with a photomultiplier detection system including a photomultiplier tube (Horiba, London, Ontario, Canada). 
As excitation source, a DeltaRamX monochromator was used and FRET data were acquired with FelixGX soft-
ware (Horiba, London, Ontario, Canada). FRET filter cubes were as follows (excitation, dichroic mirror, emis-
sion): cerulean/CFP (ET436/20 × ; T455lp; ET480/40m), FRET (ET436/20 × ; T455lp; ET535/30m) and citrine/
YFP (ET500/20 × ; T515lp; ET535/30m) (Chroma technology, Vermont, USA). The fluorescence intensities were 
measured in single cells co-expressing varying, but sufficient levels of cerulean- and citrine-tagged proteins with 
the respective filter cube. Subsequent FRET ratios (FR) were calculated from the signal intensities according to 
the 3 cube FRET equation described in Shaltiel et al.38. Apparent FRET efficiencies (EA) at given cerulean/citrine 
molar ratios (MR) were obtained from equation (1):
= − ⋅
ε
ε
E [FR 1] (436)
(436) (1)A
citrine
cerulean
εcitrine and εcerulean represent the setup specific average molar extinction coefficients for the fluorophores citrine 
or cerulean, respectively. FRET data were analyzed using FelixGX software (see above) and Excel (Microsoft 
Corporation, Redmond, Washington, USA).
Binding curves were calculated using equation (2):
=
⋅
+
E E MR
K MR (2)A
Amax
EAmax is the maximal FRET efficiency that can be calculated for saturated donor concentrations and K is an 
analogon of the dissociation constant. Ex vivo FRET experiments were conducted on single rod OS isolated from 
six pooled retinas for each FRET pair.
rAAV preparation and subretinal injections. The production of single-strand AAVs (rAAV 2/8 YF) 
containing the hRHO promoter and the subretinal injection technique were described previously30. 1010 rAAV 
particles were delivered subretinally to wild type C57Bl6/J mice by a single injection on postnatal day 14. Four 
weeks post injection, all injected retinas were analyzed for fluorescence using scanning laser ophthalmoscopy 
(Spectralis, Heidelberg Engineering, Dossenheim, Germany).
Preparation of outer segments. A detailed procedure of rod OS preparation was described recently17, 19. 
Briefly, mice were sacrificed four weeks post injection and the isolated retinas were collected in a 1.5-ml reaction 
tube containing 100 µl of PBS. The OS were separated from the retina by vortexing for 15–30 s and centrifug-
ing for 30 s at 500 × g. Afterwards the OS containing supernatant was collected and used for subsequent FRET 
measurements.
Immunohistology and Confocal Microscopy. For immunohistology, wild type C57BL6/J mice were 
injected on P14 with the respective rAAV particles. Four weeks post injection, the retinas were dissected and 
processed for immunohistology as described39. Retinal and OS images were obtained by the TCS SP8 confocal 
scan microscope (Leica, Wetzlar, Germany), acquired with the LASX software (Leica, Wetzlar, Germany), and 
processed with the ImageJ software (National Institutes of Health, Bethesda, MD, USA). We used the rabbit 
anti-CNGB1a antibody (1:10.00040) as marker for rod outer segments. Citrine was excited with the 514 nm laser 
and detected with the Hybrid (HyD) detector using a 520–540 nm emission filter. Cerulean was excited using the 
448 nm laser and detected via the HyD detector with a 460–480 nm emission filter. Images were taken using the 
40x and 63x objectives.
Confocal scanning laser ophthalmoscopy and optical coherence tomography. Confocal scan-
ning laser ophthalmoscopy (cSLO) and optical coherence tomography (OCT) were performed 6 months post 
injection using a modified Spectralis HRA + OCT system (Heidelberg Engineering, Dossenheim, Germany) as 
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described recently41. Fluorescence signals were examined at 488 nm excitation for citrine/cerulean detection (BP 
550/49 nm emission filter).
Statistics. All values are given as mean ± SEM, and n is the number of trials. For multiple comparisons 
one-way ANOVA followed by the Tukey’s test was used.
Data availability. All data generated or analyzed during this study are included in this published article (and 
its Supplementary Information files).
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Supplementary Figure 1: Expression profile of citrine and cerulean in transduced 
photoreceptors. Scale bar, 30 µm.  
 
Supplementary Figure 2: Long-term effects of perWT and perMT expression on retinal 
degeneration in transduced murine photoreceptors. A, Representative confocal 
scanning laser ophthalmoscopy (cSLO) of mice injected with the single constructs as 
indicated. Note that, in contrast to the confocal microscope settings, citrine and cerulean 
fluorescence (white signal) cannot be distinguished using cSLO. B, measurements of the 
outer nuclear layer (ONL) thickness of injected animals using optical coherence 
tomography. The single values are as follows: citr-perWT (n=4) 100.3 ± 2.7 µm; citr-perP210L 
(n=6) 100.0 ± 2.5 µm; citr-perC214S (n=4) 100.0 ± 1.9 µm; citr-perWT + citr-perP210L (n=4) 
100.3 ± 2.0 µm; citr-perWT + citr-perC214S (n=4) 98.5 ± 3.3 µm. Statistical analysis was done 
with one-way ANOVA followed by the Tukey’s test for multiple comparisons. n.s., not 
significant. 
 
Supplementary Figure 3: Tentative model of perMT protein assembly and rod OS 
targeting in presence or absence of transgenic perWT and Rom-1. For reasons of 
clarity, octamers, higher-order oligomers, and aggregates are not included in this model. 
The rectangle highlights the major SDGC fraction(s) for the single homo- or heterogenic 
interactions and the arrow length correlates with the preferential direction within the 
equilibrium. The misfolding of the distal part of the D2 loop caused by both mutants is 
symbolized by an incision. The localization of the respective constructs in rod 
photoreceptors (right panel) is indicated by colored bars symbolizing color-coded perWT, 
perMT, or Rom-1 constructs. The bar thickness represents the estimated relative amount 
of the detected constructs in the respective compartment. 
Supplementary Table 1: FRET measurements from HEK293T cells and from isolated rod OS.
WT-WT WT-P210L WT-C214S P210L-P210L C214S-C214S WT-ROM1 ROM-1-P210L ROM-1-C214S WT-WT WT-P210L WT-C214S
EAmax 34.2 9.44 8.58 30.7 26.47 15.64 6.58 6.32 25.96 37.12 26.47
% of WT-WT or WT-ROM-1 28 25 90 77 42 40 143 102
n 53 53 50 53 54 48 48 48 45 32 44
rod OSHEK293T 
Supplementary Table 2: Quantification of the SDGC experiments. Values are given as mean values ± SEM.
1 2 3 4 5 6 7 8 9 10 11
Non-covalent 0.00 0.00 0.00 2.78 ± 2.78 9.33 ± 0.71 11.53 ± 1.38 11.70 ± 2.15 10.98 ± 2.06 2.65 ±  2.65 2.76 ± 2.76 1.68 ± 1.68
Disulfide bond 0.00 2.05 ± 2.05 4.73 ± 2.39 7.97 ± 1.60 11.78 ± 1.26 12.46 ± 1.50 7.61 ± 0.57 0.00 0.00 0.00 0.00
Non-covalent 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.10 ± 2.10 20.35 ± 4.66 19.00 ± 6.53
Disulfide bond 0.00 0.00 0.00 0.00 2.86 ± 2.86 5.44 ± 3.16 4.81 ± 2.79 5.78 ± 2.13 2.67 ± 2.67 1.78 ± 1.78 0.00
Aggregate 0.00 0.00 2.08 ± 2.08 8.28 ± 3.17 10.83 ± 1.53 8.80 ± 3.07 3.18 ± 2.67 2.02 ± 1.78 0.00 0.00 0.00
Non-covalent 0.00 0.00 0.00 0.00 2.61 ± 2.61 4.36 ± 4.36 3.42 ± 3.42 3.34 ± 3.34 18.23 ± 13.07 27.29 ± 14.59 5.20 ± 5.20
Aggregate 7.28 ± 3.77 7.65 ± 4.20 5.27 ± 5.27 4.03 ± 4.03 6.78 ± 6.78 4.53 ± 4.53 0.00 0.00 0.00 0.00 0.00
Non-covalent 0.00 1.74 ± 1.74 2.84 ± 2.84 3.13 ± 3.13 5.13 ± 3.15 4.33 ± 2.80 2.07 ± 2.07 4.45 ± 2.73 23.39 ± 4.14 27.42 ± 5.71 12.38 ± 5.53
Disulfide bond 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Aggregate 0.00 1.36 ± 1.36 0.00 2.01 ± 1.27 3.57 ± 2.37 3.94 ± 2.49 2.23 ± 2.23 0.00 0.00 0.00 0.00
Non-covalent 0.00 0.00 0.00 0.00 2.37 ± 2.37 1.85 ± 1.85 9.13 ± 1.95 11.07 ± 4.26 10.79 ± 5.76 11.68 ± 3.67 0.00
Disulfide bond 3.68 ± 3.68 4.67 ± 4.67 6.60 ± 3.45 7.86 ± 4.13 12.61 ± 0.59 11.95 ± 2.62 3.35 ± 3.35 2.40 ± 2.40 0.00 0.00 0.00
Non-covalent 0.00 0.00 0.00 0.00 4.45 ± 2.64 5.22 ± 3.09 5.91 ± 3.74 16.61 ± 3.49 12.33 ± 4.41 20.32 ± 4.78 19.65 ± 10.11
Aggregate 0.00 0.00 5.87 ± 3.60 7.81 ± 2.74 1.82 ± 1.82 0.00 0.00 0.00 0.00 0.00 0.00
Non-covalent 0.00 0.00 0.00 0.00 1.45 ± 1.45 1.67 ± 1.12 5.95 ± 1.39 3.40 ± 1.90 6.41 ± 0.57 7.52 ± 0.92 4.11 ± 4.11
Disulfide bond 5.51 ± 2.76 8.75 ± 1.12 10.40 ± 0.57 11.06 ± 0.38 11.38 ± 0.63 9.58 ± 0.63 7.24 ± 0.64 3.46 ± 1.90 2.11 ± 2.11 0.00 0.00
Non-covalent 0.00 0.00 0.00 0.00 8.22 ± 0.86 10.20 ± 1.46 6.34 ± 3.17 4.70 ± 4.70 2.77 ± 2.77 0.00 0.00
Disulfide bond 8.48 ± 4.42 10.61 ± 1.81 10.18 ± 1.60 9.69 ± 1.87 10.50 ± 2.20 10.41 ± 1.38 7.92 ± 0.20 0.00 0.00 0.00 0.00
Non-covalent 0.00 0.00 0.00 1.45 ± 1.45 5.40 ± 2.89 14.96 ± 2.60 17.61 ± 1.74 18.26 ± 9.93 19.35 ± 3.61 8.99 ± 5.91 3.61 ± 3.61
Disulfide bond 0.00 0.00 0.00 0.00 3.49 ± 1.85 4.55 ± 2.65 2.33 ± 2.33 0.00 0.00 0.00 0.00
Non-covalent 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.56 ± 4.56 22.76 ± 2.11 31.48 ± 6.45 28.67 ± 9.40
Disulfide bond 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Aggregate 0.00 5.60 ± 5.60 0.00 0.00 5.01 ± 5.01 1.93 ± 1.93 0.00 0.00 0.00 0.00 0.00
Non-covalent 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 19.68 ± 9.84 43.50 ± 2.28 36.82 ± 12.12
Disulfide bond 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Non-covalent 0.00 0.00 0.00 0.00 0.00 4.59 ± 4.59 4.91 ± 4.91 0.00 29.00 ± 2.51 31.53 ± 3.67 24.34 ± 3.41
Aggregate 0.00 0.00 0.00 0.00 5.64 ± 5.64 0.00 0.00 0.00 0.00 0.00 0.00
Non-covalent 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.43 ± 2.43 28.57 ± 6.38 26.46 ± 2.94 21.20 ± 2.41
Disulfide bond 0.00 0.00 0.00 0.00 0.00 0.00 1.75 ± 1.75 6.79 ± 4.15 10.18 ± 0.14 2.60 ± 2.60 0.00
Immunoreactivity (% of Total)
n = 4
n = 3
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C214S + Rom-1        
IB: anti-myc
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